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Tissue engineering has been highlighted as a potential regenerative medicine therapy for the 
regeneration of musculoskeletal tissues, many of which have poor healing capacity. Currently 
there is no ‘gold standard’ approach to tissue engineering with many researchers 
investigating the effects of different stimuli on different cells in different culture 
environments. One of these stimuli is mechanical stimulation, a variety of which naturally 
occur in the body. Mechanical stimulation is often used in tissue engineering to recapitulate 
the structure, extracellular matrix composition (ECM) and biomechanics of tissues such as 
tendon, bone and cartilage. The extracellular matrix of these tissues is primarily composed 
of one fibril forming collagen, for tendon and bone this is collagen type I whilst for cartilage 
it is collagen II. However an array of additional collagen isoforms play important roles in ECM 
architecture and maturation. 
The aim of this thesis was to investigate if collagen synthesis can be used to assess human 
mesenchymal stem cells (hMSCs) differentiation in response to different mechanical 
stimulation. Typically tissue engineering studies use the most populous ECM components to 
highlight the success of the engineered tissues, whilst this makes sense it neglects the minor 
ECM components. For musculoskeletal tissues fibril forming collagens are routinely the 
dominant component of the ECM, however without the minor collagens these structure 
would not function appropriately. The composition of collagens varies across all 
musculoskeletal tissues, therefore by investigating the complete collagen composition the 
differentiation of the cells can be identified and the quality of the tissue being engineered 
can be established. Tensile stimulation, hydrostatic pressure and microgravity were applied 
to hMSCs seeded within fibrin hydrogels, chosen as it acts as a blank slate material for 
collagen investigation. These mechanical stimuli were selected as they have all routinely 
been used to show enhanced or inhibited MSC differentiation, offering a well-established set 
of mechanical stimulations to investigate their role in the differentiation of hMSCs and how 
the subsequent collagen production can be used to identify it. Molecular (qPCR and western 
blot), imaging (histology, TEM and fluorescence) and structural (mechanical testing and μCT) 
analytical techniques have been used to assess what collagens have been produced and how 
this relates to the structural development of the engineered tissue. 
The cell embedded hydrogels had varying responses to the different percentages of cyclic 




hMSCs would respond to the static culture (0%), low physiological dynamic strain (1-4%), 
high physiological dynamic strain (5-6%) and degenerative dynamic strain (>6%). The 0% and 
10% strain groups indicated some osteogenic differentiation through Alizarin red staining 
and ALP analysis from the culture media. Suggesting that physiologically relevant dynamic 
strain inhibited osteogenic differentiation. 3% cyclic strain saw a two-fold increase in 
maximum stress and a slight decrease in fibril diameter compared to the control. The 5% 
strain group saw increases in tendon collagens COL3A1 and COL11A1 as well as tenogenic 
markers SCXA and TNMD though expression of the negative tendon marker COL2A1 was also 
increased. At the protein level collagen II was downregulated whilst collagen III was 
upregulated compared to the control. The fibril diameter and fibre alignment was found to 
be highest in the 10% strain group, typically a marker of increased mechanical properties, 
however with 10% strain only the rate of stress relaxation was increased compared to other 
groups with a decrease in maximum stress compared to the 3% strain group.  
The microtissues used for hydrostatic pressure were cultured in one of three culture medias, 
basic, chondrogenic or osteogenic and with one of four hydrostatic pressure condition, 
control, 100 kPa, 200 kPa or 300 kPa. The effects of hydrostatic pressure was largely 
overridden by the differentiation media supplements with the basic media group showing 
the biggest changes in response to different levels of hydrostatic pressure. The chondrogenic 
media group displayed the highest level of COL1A1, COL2A1 and COL10A1 suggesting that 
the hMSCs within this media group were undergoing hypertrophy. At the protein level no 
microtissues saw significance within  a media group suggesting that hydrostatic pressure was 
not influencing the collagen synthesis of the hMSCs as much as the media types. The μCT 
analysis showed within the media groups the density of the mineralised particles was largely 
unchanged for the basic media, chondrogenic media and control and 100 kPa osteogenic 
media samples with the osteogenic 200 and 300 kPa being near two fold greater than all 
other conditions, suggesting that with appropriate media the higher loading regimens 
generated a more developed mineralised structure than the lower hydrostatic pressure. 
It appeared that the microgravity microtissues were all pre-disposed to spontaneously 
differentiate towards the osteogenic lineage as seen through the collagen gene expression. 
Further ALP concentration in the media increased in all culture condition across the three 
week culture period. PCA analysis showed evidence that the static culture was acting 
separately from the dynamic and microgravity culture suggesting that the increased nutrient 




Analysis of the ratio of COL14A1 to COL12A1  was used to demonstrate which culture was 
the most mature, COL14A1 indicating immaturity and COL12A1 maturity. The microgravity 
group had the least developed ECM due to the highest ratio, whilst the static group had the 
most developed ECM due to the lowest ratio. This was further supported through the PCA 
analysis highlighting COL12A1 as one of the largest contributing variables to the statics 
groups separation from the other two. This indicated that increased nutrient diffusion was 
inhibiting the maturation of the MSCs compared to static culture and microgravity was 
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In response to changes during development, ageing and illness the cells of a tissue will react 
by changing the extra cellular matrix (ECM), this may have a positive impact such as increased 
hydroxyapatite during bone development (Long, 2011) or a negative impact such as 
increased collagen I in osteoarthritic cartilage (Lahm et al., 2010). One of the key components 
of the ECM of musculoskeletal tissues is collagen, of which there is at least 28 different types 
with each type performing a different specific function within the ECM (Ricard-Blum, 2011). 
The presence and proportion of the different collagen types varies between tissues, for 
example in tendon types I, II, III, V, XI, XII and XIV are present with type I accounting for >90% 
of the collagen whilst in cartilage types I, II, VI, IX, X, XI, XII, XIV are present with type II 
accounting for >90% of the collagens (Thorpe et al., 2013, Sophia Fox et al., 2009). The 
specific collagen composition has the potential to be used to identify the tissue. One of the 
key regulators of collagen is the mechanical forces applied to the tissue, which has been 
shown to regulate cell differentiation and subsequent protein synthesis (Sarasa-Renedo and 
Chiquet, 2005). For example higher tensile strain rates applied to tendon will result in an 
increase in collagen I, this will result in an increase in stiffness of the tissue therefore enabling 
the tissue to better cope with the force, this is seen during exercise (Carroll et al., 2017). 
However excessive force leads to cell death and eventual tissue rupture (Wang, 2006), 
appropriate mechanical stimulation is required to grow healthy tissue.  
Tissue engineering is the in vitro development of native tissues. This can be achieved in 
multiple ways, one such approach is the use of a 3D biomimetic scaffold seeded with cells 
and exposed to chemical and/or mechanical stimulation in order to develop the targeted 
tissue. Mesenchymal stem cells (MSCs) are one of the most frequently used cell types for 
musculoskeletal tissue engineering as they possess the potential to differentiate down a 
large number of cell lineages including tenogenic, osteogenic, chondrogenic, adipogenic and 
myogenic (Dominici et al., 2006). The differentiation of MSCs is well characterised through 
the use of media supplements and the application of mechanical stimulation, with different 
stimuli better suited for different tissues, for example compression stimulation has been 
found to induce osteogenic differentiation whilst inhibiting adipogenic differentiation (Rath 
et al., 2008, Li et al., 2013) Mechanical stimulation is typically applied through the use of a 
bioreactor, these are specialised devices that are designed to apply a specific function to 
biological systems such as tensile strain, hydrostatic pressure or microgravity. The 
mechanical stimulation is received by the cell through mechanotransduction, this may be 
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through cell membrane deformation, cytoskeleton deformation or protein unfolding 
amongst others and results in the activation of signalling pathways such as the p38 MAPK 
pathway (Deng et al., 2008).  
There are many material options for the 3D culture of cells both naturally derived and 
synthetic, one of the most widely used is fibrin . Fibrin is formed at wound sites and is 
generated through the selective cleavage of the glycoprotein fibrinogen by the protease 
thrombin (Brown and Barker, 2014). The key advantages of fibrin include the well-
established approach in the field, pre-existing use as a natural scaffold in the body, cell 
adhesion and that it can be considered a blank slate material enabling investigation of an 
ECM solely produced by the cells (Paxton et al., 2012).   
The assessment of successful tissue engineering is typically done by investigating the 
production of ECM products that are widely found in a tissue, this approach excludes a 
number of important and less populous ECM components such as the minor collagen types. 
In tendon tissue engineering for example collagen I and III (the most abundant) are typically 
assessed for success excluding types II, V, XI, XII and XIV, however without the other types 
the type I and III fibrils would not form correctly resulting in a non-functional tissue. It is 
therefore necessary to assess all collagen types within the tissue engineered structure to 
assess the success. The specific collagen types and their proportion detected can then be 
used to define the cell differentiation and the tissue generated. 
1.2. Tissue Engineering 
1.2.1. Overview 
Tissue engineer is a branch of regenerative medicine that first emerged as a potential 
solution to aid in the repair and restoration of damage tissue and organs which, still to this 
day, is widely provided by donations (Lanza et al., 2020). The shortage of donors coupled 
with the increasing number of people of the donor waiting list and the ever-increasing aging 
population acts as a major limiting factor to the effectiveness of tissue and organ donations. 
In the USA there are over 113,000 people on the transplant waiting list with around 17,000 
people waiting for over five years (OPTN, 2020). The effectiveness of tissue engineering as a 
replacement for organ and tissue donations has been limited, though there has been a few 
clinical successes such as INTEGRA, used for skin repair, and Osteopore, applied during 
craniofacial bone surgery. Whilst the regenerative medicine applications are continued to be 
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tackled newer approaches which utilise tissue engineering are beginning to be used such as 
the emerging culture meat field (Ben-Arye and Levenberg, 2019).  
Tissue engineering was first proposed in the 1970/80s where initial studies focused on 
seeding cells onto existing biological scaffolds to generate new functioning tissue. One 
example by Green (1977) saw chondrocytes seeded onto decalcified bone to repair cartilage 
defects. Whilst these results were not satisfactory the principles helped to develop the basis 
for tissue engineering. The field then moved towards using biocompatible scaffolds to grow 
cells and develop the ECM. Early work looked to use natural scaffolds, such as collagen and 
fibrin, on which cells were seeded with the potential to act as replacements for tissue such 
as skin. The study by Vacanti (1988) was the next key work in the emerging field, here the 
author moved away from using natural scaffolds to seed the cells onto specifically designed 
scaffold that had appropriate chemical and physical properties for the tissue of interest. In 
1981 the first engineered tissue transplantation, artificial skin for burn injuries, was 
developed by Burke et al. (1981), here the dermal and epidermal layers were separated to 
two scaffolds, the dermal was made up of bovine collagen and chondroitin 6-sulfate from 
shark cartilage whilst the epidermal was made of medical grade Silastic. As the field 
progressed so did the engineered tissue. In 1999 the first laboratory grown organ, an artificial 
bladder, was implanted into patients (Atala et al., 2006). The artificial bladders were 
generated from a collagen and polyglycolic acid scaffold and seeded with urothelial and 
muscle cells, however there have been numerous obstacles that have since been identified 
and slowly overcome (Adamowicz et al., 2017). Whilst the use of tissue engineering has not 
progressed as rapidly in medicine as initially expected it is currently used for cartilage, bone, 
skin, bladder, vascular graft and cardiac tissues in modern medicine (Colombo et al., 2017, 
Lanza et al., 2020). 
As the tissue engineering field developed so did the applications, one of the key techniques 
to emerge was organoids for enhanced in vitro studies. Organoids are miniature tissue 
engineered versions of organs that are generated by cells by mimicking organogenesis with 
uses including drug screening and development (Sasai et al., 2012). This enables a study to 
more closely resemble the in vivo environment than the traditional 2D culture. These tissue 
engineered approaches allow for a more rapid understanding of diseases such as cancer and 
dementia, whilst also reducing the need for animal testing. With continued development, 
patient specific research may become a reality, featuring patients derived cells with organ-
on-a-chip or 3D tissue engineered models to identify genetic triggers for specific diseases 
helping to speed up and specify diagnosis.  
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Whilst the applications for tissue engineering vary the basis in which the structures are 
generated are relatively consistent. The tissue engineered structure is typically formed from 
a population of cells within a 3D environment. The 3D structure is then cultured under 
controlled conditions designed to optimise desirable outcomes such as cell differentiation, 
protein synthesis and structural development. To achieve a robust product initial 
experimental criteria need to be defined including 3D scaffold, cell type, and culture 
environment.  
1.2.2. Scaffolds 
Cells within an in vivo environment operate in a highly developed 3D structure that has 
evolved to deliver a specific function, it is therefore impossible to re-create this same 
environment in 2D cell culture. Tissue engineering better replicates the in vivo environment 
by culturing the cells within a 3D structure, of which there is a wide variety that have been 
utilised to develop the lab based engineered tissues. The cell-cell and cell-ECM interaction is 
driven by the 3D structure in which the cell reside, with increased development of the 3D 
structure material leading to a promotion in proliferation, migration and matrix production. 
There is therefore a wide range of 3D cell culture techniques including decellularised ECM 
and natural/synthetic hydrogels. The natural hydrogel fibrin has been used throughout the 
present study due to the well-established application for a range of different tissues types 
(Osathanon et al., 2008, Heher et al., 2015, Almeida et al., 2016, Gonzalez de Torre et al., 
2016, Carroll et al., 2017), natural biocompatibility and cell adhesion properties (Almelkar et 
al., 2014) and, most importantly, offering a blank slate for collagen synthesis and detection 
(Paxton et al., 2012). This section introduces a number of different biomaterials available for 
3D cell culture including fibrin.    
1.2.2.1. Hydrogels 
Hydrogels are 3D polymeric structures that are primarily made up of water and can 
incorporate and facilitate cells and proteins. Hydrogels can be broken down into two 
categories, synthetic (e.g. polyacrylamide and polyethylene glycol) and natural polymers 
(e.g. collagen, fibrin, alginate and hyaluronic acid) (Lee and Kim, 2018). The choice of 
hydrogel depends on the users preference towards 2D and 3D culture, the tissue aiming to 
be engineered with different materials enabling cells to adhere in a variety of ways, different 
levels of stability in culture and the structural properties of the material. Fabrication of the 
hydrogels is enabled by chemical or physical cross-link methods (Khunmanee et al., 2017).  
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1.2.2.1.1. Natural hydrogels 
Fibrin is formed naturally at wound sites (Weisel and Litvinov, 2013) where the serine 
protease thrombin selectively cleaves two small amino acid sequence in the amino-termini 
of the Aα and Bβ chain of the dimeric glycoprotein fibrinogen. Successful cleavage exposes 
polymerisation sites, resulting in the formation of fibrin molecules that interact through 
disulfide bonds (Brown and Barker, 2014). Factor XIIIa is activated by thrombin and increases 
the fibrin stability by introducing ε-N-(γ-glutamyl)-lysyl crosslinks between residues in the γ- 
and α-chains of fibrin monomers (Byrnes et al., 2015). The ratio of thrombin to fibrinogen 
dictates the fibril size and pore sizes (Lawrie et al., 1998). The pore size is important for 
sufficient nutrient uptake and cell transport. Larger pores allow for increased cell growth 
rates however this must be achieved without compromising the structural integrity (Chiu et 
al., 2012). Once formed fibrin will naturally contract, closing the wound site in an in vivo 
environment. The contraction is utilised during tissue engineering by casting the fibrin 
between two posts which causes the material to generates a rod like structure similar to that 
of tendon, bone or muscle. Cells can be either mixed with the raw components of the fibrin 
hydrogel prior to gelation and therefore cast within as the gel polymerises or seeded on top 
of the formed fibrin where the cells will then migrate through the structure. 
Fibrins role within the body as a natural scaffold makes it appealing as a hydrogel due to its 
cell adhesion properties resulting in the material being widely used in studies investigating 
cell-mediated collagenous tissue assembly (Bian et al., 2012, Paxton et al., 2012). Fibrin 
hydrogels exhibit viscoelastic properties with low stiffness, therefore limiting its 
effectiveness as a replacement material for damaged tissue. The long term culture of fibrin 
is restricted by the materials high susceptibility to protease mediated degradation however 
additives to the culture media such as 6-amino-n-caproic acid inhibits the fibrin degradation 
(Kupcsik et al., 2009).  
Collagen is one of the most abundantly utilised hydrogels for tissue engineering 
musculoskeletal tissue such as bone, tendon and ligament (Antoine et al., 2014). Collagen 
type I is widely used due to the relative ease of extraction with the most common source 
being rat-tail tendons, typically collagen type I is extracted using a solution of acetic acid and 
pepsin and stored in a low pH solution at a low temperature to prevent spontaneous fibril 
formation (Walters and Stegemann, 2014). By raising the temperature and pH the collagen 
will undergo gelation and form a 3D structure, cells can either be pre-mixed with the liquid 
collagen or seeded on top of the gelled collagen. Similarly to fibrin, collagen will form a rod 
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like structure if generated about two fixed posts. Through temperature controlled gelation 
the collagen I fibrils thickness can be altered, changes in fibril thickness can help control 
structural properties, cellular migration and morphology (Doyle et al., 2015).  
Collagen II has been utilised at a lower extent for hydrogel formation, primarily in cartilage 
tissue engineering. Collagen type II has been extracted from chicken sternum to generate 
hydrogels (Vidal Bde and Mello, 2016). Comparison between the collagen I and II hydrogels 
showed that the structure of collagen type II more appropriately mimicked the ECM of 
cartilage and promoted cartilage gene expression highlighting the importance of hydrogel 
material choice (Vidal Bde and Mello, 2016, Lazarini et al., 2017). The key advantages of using 
collagen based hydrogels is the cytocompatibility, cell adhesion and viscoelastic structural 
properties. The collagen based hydrogels do feature some disadvantages including low 
stiffness, batch to batch variation and limited long term stability. Some of these 
disadvantages can be alleviated with chemical cross-linking however this can drastically 
change the degradability of the structure whilst only slightly improving the structural 
stiffness (Bian et al., 2009).  
Other ECM derived hydrogels feature collagen types within the solution, this includes the 
commercially available Matrigel which is extracted from Engelbreth-Holm-swarm mouse 
sarcoma tumours and includes collagen type IV along with other basement membrane 
components. Matrigel again has low structural mechanical properties and high batch to 
batch variation. This coupled with the tumorigenic origin has resulted in high levels of 
uncertainty in tissue engineering studies and the requirement of more tuneable hydrogels. 
One of the main targets of tissue engineering is to regenerate the native ECM found in 
healthy tissue. ECM derived hydrogels present the initial culture with these components 
from the initial hydrogel formation by generating the hydrogel from solubilised and 
polymerised native ECM. This results in a hydrogel that retain the full biochemical complexity 
of the native tissue without the turmeric origin of Matrigel (Saldin et al., 2017). Many tissues 
have been solubilised for ECM hydrogels such as the esophagus (Keane et al., 2015), heart 
(Seif-Naraghi et al., 2013)  and tendon (Farnebo et al., 2014) typically using a pepsin based 
approach, however each tissue requires different digestion times, concentrations, pH among 
other process parameters.    
Whilst collagen and fibrin feature similar structural and cell adhesion characteristics, other 
natural polymers do not and require modifications to enable their use as a hydrogels, this 
includes alginate and hyaluronic acid. Hyaluronic acid, a nonsulfated glycosaminoglycan 
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composed of a repeating disaccharide unit of glucuronate and N-acetylglucosamine (Meyer, 
1958), is found in a wide range of tissues including cartilage, skin and the brain and has been 
shown to play roles in development and healing (Fraser et al., 1997). The biggest advantage 
to using hyaluronic acid hydrogels is the tunability of the structure, these modifications 
include enabling cell adhesion, release of growth factors and other proteins and 
manipulation of the mechanical properties of the structure (Burdick and Prestwich, 2011). 
CD44 expression has been found to induce cell adhesion to hyaluronic acid hydrogels 
through reduced material stiffness enabling integrin based adhesion, suppression of CD44 
was found to impair cell adhesion (Kim and Kumar, 2014). 
Alginate is a polysaccharide derived from brown algae that consists of  β-D-mannuronic acid 
M units and α-L-guluronic acid G units which assembles as block copolymers (Martinsen et 
al., 1989, Augst et al., 2006). Alginate forms a hydrogel through ionic crosslinks between the 
G units generated using divalent cations (e.g. calcium, magnesium and barium) (Augst et al., 
2006). By rapidly forming the cross linked structure cells can be encapsulated for 3D culture, 
alginate then offers the ability to easily dissolve allowing for cell recovery, though as the cells 
cannot degrade the hydrogel they remain  relatively rounded meaning this structure is most 
suited to chondrogenic 3D culture but has limited application for other cell types. 
1.2.2.1.2. Synthetic hydrogels 
Synthetic polymers offer highly tuneable structures; materials include polyacrylamide (PA) 
and polyethylene glycol (PEG). PA hydrogels are generated by reacting acrylamide monomer 
and bisacrylamide crosslinker in the presence of ammonium persulfate and tetramethyl 
ethylene-diamine (Caliari and Burdick, 2016). PEG forms a hydrogel when combined with a 
crosslinking substrate such as (meth)acrylates, alternatively when combined with diacrylate 
the mixture forms a gel when exposed to UV light (Caliari and Burdick, 2016). The advantages 
of PA derive from the well-established fabrication protocols which allows to dictate the 
mechanical properties of the structure and the ease of protein coupling (Pelham and Wang, 
1997, Tse and Engler, 2010). The structure of the PA hydrogel is highly directable and the cell 
adhesion is pre-determined this enables a more complete understanding of the cellular 
response when compared to a natural polymer derived hydrogel. However PA hydrogels 
cannot be used for 3D encapsulation of cells due to the toxicity of the hydrogel precursors, 
therefore this synthetic polymer is used with 2D culture where the adhesion layer is finely 
tuneable (Caliari and Burdick, 2016). PEG is considered a blank slate material which again 
allows for high modification to the structural and biological properties. As a basic material 
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PEG does not offer many advantageous properties but with the addition of modification 
materials the structure becomes highly adaptable and useful for a wide range of applications 
(Kong et al., 2017). 
1.2.2.1.3. Decellularised tissue 
Decellularised tissue is a highly attractive form of 3D cell culture as it offers the most close-
to-nature mechanical and biological properties of all 3D structures (Chan and Leong, 2008). 
Decellularised tissues have been used to tissue engineer heart valves (Knight et al., 2008), 
vessels (Borschel et al., 2005), nerves (Hall, 1997) and tendons (Ingram et al., 2007). 
Decellularisation of tissue is achieved through a multi-step process that involves lysing cell 
membranes through freeze thaw cycles or ionic/non-ionic solution before separating the 
cellular components from the tissue by enzymatic method such as trypsin/EDTA treatment. 
The cytoplasmic and nuclear cellular components are then solubilised and removed using 
specific detergents (Chan and Leong, 2008). Ionic detergents, such as SDS, are the most 
robust at removing cells however these ionic solutions also remove GAGs and growth factors 
from the ECM, should these components be required a non-ionic solution, such as Triton X-
100, can be used in place, though these do not decellularise the tissue as effectively (Reing 
et al., 2010, White et al., 2017). By removing the cellular components from the tissue the 
process also removes the allogenic or xenogeneic cellular antigens that may otherwise result 
in immune rejection upon implantation. The decellularised tissue can then be repopulated 
with the patient’s cells generating a structure that closely replicates the originally damaged 
tissues structure, however this technique requires surgery to acquire the scaffold. The 
decellularised tissue may not be entirely decellularised which may result in immune rejection 
and the seeded cells may not be evenly distributed across the structure leading to an 
inhomogeneous distribution and therefore incomplete tissue (Zheng et al., 2005). One of the 
main draw backs from tissue decellularization is the protocol variation between different 
tissue types, therefore requiring empirical experimentation and optimisation before the 
tissue can be used (Heath, 2019). A set of minimum criteria have been established to 
standardise the decellularization of tissues; 1) less than 50 ng double stranded DNA/mg dry 
ECM, 2) <200 base pair DNA fragment length and 3) lack of visible nuclear material when 
stained with DAPI or H&E (Crapo et al., 2011). 
1.2.2.2. Bio-Printing 
One of the major issues with scaffolds used in tissue engineering is the variation seen during 
the fabrication of the 3D structure. This can be due to batch to batch variation when using 
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naturally derived materials or due to the operator, who when dispensing and incubating the 
components will inevitably incur variation from scaffold to scaffold. A potential solution to 
the human lead variation is automation, with bioprinting offering an automated scaffold 
manufacturing process.  
Bioprinting is a relatively new form of 3D printing (Fig.1.1), this form of additive 
manufacturing works in a very similar way to standard 3D printing in that the component to 
be manufactured is generated on a computer system and then printed using the selected 
material in a layer by layer deposition process. The material is then crosslinked using 
chemical, UV or heat approaches to solidify the structure ready for use (Ozbolat et al., 2016). 
Where bio-printing differs from standard 3D printing is that the components being printed 
are designed for tissue engineering, typically as scaffolds for cells to grow on or in. If the 
material used for printing contains live cells it is referred to as bioinks (Hospodiuk et al., 
2017), bioinks may also contains growth factors and ECM components (Ozbolat et al., 2016).  
A wide range of materials are available for bio printing and are similar to those already used 
as hydrogels for tissue engineering, including natural polymers such as agarose, alginate, 
chitosan, collagen, Matrigel, fibrin, gelatin and hydroxyapatite and synthetic polymers such 
as graphene, PLA and Pluronic F127 (Aldrich, 2020), with each material better suited to 
different forms of bio printing and for different types of targeted tissues.  
Figure 1.1. Example of a 3D bio printer, the Cellink Box X (left) and a bioprinted hydrogel 
(right) (Cellink, 2021). 
The types of bio printing can be split into two broad groups, the nozzle based and the light 
based, with nozzle based including inkjet and extrusion and light base including laser 
assisted, digital light processing (DLP) and volumetric. The original bio-printing technique 
was the inkjet method developed by Thomas Boland in the early 2000s (Mironov et al., 2003). 
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Cells were encapsulated within a hydrogel solution and were stored within a sterile cartridge, 
the cartridge was connected to the printer which secreted the bioink as droplets of a 
controlled size. The droplets were dispensed in a predetermined pattern to produce the 
computer generated design and the bioink was crosslinked as required. This method prints 
designs quickly, is relatively low cost due to the simple design and retains a high cell viability 
(80-90%) (Mandrycky et al., 2016). However due to the technique used to control the droplet 
size and shape, micro-electromechanical system (MEMS), high viscosity materials cannot be 
used with this technique, the viscosity of the material is not only affected by the materials 
properties but also the cell density, a higher number of cells increases the viscosity therefore 
the cell density is limited by the technique to approximately 1x106 cells/ml (Pepper et al., 
2012). The method has also been shown to induce the settling effect; initially the cells are 
well mixed within the cartridge, however as the printing progresses the cells begin to settle 
within the cartridge, leading to uneven cell distribution and eventual clogging of the system 
as the cell density increases at the nozzle (Pepper et al., 2012). 
Extrusion printing was developed in order to print the more viscous materials. Either an air-
force pump or screw plunger is used to continuously force the material through the nozzle, 
this results in a continuous cylindrical line of bioink being dispensed onto the build plate, the 
bioink is then crosslinked as required to form the structure intended. This method allows for 
a much wider range of bioinks to be used and at a higher cell density than the inkjet method. 
This method is limited by the resolution of the printer and the geometry it is able to achieve. 
To improve the complexity of geometries extrusion printers typically come with multiple 
nozzles to allow for the printing of multiple materials in parallel, this allows for a support 
structure to be generated around the scaffold, once printing is complete the support 
structure can be dissolved away leaving the desired scaffold. High levels of shear force are 
seen as the material is extruded through the nozzle, this leads to relatively high cell death 
during the fabrication. 
Laser assisted printing originated from laser direct write (Bohandy et al., 1986) and laser 
induced transfer technologies (Duocastella et al., 2007, Kattamis et al., 2007). The laser is 
fired at an energy absorbing layer, such as gold or titanium, known as the donor layer. The 
laser is fired at the desired location on the donor layer causing the portion of the donor layer 
to vaporise and generate a high pressure bubble at the interface with the scaffold material. 
The material falls as a droplet onto the build plate and is crosslinked to form the desired 
structure. As no nozzle is involved much higher viscosity material can be used and no 
mechanical stress is seen between the nozzle and cells therefore there is a higher cell viability 
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(95%). However the effects of the laser on the cells is still not fully understood and is more 
expensive due to the more complex system (Mandrycky et al., 2016). 
DLP bioprinting works is in a similar way to laser assisted printing in that a photocurable resin 
is cured by a light source to a defined shape. However were as laser assisted focuses on a 
specific position to cure before moving onto the next position, DLP cures the entire layer 
immediately therefore printing at a much faster rate than laser assisted and subjecting the 
cells within the bioink to shorter periods of intense light (Ngo et al., 2018, Lu et al., 2006). 
DLP bioprinting generates the structure through the use of a digital micro mirror device 
(DMD) which consists of a group of micro sized, controllable mirrors. The mirrors rotate to 
control the path of the light onto the photocurable resin, the light is then directed as defined 
by a computer software to generate a specific structure. The resolution of the system is 
defined by the DMD and is typically on the micron scale (Ngo et al., 2018). DLP does not use 
a nozzle and therefore sees higher cell viability (85-95%) than nozzle based bioprinters 
(Zhang et al., 2020). 
Volumetric bioprinting looks to move away from the layer by layer approach of other printing 
types and instead generate the entire structure at once. It is argued that this approach will 
reduce the stress imposed on the cells during the relatively slow fabrication of the structure. 
The instant fabrication means more complex hollow structures with overhangs can be 
manufactured without out the need for a support structure (Kelly et al., 2019). Volumetric 
bioprinting works by the controlled projection of a series of 2D patterned optical light fields 
within a volume of a photopolymer. The 2D light pattered acts cumulatively to produce an 
optical 3D dose distribution that triggers the polymerisation of the irradiated material into 
the desired shape (Bernal et al., 2019, Loterie et al., 2018). 
The generation of 3D scaffolds by the researcher inevitably leads to variation between 
samples, by utilising bio printers the variability between samples and studies will 
dramatically reduce allowing for more comparable and trustworthy results. The ever 
developing bioprinting technology is making more complex and higher quality building a 
reality, and with the ability to share designs and ideas between labs, comparable approaches 
can be more widely used across research. Tissue engineering is only around 40 years old, and 
with the continued emergence of newer technologies the automation and reproducibility of 
lab grown tissues will continue to grow, potentially helping to generate an environment 




Bioreactors have been developed to enable high expansion of adherent cultured cells that is 
otherwise a limitation with 2D approaches. This is achieved by the tight control and 
monitoring of the environmental conditions (e.g. pH, temperature, mechanical stimuli, 
nutrient supply and waste removal) and can be applied using a stir tank bioreactor in which 
adherent cells are cultured on a microcarrier system in suspension culture, drastically 
reducing the number of tissue culture plastic vessels required. Through the high level of 
control and experimental automation the reproducibility is dramatically increased, this has 
led to the industrial utilisation of large-scale bioreactors for fermentation processing, water 
treatment, food processing and the production of pharmaceuticals and recombinant 
proteins (Martin et al., 2004). At the research level smaller bioreactors are utilised to apply 
in vivo conditions to cell cultures, driving the cells to proliferate, differentiate and produce 
targeted ECM to generate the engineered tissue (Liu et al., 2010b). Mechanical stimulation 
bioreactors fall into the category of research bioreactors, and are used to replicate the 
mechanical forces experienced by the targeted tissue in vivo such as tensile stimulation by 
tendons and hydrostatic pressure by cartilage.  
1.2.3.1. Mechanical stimulation bioreactors 
A wide range of commercial and custom designed bioreactors are available for mechanical 
stimulation. These bioreactors are designed to replicate the in vivo mechanical loads applied 
to cells including tensile stimulation, shear force and hydrostatic pressure as well as 
environmental forces such as microgravity. The application of mechanical stimulation and 
the subsequent biochemical response is known as mechanotransduction, whilst the exact 
process is not fully understood, studies have shown that integrins, cadherins, ion channels, 
focal adhesion and growth factors/receptors play a role in the process (Sarasa-Renedo and 
Chiquet, 2005). The activation of these mechanotransduction receptors activates cell 
signalling cascades which may involve nuclear factor kappa B, MAPK, protein kinase C 
pathway, Rho-dependent kinase (Sarasa-Renedo and Chiquet, 2005).  
For tensile stimulation a range of commercial bioreactors are available, these include the 
EBERS TC3, CellScale MCT6, BioDynamic 5200 and the Flex Cell Tissue train. A wide range of 
custom built bioreactors have been utilised for studies as shown by Juncosa-Melvin et al. 
(2006), Morita et al. (2013), Youngstrom et al. (2016) and Brandt et al. (2018). All tensile 
stimulation bioreactor share similar design characteristics: a culture chamber enabling 
tensile stimuli to be applied to the cells in a sterile environment, with the force applied by a 
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linear actuator controlled by displacement software. Tensile stimulation is usually applied by 
stretching the sample by a fixed amount, the sample may be cells within a 3D structure 
(Youngstrom et al., 2015, Janvier et al., 2020) or cells adhered to a flexible membrane as a 
monolayer (Juncosa-Melvin et al., 2006). In the case of the 3D cell culture, the samples are 
attached to the bioreactor at the structures two extremes, this may be by a grip or a post 
system. For both 2D and 3D tensile stimulation one end is typically fixed and the opposite 
end is attached to a linear actuator (though both ends can be attached to two linear 
actuator), the linear actuator is then electronically driven to stretch the sample by a fixed 
amount. The amount of tensile stimulation applied is usually calculated as the strain placed 
on the sample, this strain is the percentage change from the original length of the sample, 
more advanced systems may have a load cell built in to record the amount of force being 
applied. The tensile stimulation can be applied as a constant force where the only variable is 
the amount of strain or as a dynamic force where as well as strain the frequency and duration 
of the cyclic loading is also a variable. 
Compressive forces are detected by cells throughout the body particularly by chondrocytes 
(Responte et al., 2012). There are two main options to replicate compressive forces in vitro, 
direct compression and hydrostatic pressure. Direct compression involves physically pressing 
the cell culture structure with a solid object whilst hydrostatic pressure involves increasing 
the volumetric pressure the sample is cultured in. Both commercial and custom direct 
compression and hydrostatic pressure bioreactors are available. Examples for commercially 
available direct compression bioreactors include the CellScale MCTX and EBERS TC3 with 
compression grips and examples of custom are presented in studies by Cochis et al. (2017), 
Meinert et al. (2017). Examples of commercially available hydrostatic pressure bioreactors 
include the TGT Cartigen, CellScale MCTR, EBERS TC3 with hydrostatic pressure chamber and 
Flexcell’s FX-5000C and custom are presented in studies by Reinwald et al. (2015), Correia et 
al. (2012)).  
Direct compression bioreactors typically work via a piston system. Here a sterile end is driven 
down onto the test sample in a uniaxial direction, this requires the sample to all be uniform 
in size and shape with a flat surface at the top and bottom of the structure ensuring the load 
is evenly applied and the sample does not move. Hydrostatic pressure bioreactors typically 
work by applying compressed air into the system to increase the atmospheric pressure 
around the sample. As the entire atmospheric pressure within the culture environment is 
increased the load is applied uniformly across the sample (Reinwald et al., 2015). Hydrostatic 
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pressure has also been shown to enhance the transfer of small molecules such as O2 and CO2 
(Portner et al., 2005). The hydrostatic pressure systems require a large compressed air tank 
as well as a culture chamber that is able to withstand the high pressures applied. Other 
hydrostatic pressure systems, such as the EBERS TC3 hydrostatic pressure chamber, utilise a 
piston which presses against a flexible membrane wall of the culture chamber, by reducing 
the volume of the culture chamber the hydrostatic pressure increases, this type of system is 
limited by the amount of pressure able to be applied as high pressure levels see the liquid 
environment leak out. Both the piston based and compressed air systems are operated 
electronically allowing the applied load to be easily controlled. For piston based systems the 
load is measured as piston displacement, through a mounted pressure gauge the change in 
pressure can be monitored. Many systems have been designed to use existing well plates or 
petri dishes, therefore the transfer of samples from non-stimulated culture to pressurised 
culture is relatively straightforward. The pressure can be applied as a constant (Tworkoski et 
al., 2018) or as a cyclic profile (Henstock et al., 2013) where along with the pressure the 
frequency and duration are also variables.  
Some custom built compression bioreactor have been designed to allow for shear forces to 
be applied in tandem with the compressive forces (Meinert et al., 2017, Cochis et al., 2017), 
this helps to mimic mechanical environment such as the knee where compressive loads are 
applied to the cartilage whilst the synovium also applies shear force to the tissue (Escamilla, 
2001). Shear force is also seen in other tissues such as blood vessels (Lu and Kassab, 2011). 
Shear based bioreactors have been developed commercially, for example the CellScale 
Vitroflow, and work in a similar way to a rocker plate. Other systems apply shear force by 
rotating samples within a drum, this includes the Synthecon RCC 3D cell culture system. As 
well as the ability to apply shear force the Synthecon RCC 3D can also place samples within 
microgravity, this is achieved by manipulating the rotational speed so that samples placed 
within the rotation drum are in constant free fall therefore dramatically reducing the 
gravitational force applied to the samples. The rotation is electronically controlled, to 
generate the microgravity environment, the rotational drum should be entirely filled with 
cell culture medium and all air bubbles removed from the system, which then attaches to 
the rig and can begin rotation. The Synthecon RCC does not control temperature, humidity, 
O2 or CO2 conditions and therefore must be placed within an incubator during use to achieve 
the required conditions. These type of bioreactors allow researchers to investigate how 
environment factors, such as microgravity, affect the proliferation, differentiation and ECM 
production of the cells encapsulated within the system. The Synthecon RCC is the most 
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commonly used system to apply microgravity to 3D cell cultures, as shown from the authors 
literature review being used in approximately 70% of all studies investigating the effects of 
microgravity on 3D cell culture between January 2015 and August 2020. The second most 
frequently used is the custom designed random position machine (RPM) which has been 
used in 29% of studies, here the whole system is constantly reorientating with respect to 
earths gravitation field, resulting in the average gravitational force acting on the samples to 
be less the 1 g (Benavides Damm et al., 2014). 
The use of bioreactors allows specific stimuli that occur within the native environment to be 
replicated in a controlled in vitro environment. This may result in an over simplified culture 
as within a biological system these stimuli will not occur in isolation, however this does allow 
the researcher to better understand the role these stimuli play. The choice of cell type is 
equally as important as the stimuli being applied and the scaffold being used as different 
cells will have different responses to specific loading. MSCs act as an ideal starting cell for 
load based experimentation due to the MSCs multipotent characteristics enabling the cells 
to respond to the varying stimuli by differentiating down different lineages. 
1.3. Mesenchymal Stem Cells 
MSCs are a multipotent cell that have the  potential to differentiate down a variety lineages 
to form skeletal cell types, the lineages including osteogenic, chondrogenic, adipogenic and 
tenogenic (Fig.1.2) (Dominici et al., 2006, Archer and Ralphs, 2010). Tendon, bone and 
cartilage have been investigated throughout the experimental sections of this thesis and so 
have been specifically discussed in sections 1.4, 1.5 and 1.6. MSCs have been isolated in vitro 
from a number of sources including the umbilical cord, placenta, fat and skin however the 
most studied source is the bone marrow derived MSC (Zuk et al., 2002, da Silva Meirelles et 
al., 2006). Within the bone marrow, MSCs account for 0.001-0.01% of the nucleated cell 
population (Pittenger et al., 1999, Jiang et al., 2002) and therefore require a multistep 
process to extract the cell from the bone marrow source. Initially the bone marrow is flushed 
and dispensed over tissue culture plastic where, after a set period of time, the adherent cells 
are retained and the non-adherent cells, such as red blood cells, are discarded. The 
population of adherent cells can then be verified as MSCs through a variety of methods 
however the most common is the tri-lineage assay. Here the cells must be able to 
differentiate down all three of the adipogenic, chondrogenic and osteogenic lineage 
(Pittenger et al., 1999, Jiang et al., 2002). Characterisation kits are another option for MSC 
verification with the minimum criteria being defined by Dominici et al. (2006). 95% of the 
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cell population must express CD73, CD90 and CD105 whilst less than 2% of the cell 
population should express CD11b, CD34, CD45, CD79A and HLA-DR. The criteria defined in 
the verification kit has been disputed as a range of cells may express the markers, for 
example CD90 is expressed by fibroblasts in culture (Saada et al., 2006, Powell et al., 2011). 
Figure 1.2. The differentiation potential of MSCs, captured from Chan et al. (2007). 
The differentiation fate of the MSC is determined by a number of factors including chemical 
and physical stimuli and involves a two-step process; lineage commitment and maturation. 
A number of signalling pathways have been shown to be involved in osteogenic, 
chondrogenic and tenogenic differentiation including transforming growth factor-beta (TGF-
β)/BMP signalling, Wnt signalling, Hh signalling, Notch, Hippo and FGF (Chen et al., 2016). 
The TGF-β superfamily consists of three subtypes:  TGF-β1, TGF-β2 and TGF-β3 (Chen et al., 
2012, Lorthongpanich et al., 2019). This group of growth factors is widely involved in cell 
proliferation and cell differentiation, however the effect may be dose dependent, for 
example low doses of BMP2, along with rosiglitazone (an antidiabetic drug), have been 
shown to induce adipogenic differentiation whilst high doses of BMP2 accelerate 
chondrogenic and osteogenic differentiation (zur Nieden et al., 2005). TGF-βs bind to the 
appropriate serine-threonine kinase receptor and active canonical Smad-dependent 
pathways (including TGF-β/BMP ligands, receptors and Smads) and non-canonical Smad-
independent signalling pathways, such as p38 mitogen activated protein kinase (MAPK) 
pathway (Deng et al., 2008), resulting in the regulation of osteogenic genes (e.g. Runx2), 
chondrogenic genes (e.g. Sox9) and tenogenic genes (e.g. SCX).  
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The Wnt proteins bind to Frizzled (FZ) 7-transmembrane spanning receptors and activate the 
canonical Wnt/β-catenin pathway and the Wnt/β-calcium pathway (Kohn and Moon, 2005, 
Cadigan and Peifer, 2009). The Wnt proteins that belong to the canonical group are: Wnt1, 
Wnt2, Wnt2b/13, Wnt3, Wnt3a, Wnt8a/d, Wnt8b, Wnta10a, Wnta10b, Wnt9a.14, 
Wnt9b/15 and Wnt16 and the noncanonical group: Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7a, 
Wnt11 and Wnt16 (Ackers and Malgor, 2018). The Wnt signalling pathway has been 
previously shown to facilitate osteogenic and chondrogenic differentiation (Kirton et al., 
2007, Park et al., 2015) and inhibit tenogenic differentiation (Kishimoto et al., 2017).  
The Hedgehog family of secreted proteins consist of three orthologues: Sonic Hedgehog 
(SHh), Indian Hedgehog (IHh) and Desert Hedgehog (DHh) (Chen et al., 2016). Through 
binding of Hedgehog precursor to membrane proteins, Patched (Ptc) and Smoothened 
(Smo), the transcription factors Gil1, Gil2 and Gil3 are activated and regulate the expression 
of Hedgehog targeted genes (Deng et al., 2008). Hedgehog and BMP signals have been shown 
to cross-talk resulting in Smad modulation which in turn results in the promotion of 
osteogenic differentiation (Spinella-Jaegle et al., 2001). Hedgehog signalling is an important 
regulator of chondrogenesis with IHh highly expressed by prehypertropic chondrocytes and 
osteoblasts at puberty (Kindblom et al., 2002) though the regulation of the cell types is not 
identical. Osteoblast differentiation is controlled by Runx2 expression (Yuan et al., 2016) 
whilst prehypertropic chondrocyte differentiation is regulated by PTHrP (Williams et al., 
2018). IHh signalling is mediated by Wnt/β-calcium signalling during osteoblast 
differentiation (Hill et al., 2006) whilst Wnt/β-calcium acts upstream and in parallel to IHh in 
chondrocyte survival and hypertrophy, respectively (Mak et al., 2006). Hedgehog signalling 
has been shown to be present at the insertion site of tendon-bone during cell differentiation 
(Liu et al., 2013) and found via the primary cilia, to be a mechanosensitive pathway during 
tendon-bone healing (Carbone et al., 2016), suggesting it plays an important role during 
tendon development particularly at the bone attachment sight. 
Activation of the Hippo pathway negatively regulates the expression of the yes associated 
protein (YAP), a key transcriptional co-factor that has been shown to be involved in stem cell 
fate (Zhao et al., 2011a). YAP and its paralogue transcriptional co-activator with PDZ-binding 
motif (TAZ) are thought to shuttle between the cytoplasm and the nucleus and interact with 
transcription factors, regulating their activity and therefore cell differentiation (Karystinou 
et al., 2015). Low expression of YAP and TAZ has been shown to promote adipogenesis and 
chondrogenesis in MSCs whilst high expression drives MSCs towards osteogenesis (Hong et 
al., 2005, Zhong et al., 2013, Karystinou et al., 2015).  
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The notch signalling pathway involves the single transmembrane proteins Notch and Notch 
ligand (Delta/Serrate/LAG-2, DSAL protein) (Lin and Hankenson, 2011). These proteins 
regulate cell differentiation through cell-cell communication and have been shown to both 
supress and induce osteogenic differentiation by inhibiting Wnt/β-catenin signalling (Deng 
et al., 2008) whilst promoting BMP2 signalling (Shimizu et al., 2011). Similarly during 
chondrogenesis Notch signalling is necessary to initiate differentiation but must be switched 
off to allow chondrogenesis to proceed (Oldershaw and Hardingham, 2010). 
1.3.1. Mechanical Regulation of Mesenchymal Stem Cell 
Differentiation 
Each signalling pathway does not function in isolation but works with other pathways to drive 
the differentiation of MSCs, the activation of the pathways is driven by stimuli found in the 
tissue microenvironment. Stimuli can comprise biological factors such as ageing and 
chemical cues including the addition of TGF-β in vitro which initiates and maintains 
chondrogenic differentiation of MSCs through the stimulatory activities on MAPK and 
modulation of Wnt signalling (Tuli et al., 2003). Mechanical factors also act to drive MSC 
differentiation and include a range of stimuli including cell morphology, mechanical forces, 
ECM components and geometric structures. The process through which mechanical factors 
influence cell changes via intercellular biochemistry and gene expression is known as 
mechanotransduction (Wang et al., 2009). These mechanical factors arise from the MSCs not 
acting in isolation but physically interacting with components of their microenvironment, 
with changes to the microenvironment directing the MSC fate. This has been demonstrated 
by Engler et al. (2006), here the matrices the MSCs adhered to varied in stiffness, the cells 
then differentiated into either neuron cells when on the elastic matrix (0.1-1 kPa), myocytes 
when on the stiffer matrix (8-17 kPa) or osteoblasts on the stiffest matrix (25-40 kPa). The 
main cellular components that mediate mechanical forces from the ECM are integrin and 
cadherin receptors which facilitate cell adhesion to the ECM by binding to proteins and are 
able to transmit forces by physical interaction with the actin cytoskeleton (Alenghat and 
Ingber, 2002, Schwartz, 2010, Schwartz and DeSimone, 2008). Mechanical stimulus results 
in the activation of mechanosensitive ion channels, heterotrimeric G proteins, protein 
kinases and other membrane-associated single transducer molecules. This sees the 
downstream activation of signalling cascades which results in mechanical stimulation 
dependant cellular changes (Chien, 2007). The interaction with the structural cytoskeleton 
can dictate the cell shape which can then lead to the differentiation of the MSC; if the MSC 
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is to differentiate down the chondrogenic lineage it becomes round (Johnstone et al., 1998, 
Erickson et al., 2002) whereas if the MSC spreads out it may develop into an osteoblast 
(McBeath et al., 2004). The cytoskeleton can generate a response to mechanical forces, as 
the load will deform the structure. Through this deformation, proteins associated with the 
cytoskeleton will also deform which, under the right conditions, may cause the protein to 
unfold and present a new binding site, this then may lead to the activation of signalling 
pathways through the phosphorylation of proteins (Vogel and Sheetz, 2009). 
External mechanical forces act on musculoskeletal tissues through development and 
maturation. Various forces are experienced by the different tissues dependant on the role 
the tissue plays to maintain homeostasis, this includes tensile loading on tendons and muscle 
(Magid and Law, 1985, Wang, 2006) and hydrostatic pressure on bone and cartilage (Gurkan 
and Akkus, 2008, Montagne et al., 2017). The application of constant tensile stimulation to 
MSCs has been shown to promote endogenous BMP-2 expression, osteogenic gene 
expression and calcium deposition (Sumanasinghe et al., 2006, Byrne et al., 2008, Qi et al., 
2008, Hanson et al., 2009, Rui et al., 2011). The upregulations of the MAPK pathway has been 
seen with cyclic tensile strain (Ward et al., 2007) suggesting its importance as a key 
mechanotransductive pathway in tensile stimulation. The magnitude of the tensile strain has 
been found to regulate the MSC differential fate with high tensile strain resulting in 
myogenesis and low tensile strain osteogenesis (Jang et al., 2011). Tensile stimulation 
deforms the tissue and therefore the cells bound to the actin cytoskeleton, therefore 
resulting in a cell response, hydrostatic pressure is a non-deforming mechanical stimulus and 
therefore regulates cell fate in a different way. In chondrocytes static hydrostatic pressure 
inhibits the Na/K and Na/K/2Cl pump whilst enhancing the Na/H exchange (Browning et al., 
1999, Hall, 1999). There is evidence to suggest that hydrostatic pressure regulates 
hypertrophy with the application of cyclic hydrostatic pressure resulting in a decrease in 
hypertrophic markers collagen X and IHh in MSC pellet culture (Vinardell et al., 2012). 
MSCs detect and respond to external mechanical signals in a number of ways through 
mechanotransduction, these include cell membrane components and intracellular 
components. The regulation of many ions across the cell membrane is highly controlled 
though ion channels. Some of these ion channels have been found to activate or deactivate 
when the cell is exposed to mechanical stretch (Campbell et al., 2008). The importance of 
these ion channels has been shown with cyclic tensile loading of MSCs, by blocking the ion 
channels through the stretch-activated ion channel inhibitor gadolinium chloride, it was 
found that proteoglycan production was significantly decreased (McMahon et al., 2008).  
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Integrins detect the deformation to the ECM through binding sites with multiple or single 
ECM components. The response of the integrin to the mechanical stimuli has little direct 
control over the cell behaviour, instead the mechanical signals transmitted to the integrin 
from the ECM results in the formation of protein complexes that in turn trigger signalling 
cascades within the cell  (Giancotti and Ruoslahti, 1999). Integrins help to regulate cell-ECM 
interaction, cadherins help to regulate cell-cell interactions. The cadherins bind to other 
cadherins on other cells in a homophilic manner extracellularly, whilst also binding to the 
actin cytoskeleton intracellularly, this allows the cells to interact with other cells in response 
to mechanical stimulation, therefore directing the cell populations differentiation (Steward 
and Kelly, 2015). 
The cell membrane mechanoreceptors transmit the mechanical stimuli to intracellular 
sensors. One of the key responders is the actin-rich stress fibres which bind to the 
transmembrane integrins at prominent membrane-substratum adhesion sites known as 
focal adhesions (Burridge et al., 1988). The stress fibres are myosin associated, contractile 
bundles of filamentous actin that assemble in stress sensing cells (Wong et al., 1983). The 
application of mechanical stresses results in the remodelling of the actin skeleton and thus 
the focal adhesion sites. The intracellular response leads to a number of signal transduction 
pathways including kinase activation (Akt, MAPK and FAK) and β-Catenin. MAPKs are 
serine/threonine protein kinases which are essential to mechanosensing, for example 
ERK1/2 is necessary for strain response by osteoblasts (Rubin et al., 2002), and without, 
osteogenic differentiation of MSCs through TGF-β is not possible (Arita et al., 2011). The 
interaction of different intracellular responses results in different cell fate, for example 
mechanical activation of Akt (a serine/threonine kinase) increases β-Catenin activation 
which results in inhibited adipogenic differentiation of MSCs (Sen et al., 2008). Further focal 
adhesion kinases are concentrated near focal adhesions and are associated with a number 
of signalling proteins including phosphatidylinositol 3-kinases (PI3K), and paxillin (Cukierman 
et al., 2001, Hehlgans et al., 2007). Through interactions with these signalling proteins, the 
focal adhesion kinases form a functional network of integrin stimulated signalling pathways 
that result in downstream activation of the MAPK pathways (Chatzizacharias et al., 2008). 
Extra and Intracellular mechanotransduction is a complex process that involves a number of 
cell membrane mechanoreceptors and the activation of multiple signalling pathways. 
Through the appropriate activation the MSC begins to differentiate down a specific lineage 
and, under the right conditions, results in the further activation of signalling pathways and 
maturation of the cell within the lineage. 
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The 3D culture of MSCs has been routinely used to investigate the role of mechanical 
stimulation in a controlled research environment. Different types of mechanical stimulation 
has been applied to 3D MSCs culture generating different differential responses from the 
cells. Tensile stimulation has been shown to upregulate osteogenesis and tenogenesis whilst 
inhibiting adipogenesis (Simmons et al., 2003, Sen et al., 2008). Studies have shown that the 
amount of tensile strain applied can drive the type of differentiation seen, with 3% being 
shown to favour osteogenic differentiation and 10% tenogenic differentiation both seeing 
increases in COL1A1 and osteogenic or tenogenic markers (Altman et al., 2002, Chen et al., 
2008, Zhang et al., 2008, Jagodzinski et al., 2004). The profile in which the tensile stimulation 
is applied has been shown to be critical in the long term differentiation of the cells with 
constant force of 6.7 N leading to a reduced production of collagen after 21 days compared 
to the unloaded scaffold, suggesting cyclic loading is essential to targeted differentiation. 
Hydrostatic pressure has been used to drive the chondrogenic and osteogenic differentiation 
of MSCs, again it has been shown that the rate and level at which the force is applied results 
in varying effects of the MSCs. Chondrocytes are typically exposed to high magnitudes of 
hydrostatic pressure (>1 MPa) (Zhang et al., 1998), loads lower than what is seen in 
chondrogenesis have been shown to upregulate osteogenic markers ALP and RUNX2, 
suggesting the MSCs are differentiating down the osteogenic lineage (Liu et al., 2009a). 
Increasing the level of hydrostatic pressure has been found to induce chondrogenic 
differentiation, Saha et al. (2017) found that 1 MPa saw upregulation of SOX9, and the 
downregulation of COL10A1, indicating that not only was hydrostatic pressure driving the 
chondrogenic differentiation but also inhibiting hypertrophy. Higher levels of hydrostatic 
pressure, 10 MPa, has again been shown to drive chondrogenic differentiation with increases 
in GAG production and collagen II synthesis (Steward et al., 2014). It appears that lower levels 
of either tensile loading or hydrostatic pressure favour osteogenic differentiation, whilst 
higher results in different forms of differentiation, demonstrating the variable role 
mechanical stimulation can play in the differentiation of MSCs in 3D culture.  
The multiple lineage potential coupled with the well-established response to mechanical 
stimulation of MSCs has made the cell an ideal candidate when investigating tissue 
engineering of different musculoskeletal tissues. Within this study the generation of tissue 
engineered bone, tendon and cartilage has been investigated through the application of 
tensile stimulation (tendon) and hydrostatic pressure (bone and cartilage). An review of the 





Tendons are dense, organised, fibrous soft tissues that connect muscle to bone. The primary 
function of tendon is transmitting force produced by muscle to bone enabling joint motion 
(Robert et al., 1974). Whilst tendon encompasses a wide range of tissues found throughout 
the body each specific tendon has differences (e.g. composition and shape) that help it to 
adapt to the environment it is located in (Sharma and Maffulli, 2006, Thorpe et al., 2010, 
Thorpe et al., 2014). For example the human Achilles tendon and the equine superficial 
digital flexor tendon (SDFT) require energy storage properties. Therefore whilst the primary 
function of tendon is force transmission, the conflicting functions, including tensile 
resistance and energy storage, requires a specialised structure. Tendon is mainly composed 
of water, which accounts for 55-70% of the wet weight (Gomes et al., 2015). The major ECM 
component is collagen, accounting for 60-85% of the dry weight which enables the tendon 
to withstand high strain rates and prevents the loss of contractile energy during movement 
(Kjaer, 2004). The presence of a viscous matrix enables the collagen fibres to slide and 
provides the tendon with an increased range of movement and viscoelastic properties 
(Shepherd and Screen, 2013).  
1.4.2. Structure 
Tendons are composed of a complex hierarchical structure (Fig.1.3), surrounding the tendon 
is the paratenon and epitenon whilst the endotenon resides within, these are the main blood 
vessel and nerve containing regions. The paratenon is the outer most structure and is 
composed of loose connective tissue. It is found away from joints and facilitates movement 
in the subcutaneous position. The epitenon surrounds the collagen fascicles and is a layer of 
connective tissue that is continuous with the endotenon, also known as the interfascicular 
matrix (IFM) (Thorpe et al., 2015) . Whilst the paratenon and epitenon contain the majority 
of the blood vessels and nerves a percentage does reside within the fascicles, this number 
varies between tendon types, for examples the human Achilles tendon has regions of high 
vascularisation (insertion and origin points) with avascular regions (the mid region) 
(Theobald et al., 2005). The primary cell found in tendon is the tenocyte (a tendon specific 
fibroblast) and is thought to account for approximately 95% of the cells with endothelial cells, 
progenitor cells and chondrocytes making up the other 5% (Franchi et al., 2007). Tenocytes 
are thought to derive from a mesenchymal origin with the progenitor cell differentiation 
regulated by a number of transcription factors including Six1, Six2, EphA4, Eya2, follistatin, 
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tenascin, mohawk and scleraxis (Aslan et al., 2008, Jelinsky et al., 2010). The tenocytes are 
either located as groups in the IFM between the collagenous fascicles or within the 
collagenous fascicles. The tenocytes found in the IFM (termed interfascicular tenocytes) are 
relatively plump and round whilst those within the fascicles (termed intarfascicular 
tenocytes) are elongated with an extended nuclei and a complex network of cytoplasmic 
processes extending through the ECM to other tenocytes via gap junctions (McNeilly et al., 
1996). The tenocyte’s role is to produce the relevant ECM as well as repair and maintain the 
tendon tissue (Franchi et al., 2007, Kannus, 2000). 
Figure 1.3. Schematic of the hierarchical structure of collagen in tendon. Captured from 
Nourissat et al. (2015). 
1.4.2.1. ECM of Tendon 
Whilst the ECM of tendon is composed mostly of collagen other molecules also reside within 
this space. Proteoglycans are the predominant class of glycoproteins and are classified into 
two groups, the small leucine-rich proteoglycans (SLRPs) and the large aggregating 
proteoglycans (Parkinson et al., 2011). Of the proteoglycans, the SLRP decorin is the most 
common accounting for 80% of the proteoglycan content in tendon (Samiric et al., 2004a, 
Thorpe et al., 2013), other SLRP include biglycan, fibromodulin, lumican and keratocan (Rees 
et al., 2009). These proteoglycans are prevalent in collagen-rich tissues, with a horseshoe 
shaped protein core featuring a leucine-rich repeat which is involved in binding to collagen 
(Henry et al., 2001, Vogel et al., 1984, Hedbom and Heinegard, 1989, Rada et al., 1993). The 
SLRPs have been shown to help regulate collagen organisation (Danielson et al., 1997). 
Aggrecan and versican are the large aggregating proteoglycans found in the tendon (Vogel 
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et al., 1994, Campbell et al., 1996, Rees et al., 2000, Samiric et al., 2004b). Due to the 
negatively charged glycosaminoglycan (GAG) chains attached to the core proteins of the 
large aggregating proteoglycans, they have the ability to attract and bind water within the 
ECM of tendon aiding the biomechanical properties, particularly the compressive properties 
(Rees et al., 2002, Marcelino et al., 1999, Rhee et al., 2005). Other non-collagenous proteins 
include elastin, link protein, cartilage oligomeric matrix-protein, tenascin-C fibronectin, 
tenomodulin, COMP, lubricin, undulin and thrombospondin-1 (Thorpe et al., 2013, Kannus, 
2000, Parkinson et al., 2011). These proteins are involved in matrix-matrix, cell-matrix 
organisation or cell-matrix signalling (Parkinson et al., 2011). 
1.4.2.1.1. Collagens of Tendon 
The most prevalent component of the tendon ECM is collagen and as with every tissue the 
composition of collagen types found in tendon is specific to tendon. Collagen types I, III, V, 
XI, XII and XIV make up the tendon collagen composition (Riley et al., 1994, Thorpe et al., 
2013) with type I accounting for 95% of the collagen in tendon (Screen et al., 2015). Within 
tendon there are two collagen subcategories, fibril forming (I, II, III, V, XI) and FACIT (XII and 
XIV). The fibril forming collagens are secreted into the ECM by the tenocytes and 
spontaneously assemble into parallel fibrils stabilised by intra and intermolecular covalent 
crosslinking (Anttinen et al., 1977, Canty and Kadler, 2005). These fibrils bunch together 
forming the fibres which form the fascicles and finally the tendon (Fig.1.11). Collagen type I 
fibrils are the main contributor to the tendons mechanical properties providing the tendon 
with tensile strength. The other collagens within the ECM all play an important, and often 
overlooked, role to maintain tendon homeostasis. Collagen type III is the second most 
abundant collagen in the tendon ECM, accounting for up to 10% of the total collagen content 
(Kadler et al., 1990). Type III is always associated with type I collagen and forms smaller 
diameter fibrils than type I (Rees et al., 2002). Type III is found in high concentrations at 
wound sites (Voleti et al., 2012) and in the vascular wall (Buckley et al., 2013). Elaborating 
from the prevalence of type III suggests that type III fibrils have greater flexibility than the 
type I fibrils, therefore increasing the tendon’s flexibility (Parkin et al., 2017). However an 
increased ratio of type III to type I in the tendon is seen with ageing and increased pathology 
(Smith et al., 1999, Goncalves-Neto et al., 2002).  
Type V and XI act as regulatory collagens within the structure. Collagen type V is mostly 
located in the core of collagen I fibres and plays a critical role during the early process of fibril 
nucleation, type I fibre diameter regulation and organisation (Connizzo et al., 2015). The 
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collagen V fibrils incorporate into the collagen I fibres, with the triple helix present in the 
core of the fibre and the N-terminal propeptides (containing a thrombospondin or von 
Willebrand factor C domain) extending outward to the gap zone of the collagen I structure. 
Through interactions with the exposed N-terminal the collagen V fibrils help to regulate the 
collagen I fibre development (Birk, 2001). A reduction in collagen V fibrils sees a reduction in 
overall fibres and an increased fibre diameter, resulting in a major change to the mechanical 
properties of tendon (Segev et al., 2006, Wenstrup et al., 2011, Sun et al., 2015). Collagen 
type XI is expressed in developing tendons and plays a similar role to collagen type V 
(Wenstrup et al., 2011). Similarly to collagen type V, type XI’s triple helix is located in the 
core of the collagen I fibre and the N propeptides extends outward to the gap, the N 
propeptides contains a thrombospondin like domain and is thought to inhibit lateral growth 
as well as regulate fibril assembly (Seet et al., 2017). Type V and XI are structurally and 
functionally homologous and are now considered a single collagen type with multiple tissue-
specific isoforms (Hoffman et al., 2010).  
The two FACIT collagens (XII and XIV) share a similar role within the tendon though feature 
different expression patterns during tendon development (Zhang et al., 2005). Both FACIT 
collagens bind to the surface of the collagen fibrils and due to the large globular N-terminal 
domains interact with other components of the tendons ECM. Type XII has been shown to 
be expressed throughout tendon development and into adulthood though the expression is 
significantly decreased in adulthood (Zhang et al., 2003, Walchli et al., 1994, Gordon et al., 
1996). Type XIV is involved in linear fibril growth (Zhang et al., 2005) by limiting the fibril 
diameter through the prevention of lateral fusion of adjacent fibrils through interaction 
between one of the non-collagenous terminals and collagen I fibrils, and has been shown to 
be highly expressed during embryogenesis before a sharp decrease in expression (Young et 
al., 2000, Young et al., 2002). Type XIV interacts with other ECM components such as collagen 
IV, heparin and decorin (Brown et al., 1993) and various mesenchymal and epithelial cells 
(Ehnis et al., 1996). 
1.4.3. Mechanical Properties 
Tendons are predominantly loaded along the long axis in tension, however some tendons 
have the additional role of energy storage to aid in locomotion (Biewener, 1998). Uniaxial 
tensile testing gives an insight into the tendon’s mechanical properties. Fig.1.4 shows a 
typical stress-strain curve for tendon, depicting the typical non-linear response as four 
distinct regions. The initial region is known as the toe region. As the tendons structure is 
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primarily made of collagen type I the elasticity of the structure is relatively low (though 
higher for energy storing tendons). To overcome this limitation the collagen fibrils arrange 
into a crimp structure, as loading is applied the crimp straightens out and there is some 
reordering of the collagen fibres until it is aligned in the direction of loading, resulting in a 
period of relatively high elongation for low stress (Screen et al., 2004). Following the toe 
region is the heel region. Here the stiffness begins to rise due to further reordering of the 
collagen fibrils and straightening of kinks in the gaps of the D period (Misof et al., 1997). 
Once the collagen fibres are appropriately arranged the response enters the linear region. 
Here due to the composite structure of tendon (collagen and proteoglycans) the matrix 
undergoes a combination of extension and sliding of the collagen fibres (Screen, 2009). 
Eventually the load becomes great enough that the tendon begins to fail, usually seen as a 
pulling apart of collagen fibres, resulting in a gradual decrease in the recorded force rather 
than a sudden breakage (Screen et al., 2004).  
Figure 1.4. Schematic stress-strain curve for tendon. The toe region, heel region, linear 
region and point of failure have been highlighted and typical strains at each region shown. 
Due to its structure and composition tendon is a viscoelastic material, therefore a tendon 
exhibits both viscous and elastic mechanical behaviour. This results in the mechanical 
properties of the tendon being rate of force dependant. Viscoelastic properties can be 
observed through hysteresis, creep and stress relaxation, all three properties apply some 
form of load to the sample for a set period of time and demonstrate how the materials 
response changes with time.  
Hysteresis is shown by applying a load to a sample over a period of time and then unloading 
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identical loading and unloading curve, whereas a viscoelastic materials unloading curve will 
not follow the loading curve (Fig.1.5.Aii), the area between the loading and unloading curve 
is the energy lost during the loading cycle. In tendon, hysteresis is thought to occur due to 
the movement of water through the tissue and the reordering of the fibre structure (Thorpe 
et al., 2013).  
Creep is tested for by applying a constant load to the sample and the extension is monitored 
over a set period of time (Fig.1.5.Bi). If the sample is viscoelastic the material will continue 
to elongate until it fails despite no increase in load or the recorded extension stabilises 
(Fig.1.5.Bii).  
Stress relaxation is shown by displacing the sample by a fixed amount over a set period of 
time (Fig.1.5.Ci), and measuring the change in force. A typical viscoelastic response will see 
the stress decrease until it levels off and reaches equilibrium (Fig.1.5.Cii).  
Figure 1.5. Schematic of viscoelastic loading regimen graphs (Ai, Bi and Ci) and viscoelastic 
material response graphs (Aii, Bii and Cii). Viscoelastic hysteresis data points taken from 
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1.4.4. Tendon Tissue Engineering 
Tendons are susceptible to injury during overuse and overloading particularly in athletes, 
this can lead to pathological changes within the tendons structure that results in 
tendinopathy (Kaux et al., 2011). Due to the poor vascular supply in tendons repair following 
rupture is slow and leaves an impaired structure. The most common technique used to repair 
ruptured tendons is primary suture (Fig.1.6) or autologous transfer, however these 
techniques result in reduced mechanical strength of the tissues due to scar formation, 
infection, donor site morbidity and limited availability of autografts (Glass et al., 2014). 
Tissue engineered tendon therefore offer a potential alternative for the current gold 
standard. Alternatively improved tissue engineered tendon (closer to native tissue) gives 
researchers an in vitro model that can be used to investigate drug approaches, rehabilitation 
or cell therapies.  
Figure 1.6. Suture repair of torn patellar tendon. Holes are drilled into the kneecap and 
sutures are threaded through the tendon and into the holes to pull the tendon back into 
position. Adapted from (Wilkerson, 2016). 
The natural polymer is fibrin is one of the most widely used biomaterials for tendon tissue 
engineering, Breidenbach et al. (2015) showed that after 2-3 weeks the cells degrade the 
fibrin scaffold and replace it with collagen fibrils, this also shows an improved mechanical 
strength compared to collagen scaffolds. Yeung et al. (2015) showed that the collagen fibrils 
generated during collagen gelation are random in size and orientation whilst the collagen 
fibrils generated by cells in both fibrin and collagen hydrogels are narrow and aligned to the 
long axis of the structure. The cells in the collagen hydrogel appear stellate in shape with 
numerous projections similar to a 2D culture, whilst the cells in fibrin hydrogels appeared 
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more similar to in vivo, with cylindrical shape aligned to the loading axis. Therefore fibrin is 
a better model for tendon development. 
An alternative natural polymer is collagen type I which is frequently used as it is the primary 
biological component of the tendon’s ECM (Young et al., 1998, Awad et al., 1999, 
Bagnaninchi et al., 2007), and has shown to increase healing and function in damaged rabbit 
Achilles when seeded with MSCs (Young et al., 1998). However the initially formed structure 
is not aligned and instead made up of randomly orientated fibrils with impaired mechanical 
strength compared to native tendon (Bagnaninchi et al., 2007). Hybrid structures have been 
utilised to overcome some of these issues using other natural and synthetic polymers, this 
includes a collagen-silk (Chen et al., 2010), collagen-GAG (Caliari et al., 2011) and collagen-
poly(l-lactide-co-ɛ-caprolactone) (Xu et al., 2013), all having seen increased mechanical 
strength and alignment compared to solely collagen structures. 
In tissue engineering, tenocytes, fibroblast and MSCs have been the most widely used cell 
type (Engebretson et al., 2015). MSCs have been shown to be the better option as, whilst 
tenocytes do produce the correct ECM they proliferate at a much slower rate than MSCs. 
Tenocyte seeded Polyglycolide (PGA) fibres have been shown to generate high amounts of 
ECM after 10 weeks but do not have a high mechanical strength (Cao et al., 2004). When the 
tenocyte seeded PGA scaffold where implanted into rabbits the structure began to resemble 
that of native tendon however the PGA generated an immune response (Cao et al., 2002). 
Alternatively MSC seeded collagen scaffolds have shown a positive increase in mechanical 
strength but do not show improved cell morphology or alignment suggesting limited 
tenogenic differentiation (Awad et al., 1999). To further drive the differentiation and ECM 
production chemical and mechanical stimuli have been applied to the tissue engineered 
tendons. 
Whilst most tissues receive a range of mechanical forces tendons mostly undergo stretch 
and relaxation as they transfer loads from the muscle to the bone (Kannus, 2000). The most 
common in vitro force applied to tissue engineered tendon is tensile stimulation which is 
normally applied in the longitudinal direction (Calve et al., 2004). Mechanical stimulation is 
applied using bioreactors, this can be either to 2D monolayers or 3D cell cultures (Fig.1.7). 
Appropriate mechanical stimulation for human tendons has been proposed to be up to 6% 
strain, above this strain rate the tendon ECM begins to degenerate (Wang, 2006). This has 
been supported with in vitro studies showing improved cell morphology with 5% strain at 
1Hz (Sensini et al., 2019) and increased expression of tendon specific markers; scleraxis, 
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tenascin C, collagen I, collagen III, tenomodulin and VEGFA with 4% strain at 0.5Hz (Wu et 
al., 2017). However degenerative strain rates (>6%) have shown to increase the production 
of tendon degenerative markers, the study by Wang et al. (2003a) saw an increase in 
cyclooxygenase 1 and 2, prostaglandin E2 which are related to tendon inflammation when 
the tendons were strained at 12%. Further 9% strain has been shown to significantly increase 
the c-Jun N-terminal kinase pathway activation, which can lead to apoptosis (Arnoczky et al., 
2002), separately Kearney et al. (2008) showed that 7.5% strain resulted in increased rates 
of apoptosis. 
Figure 1.7. Image of tissue engineered tendon in stretch bioreactor. MSCs seeded onto a 
decellularised tendon and subjected to 24hrs of uniaxial stretch. Adapted from (Burk et al., 
2016). 
Currently no study has produced a tissue engineered tendon that has been adopted widely 
for tendon repair surgery, however progress has been made through the investigation of 
different cell sources, a variety of scaffolds and the stimuli used during cell culture giving a 
more complete understanding of how these cells proliferate, differentiate and produce ECM 
for tendon regeneration, though more still needs to be done. Whilst the tissue engineered 
tendon is becoming a more usable tool, further studies are required to confirm the long-
term usage and biosafety of the structure before it can be considered for tendon repair. The 
application of mechanical stimulation for tendon tissue engineering is proving to be 
essential. With induced differentiation of cells towards tenocytes, improved mechanical 
properties and upregulation of tendon specific markers, the use of tensile stimulation has 
been shown on multiple occasions to promote the regeneration of the tendon ECM (Carroll 
et al., 2017, Wu et al., 2017, Sensini et al., 2019). Whilst progress is being made important 
markers within the ECM are not being investigated, these include the complete collagen 










a skewed view of what is being generated is being established, for example only investigating 
the collagen I concentration is not effective if none of the regulatory collagens (V, XI, XII, or 
XIV) are investigated as the collagen I may be forming in-correctly, rendering the tissue 
useless. The field of tendon tissue engineering is promising, though no one protocol has 
proven to be optimal for the tissue generation, continued development of the biomaterial 
selection, media formulation and culture dynamics are required to create a truly effective 





The adult bone can be split into two main types, the cortical bone and trabecular bone 
(Mizokami et al., 2017) with the structure containing three main compartments, the 
extracellular organic matrix, bone cells and extracellular minerals (An and Martin, 2003). The 
conventional function of bone is to act as a static support structure for organs that govern 
the body’s movement (An and Martin, 2003). Cortical bone forms at sites of high load and is 
therefore very dense, it provides support for locomotion and other motor functions. 
Conversely trabecular bone is far less dense, forming the inner core of long bones and cranial 
plates and being in closer contact with vascular spaces (Li et al., 2017a). 
Whilst the conventional functions have long been known more recent studies have eluded 
to a wider-ranging role for bone to help maintain the body’s homeostasis, these roles 
(termed extraskeletal functions) include haematopoiesis, immune activity, energy 
metabolism and brain function (Asada et al., 2015, Han et al., 2018). The extraskeletal 
functions are mediated by bone-derived factors. 
1.5.2. Structure 
Bones are formed by the process of either endochondral or intermembranous ossification. 
Flat bones (calvariae of the skull, mandible or maxilla) form by intramembranous ossification, 
where MSCs differentiate directly into bone cells generating the bone ECM immediately 
(Ralston, 2017). Alternatively other bone forms by endochondral ossification, here an initial 
cartilage template forms before vascular tissue develops containing osteoprogenitor cells, 
the cartilage is then replaced by mineralised tissue at the middle and ends of developing 
bones. The growth plate (or epiphyseal plate), a thin layer of cartilage, is present throughout 
childhood and regulates the growth of the bone, here chondrocytes divide in the 
proliferation zone and migrate towards the centre of the bone where they enlarge and form 
hypertrophic chondrocytes in the hypertrophic zone. The hypertrophic chondrocytes 
subsequently die and the surrounding matrix calcifies before being removed by osteoclasts 
and are replaced with mature bone, this process stops during puberty as hormones prevent 
the chondrocyte cell division from occurring (Ralston, 2017). 
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From the developing bone two main structural types form, the trabecular and cortical bone. 
Woven bone is a third less common type which forms during development and at wound 
sites but does not require a preliminary cartilage template and therefore forms quickly, 
however this results in a weak structure that is replaced by cortical or trabecular bone 
(Sommerfeldt and Rubin, 2001). Trabecular bone is made up of plates and rods which 
generate a honeycomb structure (Fig.1.8) providing adequate structural support (Khurana, 
2009).  
Figure 1.8. Schematic of the interior of cortical and trabecular bone (Adapted from Whedon 
and Heaney (2019)). 
Bone marrow and blood vessels reside within the trabecular bone which has a lower calcium 
content and greater water content than cortical bone, allowing trabecular bone to act as a 
shock absorber that transfers the mechanical loads from the articular surface to the cortical 
bone (Ott, 2018). Trabecular bone does not possess the same strength as cortical bone as it 
is not as compact and dense. This more porous structure gives trabecular bone a much 
greater surface area resulting in a higher turnover compared to cortical bone (Parfitt, 2002). 
Cortical bone is composed of densely packed fibrils which form concentric lamellae that in 
turn form cortical osteons. Between the lamellae reside the lacunae, here osteoblasts 
become trapped within their secreted mineralised tissue and differentiate into less active 
osteocytes (Sommerfeldt and Rubin, 2001, Clarke, 2008, Bilezikian et al., 2008, Bonewald 










Haversian canal. Blood vessels and nerves feature within the Haversian canal and through 
connections form the Volkmann’s canals (Fig.1.8). It is via these connections that the 
osteocytes communicate within the bone, utilising the canaliculi. Through these connections 
the osteocytes acts as mechanosensors and help regulate the remodelling of the bone 
(Florencio-Silva et al., 2015). The high density of cortical bone imbues it with high mechanical 
strength and generates the protective functions of the tissue (Bilezikian et al., 2008).  
1.5.2.1. ECM of Bone 
The ECM of bone is, as with all tissue, a collection of components that each provide the tissue 
with specific functions. Within bone the ECM provides mechanical stability, cell-cell 
communication (Fan et al., 2014), acts as a repository for growth factors (ten Dijke and 
Arthur, 2007, Zhu and Clark, 2014, Wang et al., 2008) and offers the driving force for 
organogenesis (Sakai et al., 2003). Three main cell types reside within bone, the osteoblasts, 
osteoclasts and osteocytes. The ECM of bone therefore needs to provide the appropriate 
environment for these cell types to function efficiently. Bone is formed through the 
deposition of calcium phosphate onto a collagenous matrix by the osteoblasts. The calcium 
phosphate deposition is regulated through the crosslinking of the collagen fibres which is 
provided by lysyl oxidase (LOX) (Wassen et al., 2000, Bailey et al., 1993). The density of the 
bone is therefore regulated by the LOX-mediated intra/intermolecular covalent crosslinking 
of collagen and elastin (Knott and Bailey, 1998). Transversely the density of bone can be 
reduced via the activity of the osteoclasts. Here hydrogen ions and cathepsins/matrix 
metalloproteinases (MMPs) are secreted into the ECM and result in bone reabsorption (Blair 
et al., 1989, Vaananen et al., 2000, Oxlund et al., 1995). Bone homeostasis is therefore 
achieved through appropriate osteoblast and osteoclast activity.  
The ECM of bone is made up of organic (40%) and inorganic compounds (60%) (Lin et al., 
2020). The main inorganic compound is hydroxyapatite (Ca5(PO4)3OH) (Ramesh et al., 2018), 
whilst the organic compounds are mainly collagen (90%) with small amounts of non-
collagenous proteins (10%). Hydroxyapatite is deposited during biomineralisation, this 
process is controlled by interactions between matrix and minerals such as amino acids 
present in non-collagenous proteins and sees hydroxyapatite deposited onto a collagenous 
matrix (Fig.1.9) (Lin et al., 2020). 
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Figure 1.9. Schematic of collagen I fibril with hydroxyapatite crystals occupying the gaps 
generated by the staggered arrangement of the collagen triple helices (collagen green, 
hydroxyapatite crystals yellow). 
The non-collagenous proteins can be classified into four groups: !-carboxyglutamate-
containing proteins, proteoglycans, glycoproteins and small integrin-binding ligands N-linked 
glycoproteins (SIBLINGs) (Paiva and Granjeiro, 2017). The !-carboxyglutamate-containing 
proteins include osteocalcin which is specifically expressed by osteoblasts and contains three 
Gla residues enabling osteocalcin to bind to calcium and regulate calcium metabolism by 
mediating its association with hydroxyapatite (Mizokami et al., 2017). Periostin is mainly 
secreted by osteoblasts in long bones (Wen et al., 2018) and is an adhesion molecule 
required for collagen fibrillogenesis and to maintain bone strength (Wen 2018). Matrix Gla 
protein (MGP) is synthesised by osteoblast, osteoclasts and chondrocytes and is involved in 
inhibiting bone formation and mineralisation (Kaipatur et al., 2008).  
SLPRs play a major role in the bone ECM by interacting with cell surface receptors and 
cytokines to regulate normal and pathological cellular behaviour (Lin et al., 2020).  Biglycan 
and decorin are class I SLPRs and are both required for collagen fibrillogenesis and bone 
formation (Moorehead et al., 2019, Coulson-Thomas et al., 2015). Biglycan is expressed 
during cell proliferation and mineralisation whilst decorin is continuously expressed from the 
initial bone matrix deposition (Lin et al., 2020). Keratocan, mainly expressed by osteoblasts, 
promotes the mineral deposition rate and helps to regulate bone formation (Coulson-
Thomas et al., 2015). Asporin binds to collagen type I fibrils and promotes collagen 
mineralisation (Kalamajski et al., 2009).  
The glycoproteins include osteonectin, thrombospondin and r-spondins. Osteonectin is 
highly expressed by osteoblasts and through binding to collagen and hydroxyapatite crystals 
helps to regulate the release of calcium, therefore influencing the mineralisation of collagen 
(Rosset and Bradshaw, 2016). The thrombospondin family comprises of TSP1 to TSP5, is 
expressed by osteoblasts during bone development and has been shown to have an 
involvement in cell differentiation and the maintenance of bone mass (Delany and 
Hankenson, 2009, Hankenson et al., 2000). R-spondins are widely expressed throughout 
bone formation and maintenance and can be split into four groups (Rspo1-4) (Lin et al., 
2020). R-spondins reinforces the wingless-type MMTV integration site (Wnt)/β-catenin  
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signalling pathway through leucine-rich repeat-containing G-protein-coupled receptors 4, 5, 
and 6 (Lgr4/5/6) and therefore act as regulators for bone development and remodelling (Shi 
et al., 2017). 
Finally the SIBLINGs are found predominantly in mature bone and include bone sialoprotein 
(BSP), osteopontin (OPN), dentin matrix protein-1 (DMP1) and matrix extracellular 
phosphoglycoprotein (MEPE). BSP is required for osteoblast differentiation and initiation of 
matrix mineralisation (Marinovich et al., 2016). Similarly OPN help to promote bone 
formation, mineralisation and remodelling, during which OPN regulates osteoclastogenic 
and osteoclast activity which contributes to bone formation and resorption (Singh et al., 
2018). DMP1 and MEPE are mainly expressed by fully differentiated osteoblasts and have 
been show to regulate phosphate metabolism and matrix mineralisation (Zelenchuk et al., 
2015).  
1.5.2.1.1. Collagens of Bone 
The main organic component of bone is collagen, specifically collagen type I (accounting for 
90% of the collagens). As with other tissue multiple types of collagen occur within the bones 
ECM and all offer an important role to maintain the bones homeostasis throughout its life 
cycle. The collagen matrix in bone is very dense, aiding the bones mechanical and structural 
properties (Tzaphlidou, 2008). The other fibrillar collagens along with type I that occur in 
bone are type II, III, V, XI and XIV, the FACIT collagens are type IX, XII and XIV whilst type VI 
occurs as the microfibrillar collagen and type X as the Hexagonal network-forming collagen 
(Tzaphlidou, 2005). The collagen type I arrangement in bone is not as uniformly distributed 
as in tendon, though it does maintain a regular parallel pattern (Tzaphlidou, 2008). The 
collagen type I fibrils form the classical banding pattern where gaps form due to the 
staggered arrangement. In bone the collagen fibrils mineralise due to the formation of 
hydroxyapatite crystals in the gap regions (Fig.1.9). These hydroxyapatite crystals grow and 
interlink generating a interpenetrating organic-inorganic nanocomposite (Hansma et al., 
2006). Collagen type I does not itself induce the hydroxyapatite nucleation (Glimcher, 1989), 
here other components of the ECM, such as osteonectin (Clarke, 2008), drive the process of 
fibril mineralisation whilst the collagen I fibrils act as templates (Tomoaia and Pasca, 2015). 
Collagen type III occurs in small concentration in bone and similarly with tendon, is 
associated with collagen type I fibrils. In bone collagen type III has been shown to play a key 
role in skeletal development especially in the growth acceleration of osteoblasts (Maehata 
et al., 2007) and the preservation of osteogenic differentiated mesenchymal stem cells (Chen 
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et al., 2007). Collagen type V appears to play a regulatory role for the collagen fibres forming 
in the centre of the collagen I fibril bundles and working to organise the orientation and 
diameter. This is achieved via the collagen V fibril extending to the surface of the collagen I 
fibre, limiting the growth of the fibrils (Mak et al., 2016). A hybrid of collagen type V and XI 
has been shown in the bone ECM with the triple helix structure of [α1(XI)2]α2(V) (Niyibizi and 
Eyre, 1994), demonstrating the shared regulatory role of collagen V and XI in the bone ECM. 
The fibril forming collagen, type XXIV appears in the developing bone’s ECM and has been 
shown to represent a marker for osteoblast differentiation and bone formation (Wada et al., 
2006, Matsuo et al., 2008). Type XXIV is predominantly expressed in tissues containing type 
I and V, though its biological role has not yet been elucidated (Karsdal, 2019, Misawa et al., 
2014). 
Collagen type VI is a microfibril collagen and is located in the pericellular matrix (PCM). It is 
particularly present in the PCM of chondrocytes and therefore is thought to aid in the 
endochondral ossification of the growth plate (Alexopoulos et al., 2009). It has also been 
shown to feature in the PCM of pre-osteoblasts migrating to bone-forming sites (Izu et al., 
2016). Due to the globular domain collagen VI interacts with multiple components of the 
ECM (Chen et al., 2015, Doane et al., 1998, Howell and Doane, 1998) enabling cell-matrix 
interactions and has been shown to interact with collagen XII during the formation of bone 
(Izu et al., 2016). 
The FACIT collagens type XII and XIV operate in bone in a similar way as in tendon. In dense 
connective tissue both type XII and XIV bind to collagen I fibrils via the collagenous domain 
and helps to regulate the organisation of the fibril bundles through the large non-collagenous 
arm and its interactions with other ECM components (Chiquet et al., 2014). The two 
collagens have been shown to have temporal expression, with type XIV being expressed in a 
few specific areas during embryonic development whilst type XII is more widely expressed 
and continues to be so throughout bone development (Walchli et al., 1994). Collagen XII has 
been previously shown to localise at bone-forming sites with collagen XII deficient mice 
showing impaired osteoblast arrangement and therefore reduced bone mass and strength 
(Izu et al., 2012). 
Collagen type II, IX, X and XI are the characteristic collagens of cartilage and are covered in 
more detail in section 1.6.2.1.1 of this chapter. Type X is produced by hypertrophic-
preossifying cartilage, therefore this collagen is highly expressed before endochondral 
ossification. Collagen IX binds to surface of collagen II fibrils, the major collagen fibrils found 
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in cartilage. The collagen II fibrils generate an appropriate environment for the chondrocytes 
to operate and the growth plate to develop. Collagen IX offers an attachment site for other 
components of the ECM (Pihlajamaa et al., 2004, Tillgren et al., 2009, Parsons et al., 2011). 
Type XI, like type V, forms fibrils in the core of the collagen II fibres which extend to the 
surface, the extension features a thrombospondin-like domain which works to maintain the 
space and diameter of the collagen II fibrils (Kadler et al., 2008). Collagen type X is secreted 
into the ECM by hypertrophic chondrocytes, and in healthy tissue is localised to the calcifying 
zone of the growth plate. The collagen X multimer assembles into a hexagonal lattice which 
is thought to play a role in endochondral ossification by facilitating the process of 
calcification and the normal distribution of matrix vesicles and proteoglycans (Kwan et al., 
1991, Chan et al., 1995, Kwan et al., 1997). Type X deficiency results in abnormal trabecular 
bone production in mice (Kwan et al., 1997) and therefore appears to play a major role in 
the transition between cartilage to bone, though its exact role is still yet to be determined 
(Shen, 2005). 
1.5.3. Cells of the Bone 
Osteoclasts, osteoblasts and osteocytes are the main cells types found in bone and other 
mineralised tissue. To achieve homeostasis all the cells types must work optimally, balancing 
the deposition and reabsorption of the mineralised tissue.  
Osteoblasts are the bone forming cells, are mononucleated and derived from mesenchymal 
stem cells (MSCs) (Komori, 2006, Chen et al., 2016, Modder and Khosla, 2008, Liu et al., 
2009c). Osteoblasts generate bone through the synthesis and secretion of bone ECM 
proteins which in turn enable the mineralisation of the ECM (Huang et al., 2007). The pre-
osteoblasts bind through integrins to vitronectin generating a monolayer linked by cadherins 
(Schneider et al., 2001, Ferrari et al., 2000), the osteoblasts, once activated, then secret bone 
ECM proteins in order to generate bone (Fig.1.10). The osteoblasts secret ectoproteins 
including, tissue-nonspecific alkaline phosphatase (TNAP) which hydrolyses inorganic 
pyrophosphate (PPi an inhibitor of hydroxyapatite formation) resulting in the production of 
phosphate for the formation of hydroxyapatite, therefore playing a crucial role in the 
mineralisation of the ECM (Moss et al., 1967, Majeska and Wuthier, 1975, Johnson et al., 
2000, Hessle et al., 2002, Murshed et al., 2005). Progressive ankylosis gene (ANK) exports 
pyrophosphate generated intracellularly to the ECM and is primarily localised to the plasma 
membrane (Hakim et al., 1984, Kanaujiya et al., 2018). A number of signalling pathways, 
including TGF-β, BMP signalling, hedgehog (Hh), Wnt signalling, Notch and fibroblast growth 
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factors (FGFs) are involved in the differentiation and function of pre-osteoblasts to mature 
osteoblasts (Chen et al., 2016). Whilst the primary function of osteoblasts is the generation 
and remodelling of bone, they also act as regulators of bone reabsorption through regulation 
of osteoclast development. This is achieved through the secretion of macrophage-colony 
stimulating factor (M-CSF) and receptor activator of nuclear factor- κβ ligand  (RANKL), both 
essential in osteoclastgenesis (Suda et al., 1999) and the secretion of osteoprotegerin (OPG), 
a decoy receptor for RANKL (Lacey et al., 1998). Once osteoblasts have completed their main 
function they either undergo programmed cell death (apoptosis) (Jilka et al., 1998), become 
bone lining cells (Manolagas, 2000)) or are entrapped within the mineralised matrix and 
become osteocytes (Rodan and Martin, 1981) (Fig.1.10). 
Figure 1.10. Schematic of osteoblast to osteocyte cycle. Pre-osteoblasts form monolayer on 
surface of bone, activated osteoblasts remodel bone and osteocyte become "trapped" 
within self-generated mineralised tissue. Created with BioRender.com.Osteocytes are small 
dendritic-like cells and are the most abundant cells in bone, accounting for 95% of cells in an 
adult skeleton (Franz-Odendaal et al., 2006). Through long thin processes which run through 
canals called canaliculi, osteocytes connect with other osteocytes and other cells on the 
surface of the bone. The system of connecting processes is known as the lacuna canalicular 
system and acts as a metabolic exchange which allows the osteocytes to sense and respond 
to stimuli by regulating osteoblasts and osteoclasts via the release of soluble mediators 
(Baud, 1968, Goldring, 2015). Osteocytes have been shown to respond to mechanical 
stimulation through the production of RANKL and therefore to regulate osteoclast 
differentiation in response to mechanical stimulus (Xiong et al., 2011). 
Osteoclasts are a large multinucleated cell derived from haematopoietic stem cells that 
reabsorb bone and occur as a much lower percentage of bone cells than osteoblasts and 
osteocytes (Bilezikian et al., 2008). Osteoclast differentiation is dependent on two essential 







Osteoclast precursor cells interact with bone marrow stem cells via the RANKL and RANK 
receptor whilst M-CSF interacts with colony stimulating factor 1 receptor (c-fms) stimulating 
the proliferation and survival of the osteoclast precursor, motility and cytoplasmic spreading 
of mature osteoclasts and induces expression of receptor activator of RANK (Insogna et al., 
1997, Arai et al., 1999, Teitelbaum and Ross, 2003). This results in the fusion of osteoclast 
precursor cells into mature osteoclasts (Fig.1.11). The stimulation of the RANK pathway by 
RANKL is negatively regulated by a decoy receptor, OPG which is expressed by osteoblasts  
  
(Boyce and Xing, 2008).  
Figure 1.11. Schematic of osteoclast activation via RANK and c-fms receptors. Osteoblasts 
and osteocytes regulate the maturation of osteoclasts through the expression of c-fms, 
RANKL and OPG. Created with Biorender. 
Osteoclasts work to reabsorb bone through degradation of the organic and inorganic phases 
(Teitelbaum, 2000). This is only achieved when the osteoclasts have adhered to the surface 
of the bone. Once adhered the osteoclasts begin the resorption process by first polarising. 
This is achieved through the clustering of the integrin αvβ3 at adhesive sites called 
podosomes (Teitelbaum, 2000) (Fig.1.12). The podosomes enable osteoclast polarisation 
and allows the cell to adhere and spread out on the mineralised surface, sealing the 
osteoclast onto the bone. Bone reabsorption is achieved by the secretion of proteases 
(mainly cathepsin K) which dissolve the underlying bone, releasing the minerals into the 
extracellular space located in the sealed area under the osteoclasts ruffled plasmalemma 
(ruffled boarder), and resulting in the osteoclasts sitting in cavities known as the Howship’s 
lacuna (Holtrop and King, 1977, Chambers, 2000). The seal formed between the osteoclast 
and the bone is made up of podosomes rich in filamentous actin (f-actin) which forms a ring 
M-CSF 
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adjacent to the ruffled boarder (Vaananen and Horton, 1995, Chellaiah et al., 2000). The low 
pH in the Howship’s lacuna is generated by the active secretion of protons driven by the 
activity of carbonic anhydrase II (CAII) and the vacuolar H+-adenosine triphosphate (H+-
ATPase) pump, both located in intracellular vacuoles (Fig.1.12) (Baron et al., 1985, Blair et 
al., 1989, Schlesinger et al., 1997, Vaananen et al., 2000). The pH within the osteoclast is 
maintained by an energy dependent chloride/bicarbonate (Cl-/HCO3-) exchange (Teti et al., 
1989). The osteoclasts release hydrogen ions into the cavity resulting in a low pH which leads 
to the acidification and solubilisation of the mineral phase of bone into Ca2+, H3PO4, H2CO3 
and H2O (Chatterjee et al., 1992), exposing the organic phase. The degraded mineral is 
endocytosed by the osteoclasts and released into the ECM at the osteoclasts antiresorptive 
surface (Salo et al., 1997, Stenbeck and Horton, 2004). The released product is again 
degraded in secondary lysosomes, transcytosed and secreted via the secretory domain of 
into the osteocyte microenvironment (Soysa and Alles, 2016).  
Figure 1.12. Schematic of osteoclast adhered to the surface of bone via integrin αvβ3. Bone 
reabsorption is achieved through the secretion of hydrochloric acid and cathepsin K, 
producing an acidic environment within the Howship’s Lacuna. Created with BioRender.com. 
1.5.4. Bone Tissue Engineering 
Following fracture, bone usually takes between six and eight weeks to heal, this may be 
delayed by the thickness of the cortical bone or unfavourable biological (e.g. osteoporosis) 
and mechanical (e.g. excessive fracture movement) environments, additionally other  
influences could result in delayed repair including age, alcohol, tobacco, steroid abuse, 
infection, type I diabetes and nutrient deficiency (Kostenuik and Mirza, 2017). These 
unfavourable factors may result in impaired fracture healing leading to delayed union or in 








with challenges during operation due to the difficulty in re-routing and generating 
appropriate healing of the structure. Bone grafts have been developed to improve the 
treatment of impaired fracture repair with techniques including allografts and autografts. 
Allografts, the implantation of a grafts source from a non-identical donor, have the 
advantages of no morbidity of the donor site and unlimited use of the material, however this 
method has a number of drawbacks including graft rejection, disease transmission and 
potential loss of mechanical and cellular properties due to the sterilisation and storage 
process (Sohn and Oh, 2019). The current gold standard is autografts, the transplantation of 
tissue from one region of the body to another. This method is considered the gold standard 
due to their established osteoinductive and osteoconductive properties whilst eliminating 
any immune rejection (Perez et al., 2018). Whilst autografts appear as an ideal solution there 
are some drawbacks: donor site morbidity, donor site muscle weakness and potential 
surgical complications (though these are present for allografts also). Coupled with the initial 
drawbacks, after 10 years of implantation up to 60% of both graft types have been shown to 
fail to integrate resulting in non-union and late graft fracture (Soucacos et al., 2006). Tissue 
engineering is emerging as an alternative methods to those currently being used to treat 
damaged bones as well enabling in vitro research into diseases and drug responses. 
There have been a number of cell types used for bone tissue engineering including 
osteoblasts, however due to the difficulty of harvesting and expanding, studies have focused 
more on osteo progenitor cells (Perez et al., 2018). MSCs have been the most widely used 
cell type for bone tissue engineering, with different sources having varying potential as a 
therapeutic option. Bone marrow derived MSCs have been shown to be more efficient at 
differentiating into osteoblasts than adipose derived (Han et al., 2014). Adipose derived 
MSCs do not demonstrating much success when directly grafted onto critical sized bone 
defects (Peterson et al., 2005), however they have shown some promise as a potential 
option. Cui et al. (2007) showed repair to a cranial bone defect in a canine model using 
osteogenically differentiated adipose derived MSCs grafted onto a coral biomaterial whilst 
in vivo studies have shown bone regeneration with adipose derived MSCs combined with 
specialised biomaterials (Lendeckel et al., 2004, Mesimaki et al., 2009). In comparison bone 
marrow derived MSCs have been shown to be successful when treated onto large bone 
defects with complete fusion five to seven months post treatment and good integration with 
no further fractures six to seven years after treatment (Marcacci et al., 2007). Similarly Kim 
et al. (2009) showed accelerated fracture repair two months after treatment with osteogenic 
differentiated bone marrow derived MSCs encased in fibrin. Whilst bone marrow derived 
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MSCs show a lot of promise the main limitations arise from the cell harvesting from older 
patients (Mareschi et al., 2006), donor site morbidity and reduced regenerative ability with 
extended expansions (Both et al., 2011). Other MSC sources include dental pulp (Lindroos et 
al., 2008, Kanafi et al., 2014), synovial membrane derived (De Bari et al., 2001, Sakaguchi et 
al., 2005) and umbilical cord derived (Chen et al., 2013, Dilogo et al., 2017). 
Both synthetic (Polycaprolactone (PCL)) and natural (fibrin, collagen) polymers have been 
used for bone tissue engineering. PCL is the most heavily researched synthetic polymer for 
bone tissue engineered due to its high permeability, thermal stability and aliphatic semi-
crystalline  structure (Woodruff and Hutmacher, 2010). Calvert et al. (2000) showed that PCL 
maintained its mechanical properties for up to 6 months before degrading over a 2 year 
period. Natural polymers such as collagen and fibrin have been widely studied, but due to 
the low mechanical strength of the structure they are not suitable as load bearing 
replacement but more readily used as ‘glues’. Oh et al. (2014) found that fibrin is the superior 
material for in vitro bone regeneration due to greater absorption of fibronectin, more 
proliferation of large MC3T3-E1 pre-osteoblasts and increased osteoblast differentiation 
shown by higher expression of Runx2, more alkaline phosphatase (ALP) production and 
greater calcium deposition. Composite materials can be made by combining ceramics and 
polymers, enabling control over degradation, improving mechanical strength and 
biocompatibility. 
During culture of the tissue engineered bone, growth factors, that are stored within the bone 
in vivo, are added as supplements to the cell culture media, these include BMPs, FGF, 
Platelet-derived growth factor (PDGF), TGF-β and insulin-like growth factor (IGF-1). Only two 
growth factors are currently FDA approved, BMP-2 and BMP-7 (Cahill et al., 2015), though a 
range have been shown to play an important role in osteogenesis, BMP-2, 4, 5 ,6  and 7. A 
randomised study in which 120 patients were treated with BMP-7/collagen constructs saw a 
significant increase in bone union (86.7%) compared to the alternative therapy (68.3%) 
(Calori et al., 2008). BMP-2 has been shown to not be essential during prenatal limb 
formation but essential during postnatal fracture healing (Wang et al., 2011). BMP-2 has 
been shown to increase the expression of collagen I and ALP when used to stimulate MC3T3 
cells (Nohe et al., 2002). Further FGF-2 and IGF-1 have both been shown to increase the 
expression of osteogenic differentiation genes Runx2 and CDH11, whilst BMP-2 and FGF-2 
both increase the expression of WNT5A and LEF1 both of which are developmental genes 
that regulate cell fate and patterning during embryogenesis (Robubi et al., 2014). TGF-β1 has 
been shown to play an important role in the migration of MSCs to the sight of the defect 
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whilst IGF-1 has been shown to be highly responsible for creating the osteogenic 
environment in which the MSCs differentiate down the osteogenic lineage (Perez et al., 
2018). 
Mechanical stimulation bioreactors have been used to further mimic the microenvironment 
of bone for tissue engineering. Stretch based bioreactors effect the proliferation and ECM 
production of osteoblasts, with low strain magnitudes (0.8%) having higher ALP production 
and higher strain rates (3.2%) showing the highest production of collagen I, osteocalcin and 
Runx2 (Zhu et al., 2008). Perfusion bioreactors have been utilised for bone tissue engineering 
due to the size of the structure, static cultures have been found to be limited in size due to 
the nutrient diffusion for the highly metabolic requirements of the bone cells (Grayson et al., 
2011). On top of the increased perfusion, this type of bioreactor system induces fluid shear 
stress on the cells, therefore mechanically stimulating the cells in culture. The perfusion 
bioreactors utilise a pump, a culture media revisor, a tubing circuit and cartridges, chamber 
or columns that hold scaffolds (Martin et al., 2004, Chen and Hu, 2006, Yeatts and Fisher, 
2011). When used to culture tissue, engineered bone studies have shown that ALP 
production is increased compared to static culture (Goldstein et al., 2001, Gomes et al., 2003, 
Wang et al., 2003b), further osteopontin has been shown to increase with flow perfusion 
(Holtorf et al., 2005a, Holtorf et al., 2005b). Using perfusion systems has also shown the 
production of a more uniform ECM compared to a static culture (Holtorf et al., 2005b, 
Sikavitsas et al., 2005, Porter et al., 2007). Hydrostatic pressure bioreactors have been shown 
to have varying effects on osteogenic development dependant on the frequency and the 
amount of pressure applied to the cell culture. Stavenschi et al. (2018) found that the most 
robust pro-osteogenic response was found with 300 kPa applied at 2 Hz , the highest 
pressure applied at the highest frequency in this study, however low pressures (10 kPa) still 
drove osteogenic lineage commitment. 
Due to the diversity of potential solutions a greater understanding for bone tissue 
engineering is required. This is currently being achieved through the trial and application of 
different cells types including osteoblasts, bone marrow derived MSCs and adipose derived 
MSCs. Additionally the culture of these cells is continuously being improved through the 
addition of growth factors and mechanical stimulation environments used to mimic the 
healthy bone environment. Through a combination of materials, cell types and culture 
conditions, tissue engineered bone, in many different forms, will become a viable alternative 
for bone regeneration.  




There are three types of cartilage found in the human body, elastic, hyaline and fibrous each 
exhibiting different functions as a result of the differing ECM which is optimal to the location 
it is found in. Elastic cartilage is yellow in appearance, located in the outer ear and 
predominantly feature elastin in the ECM making it the most pliable of the cartilage types 
(Watkins, 2009). Fibrocartilage is located at tendon and ligament bone attachment sites and 
features the highest amount of collagen type I in healthy cartilage, making it very tough and 
strong (Benjamin and Ralphs, 2004). Hyaline cartilage is the most prevalent type of cartilage 
in the body, the embryonic skeleton is composed of hyaline cartilage that undergoes 
calcification to form bone. Hyaline cartilage is present in human adults at the end of ribs, in 
the nose and at the end of long bones as articular cartilage, (Pollard et al., 2017). The primary 
function of articular cartilage is the dissipation of mechanical loads (compressive (Eisenberg 
and Grodzinsky, 1985), shear (Parsons and Black, 1979) and tensile loads (Korhonen and 
Jurvelin, 2010)) from the bone by acting as a shock absorber and the facilitation of synovial 
joints to articulate by providing a site of low friction (Hardingham, 2010). In the adult human 
body articular cartilage can be expected to experience loads of 3.5 times the person’s 
bodyweight at the knee, 3.3 times the bodyweight at the hip and 2.5 times at the ankle (Mow 
et al., 1984). Due to the high loads that are applied to the articular cartilage, it is essential 
that the biochemical and mechanical characteristics are maintained to allow for proper 
function. Cartilage observes viscoelastic behaviour during loading that allows the force to be 
appropriately absorbed. The structure of articular cartilage is vital for this (Boettcher et al., 
2016). 
1.6.2. Structure 
Cartilaginous tissue features a specialised ECM generated by chondrocytes, the sole 
terminally differentiated cell within the structure. The precursor cell to the chondrocyte is 
the chondroblast, which themselves are derived from mesenchymal cells. As the 
chondroblasts generate the ECM they become separated from each other and become 
embedded within cavities within the matrix known as lacunae. The chondroblasts then 
terminally differentiate into chondrocytes. SRY-Box Transcription Factor 9 (Sox9) is essential 
to MSC differentiation down the chondrogenic lineage. No other transcription factor has 
been shown to effect chondrogenic cell fate as much as Sox9 (Lefebvre and Smits, 2005), 
however other transcription factors from the Pax, Hox, forkhead-helix and homeodomain 
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families have been shown to effect cell  migration, proliferation, survival and condensation 
(Mundlos and Olsen, 1997). Following Sox9 driven differentiation of MSCs into 
chondroblasts, the cartilage ECM begins to develop. As this progresses the chondroblasts 
differentiate into chondrocytes. Here the cells continue to express Sox9 along with L-Sox5 
and Sox6. The chondrocytes feature large endoplasmic reticulum and a highly developed 
Golgi apparatus required for extensive protein synthesis. The chondrocytes found within the 
lacunae organise themselves into distinct populations derived from the same original 
chondroblast referred to as isogenous groups (Armiento et al., 2019).  
The structure of the different types of cartilage is different, though the composition is 
similarly made up of ground substances (polysaccharides), fibrous proteins and interstitial 
fluid (Armiento et al., 2019). Cartilage becomes avascular during maturation therefore 
requires nutrition diffusion from surrounding tissue, such as the synovial fluid at the knee 
joint. Elastic cartilage features a structure mainly composed of collagen type II and elastin 
fibres which form a dense structure orientated in multiple directions. There are a low 
number of isogenous groups which feature large chondrocytes in between the fibres (Nielsen 
and Bytzer, 1979). Fibrocartilage is located at the attachment site of dense connective tissue 
such as tendon where it enables the tissue to resist compression thanks to the large number 
of proteoglycans (Benjamin and Ralphs, 1998, Benjamin and Ralphs, 2004). The structure 
resembles that of connective tissues, with thick densely-packed fibres and featuring the 
highest concentration of collagen type I in cartilage with a low concentration of ground 
substances (Armiento et al., 2019). The number of chondrocytes in fibrocartilage is lower 
than in other cartilage types with the chondrocytes aligning with the thick collagen fibres 
(Benjamin and Ralphs, 2004). Hyaline cartilage is the most common type of cartilage, 
receives high loads throughout its life cycle and acts as the precursor to bone formation 
during endochondral ossification.  
1.6.2.1. ECM of Cartilage 
Collagen type II and aggrecan are the most abundant proteins in the ECM of hyaline cartilage. 
The structure is highly regulated offering specific functional properties to the tissue. Water 
is the primary component of hyaline cartilage, accounting for 70-80% of the wet weight. The 
dry weight is mainly composed of collagen (50-75%) and proteoglycans (15-30%) (Darling 
and Athanasiou, 2003). It is the combination of collagen and proteoglycans within the hyaline 
cartilage structure that imbues it with the appropriate mechanical properties. SLRP are the 
only type of proteoglycans present in hyaline cartilage, and are large macromolecules made 
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up of a protein core with one or more polysaccharide chains (glycosaminoglycans (GAGs)) 
covalently attached. The chains can be made up of more than 100 monosaccharides and 
extend out from the protein core and remain separated by charge repulsion (Sophia Fox et 
al., 2009). The ECM of articular cartilage contains multiple proteoglycans including aggrecan, 
decorin, biglycan and fibromodulin with aggrecan representing the most abundant and 
largest structure. Aggrecan features more than 100 chondroitin sulfate and keratin sulfate 
chains and interacts with hyaluronan via the N-terminal G1 domain whilst the C-terminal G3 
domain binds to ECM molecules such as tenascins and fibulins to form large proteoglycan 
aggregates which are stabilised by cartilage link proteins (Hardingham, 1979, Casscells, 
1990). Through the development of these proteoglycan aggregates within the intrafibrillar 
space, aggrecan generates a negative charge providing cartilage with osmotic properties that 
draws water into the tissue which is crucial to the structures ability to withstand compressive 
forces (Sophia Fox et al., 2009). SLRP class I-IV have been detected within the ECM of 
cartilage (Aspberg, 2016). These include decorin and biglycan from class I. Both SLRP feature 
chondroitin sulfate chains at the N-terminal (one chain in decorin, two chains in biglycan). 
Decorin binds to collagen fibrils at the D period via its core protein and through its N-terminal 
GAG (e.g. dermatan sulfate), decorin plays a role in fibril assembly in vitro , resulting in slower 
fibrillar assembly (Yamaguchi et al., 1990, Ruhland et al., 2007). Similarly to decorin, biglycan 
binds to collagen fibrils and is highly expressed in the pericellular matrix where it interacts 
with collagen type VI, linking it with collagen type II (Wiberg et al., 2001, Wiberg et al., 2002, 
Wiberg et al., 2003). Biglycan has been shown to regulate innate immunity through 
activation of TLR2 and TLR4 signalling, which may be involved in the inflammation of the joint 
(Schaefer et al., 2005). The class II proteoglycans include fibromodulin which features 
tyrosine residues at the N-terminal. Fibromodulin binds to the gap region of fibril forming 
collagens where it inhibits and therefore regulates the formation of fibrils (Hedbom and 
Heinegard, 1989). Epiphycan is a class III proteoglycan that fluctuates in expression 
throughout the cartilage lifecycle. It is highly expressed in the growth plate and in developing 
bones but expression in articular cartilage reduces with maturation (Onnerfjord et al., 2012). 
The class IV SLRP chondroadherin has been shown to be involved in cell adhesion through 
α2β1 integrins (Haglund et al., 2013). Though proteoglycans are not the main component of 
the cartilage ECM they provide vital functions as structural components, regulators of other 
ECM proteins, regulators of growth factors and regulation of innate immunity ensuring the 
tissue operates optimally. 
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1.6.2.1.1. Collagens of Cartilage 
The main component of mature hyaline cartilage ECM is collagen, specifically collagen type 
II accounting for more than 90% of the collagen content (Eyre, 2002). Other minor collagens 
are required to ensure cartilage functions correctly, these minor collagens include type I, V, 
VI, IX, X, XI and XII (Luo et al., 2017). Whilst collagen type XII is expressed across a wide range 
of tissue, especially those containing collagen type I, collagens II, VI, IX, X and XI are 
predominantly localised to cartilage. The role of collagen type II in cartilage is similar to that 
of collagen type I in tendon as it is the primary fibre-forming collagen in healthy cartilage. 
Collagen type II therefore is the main structural component supplying tensile strength to the 
ECM as well as a binding structure for other ECM proteins. The collagen type II fibrils are 
thinner than collagen type I fibrils. A reduction of collagen type II in the ECM of hyaline 
cartilage results in excessive production of collagen I and III, this can lead to diseases such as 
osteoarthritis (Mundlos et al., 1996, Lorenz et al., 2014). Collagen type II forms as a 
homotrimer of three α1(II) chains encoded by the COL2A1 gene in humans.  
Collagen VI is the sole member of the microfibrillar group and is formed through the 
combination of six different alpha chains (α1-6(VI)) (Fitzgerald et al., 2008), which go through 
a complex multistep process of intracellular assembly before secretion into the ECM (Knupp 
et al., 2006). In cartilage collagen VI is primarily expressed in the chondrocyte pericellular 
matrix (Keene et al., 1988). Whist the functional role of the pericellular matrix is still not fully 
known (Grässel and Aszódi, 2016) it is hypothesised that due to it completely surrounding 
chondrocytes within healthy cartilage it helps to regulate the biochemical, biophysical and 
biomechanical signals that the cells receives (Guilak et al., 2006). The collagen VI fibrils 
interact with hyaluronan (Kielty et al., 1992), decorin (Bidanset et al., 1992) and fibronectin 
(Chang et al., 1997) to anchor the chondrocytes to the ECM (Sherwin et al., 1999). A study 
by Wiberg et al. (2003) found that collagen VI binds to collagen II fibres through biglycan 
whilst other proteoglycans bind to the collagen VI scaffold. These proteoglycans help to 
organise the collagen II fibres which generates a healthy ECM, therefore the author 
hypothesise that collagen VI acts as a scaffold to bring the regulatory proteoglycans into 
close proximity with the collagen II fibres. A deficiency in collagen VI has been shown to delay 
cell differentiation and proliferation which subsequently leads to delayed and decreased 
cartilage development, and spontaneous development of osteoarthritis (Alexopoulos et al., 
2009). 
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Collagen XI is distributed across multiple tissues however the triple helical composition is 
specific to cartilage. In developing cartilage it is made up of α1(XI) and α2(XI) and a third 
chain, α1(II). In mature cartilage collagen XI forms in two distinct heterotrimeric molecules, 
α1(XI)α2(XI)α3(XI) or the hybrid molecule α1(XI)α3(XI)α1(V). The function of this hybrid is 
currently unknown. As the cartilage continues to mature the amount of α2(XI) in the collagen 
XI fibrils decreases whilst α1(V) increases (Wu et al., 2009). Type XI forms uniformly thin 
fibrils which act as the basic structure for type II fibrils in developing cartilage (Kadler et al., 
2008, Fernandes et al., 2007, Vaughan-Thomas et al., 2001) and resides in the core of 
collagen II fibres. Collagen XI features a thrombospondin-like domain which extends from 
the core of the collagen II fibres. It is thought that through the extension of this domain, 
collagen XI helps to regulate the spacing and diameter of the collagen II fibrils as well as 
inhibit lateral growth (Seet et al., 2017). In a study by Li et al. (2018) collagen XI has been 
shown to have strong chondrogenic effects through the promotion of cell proliferation and 
ECM production, specifically synthesis of collagen II, SOX9 and aggrecan. 
The FACIT collagens found within cartilage are type IX and XII, with collagen IX being the 
primary FACIT collagen found in hyaline cartilage accounting for 1% of the collagen content 
(Martel-Pelletier et al., 2008). Whilst type XII was initially thought to be absent in cartilage it 
has been shown to occur in small quantities (Watt et al., 1992). Collagen IX assembles from 
three alpha chains α1(XI), α2(XI) and α3(XI) and features a hinge-like globular non-
collagenous region at the N-terminal of the α1 chain (Shaw and Olsen, 1991). During 
embryonic development collagen IX is widely distributed and binds to the collagen II fibrils, 
through interactions with other ECM components via the hinged N-terminal and alongside 
the collagen XI fibrils, collagen IX regulates the fibril orientation generating the appropriate 
heterofibril network (Eyre et al., 2002). One of the key interactions collagen IX makes is with 
cartilage oligomeric protein which influences the diameter of the type II fibrils (Blumbach et 
al., 2009). In mature hyaline cartilage collagen IX is present in specific regions of the tissue 
rather than widely occurring (Hagg et al., 1998b). Collagen XI alpha chains consist of three 
triple helix domains (COL1, COL2 and COL3) which are separated and flanked by non-
collagenous domains (NC-1, NC-2, NC-3 and NC-4), with the NC-4 domain only present on 
the α1 chain and allowing for interactions with the ECM. The COL2 domain of the α3(XI) chain 
covalently bonds to the N-telopeptide of the α1(II) chain and the COL2 (IX) domain of the 
α2(XI) chain forms an intra-molecular covalent bond to the C-telopeptide of the α1(II) chain 
(Diab et al., 1996). The NC-4 projection into the ECM is achieved via a kink between the COL2 
and COL3 domains. Collagen XII is highly distributed in the superficial zone of developing 
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cartilage especially in areas of highly organised fibrils, suggesting that collagen XII plays a role 
in the development, alignment and stabilisation of the superficial zone of hyaline cartilage 
(Gregory et al., 2001). Similarly to collagen XI, collagen XII binds to the surface of collagen II 
fibrils and via a hinge in the structure the N-terminal domain extends into the ECM. Through 
the extension collagen XII has been shown to bind to decorin, fibromodulin (Font et al., 1996) 
and COMP (Agarwal et al., 2012).  
Collagen X is a member of the hexagonal network forming collagens and is primarily found 
in the calcified zones of cartilage, this may be during endochondral ossification or in 
calcifying regions of mature cartilage where it is seen as a marker for cartilage degeneration 
(Boos et al., 1997). In healthy mature cartilage, collagen X should only account for around 
1% of the total collagen content (Eyre, 2002). Collagen X is predominantly expressed in the 
hypertrophic zone of cartilage. Here chondrocytes undergo hypertrophy and differentiate 
into hypertrophic chondrocytes. During hypertrophic differentiation chondrocytes enlarge 
by up to 20 fold, which also sees the development of a granular cell surface and protrusion 
of numerous microvilli which release matrix vesicles required for matrix mineralisation 
(Wuthier, 1988, Mackie et al., 2008). Sox9 continues to drive chondrocyte differentiation and 
is expressed by early hypertrophic chondrocytes but expression ceases in late hypertrophic 
chondrocytes (Zhao et al., 1997, Hattori et al., 2010). The reduction in the expression of Sox9 
is mediated by the increased expression of osteogenic genes including Runx2, osterix, 
osteopontin and bone sialoprotein (Komori, 2010). Runx2 promotes the expression of 
collagen X and the maturation of hypertrophic chondrocytes (Wang et al., 2004, Stricker et 
al., 2002). Furthermore, Runx2 induces the expression of VEGFA and MMP13. VEGFA is 
required for the invasion of capillaries into the hypertrophic cartilage (Gerber et al., 1999, 
Carlevaro et al., 2000, Zelzer et al., 2001), Mmp13 loosens the matrix of the hypertrophic 
cartilage to allow the invasion of bone marrow sprouts (Inada et al., 2004). The hypertrophic 
chondrocytes develop the required ECM for mineralisation and undergo apoptosis, laying a 
cartilage template for bone formation (Shapiro et al., 2005). Whilst the role of collagen X is 
still unknown (Shen, 2005) it is thought to play a major role in endochondral ossification 
through the facilitation of calcification and the normal distribution of matrix vesicles and 
proteoglycans at the growth plate, with deficiencies in collagen X, resulting in abnormal bone 
development (Kwan et al., 1997). 
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1.6.3. Cartilage Tissue Engineering 
Defects to articular cartilage may result in significant pain and reduction in function of the 
joint with long lasting treatment not currently available. This is a particular problem for 
younger patients who may require repeat treatment to alleviate the symptoms, and the 
inevitable development of osteoarthritis (Robertsson et al., 2007, Julin et al., 2010). There 
are several surgical options for such defects; bone marrow stimulation treatment, direct 
chondral replacement and cell-culture treatment (Fig.1.13). The most commonly used 
technique is microfracture, a form of bone marrow stimulation, here micro pores are drilled 
into the subchondral bone to allow blood and bone marrow to infiltrate, clot and stimulate 
cartilage repair (Steadman et al., 1999). A less widely used technique, autologous 
chondrocyte implantation (a cell-culture treatment), harvests cartilage from non/low weight 
bearing regions, isolates and expands the chondrocytes, before re-implantation into the 
defect (Brittberg et al., 1994). Mosaicplasty, a direct chondral replacement treatment (not 
recommended for use on cartilage showing signs of osteoarthritis, rheumatoid arthritis, 
infection or tumour growth), involves the extraction of cartilage plugs from non/low weight 
bearing regions and implantation into the lesions (Hangody et al., 2004). The production of 
fibrocartilage during repair and treatment is a major barrier in long term viability (Redman 
et al., 2005) therefore new treatments are being pursued with 3D tissue engineering a 
potential option (Francis et al., 2018). Similarly with bone and tendon tissue engineering, 
MSCs have emerged as the most frequently used cell type for cartilage, partially due to the 
range of sources and ease of culture in addition to the well-established ability for 
chondrogenic differentiation (Rada et al., 2009, Ronziere et al., 2010). The most frequently 
utilised MSC sources are bone marrow and adipose with adipose derived MSCs showing 
more superior chondrogenic differentiation compared to bone marrow derived (Strioga et 
al., 2012, Jang et al., 2015). Chondrocytes have also been utilised for cartilage tissue 
engineering, though isolation from articulating surfaces is difficult therefore other regions 
have been used including cartilage from the nose and ear as the chondrocytes from these 
regions are easier to harvest and proliferate at a greater rate, it is unclear whether these 
cells would produce the appropriate cartilage (Van Osch et al., 2004, El Sayed et al., 2010, El 
Sayed et al., 2013, Lohan et al., 2014). 
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Figure 1.13. Damaged cartilage repair techniques. (a) full thickness focal chondral lesion. (b) 
debrided lesion. (c) The microfracture techniques for MSC repair from bone marrow. (d) 
Autologus chondrocyte implant sealed with collagen glue. (e) Tissue engineered cartilage 
plug generated from in vitro culture of chondrocytes in hydrogel and secured inplace with 
fibrin glue. Adapted from (Makris et al., 2015).   
For chondrogenic culture, specific growth factors are added to the culture medium in place 
of foetal calf serum as the composition and concentration of the serum varies from batch to 
batch, instead TGF-β and IGF are regularly added to the media to induce differentiation. TGF-
β is necessary for chondrogenic differentiation of MSCs and has been shown to inhibit 
chondrogenic hypertrophy for at least seven weeks, though not entirely as the MSCs still 
express hypertrophy-related genes including collagen type X, ALP, MMP13, VEGF, PTHR1 and 
Runx2 (Mueller and Tuan, 2008, McCarthy et al., 2012, Giuliani et al., 2013). Other growth 
factors have been shown to have differing effects on the differentiation and subsequent ECM 
production of MSCs down the chondrogenic lineage, FGF-2 has been shown to prime MSCs 
for chondrogenic differentiation through the increased expression of Sox9 and formation of 
chondrogenic specific ECM (Solchaga et al., 2005, Solchaga et al., 2010, Hagmann et al., 2013, 
Somoza et al., 2014). BMPs have been shown to play a major role in endochondral bone 
formation driving cells along the osteochondral pathway (O'Connor et al., 2000). BMP-1 and 
2 have been found to upregulate proteoglycan and collagen expression from chondrocytes 
(O'Connor et al., 2000, Pecina et al., 2002, Gooch et al., 2002, Valcourt et al., 2002), BMP-7 
inhibited collagen I formation and fibroblast infiltration in vivo (Kaps et al., 2002) and 
treatment with BMP-12 and 13 has shown increased production of GAGs, though this was 
less so than BMP-12 (Gooch et al., 2002). However BMP-4 has shown an increase in bone 
formation, suggesting that the type of BMP is important to maintain the desired lineage 
(Pecina et al., 2002, Luyten et al., 1992), a study by Kuroda et al. (2006) showed that BMP-4 
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enhanced chondrogenesis and significantly improved articular cartilage repair in rats, 
suggesting that further work is required to fully evaluate the role BMPs can play in the 
controlled differentiation of MSCs to chondrocytes.  
A number of different types of bioreactors have been used to mimic the cartilage in vivo 
environment for in vitro experiments, this includes hydrostatic pressure, compression and 
shear bioreactors. Compression bioreactors are regularly used for tissue engineering 
cartilage to replicate the compressive forces applied to the articular cartilage of the knee 
joint, these loads are typically in the range of 0.5-7.7 MPa (Afoke et al., 1987, Mow and 
Wang, 1999, von Eisenhart et al., 1999), with the average deformation of the articular 
cartilage being 13% of its initial thickness (Chung and Burdick, 2008). Cyclic compression has 
been shown to increase the Young’s modulus of the constructs whilst also increasing the 
production of cartilage oligomeric matrix protein and collagen type II and IX (Ng et al., 2009). 
The frequency at which the compression is applied at can help drive the differentiation, with 
low frequency (1 Hz) causing MSCs to differentiate down the chondrogenic lineage and high 
frequencies (100 Hz) resulting in osteogenic differentiation (Cashion et al., 2014). Many 
groups have seen increases in cartilage specific matrix components such as collagen II, GAGs 
and aggrecan (Nebelung et al., 2011, Correia et al., 2016, Gharravi et al., 2012, Gharravi et 
al., 2016), however direct compression does have disadvantages; the applied pressure is not 
uniform with the highest pressure being seen at the centre of the sample, the transfer of 
nutrients and waste across the sample is limited with the centre receiving very little and 
storing a high amount of waste production (Li et al., 2017b). 
Hydrostatic pressure bioreactors look to mimic the hydrostatic forces sensed by the cartilage 
in vivo, here under the applied force the fluid flows out of the cartilage and into the joint 
space, however this is controlled by the small effective pore size of the cartilage preventing 
rapid fluid flow. This results in the pressure increasing with each cycle of pressure applied 
and is thought to be applied at 7-10 MPa (Stockwell, 1971, Hall et al., 1996). The application 
of the hydrostatic pressure can have varying effects on the cellular response, Smith et al. 
(1996) found that a monolayer of articular chondrocytes exposed to cyclic 10 MPa 
hydrostatic pressure at 1 Hz for four hours increased the expression of collagen II and 
aggrecan whilst the static loaded group saw a decrease in collagen II expression. The positive 
effects of hydrostatic pressure are also seen in 3D culture, Kawanishi et al. (2007) showed 
that chondrocytes cultured in pellet culture and loaded with 5 MPa at 0.5 Hz see a 4 fold 
increase in collagen II and a 5 fold increase in aggrecan gene expression compared to the 
non-loaded controls. Further, differentiation genes have shown significant increases within 
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cyclic hydrostatic pressure environments,. Sakao et al. (2008) saw significant increase in the 
expression of Sox9 and collagen II by synovium derived MSCs cultured in hydrostatic 
pressure.  
Shear stress is seen in cartilage during the loading and unloading phase (Wang and Peng, 
2015), and has been shown to affect chondrocytes though changes in membrane potential, 
solute transport or cellular deformation (Sharifi and Gharravi, 2019). A number of studies 
have shown positive changes in the chondrogenic gene production and ECM development 
with shear bioreactors (Waldman et al., 2003, Frank et al., 2000, Jin et al., 2003, Jin et al., 
2001), while Cochis et al. (2017) used a shear-compression bioreactor that enabled the two 
stimuli to act simultaneously, here they saw significant chondrogenesis in the stimulated 
group compared to the non-stimulated group. Certain types of fluid shear bioreactors and 
microgravity bioreactors work in a similar way, the constructs are cultured within a vessel 
and shear in applied through either the rotation of the vessel itself or the rotation of a mixer. 
Due to the long lasting impairment seen at damaged cartilage, the use of grafts from healthy 
locations on the patient’s body is not an ideal solution as the graft site will likely remain 
impaired for the remainder of their life. Tissue engineering offers the option to source pre-
chondrogenic cells from a self-replenishing site, such as adipogenic tissue, and culture the 
graft artificially. similarly to bone, different damage types seen on cartilage require different 
procedures to repair. A range of materials with different properties (mechanical and 
chemical) are therefore required to successfully restore the cartilage, however one of the 
current issues with cartilage tissue engineering is the progression of the chondrocytes 
towards hypertrophy. Recent studies have suggested that different growth factors and 
chemical supplements may be able to dictate the cellular fate, whilst others point towards a 
combined mechanical stimulation approach. It is clear that only by better re-creating the 
healthy native chondrogenic environment, both chemically and mechanically, will more 
successful tissue engineering cartilage be generated, this will most likely require a 
combination of the chemical supplements and the mechanical environments supplied by 
bioreactors.
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1.7. Collagen 
To date there are known to be at least 28 different types of collagen and as outlined in 
section 1.4, 1.5 and 1.6 the different types of collagen feature in varying proportions in 
different tissue types. Each collagen type exhibits a specific characteristic that enables the 
tissue it features in to perform appropriately (Kadler et al., 2007, Gordon and Hahn, 2010, 
Ricard-Blum, 2011, Johnstone, 2000). There is potential to use the collagens found in specific 
musculoskeletal tissues as a marker for the quality of tissue engineered tissue, this is 
currently not being fully utilised as most studies focus on the major collagen type of the 
tissue or a type specific to the study. By investigating the complete collagen composition the 
researcher can establish the developmental stage of the tissue, infer the phenotype of the 
cells and determine what tissue has been generated within the study.  
Collagen is the most abundant structural protein found in vertebrates (Landis and Jacquet, 
2013). In humans, collagen is known to comprise of one-third of the total protein and is the 
most prevalent component of the extracellular matrix (ECM) (Shoulders and Raines, 2009). 
In some tissues, such as tendon and the organic components of bone, collagen potentially 
accounts for more than 90% of the structure (Friess, 1998). Whilst being present across a 
wide variety of tissues, collagen has not been detected in a small number, these include the 
nail plate and hair shaft (Lee et al., 2006, Rice, 2011). Each collagen type exists within a 
subcategory of fibrillar or non-fibrillar collagen, with the non-fibrillar having further 
subcategories: fibril associated collagen with interrupted triple helix (FACIT), hexagonal 
network-forming, basement membrane, microfibrillar, anchoring fibrils, membrane 
associated collagen with interrupted triple helix (MACIT) and multiplexins (van Huizen et al., 
2019). Table 1.1 lists the different collagen types and the subcategory they fall into.  
Changes in collagen composition within a particular tissue can be a result of development, 
degradation and regeneration. The cells found within the tissue will naturally turn over the 
proteins within the ECM to ensure the tissue health and homeostasis, and an imbalance to 
this protein turnover may result in an impaired function of the tissue (Karsdal et al., 2017). 
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Table 1.1. Table of collagen types and the associated category, adapted from Canty and Kadler (2005) and van Huizen et al. (2019).  
Type Human Genes Category Triple helix composition Tissue distribution References 
I COL1A1, COL1A2 Fibril-forming [!1(I)]2, !2(I) Fibrils in tendon, ligament, bone, skin, cornea and blood vessel walls 
(Myers et al., 
1981, Chu et al., 
1982) 
II COL2A1 Fibril-forming [!1(II)]3 Fibrils in Cartilage 
(Miller and 
Matukas, 1969) 
III COL3A1 Fibril-forming [!1(III)]3 Forms heterotypic fibrils with type I 









(Timpl et al., 
1981, Timpl and 
Brown, 1996) 







Forms heterotypic fibrils with type I (Birk, 2001) !1(V)]2, !2(V) 





!1(VI), !2(VI), !3(VI) 
Fine microfibrils with ubiquitous distribution 
(Kielty et al., 
1992) !1(VI), !2(VI), !4(VI) 
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VII COL7A1, COL7A2 Anchoring fibrils 
[!1(VII)]3 
Forms anchoring fibrils in skin at the dermal/epidermal junction 
(Keene et al., 
1987) 
[!1(VII)]2, !2(VII) 
VIII COL8A1, COL8A2 Hexagonal network-forming 
[!1(VIII)]3 
3D hexagonal lattice is Descemet’s membrane in the eye 
(Kapoor et al., 
1986, Kapoor et 
al., 1988, 








X COL10A1 Hexagonal network-forming [!1(X)]3 Hexagonal lattice in the hypertrophic cone of the growth plate 





Fibril-forming !1(XI), !2(XI), !3(XI) Forms heterotypic fibrils with type II 
(Mendler et al., 
1989) 
XII COL12A1 FACIT [!1(XII)]3 Associated with type I 
(Keene et al., 
1991, Nishiyama 
et al., 1994) 
XIII COL13A1 MACIT [!1(XIII)]3 Transmembrane and possibly involved with cell adhesion 
(Latvanlehto et 
al., 2003) 
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XIV COL14A1 FACIT [!1(XIV)]3 Associated with type I 
(Young et al., 
2000, Young et 
al., 2002) 
XV COL15A1 Multiplexins [!1(XV)]3 
Specialised basement membrane, cleaved to produce antiangiogenic fragments 
(restin) 




XVI COL16A1 FACIT [!1(XVI)]3 
Components of specialised fibrillin-rich microfibrils in skin and type II collagen 
fibrils in cartilage 
(Kassner et al., 
2003) 
XVII COL17A1 MACIT [!1(XVII)]3 
Transmembrane component of hemidesmosomes (cell-cell junction), which 
attach epidermis to basement membrane in skin 
(Hopkinson et 
al., 1998) 
XVIII COL18A1 Multiplexins [!1(XVIII)]3 Cleaved to produce antiangiogenic fragment (endostatin) 
(Sasaki et al., 
1998) 
XIX COL19A1 FACIT [!1(XIX)]3 Radially distributed aggregates formed by association at one end in vitro 
(Myers et al., 
2003) 
XX COL20A1 FACIT [!1(XX)]3 Associated with type I 
(Koch et al., 
2001) 
XXI COL21A1 FACIT [!1(XXI)]3 Fibril associated, widespread expression pattern 
(Fitzgerald and 
Bateman, 2001) 
XXII COL22A1 FACIT [!1(XXII)]3 Located in specific tissue junctions and may be associated with microfibrils 
(Koch et al., 
2004) 
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XXIII COL23A1 MACIT [!1(XXIII)]3 Transmembrane collagen identified in cell culture 
(Banyard et al., 
2003) 
XXIV COL24A1 Fibril-forming [!1(XXIV)]3 Associated with type I 
(Koch et al., 
2003) 
XXV COL25A1 MACIT [!1(XXV)]3 




XXVI COL26A1 FACIT [!1(XXVI)]3 Expressed in testis and ovary of adult tissue 
(Sato et al., 
2002) 
XXVII COL27A1 Fibril-forming [!1(XXVII)]3 Widespread expression in cartilage 
(Boot-Handford 
et al., 2003, Pace 
et al., 2003) 
XXVIII COL28A1 Multiplexins [!1(XXVIII)]3 Beaded filament forming (Veit et al., 2006) 
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1.7.1. Collagen Types – Structure and Function 
All collagen types share a structural motif that has become the hallmark of the protein: the 
collagen triple helix (Fig.1.14). The triple helix structure is composed of three parallel 
polypeptide strands in a left-handed helical conformation coil with a one-residue stagger to 
form a right-handed triple helix (Shoulders and Raines, 2009). Each left handed helix is one 
of three procollagen alpha chains that compose the triple helix. 
Figure 1.14. Schematic of the collagen triple helix showing the Gly-X-Y sequence within the 
left handed triple helices. The three left-handed triple helices (either three different alpha 
chains, two different alpha chains or one alpha chain) wind together and pack tightly at the 
Gly residues generating the right handed triple helix. Adapted from Fidler et al. (2018). 
Created with BioRender.com. 
Every third residue within the triple helix is Glycine (Gly) due to the tight packing of the 
helices. This results in a repeating Gly-X-Y sequence, where X and Y can be any amino acid 
but are most often proline (Pro) and hydroxyproline (Hyp) respectively. Therefore the most 
common sequence is ProHypGly accounting for 10.5% of all triples (Ramshaw et al., 1998). 
The number of triple helices found in each collagen varies from type to type; in some less 
common types of collagen the triple helical domain accounts for less than 10% of the amino 
acids in the mature protein whilst the mature forms of fibrillar collagens are formed of 
essentially a long triple helix made up of over 1000 amino acids (Ricard-Blum, 2011). The 
primary structure of the collagen type varies across all alpha chains. The triple helix structure 
features across the collagen superfamily with every member containing at least one triple-
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helical domain. The collagens also contain nontriple-helical domains which act as building 
blocks with the other ECM protein. The structure of the collagen alpha chains is depicted in 
Fig.1.15. 
In the triple-helical domains the three alpha chains supercoil around each other to form the 
right handed triple helix with the adjacent alpha chains linked together by a intermolecular 
backbone of N-H···O=C hydrogen bonds. To form the triple helix two structural events must 
occur: the three chain must form in a staggered arrangement with one residue rising in the 
direction of the helical axis approximately 0.29 nm in relation to the next residue, and every 
third residue in the strand must be placed near the common helical axis due to the close 
packing of the three chains. This packing is achieved by the repetitive Gly-X-Y sequence 
where the smallest amino acid (Gly) occurs in this position (Bella, 2016), and correct 
alignment during in-cell synthesis of the collagen structures. 
The amino acids located in the X and Y positions of the alpha chain sequence are most 
commonly Pro or Hyp (Ramshaw et al., 1998). This leads to a reduction in the entropic cost 
for collagen folding as the abundance of the Pro and Hyp residues pre-organises the helical 
conformation in the unfolded state and primes it for the folded state (Cram, 1988). However, 
the presence of Pro results in some detrimental effects to the triple helix folding and stability. 
All peptide bonds in collagen are trans, however Pro has a secondary amino group which 
forms tertiary amides within a protein resulting in a population of both trans and cis isomers. 
Before a sequence featuring Pro can form into a triple helix all cis peptide bonds must 
isomerize to trans peptide bonds (Kersteen and Raines, 2001). Isomerisation of cis to trans 
bonds in the unfolded alpha-chains acts as a rate-limiting step for triple helix formation 
(Bachinger et al., 1978, Bachinger et al., 1980, Bruckner and Eikenberry, 1984, Bachinger, 
1987). The isomerisation is catalysed by the peptidyl prolyl cis-trans isomerases (PPIase) of 
which three PPIase families exist in the cell: cyclophilins, FK506 binding proteins (FKBP) and 
parvulins (Ishikawa and Bachinger, 2013). 
The presence of hydroxylated proline in the Y position dramatically increases the thermal 
stability of the triple helix; for example a (ProProGly)10 sequence has a melt temperature of 
31-41°C whilst a (ProHypGly)10 sequence has a melt temperature of 61-69°C (Holmgren et 
al., 1999). If the Hyp features in the X position ((HypProGly)10) no helix will form (Inouye et 
al., 1976). These results led to the hypothesis that the 4R configuration of a prolyl hydroxyl 
group is the sole contributor to water mediated hydrogen bonds that ensure the stable 
folding of the triple helix. 
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Figure 1.15. Schematic of collagen α-chain primary structures and functional domains. 
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The frequency of Hyp in most natural collagen is too low to support the extensive network 
of water bridges (Shoulders and Raines, 2009). This hypothesis was further tested by 
replacing the Hyp residue with (2S,4R)–4–fluoroproline (Flp) generating a sequence of 
(ProFlpGly)10. Fluoro groups do not form strong hydrogen bonds, however the (ProFlpGly)10 
sequence generated a hyperstable triple helix (melt temperature of 91°C) therefore water 
bridges cannot be fundamental to the stability of the triple helix (Holmgren et al., 1999). 
Further work by Bretscher et al. (2001) replaced the Hyp with (2S,4S)–4–fluoroproline (flp) a 
diastereomer of Flp, which resulted in the triple helix not forming. This highlighted that the 
stereochemistry of electronegative substituents at the 4-position of the Pro ring are 
important in the stability of the triple helix and therefore the residue in the Y position 
stabilises the triple helix via a stereo-electronic effect. The stereo-electronic effect is due to 
the preference of the residue to one of two major pyrrolidine ring puckers (Cγ-exo and Cγ-
endo). Hyp and Flp cause an  imposition of a Cγ-exo pucker on the pyrrolidine ring via the 
gauche effect resulting in the pre-organisation of the main chain angle to the residue in the 
Y position of the triple helix, therefore stabilising the triple helix (DeRider et al., 2002). This 
has been further supported by insertion of (2S,4R)-4-chloroproline (Clp) in the Y position 
which resulted in a stable triple helix (melt temperature of 52°C (Shoulders et al., 2008)), Clp 
like Flp and Hyp has a strong preference for the Cγ-exo ring pucker supporting the hypothesis 
that the triple helix is stabilised by a stereo-electronic effect. 
1.7.1.1. Fibril Forming Collagens 
Whilst the hallmark of the collagen structure is the triple helix motif, the overall structure of 
the different collagen types changes dramatically between each subcategory (Fig.1.15). Due 
to the abundance of collagen type I, fibril forming collagens occur the most frequently across 
vertebrates. The fibril forming collagens are rod-like with a large triple helical domain made 
of approximately 1000 amino acids per polypeptide chains. The non-collagenous domains 
are composed of a specific C-terminal and a variant dependant N-terminal which is either 
completely or partially removed during collagen processing (Bella and Hulmes, 2017). To 
form fibrils, these collagen triple helices arrange into longitudinally staggered arrays of 
molecules which generate the distinct banding pattern known as the D-period (Fig.1.16) (Birk 
and Bruckner, 2005), these staggered molecules are held together and stabilised by covalent 
intramolecular cross-links (Barnard et al., 1987, Bailey, 2001, Magnusson et al., 2003). The 
collagen molecules are themselves approximately 300 nm long with a width of 1.5 nm, these 
molecules are then staggered with respect to the neighbouring collagen molecule at a fixed 
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length equal to multiple of the size of the D-period (Hodge and Schmitt, 1960, Kadler et al., 
1996, Christiansen et al., 2000, Zhao et al., 2011b).   
Figure 1.16. Schematic of fibrillar forming collagen triple helices arranged in staggered 
pattern. The staggered patter generates the D-period banding patter seen on collagen fibrils 
due to the presence of gaps and overlays in the network. TEM images taken from section 
4.4.7. Collagen drawings created with BioRender.com. 
Collagen types I, II, III, V, XI, XXIV and XXVII make up the fibril forming collagen subgroup 
where types I, II and III are the major fibril forming collagens, type V and XI the minor fibril 
forming collagens and types XXIV and XXVII functions are still being investigated (Bella and 
Hulmes, 2017). The different types of fibril forming collagens are located across connective 
tissues with type I appearing in tendon, bone and skin, type II predominantly in cartilage, and 
type III (along with type I) forming the main structural component in the blood vessel. The 
main fibril forming collagens imbue the tissue with the required mechanical properties to 
ensure the appropriate function, whilst the minor fibril forming collagens act as regulatory 
proteins for the major fibril forming collagens helping to maintain the fibril diameter and 
orientation. It is therefore incorrect to consider a collagen fibre to be composed of one 
collagen type, as whilst the fibre may predominantly feature one fibril forming collagen, 
other fibril forming collagens are required to ensure the tissue functions correctly (Bella and 
Hulmes, 2017). The percentage of the different fibril forming collagens found in specific 
tissues varies between tissue function, development, ageing, disease and regeneration 
(Ricard-Blum, 2011, Mienaltowski and Birk, 2014). 
Gap Overlap 
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1.7.1.2. FACIT Collagens 
Whilst the fibril forming collagens possess a long triple helix domain, the FACIT collagens 
contain short triple helical domains (200 amino acids in collagen IX (Von der Mark, 2006)) 
interspersed with non-helical domains (the interrupted helix). These interruptions give the 
collagen specific properties required in the tissue it resides in, which may result in 
intramolecular flexibility or specific proteolytic cleavage (Gelse et al., 2003). The FACIT 
collagens do not form fibrils as the fibril forming collagens do, but instead, bind to specific 
regions on the fibril forming collagens (Fig.1.17) which leads to altered surface properties 
and assembly of the fibrils (Birk and Brückner, 2011). FACIT collagens form covalent lysine-
derived crosslinks to the N-telopeptide of the fibril forming collagen. The NC3 domain 
features a hinge which allows a large N-terminal domain to ‘reach out’ from the fibril where 
it interacts with other matrix components (Vaughan et al., 1988).  
Figure 1.17. Schematic of FACIT collagens attached to surface of a collagen fibril, triple helix 
interruptions are displayed as red circles whilst the globular N-terminal domain is shown as 
an orange oval (A). Rotary-shadowed images of type II collagen fibril with type IX (FACIT) 
collagen molecules attached to the surface. White arrows indicate type IX. Scale bar=100nm 
(B), adapted from Vaughan et al. (1988). Created with BioRender.com. 
A 
B 
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1.7.1.3. Basement Membrane Collagen 
Collagen type IV is the only collagen to make up the basement membrane sub category. 
There are six alpha chains that combine to generate the collagen IV triple helix. The 
combination of the six different alpha chains depends on the tissue the collagen is located 
in, for example α1(IV) [α2(IV)]2 is found in the liver, whilst  α3(IV) α4(IV) α5(IV) is found in 
the kidney, lung and neuromuscular junction (Miner, 2011). As with all collagen types the 
structure is composed of a triple helix with non-collagenous domains at either end of the 
helix. The triple helix is a long chain (approximately 1400 amino acids) with 21-26 short non-
collagenous interruption giving the structure flexibility (Khoshnoodi et al., 2008). The ends 
of the triple helix are composed of a short N-terminal non-collagenous 7S domain and a C-
terminal globular non-collagenous domain, both of which are required for collagen IV 
network formation (LeBleu et al., 2007). Once the triple helix is formed, two collagen IV 
monomers associate via the C-terminal trimers forming a dimer. Four protomers then form 
cross links at the N-terminal 7S region forming the collagen IV tetramer. As more and more 
protomers bind a polygonal lattice forms generating the basement membrane network to 
which other basement membrane molecules such as Laminins bind (Fig.1.18) (Mak and Mei, 
2017). 
Figure 1.18. Schematic of the collagen basement membrane subcategory. The collagen 
forms as the protomer before associating with a second collagen IV protomer at the C-
terminal (the dimer). The dimers then associate with other dimers via the 7S domain forming 
a tetramer which then proceed  to form the polygonal lattice. Created with BioRender.com. 
Triple helical 
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1.7.1.4. Hexagonal Networking Forming Collagen 
There are two hexagonal network forming collagens; type VIII and type X, and this 
subcategory is sometimes combined with collagen type IV as the network forming collagens. 
Both are short chain collagens which form hexagonal lattices within the tissue (Fig.1.19). 
Type VIII collagen is found predominantly in the Descemet’s membrane, the basement 
membrane that separates the corneal endothelial cells from the stroma. Type X is secreted 
by hypertrophic chondrocytes during endochondral bone formation (Sutmuller et al., 1997). 
The triple helical domain of both type VIII and X collagens features eight imperfections in the 
Gly-X-Y repeat (Knupp and Squire, 2003). Type VIII molecules bind to form four molecule 
tetrahedrons which subsequently bind laterally with multiple tetrahedrons to generate the 
hexagonal lattice (Hansen et al., 2019). Collagen type X generates a hexagonal lattice 
structure by forming multiple hexagonal multimers through the non-collagenous globular 
NC1 domain, which then associate by interaction between juxtaposed triple helix domains 
(Chan et al., 1995). 
Figure 1.19. Schematic of collagen type VIII and X hexagonal lattices. Created with 
BioRender.com. 
1.7.1.5. Microfibrillar Collagens 
Similarly with the basement membrane collagen, the microfibrillar collagen is made up of 
one collagen type (VI) which has six different alpha chains. Initially the α1, α2 and α3 were 
thought to be the only chains, subsequently the α4, α5 and α6 chains were discovered in 
2008, these chains are homologous to α3 (Fitzgerald et al., 2008, Gara et al., 2008, Fitzgerald 
et al., 2013). The α4 chain is not present in humans due to a chromosome inversion rendering 
the COL6A4 gene non-functional (Gara et al., 2008). Similarly to type IV, the alpha chains 
Type X Type VIII 
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form the triple helix in different combinations in different tissues (Sabatelli et al., 2011). The 
microfibrillar collagen is found across a variety of tissues including the lung, blood vessels 
and cartilage (Kuo et al., 1997) and is located near the basement membrane. The 
microfibrillar structure contains many binding sites for basement membrane proteins such 
as collagen type IV, decorin, fibronectin and integrin (Kuo et al., 1997, Bidanset et al., 1992, 
Carter, 1982, Fitzgerald et al., 2008). Each alpha chain contains a short collagenous region 
with globular regions at both the N- and C-termini (Baldock et al., 2003). The α1 and α2 
chains contain one N-terminal subdomain and two C-terminal subdomain which are 
homologous to type A domains of von Willebrand factor (vWF-A). The α3 chain, and 
therefore the α4, α5 and α6 chains, are much longer than the α1 and α2 chains, containing 
10 N-terminal subdomains and five C-terminal subdomains including two vWF-A like 
domains (Lamande et al., 2006). The structure forms intracellularly by two monomers 
associating in an antiparallel fashion to generate a dimer. Tetramers then form by two dimers 
arranging in a side-by-side alignment. The tetramers are then secreted into the ECM and 
form a microfibril via end-to-end association through non-covalent bonds with other 
tetramers (Fig.1.20) (Sun et al., 2019).  
Figure 1.20. Schematic of microfibril collagen production. Within the cell monomers are 
generated, two monomers then bind to form a dimer. The dimer then undergoes further 
translation and two bind to form a tetramer. The tetramer is secreted from the cell and binds 
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1.7.1.6. Anchoring Collagen 
Collagen type VII is the only collagen found in the anchoring collagens subcategory. The triple 
helix is a homotrimer composed of three α1 chains. The anchoring collagen consists of a 
central collagenous domain flanked by the non-collagenous N- and C-terminal. The 
collagenous domain is made up of a long triple helix (1530 amino acids) with 19 
imperfections offering the collagen structure flexibility  (Christiano et al., 1994b). The most 
notable feature of the anchoring collagen is the non-collagenous ‘hinge’ region, located in 
the middle of the tripe helix, which is made up of 39-amino acids. The N-terminal is relatively 
large (145 kDa) and made up of sub-molecules with homology to known adhesive proteins 
including cartilage matrix protein, nine fibronectin type III-like domains and a short cysteine 
and proline rich region (Christiano et al., 1992). The C-terminal is conversely small (30 kDa) 
with a sub-molecule homologous to the Kunitz protease inhibitor molecule (Christiano et al., 
1994a). The anchoring collagen forms in the ECM where initially two collagen VII molecules 
form an anti-parallel dimer with the N-terminal exposed at both ends (Sakai et al., 1986). A 
portion of the C-terminal is then proteolytically removed and the structure stabilised by 
inter-molecular disulphide bonds (Colombo et al., 2003). Multiple dimers then align laterally 
to form the anchoring fibril (Fig.1.21) (Chung and Uitto, 2010). The anchoring collagen 
appears predominantly in the skin, anchoring the lower portion of the dermal-epidermal 
basement membrane to the underlying papillary dermis (Chung and Uitto, 2010).  
Figure 1.21. Schematic of collagen type VII. (A) The monomer forms a antiparallel dimer with 
a second monomer at the C-terminal (orange oval is NC2 domain). The C-terminal is partially 
proteolytically removed and multiple dimers bond to form the anchoring fibril (red band is 
post cleaved NC2 domain). (B) The anchoring fibril then anchors ECM proteins to the 
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1.7.1.7. MACIT Collagens 
The MACIT collagens are type II transmembrane proteins (N-terminal is located 
intracellularly, C-terminal is located in the ECM) composed of a short N-terminal, a 
hydrophobic single-span transmembrane domain and the triple helical domain with three 
non-collagenous interruptions allowing the structure to bend (Fig.1.22) (Hagg et al., 1998a, 
Hashimoto et al., 2002, Banyard et al., 2003). Despite sharing a closely homologous 
structure, the collagens that make up the MACIT subgroup feature across different tissues. 
The most widespread MACIT is type XIII, which is expressed by cells of mesenchymal and 
epithelial origin and accumulates in low amounts (Peltonen et al., 1999, Sund et al., 2001, 
Ylonen et al., 2005, Latvanlehto et al., 2010). Type XXIII is primarily expressed by fibroblasts 
(Koch et al., 2006) whilst the types of cells that express type XXV change with ageing. During 
development the protein is expressed by the peripheral nervous system and the neuro-
muscular junction, then in adulthood it is exclusively produced by central neurons 
(Hashimoto et al., 2002, Goncalves et al., 2019, Tanaka et al., 2014). Type XVII is involved in 
the linkage between the ECM and intracellular regions of the epidermal (Diaz et al., 1990). 
Figure 1.22. Schematic of MACIT collagens spanning the intra and extracellular matrix 
through the cell membrane. Created with BioRender.com. 
1.7.1.8. Multiplexin Collagens 
The multiplexin collagens share a multidomain structure with an interrupted triple helix 
resulting in flexibility (Myers et al., 1992, Rehn et al., 1994, Rehn and Pihlajaniemi, 1994). 
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composed of a laminin-G-like thrombospondin-1 homologous domain and the C-terminal 
domain featuring a endostatin or restin motif (Rehn and Pihlajaniemi, 1994). The 
multiplexins are the only collagens that feature a proteoglycan domain, which occurs as 
different forms of glycosaminoglycans (either heparan sulphate or chondroitin sulphate) 
(Iozzo and Schaefer, 2015). The multiplexin collagens are widely distributed in normal tissues 
where they associate with endothelial, epithelial, nerve, muscle and fat cells (Saarela et al., 
1998, Hagg et al., 1997). Type XV is located at the interface between the basement 
membrane and fibrillar collagen network, linking the fibrillar collagens to the basement 
membrane. It is not considered an integral component of the basement membrane (Amenta 
et al., 2005, Rasi et al., 2010, Lisignoli et al., 2009). Type XVIII is an integral part of the 
basement membrane binding different basement membrane components together (Sasaki 




1.7.2. Collagen Synthesis 
The biosynthesis of collagen is well characterised for the fibril forming collagens, however it 
is less well known for the non-fibril forming types. This section will discuss in detail the 
process for the synthesis of the fibril forming collagens, and where available the synthesis of 
the other collagen types. As previously stated the mature collagen structure varies across all 
collagen types with the collagen triple helix acting as the consistent motif present. This triple 
helix is formed of three alpha chains unique to the specific collagen and can form as a 
homotrimer or heterotrimer. The alpha chains form as procollagen which is  cotranslationally 
translocated into the lumen of the endoplasmic reticulum (ER) where it folds and undergoes 
post translational modification due to the presence of a variety of enzymes including prolyl 
4-hydroxylases, prolyl 3-hydroxylases and lysyl hydroxylases for hydroxylases of the Y 
position proline (Heard et al., 2016), GLT25D1 and GLT25D2 for glycosylation (Schegg et al., 
2009) and peptidyl proline cis-trans isomerase (Ishikawa and Bachinger, 2013). Heat shock 
protein 47 (HSP47), a molecular chaperone, is also required during the synthesis of collagen, 
ensuring correct folding of the procollagen. HSP47 binds to the surface of the collagen 
stabilising the triple helix and preventing lateral aggregation within the ER that is otherwise 
induced due to the hydrophobic nature of collagen (Ito and Nagata, 2017).  
Once translation in the ER is complete the three alpha chains assemble at the C-propeptides 
region forming inter-chain disulphide bonds (Bourhis et al., 2012). The triple helix then forms 
in a zipper-like manner from the C-terminal to the N-terminal forming the procollagen trimer 
(Engel and Prockop, 1991). Once the stable procollagen trimer is formed it is transported 
from the ER to the cis-Golgi. HSP47 travels with procollagens from the ER to the cis-Golgi at 
which point it dissociates and is recycled (Satoh et al., 1996). The length of the procollagen 
trimer is approximately 300 nm which is too large for the on average 60-80 nm diameter 
COPI and COPII coated vesicles (Bonfanti et al., 1998, Miller and Schekman, 2013), suggesting 
that the procollagen is transported via a specialised system. Transport and Golgi 
organisational protein 1 (TANGO1), an ER-exit site protein, has been identified as a key factor 
in the trafficking of procollagen (Bard et al., 2006, Saito et al., 2009). TANGO1 features an 
SH3-like domain which has been shown to bind to procollagen VII in the lumen, whilst the 
second coiled coil domain of TANGO1 binds to the protein cTAGE5 in the cytoplasm (Santos 
et al., 2015). The C-terminal proline rich domains of both TANGO1 and cTAGE5 then interact 
with the COPII coated proteins Sec23A and Sec24C (Saito et al., 2009, Saito et al., 2011), 
which leads to the nucleation of the proteins generating the complex that drives procollagen 
VII export from the ER (Malhotra et al., 2015, Miller and Schekman, 2013). TANGO1 knockout 
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in mice has shown defective sorting and exporting of many collagen types (Wilson et al., 
2011) further supporting the role of TANGO1 in the connection of procollagen between the 
ER and cytoplasmic components. However in vitro studies have shown that TANGO1 
knockdown does not affect procollagen export from the ER (Saito et al., 2009, Nogueira et 
al., 2014).    
Procollagen has been suggested to be transported from the ER to the Golgi via cytoplasmic 
vesicular tubular cluster (VTCs) which are surrounded by small vesicles (Bonfanti et al., 1998) 
and requires both COPI (mediates the retrograde transport of ER resident proteins  (Murshid 
and Presley, 2004)) and COPII (involved in the export of proteins from the ER). This 
hypothesis of large vesicles used to transport procollagen between the ER and Golgi has been 
disputed by a number of studies. McCaughey et al. (2019) proposes that the procollagen is 
trafficked via a ‘short-loop’ pathway between the ER and Golgi, whilst Santos et al. (2015) 
suggests that the procollagen is trafficked via ER-Golgi intermediate compartment-
membrane derived megacarriers; however the process is still not completely understood and 
may be a combination of the hypotheses (Omari et al., 2020).  
The transport of collagen (and other proteins) through the Golgi stacks in mammalian cells 
is still not fully understood (Malhotra and Erlmann, 2015), although a study by Bonfanti et 
al. (1998) showed that the procollagen I trimer remains in a Golgi cisterna lumen rather than 
in transport vesicles at the perimeter of the cisterna. They go further to suggest that 
progression is due to the cisternal maturation model, here the cargo remains in the lumen 
whilst the cisternae themselves progress through the stack (cis-to-trans direction) and 
‘mature’ through recycling of their resident enzymes (Beznoussenko et al., 2014). The 
maturation model has continued to be challenged with reports of megacarriers, tubules, rim 
progression and direct/transient connections between cisternae (Glick and Nakano, 2009, 
Lavieu et al., 2013, Beznoussenko et al., 2014) suggesting that the maturation model is not 
solely correct. Whilst the exact process of transportation through the Golgi is still unknown 
it appears that it is not a singular process but a range of different processes may all be 
required for the efficient processing of specific proteins of different sizes and complexity. 
Fibrillar procollagen processing involves the removal of the globular N- and C- propeptides 
by the enzymes N- and C- proteinases respectively (Leung 1979). The activity of the enzymes 
is provided by different molecules; C-proteinases activity is provided by members of the 
metalloproteinase family, bone morphogenetic protein 1 (BMP1), mammalian tolloid (mTLD) 
and tolloid like 1 (TLL-1) (Li et al., 1996, Kessler et al., 1996, Scott et al., 1999, Hartigan et al., 
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2003) whilst N-proteinase activity is provided by members of the ADAMTS family; ADAMTS-
2, ADAMTS-3 and ADAMTS-14 (Colige et al., 1997, Fernandes et al., 2001, Colige et al., 2002). 
The removal of the C-propeptides triggers the self-assembly of the collagen into fibrils due 
to the large reduction in critical concentration required for fibril assembly (Kadler et al., 
1987, Hulmes et al., 1989). Assembly of fibrils begins within the plasma membrane and 
continues as the collagen is secreted into the ECM (Canty et al., 2004). The major fibril 
forming collagens (I, II, and III) undergo the stated processing whilst the minor fibril forming 
collagens (V and XI) undergo a more complex process. Here furin-like cleavage plays a major 
role in the proα1(V), proα1(XI) and proα2(XI) chains and BMP1/mTLD cleave the proα2(V) 
chain as well as within the large N-terminal regions of the proα1(V), proα1(XI) and proα2(XI) 
chains (Hulmes, 2008), with both enzymes cleaving at the C-propeptide (Unsold et al., 2002). 
Furthermore BMP1/mTLD cleave procollagen VII, showing that this process is not exclusive 
to fibril forming collagen (Hopkins et al., 2007). 
Secretion from the cell into the extracellular matrix requires transport of the protein from 
the Golgi to the plasma membrane. There are numerous exits routes, however the most well 
understood is the clathrin-coated, vesicle mediated transport of cargo from the trans-Golgi 
network (TGN) to the endosomes, lysosomes and plasma membrane (Bard and Malhotra, 
2006, De Matteis and Luini, 2008, Guo et al., 2014, Kienzle and von Blume, 2014). The sorting 
and transportation of proteins to the relevant position of the cell is a complex process, for 
example mature epithelial cells and neurons have functional and morphological polarization 
and therefore require the protein to be secreted at a specific region of the cell (Pakdel and 
von Blume, 2018). The mechanism of how collagen is sorted at the TGN remains unknown 
(Pakdel and von Blume, 2018). Transport of procollagen from the TNG to the plasma 
membrane before secretion into the ECM has been suggested to be via carriers that are 
generally tubular-saccular but are heterogeneous in shape. These clathrin-coated carriers 
are 300-1700 nm in length and form via the detachment of larger regions of the TGN 
(Polishchuk et al., 2003). 
Before the mature collagen fibrils are generated, a precursor suprastructure is first 
assembled called the protofibrils (Birk and Trelstad, 1986, Birk et al., 1989). These fibrils are 
immature, short and feature small uniform diameters (diameter: ~20 nm, length: 4-12 μm 
length (Birk and Brückner, 2011)). The protofibrils are secreted into the developing ECM 
where they are stabilised through interactions with other ECM components including FACIT 
collagens and small leucine-rich proteoglycans (SLRP). The mature fibril is assembled by end-





Collagen is one of the major structural proteins found in the body and is known to occur as 
at least 28 different isoforms. The concentration of different types of collagen found in 
tissues varies, with the major fibril forming collagens typically accounting >90% of the dry 
protein weight of musculoskeletal tissues. This has led to many researchers considering the 
synthesis of these collagens as a key marker for successful tissue engineering, however the 
role of the minor collagens is key to achieve tissue homeostasis.  
From early embryogenesis to maturation musculoskeletal tissue undergo a variety of 
mechanical forces that help to direct the differentiation of the cell found within the tissues. 
These mechanical stimuli also drive the production of collagens, acting as a key regulator for 
the appropriate development of the structures. The use of such mechanical stimulations in 
tissue engineering is key to achieve an appropriate engineered tissue. A number of 
bioreactors are now commercially available and regularly custom built to provide specific 
mechanical stimuli to tissue cultures, which has resulted in more organised ECMs, increases 
in differential markers and inhibitory effects on others. The magnitude, frequency and 
duration of a specific mechanical force has been found to have differing effects on the cells 
fate. This thesis will focus on how changes to these mechanical forces results in changes to 
the collagen synthesis and arrangement within tissue engineered structures.     
1.9. Hypothesis 
Mesenchymal stem cells will generate varying concentrations of the major and minor types 
of collagen in response to different mechanical stimuli. This composition can be used to 
identify the differentiation of the cells and the quality of the tissue engineered structure 
generated. 
1.10. Aims 
• To investigate the potential of 3D printing as a manufacturing technique for novel 
approaches to tissue engineering. 
• Investigate the role of a variety of mechanical stimulations on MSC differentiation 
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Materials are listed below and grouped by supplier: 
Abcam – Anti-collagen α1(I) antibody (ab138492), Anti-collagen α1(III) antibody (ab7778), 
Anti-collagen α1(V) antibody (ab112551), Anti-collagen α1(X) antibody (ab182563), Anti-
collagen α1(XI) antibody (ab64883), Anti-collagen α1(XII) antibody (ab121304), Anti-collagen 
α1(XIV) antibody (ab101464), Biebrich scarlet (ab146312). 
Accu.co.uk – Grub screw (SSU-M5-30-A2), M3 thread insert (HSTI-M3-A2), M5 thread insert 
(HSTI-M5-A2), Thumb screw (SKT-M3-10-A1). 
Agar scientific – ‘Diatome’ ultra-diamond knife (AGG3397), 200 mesh copper grid 
(AGG2700C). 
BD Bioscience – BDTM CompBeads  (552843). 
Benam – XTC-3D oxirane resin (XTC-3D) 
Bio-Rad – Criterion Blotter (1704071), Criterion Vertical Electrophoresis system (1656001), 
iScript (1708891). 
Cambridge bioscience – Zymo Direct-zol DNA/RNA Miniprep (R2080). 
Cole Palmer – Luer Lock adapter (OU-30800-00), 0.2-um syringe filter (16534-------------K). 
Don Whitley Scientific – Bellow (SP-90.007.06). 
Farnell – Sylgard 184 (I0I697). 
Fisher Sci – Nuclease free water (11538646). 
Gibco – DMEM (11880028),  FCS (A3160802, Lot- 42F7584K). 
Greiner – T-flasks (660175). 
Li-cor – Chameleon 800 Pre-stained Protein Ladder (929-800000), IRDye® 800CW Donkey 
anti-Mouse IgG Secondary Antibody (926-32212), IRDye® 800CW Donkey anti-Rabbit IgG 
Secondary Antibody (926-32213), REVERT Total Protein Stain (926-11021), REVERT Wash 
Solution (926-11012). 
Lonza – Bone marrow aspirate (Pt-2501). 
Merck – Amicon Ultra-15 centrifuge filter unit (UFC901008). 
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Millipore – BugBuster Ni-NTA His-Band purification kit (70751), RIPA buffer (20-188).  
New England BioLabs – BamHI-FI (R3136), Pstl-HF (R3140), Cutsmart buffer (B72042). 
Peprotech – TGF-β3 (100-36E).  
Promega – PureYield plasmid miniprep (A1223). 
Qiagen – COL5A1 primer (NM_000093), COL6A1 primer (NM_001848), COL9A1 primer 
(NM_001851), COL14A1 primer (NM_021110), COL24A1 primer (NM_152890), DCN primer 
(NM_133503) RNeasy Mini kit (74104), SXCA primer (NM_001080514), TNMD primer 
(NM_022144), QIAGEN TissueRuptor II (9002757). 
R&D Systems – MSC verification kit (FMC020). 
RS Components – Loctite super glue (787-7406), M3 screw (280-981), M5 thumb nut (664-
4886), Polycarbonate sheet (681-665).  
Santa Cruz – Anti-collagen α1(II) antibody (sc-52658), Anti-collagen α1(VI) antibody (sc-
377143), Anti-collagen α1(IX) antibody (sc-376969). 
Sigma Aldrich – Acid Fuchsin (F8129), Alcian blue 8GX (A5268), Alizarin red S (A5533), 
Aluminium ammonium sulphate (A2140), Aniline blue (415049), β-glycerophosphate 
(G9422), Bradford reagent (B6916), Bovine serum albumin (A2153), Chloroform, 
Dexamethasone (D4902), Direct red 80 (365548), Dimethyl sulfoxide (D2650), DPX mounting 
solution (06522), Eosin Y (E4009), Ethanol (459844), Ferric chloride (236489), Fibrinogen 
(341573), Fibronectin (F4759), Formaldehyde (F8775), Glacial acetic acid (10000631011), 
Glycerol (G9012), Haematoxylin (H3136), Hydrochloric acid (320331), Hydrogen peroxide 
(H1009), Indomethacin (17378), Insulin (I6634), Isopropyl B-d-1-thiogalactopyranoside 
(420322), Isopropanol (I9516), Insulin Transferred Sodium (I3146), L-ascorbic acid (A92902), 
LB Broth (L3522), L-Glutamine (G7513), Nitrocellulose membrane (WHA10401403), Paraffin 
wax (327204), Pellet pestles Z359971, Pepsin (P7012), Picric acid solution (P6744) 
Phosphomolybdic acid (221856), Phosphotungstic acid (P4006), Phloxine B (P4030), Sodium 
azide (S2002), Sodium chloride (S7653), Sodium iodate (S4007), SYBR Green JumpStart Taq 
ReadyMix (S4438), Tissue processing cassette (H0542), Trypsin (59427C), Thrombin (T4648), 
Tris HCL, Trisma-base (T1503), Tween 20 (P1379), Xylene (534056), 4X SDS sample buffer 
(70607-3), 6-aminocaproic acid (A2504), 3-Isobutyl-1-methylxanthine (I5879). 
Simply Bearings – O-ring (3 mm diameter, 134 mm bore VITON) 
SLS – Methanol (34860). 
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TAAB Laboratories Equipment Ltd – Acetone (A018), Borax (B021)., Epoxy resin (T001, D025, 
M011, D032), Ethanol (E047), Glutaraldehyde (G002), Maleic acid (M003), Methanol, 
Osmium tetroxide buffer (O001), Reynolds lead citrate stain (L037), Sodium cacodylate 
(S011), Toluidine blue (SD211), Uranyl acetate (U007). 
ThermoFisher – Antibiotic-Antimitotic (15240062), Anti-collagen α1(XXIV) antibody (MA5-
24533), DAPI (D1306), Designed primers, DNA gel loading dye (R0611), (6X) DyLight 488 NHS 
ester dye (46402), EDTA (15576028), Foetal calf serum (A3160802), GelCode Blue Stain 
Reagent (24590), Low melting point agarose (16520100), Mini Gel Tank (A25977), Non-
essential amino acids (11140035), Novex Sharp Pre-stained Protein Standard (LC5800), 
Novex Tris-Glycine SDS running buffer (LC2675), Novex™ WedgeWell™ 4 to 12%, Tris-Glycine 
(XP04120BOX), Nuclease free water (11538646), NuPAGE LDS Sample Buffer (NP0007), 
NuPage Sample Reducing Agent (10X) (NP0004), NuPAGE Transfer Buffer (20X) (NP0006), 
NuPAGE Tris-Acetate SDS Running Buffer (10X) (LA0041), NuPAGE 3-8% Tris-Acetate midi 
protein gels (WG1603A), Phalloidin 647 (A22287), Pierce BCA assay kit (23227), Pierce Bovine 
Serum Albumin Standard Pre-Diluted Set (23208), Pierce Dimethylformamide (20673), Pierce 
LDH assay kit (88953), Superfrost Plus Adhesion Microscope Slides (J1800AMNT), TrackIt 1Kb 
Plus DNA ladder (10488085), TRIzol (15596026), 4-12% tri-glycine WedgeWell gel 
(XP04122BOX). 
VWR – PegGREEN (732-3196). 
3DGBIRE – PLA filament, Nylon Filament. 
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2.2. Methods and Optimisation 
2.2.1. Cell Culture 
Human mesenchymal stem cells (hMSCs), from bone marrow, were used in all tissue 
engineering experiments. The hMSCs were purchased as four 10 ml aspirates from Lonza. All 
four aspirates were donated from a single normal (non-diabetic) adult. The human bone 
marrow was withdrawn from bilateral punctures of the posterior iliac crests from the donor 
in the US, before being shipped as aliquots to UK on dry ice.  
The mononuclear count provided by the supplier was 2.6x107 cells/ml. Before plating the 
cells the required number of tissue culture vessels was determined from the mononuclear 
cell count as 1x105 mononuclear cells/cm2. The final cell count was found to be 1.554x109 
cells, therefore a surface area of 14,505 cm2 or 90 T175 flasks was required. 
The flasks were coated in 10 ml of sterile fibronectin to a final concentration of 10 ng/ml and 
left for one hour at room temperature. The fibronectin solution was removed and 15 ml of 
low glucose, phenol free Dulbecco’s modified Eagle’s Medium (DMEM) containing 10% foetal 
calf serum (FBS), 1% L-Glutamine, 2% Antibiotic-Antimitotic and 1% Non-essential Amino 
Acids was added to each flask, this media was designated basic media throughout the rest 
of the study. Approximately 600 μl of the bone marrow aspirate was added to each flask. 
The flask was gently mixed and incubated at 37°C in a humidified environment (5% CO2, 21% 
O2) for seven days. During the initial culture, hMSCs adhered to the fibronectin coated tissue 
culture plastic while red blood cells floated in the basic media, which prevented visualisation 
of the hMSCs adhered to the flasks. After seven days, 50% of the basic media was replaced 
and the flasks were again incubated at 37°C in a humidified environment (5% CO2, 21% O2) 
for a further seven days. Finally 100% of the basic media was replaced and hMSCs could be 
visualised (Fig.2.1).  
Figure 2.1. Human mesenchymal stem cells following isolation from bone marrow aspirate. 
A) 14 days post adherence, B) 16 day post adherence, C) 18 days post adherence. Scale bars 
represent 300 μm. 
A B C
300 μm 300 μm 300 μm 
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Once the hMSCs had reached confluence they were passaged and stored in liquid nitrogen 
at P0. Confluence density was confirmed using a microscope with 10x objective. The basic 
media was removed and each flask washed in 10 ml of Phosphate buffered saline (PBS). Once 
washed the PBS was replaced with 7 ml PBS + 3 ml 10x Trypsin. The flasks were then 
incubated at 37°C in a humidified environment (5% CO2, 21% O2) for 5 minutes to dissociate 
the cells from the flask. The flasks were “tapped” to dissociate any cells still adhered to the 
flask before aspirating the cell solution into a 50 ml sterile centrifuge tube containing 5 ml 
basic media. The flask was washed with 10 ml basic media which was also added to the 50 
ml sterile centrifuge tube. The cell solution was then spun down at 500 g for 5 minutes to 
pellet the cells. The supernatant was poured away and the cell pellet was re-suspended in 
20 ml basic media. The cell number was determined using a haemocytometer on 10 μl 
samples. Cells were re-pelleted by centrifuging at 500 g for 5 minutes and re-suspended in 
10% Dimethyl Sulfoxide (DMSO) + 90% FBS at 400,000 cells/ml and stored in liquid nitrogen 
until required. 
2.2.2. hMSC Validation 
Fluorescence-activated cell sorting (FACS) and the tri-linage assay was used to characterise 
the cells extracted from the bone marrow aspirates as hMSCs. 
2.2.2.1. hMSC FACS Verification 
An MSC verification kit was used to define the cells grown from the bone marrow aspirate. 
The kit contains the MSC markers that have been defined by Dominici et al. (2006) as the 
minimum criteria to class the cells as MSCs. The markers include CD73, CD90, CD105 and a 
cocktail of negative markers: CD11b, CD34, CD45, CD79A and HLA-DR. All positive markers 
are required to be expressed by >95% of the population and the negative marker cocktail at 
<2% of the population to meet the criteria requirements. 
The verification kit was run on the cells extracted from the bone marrow aspirate at passage 
1 (P1). The cells not used for the verification kit were taken forward to be used in the tensile 
stimulation experiment. Antibody compensation was performed using BDTM CompBeads 
following the manufactures protocol: 100 μl of staining buffer was added to one flow 
cytometry tube per antibody. One drop (approximately 60 μl) of the BDTM CompBeads 
Negative Control and one drop of the BD CompBeads Anti-Mouse Ig was added to each tube 
and vortexed. 10 μl of each antibody supplied in the MSC verification kit was added to the 
appropriately labelled flow cytometry tube, including an unstained tube. The tubes were 
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incubated in the dark for 45 minutes at room temperature. After incubation 2 ml of staining 
buffer was added to each tube, the tubes were centrifuged at 200 g for 10 minutes. The 
supernatant was discarded and the bead pellet was re-suspended in 500 μl of staining buffer. 
Each tube was run on the BD FACS Canto II flow cytometer and the singlet bead population 
was gated based on forward light scatter (FSC) and side light scatter (SSC) characteristics. 
Once compensation gates were acquired the process was applied to the cell population. The 
P1 cells were disassociated from tissue culture plastic via trypsin (as stated in section 2.2.1) 
and counted using a haemocytometer. 100,000 cells were transferred into a 1.5 ml 
centrifuge tube with 100 μl of staining buffer and 10 μl of each antibody. The tube was 
vortexed and incubated at room temperature in the dark for 45 minutes. The centrifuge tube 
was spun down at 200 g for 10 minutes and the supernatant was discarded. The cell pellet 
was re-suspended in 500 μl of staining buffer and transferred to a flow cytometry tube. The 
marker expression was analysed by the BD FACS Canto II flow cytometer and measured 
against the compensation beads gating. Analysis was completed using FlowJo software. 
Fig.2.2 shows the expression for each marker from the verification kit. The positive markers 
were found to be present in >95% of the cell population (CD73 99.07%, CD90 99.55% and 
CD105 98.57%) meeting the criteria as defined by Dominici et al. (2006), however the 
negative marker cocktail was found to be 2.83%, which marginally exceeds the criteria. 
Figure 2.2. Flow cytometric analysis of minimal stem cell markers as defined by Dominici et 
al. (2006) expressed by P1 hMSCs. Red peaks represent IgG controls, blue peaks represents 
hMSCs. 
2.2.2.2. Tri-Linage Differentiation Assay 
The cells extracted from the bone marrow aspirate were grown to P2 before being 
disassociated from the tissue culture plastic by trypsin. Cells were re-plated in triplicate at 
seeding densities based on the required differentiation. For both osteogenic and adipogenic 
99.07% 99.55% 
98.57% 2.83% 
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differentiation the cells were seeded in monolayer in the wells of a 6-well plate. For 
osteogenic differentiation, cells were seeded at 3,000 cells/cm2 and cultured in osteogenic 
media containing DMEM, 10% FBS, 1% L-Glutamine, 2% Antibiotic-Antimitotic, 1% Non-
essential Amino Acids, 100 nM dexamethasone, 10 mM β-glycerophosphate and 50 μM L-
ascorbic acid (Jaiswal et al., 1997). For adipogenic differentiation the cells were seeded at 
10,000 cells/cm2 and cultured in adipogenic media containing DMEM, 10% FBS, 1% L-
Glutamine, 2% Antibiotic-Antimitotic, 1% Non-essential Amino Acids, 1 μM dexamethasone, 
100 μM indomethacin, 10 μg/ml insulin and 500 μM 3-Isobutyl-1-methylxanthine (IBMX) 
(Cheng et al., 2009). Chondrogenic differentiation required the cells to be present in a 3D 
arrangement, this was achieved by suspending 500,000 cells in 500 μl of basic media in a 1.5 
ml screw cap centrifuge tube. The sample was then centrifuged at 240 g generating a pellet 
of cells. The supernatant was removed and carefully replaced with chondrogenic media 
without disrupting the pellet. The chondrogenic media contained DMEM, 1% L-Glutamine, 
2% Antibiotic-Antimitotic, 1% Non-essential Amino Acids, 100 nM dexamethasone, 10 ng/ml 
TGF-β3, 1% Insulin-Transferred-Sodium (ITS), 25 μg/ml L-ascorbic acid (Murdoch et al., 
2007). Control groups were cultured identically to differentiated groups, but in basic media. 
Osteogenic and adipogenic media were changed twice a week for 21 days and chondrogenic 
media changed every other day for 21 days. To assess differentiation the groups were stained 
with Alizarin Red for osteogenic differentiation where calcium deposits stain red, Oil-Red-O 
for adipogenic differentiation where the lipid droplets stain red or Alcian blue for 
chondrogenic differentiation where the glycosaminoglycans are stained blue. For Alizarin 
Red the culture media was removed from the culture well and the cell monolayer was 
washed in three changes of PBS. The monolayer was fixed in 1% neutral buffer formalin 
solution (NBF) for 30 minutes. The monolayer was carefully washed with distilled water so 
as to not disrupt the cells (some disruption of the cells was observed) and stained with 2% 
Alizarin Red S solution (pH 4.1-4.3) (recipe in section 2.2.4) for 45 minutes in the dark at room 
temperature. The cells were washed a further three times with distilled water and imaged. 
For Oil-Red-O staining the monolayer was washed with three changes of PBS and fixed with 
1% NBF for 30 minutes. Once fixed the cells were washed with distilled water, 60% 
isopropanol was then added to each well and the culture plate was incubated at room 
temperature for 5 minutes. The 60% isopropanol was removed and 0.18% Oil-Red-O solution 
(0.288 g Oil-red O mixed with 100 ml isopropanol to generate a stock solution). 30 ml of stock 
solution was mixed with 20 ml distilled water (generating 0.18% oil-red O solution) was the 
added to the culture plate, which was incubated at room temperature for 15 minutes. The 
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monolayers were washed with two changes of distilled water before the addition of 
haematoxylin for 1 minute. The cells were washed a further four times and then imaged. For 
Alcian blue staining the cell pellets were washed in three changes of PBS and fixed in 1% NBF 
for 60 minutes before paraffin embedding using the Leica ASP300 tissue processor (Leica 
Microsystems, UK) and Leica EG1150 tissue embedder (Leica Microsystems, UK) (explained 
in more detail in section 2.2.4). After the pellets were embedded, 6 μm sections were cut 
using the Leica RM2265 (Leica Microsystems, UK) and mounted on Superfrost Plus Adhesion 
Microscope Slides. Sections were deparaffinised in two changes of xylene (5 minutes each), 
rehydrated in 70%, 90% and 100% ethanol (5 minutes each) and washed in running tap water 
for 2 minutes. Sections were stained in 1% Alcian blue solution (recipe in appendix A) for 30 
minutes and washed for a further 2 minutes in running tap water. Sections were dehydrated 
in 90% ethanol and two changes of 100% ethanol (30 seconds each) and cleared in two 
changes of xylene (1 minutes each). Sections were mounted with DPX mounting solution and 
imaged. Fig.2.3 shows representative images from each of the differentiation stains. Higher 
levels of staining were seen in each differentiation group. Low levels of calcium staining was 
detected in the control group with far higher seen in the osteogenic differentiated group. 
The chondrogenic differentiated pellet was more structurally stable with a complete Alcian 
blue staining whilst the control group generated a less complete pellet culture with fainter 
staining. There was no lipid droplet staining detected in the control group, whilst the 
adipogenic differentiated group had a high level of staining. This demonstrated that the cells 
had the potential to differentiate down the osteogenic, adipogenic and chondrogenic 
lineages. 
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Figure 2.3. Histological analysis of trilineage differentiation potential of P1 hMSCs. 
Representative images are shown for cells after induced osteogenic, chondrogenic or 
adipogenic differentiation (Differentiated) and non-differentiated cells (Control) with 
appropriate staining. Cells differentiated down the osteogenic lineage were stained for 
calcium deposits using alizarin red. Cells differentiated down the chondrogenic linage were 
stained for GAG formation using Alcian blue. Cells differentiated down the adipogenic 
lineage were stained for lipid droplets using oil-red-O staining. n=3 repeats from same donor, 
scale bars represent 600 μm. 
2.2.2.3. Conclusion 
From the flow cytometry analysis and the tri-linage images it can be seen that the cells 
extracted from the bone marrow aspirate met the majority of the criteria needed to define 
the cells as MSCs. The only criteria not seen was the population of cells expressing the 
negative marker exceeding 2%, however this was exceeded by less than 1% (this may be 
contamination of other cell types). As all other criteria was met and the negative criteria was 
exceeded by less than 1% it was concluded that a mixed population of cells was present with 
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2.2.3. Fibrin Hydrogel Formation Optimisation 
Fibrin was chosen as the 3D biomimetic material used throughout the experimental runs for 
all mechanical stimuli as it has been previously used for tissue engineering of tendon, bone 
and cartilage (the musculoskeletal tissues investigated throughout this study) (Eyrich et al., 
2007, Wang et al., 2010, Almeida et al., 2016) and that it acts as a blank slate for collagen 
synthesis, where the only detected collagen is that produced by the cells. The recipe used to 
generate the fibrin hydrogels was consistent across experiments, however the culture 
environment altered between the tensile stimulation (3D printed chamber), the hydrostatic 
pressure (24-well plates) and the microgravity groups (12-well plate and rotation drums). 
Tensile stimulation required rod like structures, similar to that of native tendon, whilst the 
hydrostatic pressure and microgravity required a free swelling ssamples, designated 
microtissues. Detailed methods for generation of the tensile stimulation fibrin hydrogels can 
be found in section 2.2.3.1 and for the hydrostatic pressure and microgravity samples can be 
found in section 2.2.3.2. 
Fibrin is formed by the coagulation of the protein fibrinogen due to the enzyme thrombin. 
By mixing cells with the solution before it polymerises, a 3D network of suspended cells is 
formed that can be mechanically stimulated. The basis for the fibrin recipe was built on 
published work previously completed by members of our group (Kharaz et al., 2016), with a 
final protocol established following optimisation through a titration of thrombin with 
consistent fibrinogen and cell suspension of 1x106 cells/ml (10-80 μl of 200 U/ml thrombin 
with 250 μl of 20 mg/ml fibrinogen and 600 μl cell suspension) a volume of 50 μl was taken 
forward following optimisation (Fig.2.4). 
Figure 2.4. Effects of thrombin concentration of fibrin formation. Fibrin gels formed between 
early anchor post design, used for tensile stimulation optimisation. (A) End of week one, the 
10 μl group formed the smallest hydrogel and contracted the most. (B) End of week two, the 
80 μl group was almost completely degraded and 10 μl group hadn't changed from week 
10 μl 30 μl 50 μl 
60 μl 80 μl 
10 μl 30 μl 50 μl 
60 μl 70 μl 80 μl 
A B 
70 μl 
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one, the 50 μl and 60 μl produced the best hydrogels. 50 μl was taken forward due to slightly 
longer coagulation time. 
For the final experiments with mechanical stimulation, the ratio of cell suspension, 
fibrinogen and thrombin was maintained at 12:3:1 using the same batches of fibrinogen, 
thrombin and MCS. All samples were generated with the same initial volume of fibrin though 
in different seeding environments which is explained in detail in the following sections. All 
fibrin protocols were based around the following protocol: in a well plate a layer of sterile 
4% agarose was dispensed and set, this layer was then washed with sterile PBS. The hMSCs 
were disassociated from the tissue culture plastic via the trypsin method (see section 2.2.1) 
and counted using a haemocytometer. For the final hydrogels 1.25x106 cells/ml were used; 
this equated to 5x105 cell/hydrogel. Once the cells were counted and suspended in the 
correct volume of basic media, 75 μl (20 mg/ml) fibrinogen was added to each well. 300 μl 
of the cell suspension was added to the fibrinogen and mixed by pipetting up and down. 25 
μl (200 U) of thrombin was then added to each well and mixed with a sterile 10 μl pipette 
tip. The plates were then placed into the incubator at 37°C, 5% CO2 for one hour, or until 
polymerised. Once the fibrin had formed the edges were scored with a pipette tip to detach 
the fibrin from the edge of the well and encourage contraction. Each well was filled with 
basic culture media (volume depended on experimental group) containing fresh 800 μM L-
ascorbic acid and 1 mg/ml 6-aminocaproic acid. Media was changed and the fibrin was 
scored with a pipette tip every other day during the contraction phase (contraction phase 
was one week for hydrostatic pressure and microgravity and two weeks for tensile 
stimulation). After the contraction phase the fibrin hydrogels were placed into the 
experimental environment as defined in the sections 2.2.3.1 and 2.2.3.2. 
2.2.3.1. Tensile Fibrin Hydrogel Generation 
Cells were grown as describe in section 2.2.1. Briefly hMSCs were thawed at passage 1 and 
grown in T175 flasks to passage 3. The cells were cultured in basic medium at 37°C in 
normoxia and 5% CO2. Once the required cell number was achieved to enable formation of 
30 fibrin hydrogels (>15,000,000 cells), the hMSCs were dissociated from the tissue culture 
plastic and counted. Cells were diluted to 1.25x106 cells/ml, which was the required 
concentration for the fibrin hydrogels. The ratio of components to generate the fibrin 
hydrogel was maintained from section 2.2.3: 75 μl (20 mg/ml) fibrinogen, 25 μl (200 U) 
Thrombin and 300 μl cells diluted in basic medium.  
Chapter 2  
89 
 
The anchor frames (describe in detail in section 3.5.1.6) were used to generate the tendon 
like structures that were subjected to tensile stimulation. Before use the anchor frames and 
spar covers were washed in PBS and then sterilised in 70% ethanol by submerging for 30 
minutes within a BSC. After 30 minutes they were removed from the 70% ethanol with sterile 
forceps and placed on sterilised paper. The anchor frames and spar covers were then sprayed 
with 70% ethanol and left to dry for an hour. Whilst drying the six well plates were prepared. 
1 ml of sterile 4% agarose was carefully dispensed into the base of each well of five 6-well 
plates (30 wells in total), ensuring the agarose set level across the base. Once dry, an anchor 
frame was moved into each well. The spar covers were then placed in position over the 
breakable spars and a further 2.5 ml of sterile 4% agarose dispensed around the anchor 
frame and spar cover ensuring no agarose moved into the centre of the anchor frame. The 
agarose was then left to set for 15 minutes. Once the 4% agarose was set, 300 μl of sterile 
PBS was dispensed the middle of each anchor frame to confirm that the agarose had set 
without forming any escape routes that the fibrin may run down before polymerising. If any 
PBS did escape the well the escape route was filled in with more sterile 4% agarose and re-
tested to ensure the well was watertight. The well was then washed in 3 changes of 3 ml 
sterile PBS and the plate left with the final change of sterile PBS until required. 
To generate the fibrin hydrogels, first the sterile PBS was removed from all wells. Next 25 μl 
(200 U) thrombin was dispensed into the centre of each anchor frame. 300 μl of the 
suspended cells (1.25x106 cells/ml) was then added each anchor frame (5x105 
cells/hydrogel). Finally 75 μl (20 mg/ml) fibrinogen was dispensed into each anchor frame. 
The six well plates were then moved to an incubator operating at 37°C in normoxia and 5% 
CO2. The samples were left for one hour to allow the fibrin to fully polymerise. Once 
polymerised, using a 10 μl pipette tip, the edges of the fibrin were scored away from the 
anchor frame to encourage contraction and covered in 3 ml of basic medium. 1 mg/ml 6-
aminocaproic acid was added to the culture medium to inhibit fibrin degradation during the 
contraction phase (first two weeks) (Kupcsik et al., 2009). The medium was changed and the 
fibrin hydrogels scored every 48 hours during the contraction phase. The fibrin hydrogels 
reached ideal contraction after two weeks and were ready to be moved into the 3D printed 
culture chamber. 
Before the fibrin hydrogels could be moved into the bioreactor chamber it was sterilised with 
70% ethanol; initially all components were disassembled and washed individually in 70% 
ethanol before drying within a sterile cell culture hood for one hour. Once dry the parts were 
assembled and washed a second time in 70% ethanol and left to dry in the sterile cell culture 
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hood for a further hour. Once dry the culture wells were washed 3 times with PBS and two 
0.2 μm syringe filters attached to the lid for sterile air flow. Once washed the PBS was 
discarded and the bioreactor chamber was ready to use. 
To transfer the fibrin hydrogels from the six well plate to the bioreactor chamber, the spar 
covers were first removed and the agarose seal was broken with sterile forceps. The anchor 
frame and fibrin hydrogel was them moved to a sterile petri dish again using the sterile 
forceps. The 90° attachment arms (which had been sterilised in the same method as the 
anchor frames) were installed onto the anchor frames and the system was picked up using 
sterile forceps and moved into the designated culture well.  
To decide which fibrin hydrogel went into which well, each culture well was given a number 
(control chamber 1-6, tensile chamber one 7-12, tensile chamber two 13-18 and tensile 
chamber three 19-24) and each fibrin hydrogel given a number 1-30. The fibrin hydrogel 
numbers were then randomised using an online random number sequence generator 
(Random.org). The first number of the sequence was then assigned to well number one (i.e. 
control chamber well one).  
Once in the bioreactor chamber the spars were broken using sterile scissors leaving the fibrin 
hydrogel to support itself between the anchor frame. The lid was fitted and secured using 
thumb screws, creating an airtight seal with the O-ring. The hydrogels were cultured in 3.5 
ml of basic medium with 800 μM of L-ascorbic acid which was added fresh during every 
media change, there was no 6-aminocaproic acid in the culture media during the loading 
phase. Medium continued to be changed every 48 hours. The bioreactor chambers with 
fibrin hydrogels installed were incubated in non-humidified incubator at 37°C in 5% CO2. 
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2.2.3.2. Hydrostatic Pressure and Microgravity Fibrin 
Hydrogel Generation 
The method for generating the fibrin hydrogel was the same for both the hydrostatic 
pressure stimulation and the microgravity culture experiments. Cells were grown as 
described in section 2.2.1. Briefly hMSCs were thawed at passage 1 and grown in T175 flasks 
to passage 3. The cells were cultured in basic medium at 37°C in normoxia and 5% CO2. Once 
the required cell number was achieved for the fibrin hydrogels, the hMSCs were dissociated 
from the tissue culture plastic and counted. Cells were diluted to 1.25x106 cells/ml, this was 
the required concentration for the fibrin hydrogels. The ratio of components to generate the 
fibrin hydrogel was maintained from section 2.2.3, 75 μl (20 mg/ml) fibrinogen , 25 μl (200 
U) thrombin and 300 μl cells diluted in basic medium.  
Before the fibrin hydrogels were generated the well plates were prepared. Initial culture was 
done within 48 well plates as this was found to generate optimum hydrogel size. 100 μl of 
sterile 4% agarose was added to each well and left to set, forming a non-adherent base layer 
with a curved meniscus. Once set, 500 μl of sterile PBS was added to each well to wash away 
any unset agarose, the PBS was then removed. 25 μl (200 U) thrombin was then dispensed 
into each well, to this 300 μl (1.25x106 cell/ml) of cells in basic medium (5x105 cells/hydrogel) 
was added and mixed. Finally 75 μl (20 mg/ml) fibrinogen was added and mixed. The 48 well 
plate was then moved to an incubator operating at 37°C in normoxia and 5% CO2. The 
samples were left for one hour to allow the fibrin to fully polymerise. Once polymerised, 
using a sterile 10 μl pipette tip, the edges of the fibrin were scored away from the well wall 
to encourage contraction and the samples then covered in 100 μl of basic medium. 1 mg/ml 
6-aminocaproic acid was added to the culture medium to inhibit fibrin degradation during 
the contraction phase (first week) (Kupcsik et al., 2009). The medium was changed and the 
fibrin hydrogels scored every 48 hours during the contraction phase to prevent sticking and 
ensure consistent hydrogel morphology. The fibrin hydrogels reached optimum contraction 
after one week and were now designated microtissues. The microtissues were either moved 
into a 24 well plate for hydrostatic pressure conditions or into 12 well plates for static and 
dynamic microgravity condition. The hydrogels to be cultured under microgravity conditions 
were moved to the microgravity chamber. 
Before the microtissues were moved into the 24 well plate 100 μl of sterile 4% agarose was 
dispensed into each well and left to set before washing with sterile PBS, the microtissues 
were then gently transferred into the 24 well plate using passive suction with a 5 ml pipette 
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tip. Similarly for the 12 well plates 200 μl of sterile 4% agarose was dispensed into each well 
and washed with sterile PBS. The samples within the 24 well plates (hydrostatic pressure) 
were cultured with 500 μl of appropriate media (chondrogenic, osteogenic or basic) with 800 
μM of L-ascorbic acid added fresh during each media change. In the microgravity group the 
samples were cultured in basic media with 800 μM of L-ascorbic acid which was added fresh 
during each media change. 1 mg/ml 6-aminocaproic acid was not added after the initial one-
week contraction period for either hydrostatic or microgravity microtissues.  
To generate the equal ratio of media for the different microgravity microtissues 
(microgravity, dynamic and static), 27 microtissues were cultured in 54 ml media within the 
microgravity chamber, whilst 24 static and dynamic microtissues were cultured in 2 ml within 
12 well plates (two 12 well plates per condition); a ratio of 2 ml of culture media per 
microtissue in all groups. Media continued to be changed every 48 hours for the hydrostatic 
pressure experiment and every third day for the microgravity groups. The well plates were 
cultured within an incubator operating at 37°C in normoxia and 5% CO2, whilst the 
microgravity chamber was attached to the microgravity bioreactor and cultured in an 
incubator operating at 37°C in normoxia and 5% CO2. 




The same five histological stains (haematoxylin and eosin (H&E), Alcian blue, Alizarin Red and 
Picrosirius Red) were applied to all experimental groups. Microtissues in the hydrostatic 
groups were washed with three changes of PBS in the culture plates, fixed with 1% NBF for 
30 minutes at room temperature, washed a further three times with PBS and stored in 0.01% 
sodium azide in PBS at 4°C until required. The microgravity microtissues were fixed and 
stored in the same way as the hydrostatic pressure microtissues, except the microtissues in 
the Synthecon microgravity bioreactor were first removed from the rotation drums and 
placed into a 24 well plate (one microtissue per well). The tensile stimulation samples were 
washed in three changes of PBS and fixed with 1% NBF for 30 minutes directly within the 3D 
printed bioreactor chamber whilst still attached to their anchor frames. Once fixed the 
samples were transferred to two 24 well plates (one sample per well), washed a further three 
times with PBS and stored in 0.01% sodium azide in PBS at 4°C. The fixed samples were 
washed with two changes of PBS before being placed into tissue processing cassettes (one 
cassette per experimental condition). The cassettes were placed into a beaker filled with 100 
ml of 70% ethanol for short term storage (<2 hours). The cassettes were then placed into the 
Leica ASP300 tissue processor (Leica Microsystems, UK) and processed with the protocol 
shown in Table 2.1. 
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Table 2.1. Tissue processing protocol for fibrin hydrogels 
Step Chemical Step duration 
1 70% Ethanol 30 minutes 
2 90% Ethanol 30 minutes 
3 100% Ethanol 10 minutes 
4 100% Ethanol 10 minutes 
5 100% Ethanol 10 minutes 
6 100% Ethanol 10 minutes 
7 Xylene 30 minutes 
8 Xylene 30 minutes 
9 Paraffin wax 2 hours 
10 Paraffin wax 2 hours 
Total time 6 hours and 40 
minutes 
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After processing the samples were removed from the cassettes and embedded in paraffin 
wax using the  Leica EG1150 tissue embedder (Leica Microsystems, UK). Embedded samples 
were sectioned using the Lecia RM2265 microtome (Leica Microsystems, UK) generating 6 
μm sections. Sections were mounted onto Superfrost Plus Adhesion Microscope Slides and 
dried at 37°C overnight. For all stains, sections were deparaffinised in two changes of xylene 
(5 minutes each), rehydrated in 70%, 90% and 100% ethanol (5 minutes each) and washed 
in running tap water for 2 minutes. The following protocols were then used for each stain: 
Alcian Blue staining – Following deparaffinisation the slide was placed into Alcian blue 
solution for 30 minutes at room temperature. After the 30 minutes had elapsed the sample 
was placed under running tap water for two minutes to wash away excess and unbound dye. 
Finally the sample was rinsed in distilled water before being dehydrated and mounted as 
outlined below. 
Alizarin Red staining – Following deparaffinisation the slide was placed into Alizarin red 
solution (pH 4.3-4.5) for two minutes before excess stain was shaken and the slide was 
blotted dry. The sample was then dehydrated and mounted as outlined below. 
H&E staining – Following deparaffinisation the cell nucleus was stained by submerging the 
sample in Mayer’s haematoxylin solution for five minutes. The sample was then washed in 
running tap water for one minute and then differentiated in 0.3% acid alcohol for 30 seconds. 
The sample was then  washed again in running tap was for 5 minutes and counter stained in 
eosin for three minutes. The excess eosin was washed off by dipping the slide in distilled 
water before dehydrating and mounted as outlined below.  
Picrosirius Red staining – Following deparaffinisation the cell nucleus was stained by 
submerging the slide in Weigert’s haematoxylin for eight minutes. Once the eight minutes 
had passed the sample was washed in running tap water for 10 minutes before submerging 
in picrosirius red solution for one hour at room temperature. After one hour the sample was 
washed in two changes of acidified water before dehydration and mounting as outlined 
below. 
Dehydration and mounting – Following staining all sections were dehydrated in 90% ethanol 
and two changes of 100% ethanol (30 seconds each) and cleared in two changes of xylene (1 
minutes each). Sections were mounted with DPX mounting solution and imaged. H&E, Alcian 
blue and Alizarin red images were acquired using the Nikon Eclipse Ci, picrosirius red images 
were acquired using an Olympia BX60 in both brightfield and polarized light. All microscopy 
images were taken using either a x4 or x10 objective. 
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2.2.4.1. Calcium Quantification with Alizarin Red 
After the hydrostatic pressure loading regime was completed, six samples from the 
osteogenic media group were randomly selected. The samples were submerged in 1ml of 
sterile PBS and washed in three changes three times. Once washed the samples were fixed 
in 1% NBF for 30 minutes at room temperature and washed again in three changes of sterile 
PBS. The samples were then stained with 1% Alizarin red solution (pH 4.1-4.3) for one hour 
at room temperature followed by washing in three changes of sterile PBS. The first two PBS 
washes were for one hour at room temperature, whilst the third wash was overnight at 4°C. 
The osteogenic samples were imaged using a dissection microscope fitted with an HD digital 
camera. Quantification of stained calcium in the osteogenic samples was achieved by de-
staining the samples in 5% cetylpyridinium chloride solution for 24 hours at 4°C, yielding a 
purple solution containing the cetylpyridinium-Alizarin complex, which was quantified at 562 
nm. Following the de-stain, some calcium deposits strongly associated with the matrix 
remained stained. Standard curve was generated using 1% Alizarin red serial diluted in 5% 
cetylpyridinium chloride (Henstock et al., 2014). 
2.2.4.2. Alkaline Phosphatase Assay 
Culture medium was collected at seven day time points throughout the experimental run for 
all loading conditions (tensile, hydrostatic pressure and microgravity) From the collected 
culture medium 50 μl was dispensed into a 96 well plate, along with 100 μl of p-nitrophenyl 
phosphate, a phosphatase substrate that turns yellow (λmax= 405 nm) when 
dephosphorylated by alkaline phosphatase after 10 minutes of incubation at room 
temperature. Standard curves were generated with known concentration of bovine mucosa 
alkaline phosphatase enzyme. 
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2.2.5. Protein Extraction and Western Blotting 
Complete extraction of collagen requires the addition of an enzyme as it is largely insoluble, 
therefore simple grinding and suspending in lysis buffer would not give an accurate 
representation of the collagen composition. Collagen solubilisation was done by digesting 
the sample with the enzyme pepsin. In weak acid pepsin cleaves the N- and the C -terminal 
telopeptides of the collagen molecule isolating the soluble triple helix from the insoluble 
telopeptides (Qian et al., 2017).  
To optimise the pepsin digest a number of pepsin (≥2,500 U/mg) concentrations were 
trialled: 25, 50, 100 and 1000 μg/ml. The pepsin was suspended in a 0.5 M acetic acid with 
25 mM Ethylenediaminetetraacetic acid (EDTA) solution, based on the solution used by 
ChandraRajan (1978). Optimisation samples were generated by culturing fibrin hydrogels 
(protocol as defined in section 2.2.3.1) between posts for two weeks in basic media with the 
addition of 800 μM L-ascorbic acid (refreshed every 48 hours). After pepsin digestion was 
complete the protein concentration was measured using the Bradford assay: the sample was 
diluted 1:10 in distilled water and dispensed in triplicate into a 96-well plate. 200 μl of 
Bradford reagent was then added to each well. Absorbance was measured at 470 nm using 
the SPECTROstar Nano microplate reader (BMG LABTECH), this measured the total protein 
found in the sample. The standard curve was generated with a serial dilution of bovine serum 
albumin (BSA) (0-1000 μg).  As can be seen in Fig.2.5, as pepsin concentration decreased the 
extracted protein concentration increased. As 25 μg/ml pepsin produced the highest protein 
concentration it was chosen as the concentration for experimental protein extraction. It 
should be noted than no concentration below 25 μg/ml was tested and this may further 
increase the collagen yield from the digested tissue.   
Figure 2.5. Protein concentration from fibrin hydrogels with varying pepsin concentration. 
Statistical significance measured using one way Anova with Tukey’s multiple comparisons 
(**** P<0.001, **** P<0.01, * P<0.5). 
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At the end of each experimental run, samples were removed from culture, weighed, snap 
frozen and stored at -80°C before digestion. Fig.2.6 outlines the 7 step process for digestion 
and protein extraction. For SDS page analysis, expression of collagen types was normalised 
to total protein, therefore soluble proteins were extracted (step 5a) before the samples were 
digested by pepsin, which degrades non-triple helical proteins. Soluble protein extraction 
was achieved by thawing the sample on ice and homogenising with a motorised pellet pestle. 
The homogenised sample was then suspended in 75 μl of RIPA buffer and vortexed. The 
sample was centrifuged at 10,000 g for 10 minutes at 4°C to separate the insoluble protein 
(pellet) from the soluble protein (supernatant); the soluble protein was removed and stored 
in a appropriately labelled tube at -20°C. The insoluble protein was suspended in the pepsin 
solution (25 μg/ml pepsin, 0.5 M acetic acid and 20 mM EDTA) and placed on a plate shaker 
overnight at 4°C. the digested sample then followed steps 5b and 6 with each NaCl molarity 
taking 12 hours to complete. The undigested sample was re-digested with fresh pepsin 
solution and again taken through steps 5b and 6. All extracted protein (both soluble and 
insoluble) were then combined at step 7. 
Figure 2.6. Collagen extraction flow diagram. 
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6. Digested solution was salt precipitated to extract 
collagen through three molarities of salt (0.9, 1.2 and 
2.0 M) each for 12 hours. After each precipitation the 
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Protein content was measured using the Pierce BCA protein assay following the 
manufacturers protocol. The BCA assay uses bicinchoninic acid (BCA) to detect the reduction 
of Cu2+ to Cu+ by protein in an alkaline medium. The assay works through two steps; the first 
step is the chelation of copper with protein in the alkaline environment, which results in a 
light blue complex and is known as the biuret reaction, where peptides containing three or 
more amino acid residues form a complex with cupric ions. The second step is used to 
enhance the detectability 100 times, compared to the first step alone. Here the colour of the 
complex is developed by reacting with BCA, generating an intense purple colour which forms 
due to the chelation of two BCA molecules with one cuprous ion. The BCA/copper complex 
exhibits strong linear absorbance at 562 nm with increasing protein concentration. The 
protein concentration was measured using the SPECTROstar Nano microplate reader (BMG 
LABTECH).  
The protein concentration was used to determine the volume of the sample required for SDS 
page. For SDS page electrophoresis, 26 well, 1 mm, NuPAGE 3-8% Tris-Acetate midi protein 
gels were used with the Criterion Vertical Electrophoresis system. Tris-acetate gels were 
selected as they allow for the running of larger proteins with a range from 30-500 kDa. The 
proteins analysed throughout this study range from 35 to 333 kDa allowing for complete 
analysis with one gel type. Protein samples were thawed on ice, 15 μg of protein removed 
from stock and added to an appropriately labelled 1.5 ml centrifuge tube; stock sample was 
then returned to -20°C storage. 3.75 μl of NuPAGE LDS Sample Buffer and 1.5 μl of NuPAGE 
Sample Reducing Agent (10X) was added to the protein sample and the volume made up to 
15 μl with distilled water. The samples were vortexed and heated to 70°C for 10 minutes to 
denature the protein. Once heated the samples were quickly centrifuged to collect any 
condensation generated during heating. The Tris-acetate gel was loaded into the Criterion 
system, as per the manufacturer’s instructions and the tank filled with NuPAGE Tris-Acetate 
SDS Running Buffer (10X) diluted to 1x with distilled water. 5 μl of the Chameleon 800 Pre-
stained Protein Ladder was added to the first well, then the reduced samples added to the 
remaining 25 wells in blocks of four or three depending on experiment, i.e. for the tensile 
stimulation experiment, wells were loaded as: protein ladder, Control A, 3% A, 5% A, 10% A, 
Control B, 3% B, 5% B, 10% B and so on. Electrophoresis was carried out at 150 V for one 
hour. During the run the Criterion Blotter was prepared for the protein transfer. The sponges 
and filter paper were submerged in NuPAGE Transfer Buffer (20X) diluted to 1X in 850 ml 
distilled water and 100 ml methanol. Once the run was complete the gels were removed 
from the chamber, broken out of the cassette and placed into the transfer system via the gel 
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and membrane setup as defined by Bio-Rad (Fig.2.7). Nitrocellulose membranes were used 
for transfers throughout this study.  
Figure 2.7. Gel and membrane setup for electrophoretic transfer. 
Once the gel and transfer membranes were arranged correctly they were installed into the 
Criterion Blotter system and the tank was filled with 1x NuPAGE Transfer Buffer. Protein was 
transferred at 10 V for two hours, the gel was then discarded and the transfer membrane 
was washed in distilled water before being stained with REVERT Total Protein Stain. The 
membrane was incubated with the stain in the dark at room temperature for 5 minutes on 
a rocker plate. Once stained, the REVERT solution was thoroughly decanted and the 
membrane rinsed twice with REVERT Wash Solution. The membrane was imaged using the 
700 nm channel on the Odyssey CLx imaging system (Li-cor, Nebraska, USA) generating a 
fluorescent image for the total protein on the membrane (example shown in Fig.2.8A). The 
membrane was briefly washed in distilled water before being blocked for one hour at room 
temperature with 5% reconstituted dehydrated milk in TBS-T.  
The blocking buffer was removed and the membrane was incubated overnight at 4°C with 
the appropriate antibody diluted in 5% reconstituted dehydrated milk in TBS-T (antibody 
dilutions are shown in Table 2.2) The primary antibody was removed and the membrane 
washed three times with TBS-T before incubating at room temperature for one hour in the 
appropriate secondary antibody (Table 2.2) diluted in 5% reconstituted dehydrated milk in 
TBS-T at 1:10,000. The secondary antibody was removed and the membrane washed a 
further three times with TBS-T. The membrane was imaged using the Odyssey CLx imaging 
system at 800 nm (example shown in Fig.2.8B). Densitometry was performed on the acquired 
images using the Empiria software (Li-cor, Nebraska, USA) with the targeted protein 
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Figure 2.8. Example of western blot for chondrogenic media samples stimulated under 
hydrostatic pressure. (A) REVERT total protein stain of membrane, (B) Collagen Iα1 probe on 
membrane. 






Collagen α1(I) ab138492/Abcam 1:1000 926-32213/Li-cor 
Collagen α1(II) sc-52658/Santa Cruz 1:500 926-32212/Li-cor 
Collagen α1(III) ab7778/Abcam 1:1000 926-32213/Li-cor 
Collagen α1(V) ab112551/Abcam 1:500 926-32212/Li-cor 
Collagen α1(VI) sc-377143/Santa Cruz 1:500 926-32212/Li-cor 
Collagen α1(IX) sc-376969/Santa Cruz 1:500 926-32212/Li-cor 
Collagen α1(X) ab182563/Abcam 1:1000 926-32213/Li-cor 
Collagen α1(XI) ab64883/Abcam 1:500 926-32212/Li-cor 
Collagen α1(XII) ab121304/Abcam 1:500 926-32213/Li-cor 
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2.2.6. RNA Extraction and qPCR 
RNA was extracted from all sample by transferring fibrin hydrogels from culture to an RNase 
and DNase free 2 ml centrifuge tube. For the tensile stimulated samples, each strain rate was 
applied for a final two hours before transfer to the centrifuge tube, whilst hydrostatic 
microtissues underwent a final one hour stimulation. All control and microgravity 
microtissues were transferred directly to the centrifuge tubes. 300 μl of TRIzol was added to 
each centrifuge tube and samples were frozen at -80°C. To extract RNA, samples were first 
thawed on ice, then homogenised using the QIAGEN TissueRuptor II before being drawn up 
into a 1 ml syringe and passed through a 23 gauge needle into a fresh 1.5 ml centrifuge tube. 
RNA was extracted using the phenol chloroform method: 60 μl of chloroform was added to 
each homogenised sample in a 1.5 ml centrifuge tube. The samples were vortexed for 15 
seconds before incubating at room temperature for 3 minutes. After incubation the samples 
were centrifuged at 12,000 g for 15 minutes at 4°C. The upper aqueous layer was transferred 
to a fresh RNase and DNase free 1.5 ml centrifuge tube, to which 150 μl of 100% isopropanol 
was added. The samples were left for 15 minutes at room temperature to precipitate the 
RNA. Samples were then centrifuged at 12,000 g for 10 minutes at 4°C, the supernatant was 
removed and discarded. 300 μl of 75% ethanol was added to each sample to wash the pellet. 
The samples were briefly vortexed and then spun down at 7,500 g for 10 minutes, the 
supernatant was removed and discarded and the wash step was repeated. Samples were left 
to air dry for 10 minutes in a fume hood before re-suspending RNA pellet in 11 μl ultra-pure 
water. The quality and quantity of RNA was measured using the SPECTROstar Nano 2000 
nanodrop (Thermo Scientific). 260/280 ratios between 1.6-2.1 were deemed acceptable. 
cDNA was synthesised using the Bio-rad iScript kit in a 20 μl reaction with 0.2-1 μg total RNA. 
The 20 μl reaction comprised  0.1-11 μl extracted RNA, 1 μl iScript Reverse Transcriptase, 4 
μl 5x iScript Reaction Mix and was made up to 20 μl with Nuclease free water. The reaction 
was ran using the VeritiTM 96-well Thermal Cycler (Appled Biosystems, ThermoFisher). 
Samples were initially primed at 25°C for 5 minutes, reverse transcription was applied at 46°C 
for 20 minutes before the reverse transcriptase was inactivated at 95°C for 1 minute.  
Samples were then stored at -20°C until required. 
The qPCR reaction was ran using a Stratagene MX3005P instrument, were each sample is 
present within a well of a 96-well plate. Each well contained 10 ng (0.2-3 μl) cDNA, 0-2.8 μl 
(depending on sample volume) distilled water, 5 μl SYBR Green JumpStart Taq ReadyMix, 1 
μl 10 μM Forward Primer, 1 μl 10 μM Reverse Primer and 1x reference dye (ROX). Fig.2.9 
shows the thermal profile for qPCR reactions. Initial denaturing occurs during segment 1 
Chapter 2  
103 
 
were samples are heated to 95°C for 5 minutes; following this 40 cycles were applied during 
segment 2 starting with denaturing at 95°C for 10 seconds, annealing at 55°C for 10 seconds 
and extension at 68°C for 30 seconds. The melt peaks were then generated during segment 
3. qPCR data was analysed using the efficiency corrected ∆CT method (Pfaffl et al., 2004, 
Svec et al., 2015). 
Figure 2.9. Thermal profile for qPCR. 
Primers used were either designed in-house or purchased from QIAGEN (sequence not 
provided) as shown in Table 2.3. Primer sequences were designed using Primer-Blast (NCBI) 
or taken from published work. Sequence quality was confirmed using the IDT OligoAnalyzer 
tool and the ThermoFisher oligo design tool (primer parameters shown in Appendix B). 
Primers were tested for efficiency and melt peaks before use in experiments, Appendix C 
details efficiency and melt peak analysis. The most suitable housekeeper genes for each 
mechanical stimulation was confirmed using GeNorm (see Appendix D) and was found to be 
YWHAZ for tensile stimulation and GAPDH for hydrostatic pressure and microgravity.
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Table 2.3. Primer sequences for investigated genes. 
Gene Forward Reverse Origin 














COL5A1 NM_000093, QIAGEN QIAGEN 
COL6A1 NM_001848, QIAGEN QIAGEN 



















COL14A1 NM_021110, QIAGEN QIAGEN 
COL24A1 NM_152890, QIAGEN QIAGEN 
DCN NM_133503, QIAGEN QIAGEN 
SCXA NM_001080514, QIAGEN QIAGEN 
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2.2.7. Transmission Electron Microscopy 
Transmission electron microscopy (TEM) was preformed externally at the department of 
Veterinary Pathology and Public Health, Leahurst Campus, University of Liverpool by Miss 
Marion Pope. Method for fixation, sectioning and imaging was provided by Miss Marion 
Pope. Samples were prepared in the Institute of Ageing and Chronic disease before being 
shipped to be imaged. 
At the end of the three week loading phase during run 4, 5 and 6 one sample was randomly 
selected from each group, the media was removed and the sample was washed in three 
changes of  sterile PBS within the bioreactor chamber. Once washed the samples were fixed 
in 2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.4) for four hours. After four 
hours the tissue engineered tendon were removed from the anchor frame and placed into 
labelled 1.5 ml Eppendorf’s with 1 ml of fresh glutaraldehyde buffer. The samples were then 
shipped for imaging. 
Once at the Leahurst campus the samples were cut into five pieces all approximately 1.6 mm 
long (maximum embedding length 2 mm), along the transverse axis (Fig.2.10). The samples 
were washed in 0.1 M sodium cacodylate buffer for 30 minutes, and underwent a secondary 
fixation and contrast stain in 1% osmium tetroxide buffer for one hour. The samples were 
again washed in the 0.1 M sodium cacodylate buffer before ‘en bloc’ staining with 2% uranyl 
acetate in 0.69% maleic acid (pH 4.5).  
Figure 2.10. Axis the fibrin hydrogels were cut along for TEM analysis and direction fibrin 
hydrogel was imaged in. 
Upon completion of the fixation process the samples were dehydrated through two changes 
of ascending ethanol concentration of 50%, 70% and 90% for five minutes each, three 
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After the samples had been dehydrated, Taab epoxy resin was used to infiltrate the samples 
with ascending resin-acetone mixes with an initial ratio of 1:3 resin to acetone for one hour, 
then 2:2 resin to acetone for one hour, 3:1 resin to acetone for one hour and finally 100% 
resin for two hours. 
Resin infiltrated samples were left to polymerise overnight at 60°C. Once polymerised the 
samples were sectioned. For Toluidine blue staining the samples were sectioned to semi-thin 
sections (0.5 μm) on a Reichert-Jung Ultracut ultramicrotome (Leica Microsystems) and 
stained with 1% Toluidine blue in 1% borax. Toluidine blue staining was used to highlight 
areas of collagen deposition to allow for more targeted TEM imaging. 
For TEM the samples were cut to ultrathin sections (60-90 nm) with a ‘Diatome’ ultra-
diamond knife on a Reichert-Jung Ultracut ultramicrotome and mounted on a 200 mesh 
copper grid. The sample was contrast stained with saturated soluble uranyl acetate in 50% 
methanol for 5 minutes, followed by Reynolds lead citrate stain for 5 minutes. All TEM 
images were taken using the Phillips EM208S transmission electron microscope at 80 kV 
(ThermoFisher, Massachusetts, USA). To correctly measure the samples the magnification 
was calibrated. For the x110,000 objective, 23 spheres with known diameter of 0.09 μm 
diameter were imaged using the EM208S transmission electron microscope. The calibration 
images were imported to Image J/Fiji (Schindelin et al., 2012) and the known diameter was 
used to correctly set the scale bar for subsequent image analysis. 
All image analysis was completed using Image J/Fiji (Fig.2.11), first the images were imported 
to the programme and the 100 nm scale bar was correctly set to 113.84 nm. FThe extreme 
intensities in the image was next removed by despeckling followed by noise smoothing by 
applying a Guassian’s blur. The cleaner image then had the sigma value (radius) set to1 and 
a threshold was taken to minimise fibril merging. The thresholded image was then made 
binary and using the ctrl + f shortcut the empty spaces in the fibrils were filled. Any fibrils 
that remained merged following the previous processing were separated by applying a 
watershed to the image. To measure the fibrils the measurements were set to “acquiring the 
area”, “ shape description”, “perimeter” and “fit ellipse”. Finally the fibrils were measured 
by selecting “show outlines”, “display results” and “exclude on edges”.
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Figure 2.11. TEM image processing. 1) TEM images opened in ImageJ, 2) images despeckled, 3) Guassians blur applied to smooth noise, 4) threshold of images 
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2.2.8. CNA35 Collagen-Probe 
The CNA35 collagen probe was used to image collagen generated by MSCs in response to 
tensile stimulations within fibrin hydrogels. The CNA35 collagen probe was used in place of 
traditional antibody staining as it is non-specific and so highlights all fibrillar collagen within 
the structure rather than the antibody specific isoform. The probe is approximately five times 
smaller than antibodies that bind to collagen therefore making staining of 3D structures 
more comprehensive as a greater proportion of collagen fibrils are exposed to the probe 
(Megens et al., 2007). 
To generate the CNA35 collagen-probe, a plasmid vector, pQE-30, containing CNA35 
(provided by the Mangus Höök group, Texas A&U University to Dr Elizabeth Laird 
(supervisor)) was added to Escherichia coli on ice, the mixture was heat shocked at 42°C for 
30 seconds. Colonies were grown up on LB-ampicillin plates overnight.  A single colony was 
selected and added to 25 ml of LB broth and incubated overnight at 37°C, 250 rpm. The 
following day the 25 ml culture was inoculated with 500 ml LB broth and grown further at 
37°C, 250 rpm. The OD600 value was monitored  until it reached 0.1. Once the OD600 value 
reached 0.1 , 1 mM Isopropyl B-d-1-thiogalactopyranoside (IPTG) was added to the culture 
inducing protein expression (CNA35). The culture was grown for six hours at 37°C, 250 rpm.  
To confirm the  protein had been produced by the bacteria, a sample of the DNA was run on 
a 1% agarose gel. DNA was extracted using PureYield plasmid Minipreps following the 
manufacturer’s protocol. 5 ml of 2x YT medium was inoculated with 50 ml of the bacterial 
culture overnight at 37°C. The following day 5 ml of the overnight culture was centrifuged at 
8000 rpm for 3 minutes at room temperature. The pellet was then re-suspended in 250 μl 
buffer P1 and transferred to a 1.5 ml centrifuge tube. 250 μl of buffer P2 was added and 
mixed by inverting the tube until the solution turned blue. The sample was then incubated 
at room temperature for 5 minutes. 350 μl of buffer N3 was added and mixed by inverting 
tube until the solution turned colourless. The sample was then centrifuged at 8000 rpm for 
10 minutes. The supernatant was added to a QIAprep spin column and centrifuged at 8000 
rpm for 30-60 seconds before the flow through was discarded. The QIAprep spin column was 
washed with 500 μl buffer PE and re-centrifuged as before. The QIAprep spin column was 
moved to a collection tube and centrifuged at 8000 rpm for 1 minutes to remove residual 
wash buffer. The QIAprep spin column was placed into a clean 1.5 ml centrifuge tube and 60 
μl buffer EB was added and incubated at room temperature for 1 minute before centrifuging 
for a further minute, the solution was taken forward for DNA analysis. DNA concentration 
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was found to be 57.9 ng/μl using the SPECTROstar Nano 2000 nanodrop (ThermoFisher, 
Massachusetts, USA). 
The DNA was cut using two enzymes, BamHI-FI and Pstl-HF, and ran on a 1% agarose gel. The 
gel was made by dissolving 1 g of agarose in 100 ml TAE buffer. Once dissolved the 1% 
agarose solution was poured into a gel mold and 5 μl of PeqGREEN was added and mixed in, 
a comb was placed in position and the gel was left to set (approximately 30 minutes). 17.3 
μl (1 μg DNA) of the sample was mixed with 5 μl cutsmart buffer and 1 μl of each enzyme, 
the sample was then diluted with 25.7 μl of sterile distilled water to generate a 50 μl sample. 
The solution was incubated at 37°C for 15 minutes. 10 μl of DNA Gel Loading Dye (6x) was 
added to the sample. 10 μl of Tracklt 1 Kb Plus DNA ladder was dispensed into the first well 
of the 1% agarose gel and 60 μl of the sample into the second well. The gel was run at 90 V 
for 40 minutes and then imaged using the Chemicdoc Chemiluminescence imager (Bio-Rad) 
as shown in Fig.2.12. Two bands appear on the gel, one near 4000 bp and one near 900 bp. 
This agrees with what was expected to be seen; once cut by the BamHI-FI and Pstl-HF 
enzymes the vector pQE-30 should appear at 3461 bp and the cut away CNA35 should appear 
at 948 bp, therefore the vector appeared to have been successfully been taken up by the 
bacteria. 
Figure 2.12. 1% agarose gel electropgoresis of DNA extracted from bacteria grown with 
CNA35 plasmid. Two products on gel at approximately 3500bp and 900bp, the two products 
are consistent with the pQE30 vector (3461 bp) and CNA35 (948 bp). 
The protein was extracted and purified from the culture broth (475 ml remaining after DNA 
analysis) using the BugBuster Ni-NTA His-Bind purification kit. 40 ml aliquots were dispensed 
into 50 ml centrifuge tubes and centrifuged at 10,000 g for 10 minutes. The supernatant was 
removed and stored as lysate 1. The pellets were combined and resuspended with BugBuster 
protein extraction reagent (BBPER). 5ml of BBPER was added per 1 g of cell pellet. Benzonase 
nuclease was added to the suspended cells as 1 μl per ml of BBPER. The cell suspension was 
incubated on a shaking platform on a low setting (approximately 25 rpm), at room 
temperature for 20 minutes (suspension should no longer be viscous due to the benzonase 
Sample 
4000 bp 1000 bp 
Ladder 
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nuclease). The suspension was transferred to a centrifuge tube and spun down at 16,000 g, 
4°C for 30 minutes to remove insoluble cell debris. The soluble protein supernatants were 
pooled together in a fresh tube and the cell debris was re-suspended as lysate 2.  
The supernatants were next passed through a chromatography column to filter the soluble 
protein (reagent listed in Appendix E). 1 ml of 50% Ni-NTA His bind slurry was added to 4 ml 
of the binding buffer and mixed gently. The resin was left to settle by gravity and then 4 ml 
of the supernatant was removed and added to a capped column. Imidazole was then added 
to the soluble protein solution to a final concentration of 10 mM. The solution was run 
through the chromatography column, followed by two washes with 8 ml of wash buffer 
(wash flow through kept as wash 1 and wash 2). Protein was then eluted through six runs of 
1 ml elution buffer, each elution was stored separately as elution 1-6. 
Protein content was investigated using SDS page (Fig.2.13). Samples (lysate 1, lysate 2, wash 
2, wash 2, elution 1, elution 2, elution 3, elution 4, elution 5 and elution 6) were diluted with 
4x SDS sample buffer and heated at 85°C for 3 minutes. Gel electrophoresis was performed 
using the Mini Gel Tank with 4-12% Tris-glycine WedgeWell gels, 10 μl of Novex Sharp Pre-
stained Protein Standard was loaded in wells 1 and 6 and 40 μl of the samples loaded in wells 
2-5 (lysate 1 and 2, wash 1 and 2) and 7-12 (elution 1-6). The Mini Gel Tank was filled with 
1x Novex Tris-Glycine SDS running buffer and gels ran at 225 V for 40 minutes. Once ran the 
gel was removed from the Mini Gel Tank and washed three times (5 minutes per wash) in 
distilled water. The gel was then incubated on a rocking plate in GelCode Blue Stain Reagent 
for one hour at room temperature. Once stained the gel was imaged using the Chemidoc 
chemiluminescence imager (Bio-Rad, California, USA) (Fig.2.13). Based on the SDS page 
results, eluates 3 and 4 were pooled and taken forward to generate the collagen probe, other 









Figure 2.13. SDS-PAGE gel of extracted protein from CNA35 culture. Gel was stained with 
GelCode blue revealing larger amounts of protein at 35 kDa corresponding with the 
molecular weight of CNA35. Elutes 3 and 4 were pooled for subsequent use. 
Eluates 3 and 4 were pooled together and added to an Amicon Ultra-15 centrifuge filter unit 
and centrifuged at 4000 g for 20 minutes, flow through was discarded. 10 ml of sodium 
bicarbonate buffer was then added to the membrane and the unit was again centrifuged at 
4000 g for 15 minutes, flow through was discarded. The addition of sodium bicarbonate 
buffer and centrifugation was repeated twice. The concentrated protein was then suspended 
in 1.5 ml of buffer and recovered by pipetting out of the filter.  
Protein concentration was measured using the BCA protein assay kit. The absorbance was 
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488 NHS ester dye was bound to the protein. To calculate the amount of dye needed the 
following equations were applied: 








× 1011 × 15 = 0.9099	#:	)<	<%/)* 
The molecular weight (MW) of protein was obtained from the manufacturer (ThermoFisher, 
Massachusetts, USA). The MW of DyLight 488 was found from the manufactures data sheet. 




= 0.9099	 × 100 = 90.99	L%	MN! − &H(&*	<%/)*	"(	10	#:/#% 
100 μl of Pierce Dimethylformamide (DMF) was added to DyLight 488 and pipetted up and 
down to mix. The solution was left to dissolve for 5 minutes at room temperature before 
vortexing. 90.09 μl of the DyLight 488 solution was added to 174 μl of the sample, mixed by 
pipetting up and down and incubated at room temperature for 1 hour in the dark. The now 
labelled protein was added to a fresh Amicon Ultra-15 centrifuge filter unit to remove excess 
dye. The filter was topped up with 10 ml sterile PBS and centrifuged at 4000 g for 20 minutes. 
The flow through was discarded, 10 ml of sterile PBS was added and the sample was re-
centrifuged for 15 minutes at 4000 g. The sample was suspended by adding 10 mL PBS` to 
the filter and extracting carefully with a pipette.  
Conformation that the DyLight 488 had bound to the protein was achieved by measuring the 
absorbance using the SPECTROstar Nano 2000 nanodrop (ThermoFisher, Massachusetts, 
USA) (Fig.2.14). 
Figure 2.14. Nanodrop results to investigate the success of the DyLight 488 binding. Values 
for 280nm and 488nm recorded for calculations. 
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 The A280 and Amax (max wavelength of DyLight 488 is 493 nm) values were recorded. A280 was 
found to be 1.72 and Amax was found to be 5.412. The following calculations were used to 





Where CF is the correction factor, given by the manufacturer (ThermoFisher) as 0.147 for 
DyLight 488 and εprotein is the protein molar extinction coefficient which is 33176M-1 cm-1, 
given by the manufacturer (ThermoFisher). 
Q*)(&+,	R),G&,(*"(+),	(C) =
[1.72 − (5.412 × 0.147)]
33176




  [5] 
Where εfluor is the molar extinction coefficient at Amax, given by the manufacturer 
(ThermoFIsher) for DyLight 488 as 70,000M-1 cm-1. 
C)%&H	E>&	$&*	#)%&H	$*)(&+, = 	
5.412
70000 × (2.786 × 105=)
= 2.77 
CNA35 was therefore assumed to have almost 3 moles dye per moles protein, consistent 
with previous work (Krahn et al., 2006) 
The CNA35 collagen-probe was applied to fixed triplicate tensile stimulated samples from 
each tensile stimulation group at the end of the three week loading period. Sample 
processing was applied through the combination of two protocols previously published, 
sample fixation and sectioning is outlined by Short et al. (2017) and CNA35 staining by 
Megens et al. (2007).  
Short et al (2007) demonstrates the use of a vibrotome to section the samples to 100 μm 
thick as vibratomes are frequently used for delicate tissues such as brain which has similar 
modulus  to that of fibrin hydrogels (Miller et al., 2000, Breidenbach et al., 2015). At the end 
of the three week loading phase a sample from each tensile group was fixed in 1% NBF for 
30 minutes within the bioreactor chamber. Once fixed the sample was removed and placed 
into a weighing boat dish. Low melting point agarose was mixed with PBS to a final 
concentration of 6% and melted. Once melted the agarose was poured over the sample in 
the weighing boat and left to set. A rectangle was cut around the sample encased in agarose 
removing excess, which was mounted onto a in house developed 3D printed platform on the 
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vibrotome and fixed in place with Loctite superglue (Fig.2.15). The sample was covered in 
PBS and the vibrotome set to speed 3 and frequency 8. 100 μm sections were cut from each 
sample in the longitudinal direction (along the fibre axis) and stored in 500 μl PBS in a 24 well 
plate (one well per sample) at 4°C. 
Figure 2.15. Schematic of the sample preparation process for vibrotome sectioning. (A) Fixed 
sample placed into weighing boat. (B) Weighing boat filled with low melting point agarose. 
(C) encased tissue engineered tendon removed from weighing boat and excess agarose cut 
away. (D) sample mounted onto 3D printed vibrotome platform and held in place with 
superglue (top view). (C) side view of the sample mount on the 3D printed platform. 
Once all sections were cut they were stained with the CNA35 collagen-probe and DAPI. The 
samples were moved from PBS to Tris-buffered saline (TBS). The TBS was generated from 
136.9 mM/l NaCl, 5 mM/l Trizma Base, 0.1% Tween 20 and 1% Bovine Serum Albumin. All 
solutions were suspended in TBS. First, endogenous peroxidase activity was blocked and 
each section was permeabilized with 3% hydrogen peroxide in methanol for 15 minutes at 
room temperature. The sections were then washed in three changes of TBS before 
incubation in 0.1% pepsin (≥2,500 U stock) in 0.01 M HCL for 30 minutes at room 
temperature. Sections were again washed with three changes of TBS and then incubated in 
1 M CNA35 collagen-probe and 1:40 phalloidin 647 for one hour at room temperature in 
darkness. Dye was discarded and the sections were washed with three changes of TBS. 1% 
DAPI in TBS was then added to each section and samples were incubated for 20 minutes in 
darkness. Sections were washed in two changes of TBS and stored in a final change of TBS at 
4°C. 
Sections were imaged on the Confocal LMS800 (Zeiss). Acquisition information is shown in 
Appendix F. Phalloidin was not detected so is not shown in any images. Images were saved 
as CZI files for storage and TIFF files for analysis. Images were taken in two distinct regions, 
the mid region and the anchor point region (Fig.2.16). It was hypothesised that the anchor 
point region would be less aligned compared to the mid region as previous studies have 
shown a less uniform stresses in these regions (Lee et al., 2017, Atkinson et al., 2020). The 
anchor point region was therefore used as an internal control.  
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Figure 2.16. Anchor point region and Mid region highlight on fibrin hydrogel installed within 
the 3D printed chamber. 
Image analysis was preformed using the Image J plugin OrientationJ (BIG). Images were 
imported into ImageJ and transformed into 16-bit monochromatic images. The fluorescent 
channels were separated by selecting Image > Color > Split Channels. The channels not 
corresponding to the CNA35 collagen-probe were closed (Fig.2.17). 
Figure 2.17. CNA35 mage opened in Image J, channels split and non CNA35 collagen-probe 
channels closed. 
Once the CNA35 channel was the only channel open the OrientationJ plugin was ready to be 
used. First the mode fibre angle was determined by selecting Plugin > OrientationJ > 
OrientationJ Dominant Direction. This value was later used to normalise the fibre angles 
across all images. Next all fibre angles were determined by selecting Plugins > OrientationJ > 
OrientationJ Distribution, from here the fibre angle was displayed as frequency of fibres at a 
particular angle, from -90° to 90° at 0.5° increments. 
By subtracting the dominant direction from all values the mode across all images was 
normalised to 0°. To get all angles to lie between -90° to 90° any normalised angle that lay 
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the value if it was lower than -90°. The mean percentage frequency distribution was then 
found for each repeat sample and the mean was then found for each group for statistical 
analysis. 
The angle distribution was visualised by selecting Plugin > OrientationJ > OrientationJ 
Analysis. Once ran a coloured representation of the original image is generated; here the 
fibres are designated a colour based on the angle of the fibre, the colour key is shown in 
Fig.2.18. The more aligned the fibres are in the image the more constant the colour is across 
the image, for example, 100% aligned fibres would all be one colour. 
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2.2.9. Mineralised Hydrogel Imaging by Micro-Computed 
Tomography 
Following the completion of the experimental run (either one week of static culture followed 
by three weeks of hydrostatic pressure stimulation or three weeks of microgravity culture) 
six microtissues were randomly selected from each group and arranged within the imaging 
tube as required (Fig.2.19). Samples were spaced using cut polystyrene and the tube was 
sealed with parafilm. 
Figure 2.19. Example arrangement of samples in imaging tube for μCT. 
Samples were then scanned by μCT using a Skyscan 1272 system (SKYSCAN, Belgium) with a 
rotation step size of 0.4° over 180°, an isotropic resolution set at 9 μm, X-ray source at 50 kV 
and 200 μA, 0.5 mm aluminium filter, 2x2 camera binning and average on. Images were 
reconstructed using Skyscan NRecon software (SKYSCAN, Antwerp, Belgium) which provides 
images of the analysed hydrogel slice-by-slice. Reconstructions were then reorientated in 
Skyscan’s -Data-Viewer- software (SKYSCAN, Antwerp, Belgium) and volume of interest were 
selected for analysis. The volume of interested was then analysed using Skyscan CT-Analyser 
(SKYSCAN, Antwerp, Belgium) for mineralisation using a macro (details in Appendix G) with 
a fixed threshold to differentiate mineralised ECM from non-mineralised ECM. To find the 
hydrogel density the Skyscan 1272 system was calibrated using Bruker-MicroCT BMD 
calibration phantoms. The phantoms were supplied in pairs with concentrations of calcium 
hydroxyapatite of 0.25 and 0.75 g/cm3. Due to the size of the hydrogels, 2 mm diameter 
phantoms were used (smallest available). Calibration was achieved using the attenuation 
coefficients following guidelines supplied by Bruker (Bruker-Mikro-CT, 2010). First the 
phantoms were imaged by the Skyscan 1272 system using the same settings as for the 
hydrogel samples. The image was then reconstructed using the NRecon software and region 
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was calculated using the CT-Analyser software with a macro (details in Appendix H) for both 
of the phantoms (found to be 0.029817 for the 0.25 g/cm3 phantom and 0.061498 for the 
0.75 g/cm3 phantom), and this then factored into the density calibration. The density for the 
hydrogels was calculated using the same macro. 
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2.2.10. Tensile Mechanical Testing  
Mechanical testing was performed on one sample from each tensile stimulation group 
(control, 3%, 5% and 10%) at the end of the three week loading phase from run 4, 5 and 6. 
To improve ease of handle of the engineered tendon, paper frames were used to hold 
samples in position (Fig.2.20). One paper frame was laid out on a flat surface and the 
engineered tendon sample was removed from the bioreactor chamber by breaking it away 
from the anchor frame before being laid lengthways in the middle of the paper frame. A 
second paper frame was then laid on top of the engineered tendon sandwiching it between 
the two frames (Fig.2.20).  
Figure 2.20. Schematic of fibrin hydrogel within paper frame. 
Once the engineered tendon was secured within the paper frames it was moved to the 
tensile tester grips  (Fig.2.21A). The system used  for tensile testing  was the Univert CellScale 
with a 1 N load cell. The fibrin hydrogels were tested for hysteresis, stress relaxation and 
stiffness, a graphical schematic of the testing regime is depicted in Fig.2.21B. Pre-
conditioning was performed during the four cycles of hysteresis testing.  
Figure 2.21. Tensile Mechanical testing. (A) Fibrin hydrogel sample loading into the Univert 
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Where Δl is the change in length and l is the initial length 
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Where σ0 is the initial stress (at 0s), σ60 is the final stress (at 60s) and T is the  relaxation time 
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2.3. Statistical Analysis 
Cyclic Tensile Stimulation: A total of six experimental runs were performed, using three 
separate bioreactor chambers which were used for all loading conditions each to account for 
any hardware variation between bioreactor chambers. Samples taken for experimental 
repeats for each analysis were selected from across the six bioreactor wells by random 
determination using an online tool (www.random.org/sequences/) and varied across each 
run. In run #1, #2 and #3 two samples from each loading condition were taken for western 
blot analysis, and two samples for qPCR analysis, with two spare (n=6 total). In run #4, #5 
and #6 one sample was taken for histology, one sample for collagen probe imaging, one 
sample for mechanical testing, and one sample for TEM with two spare samples (again n=6 
total). One-way analysis of variance (ANOVA) with Tukey’s post hoc test and multiple 
comparison tests was used for gene analysis, western blot analysis, collagen probe analysis 
and mechanical testing all carried out using GraphPad Prism 9. Where residuals did not meet 
assumptions of normality (Shapiro-Wilk test) or equal variance (Brown-Forsythe test) data 
were transformed before analysis. Two-way ANOVA with Tukey’s post hoc test and multiple 
comparisons was used for the Alkaline Phosphatase analysis after data was confirmed to be 
normally distributed and equal variance confirmed with Spearman’s test. Non-parametric 
data was analysed using the Kruskal-Wallis test. 
Statistical analysis of collagen fibril diameters using TEM was undertaken in R (R, Version 
4.0.3) (RCoreTeam, 2020) and performed by Mr. Daniel Green (University of Liverpool). The 
lmer function from the package lme4 was used to fit linear mixed models to assess 
differences in measured outcome variables between different loading conditions (Bates et 
al., 2015). In all cases, the measured outcome was specified as the response variable, the 
loading condition as the fixed effect and the run of the experiment as the random effect. For 
TEM analysis the means of the minimum diameters were determined for each image and 
different images accounted for with the specification of run as a random effect. Estimated 
marginal means and Tukey adjusted p values were extracted using the emmeans package 
(Lenth, 2020). 
Hydrostatic Pressure: Samples taken from experimental repeats for each analysis were 
selected by random determination using an online tool (www.random.org/sequences/). 
One-way ANOVA with Tukey’s post hoc test and multiple comparison tests was used for gene 
analysis of COL9A1 and COL24A1, densitometry for collagen α1(XI) and the Alizarin red assay. 
Where residuals did not meet assumptions of normality (Shapiro-Wilk test) or equal variance 
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(Brown-Forsythe test) data were transformed before analysis. Two-way ANOVA with Tukey’s 
post hoc test and multiple comparisons was used for all remaining analysis after data was 
confirmed to be normally distributed and equal variance confirmed with Spearman’s test. 
Where residuals did not meet assumptions of normality or equal variance data were 
transformed before analysis non-parametric data was analysed using the Kruskal-Wallis test. 
All statistical analysis was carried out using Prism 9. 
Microgravity culture: Samples taken from experimental repeats for each analysis were 
selected by random determination using an online tool (www.random.org/sequences/). 
One-way ANOVA with Tukey’s post hoc test and multiple comparison tests was used for gene 
analysis, western blot analysis, sample weight and μCT analysis. Principle component analysis 
(PCA) on the genes was based on eigenvalues and carried out in Prism 9. Where residuals did 
not meet assumptions of normality (Shapiro-Wilk test) or equal variance (Brown-Forsythe 
test) data were transformed before analysis. Two-way ANOVA with Tukey’s post hoc test and 
multiple comparisons was used for ALP analysis after data was confirmed to be normally 
distributed and equal variance confirmed with Spearman’s test. Non-parametric data was 
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Design and validation of 3D printed universal 








3.1.1. Bioreactors for Tendon Tissue Engineering 
One of the fundamental obstacle to research in tissue engineering is the variety of 
bioreactors available, with very few research groups using identical or comparable platforms. 
This is highly apparent with tensile stimulation bioreactors were studies typically use custom 
made tensile bioreactors or commercially available systems such as the EBERS TC-3 and 
CellScale MC series. A search of literature published between January 2016 and March 2020 
indicates that for cyclic loading studies focusing towards tendon tissue engineering, three 
groups published data generated using a CellScale bioreactor (Garcia et al., 2018, Wu et al., 
2017, Sensini et al., 2019) and one group published using an EBERS TC-3 bioreactor (Deniz et 
al., 2020), with over twenty using custom designed bioreactors (Burk et al., 2016, Talò et al., 
2020, Raveling et al., 2018, Engebretson et al., 2018, Youngstrom et al., 2016, Qiu et al., 2016, 
Carroll et al., 2017, Grier et al., 2017, Subramanian et al., 2017, Brandt et al., 2018, Lee et al., 
2018, Liu et al., 2018, Patel et al., 2018, Raimondi et al., 2018, Wunderli et al., 2018, Grier et 
al., 2019, Hsiao et al., 2019, Atkinson et al., 2020, Banik and Brown, 2020, Ciardulli et al., 
2020, Tohidnezhad et al., 2020). Furthermore, many research groups are moving towards 
combination strategies for tissue engineering, using increasingly complex combinations of 
scaffolds, cells and biomolecules. A clear requirement for greater reproducibility and 
consistency in approach is needed to enable repeatable consistency between these different 
approaches for both research and translation towards clinical therapies.  
Regardless of the specific bioreactor (commercial brand or custom-built), all of these systems 
share similar design characteristics: a culture chamber enabling mechanical stimuli to be 
applied to the cells in a sterile environment, with the force applied by a linear actuator 
controlled by displacement software. To apply tensile forces to cells, the biological material 
must form an interface with the loading hardware via a direct friction grip or clamp, pinning 
a mature (usually ex vivo) tissue in place, or incorporation of the biological sample with a 
loading anchor during the formation of the tissue. In most tensile bioreactors, one end of the 
sample is typically held in a fixed position, while the second is attached to a linear actuator, 
permitting movement in just one axis. 
3D printing is a now established technology for rapid prototyping and manufacturing of 
simple and complex parts and components. Usefully for the research community, it also 
enables free sharing of designs, tools and technologies to facilitate greater reproducibility of 
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experimental approaches and methodology. Here 3D printing has been used to design and 
test an optimised bioreactor chamber for engineering tissues under cyclic tensile loads. The 
first of these design criteria were that the bioreactor culture chamber should have six 
isolated wells to enable either simultaneous stretching of up to six differently treated 
samples, or an effective n=6 number of experimental repeats. This design criterion was 
paramount since many commercially available bioreactor chambers have a single 
unsegregated volume which does not allow for statistically distinct repeats (Carroll et al., 
2017, Wu et al., 2017). This also overcomes a limitation imposed by the conventional single-
well set up, which necessitates serial rather than parallel experimental runs and forces a 
compromise between experiment loading time and n-number. Based on the available 
literature, it was determined that each of the six wells should have a displacement volume 
of 6 mm to allow the culture of a variety of engineered tissues, whilst ensuring the tissues 
can remain submerged in 3-5 ml culture media subject to the application, for example, the 
size of the engineered tissue construct. The media volume was carefully considered based 
on the volumes typically used in a 6-well cell culture plate, and optimised to provide 
sufficient nutrient availability and buffering during culture, whilst minimising media wastage. 
3.2. Hypothesis 
3D printing will allow the design and fabrication of a universally usable bioreactor chamber 
that, with minimal manipulation, can be fitted to a wide range of custom and commercially 
available systems.  
3.3. Aims 
1. To design and manufacture a 3D printable system that allows for user friendly and 
reproducible cyclic uniaxial tensile stimulation. 
2. Investigate the bio-compatibility of the fabrication materials for cell culture
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3.4. Bioreactor Chamber Fabrication 
3.4.1. 3D Printing 
All prototypes and final components were designed using Creo Parametric (Fig.3.1). The 
designs were saved as an STL (StereoLithography) file and exported to CURA (Fig.3.2), were 
the software converts STL files to gcode files that can be read by the Utimaker 2+ for 3D 
printing. 
Figure 3.1. Bioreactor chamber CAD during design process in Creo Parametric. 
For prototype prints the print settings were maintained as default; 0.4 mm nozzle, PLA 
filament, fine (0.1 mm) layer height and 100% infill (Fig.3.2A). Print setting for the bioreactor 
chamber were changed to reduce the time taken to complete the printing. If the print 
settings were maintained the main body would have taken two days, 14 hours and 54 
minutes to 3D print. By increasing the nozzle size to 0.6 mm, increasing the layer height to 
0.15 mm and reducing the infill to 40% the print time reduced to 12 hour and 58 minutes 
without compromising the quality of the print (Fig.3.2B). This option isn’t available for 
smaller components as the larger nozzle doesn’t have the resolution to print the more 
detailed sections.  
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Figure 3.2. CAD on CURA software. (A) 3D printed anchor post mark 5 generated in CURA. 
(B) Main body of culture chamber mark 1 design generated in CURA 
For the final designs of the culture chamber three components required 3D printing: the 
chamber body, the 6-way tensile arm and the tensile runner (Fig.3.11). The print settings for 
the chamber body were (this includes support prints and no brim): 
• Nozzle diameter – 0.6 mm 
• Filament – PLA 
• Layer height – 0.15 mm 
• Infill – 30% 
This took 23 hours and nine minutes to print using 243 g (30.72 m) of PLA filament. 
The print setting for both the 6-way tensile arm and tensile runner were (this includes 
support prints and no brim): 
• Nozzle diameter – 0.4 mm 
• Filament – PLA 
• Layer height – 0.1 mm 
• Infill – 50% 
The 6-way tensile arm took six hours and 15 minutes to print using 29 g (3.63 m) of PLA 
filament. The tensile runner took six hours and 12 minutes to print using 33 g (4.15 m) of PLA 
filament. 
In total the 3D printed components took 35 hours and 36 minutes to print using 305 g (38.5 
m) of PLA filament. To print with the ultimaker 2+ using PLA filament the build plate was first 
coated with glue stick, and then heated to 60°C. The nozzle was heated to 210°C to allow the 
PLA filament to extrude through. Once all components reach temperature the 3D printer 
automatically begins to print the component. 
A B 
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Once printed, finishing was applied to all components. Any support structures were cut away 
and rough areas were filed down. Thread inserts were installed using a pillar drill (on the top 
face for the grub screws and rear face for the tensile arm runner screws). The interior of the 
chamber body was coated with XTC-3D ‘Smooth on’ High Performance 3D print coating (an 
oxirane epoxy resin used to waterproof the chamber), cured overnight and washed with PBS. 
The XTC-3D was prepared as specified by the manufacturer; part A (resin) and part B 
(hardener) were mixed at a ratio of 2:1 and applied as a thin coat to the base and walls of 
each culture well. The chamber was then left to cure overnight.  The base of each culture 
well was then coated with polydimethylsiloxane (PDMS) Sylgard-184 to prevent the cell 
embedded hydrogels from sticking to the well base during loading. The Sylgard-184 was 
prepared according to the manufacturer’s instructions, and mixed with the curing reagent at 
a ratio of 9:1 in a 50 ml centrifuge tube, then left to mix on a rotormixer for 10 minutes at 
room temperature. 1 ml of the Sylgard-184 mixture was pipetted into the base of the culture 
well and a level coating was ensured by placing the chamber on a flat surface, then left to 
cure for three days at room temperature. Degassing was not required as bubbles were not 
observed in either the XTC-3D or the Sylgard-184. Once the XTC-3D and Sylgard-184 were 
fully cured and hardened the culture wells were washed through six changes of PBS to 
remove any residual cytotoxic monomers. 
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3.4.2. 3D Printed Culture Chamber Validation 
3.4.2.1. 6-Way Tensile Arm Displacement 
The displacement of the 6-way tensile arm was measured by monitoring the controlled 
movement of the arm and relating the observed displacement to the expected displacement. 
The bioreactor chamber was mounted onto the EBERS-TC3 base platform and attached to 
the linear actuator which was controlled by the EBERS software. The 6-way tensile arm was 
displaced in 5% iterations of the initial length of the fibrin hydrogel (8 mm). The displacement 
of the tensile arm was measured using a HD USB camera (MicroDirect, Celstron) (Fig.3.3), 
distances calculated using ImageJ/Fiji and analysed using GraphPad Prism 9. 
Figure 3.3. Schematic of displacement measurements for chamber validation.  
3.4.2.2. Chamber Cytotoxicity 
The lactate dehydrogenase (LDH) assay (Pierce, Thermo Scientific) was used to determine 
biocompatibility of the materials which interfaced with the cell culture media – PLA, XTC-3D 
‘smooth on’ oxirane epoxy resin, and PDMS Sylgard-184. hMSCs (passage 3) were seeded in 
triplicate in wells of a 12-well plate at a density of 1.5 x105 cells/ml and allowed to attach for 
12 hours. Separately pieces of PLA and XTC-3D oxirane resin coated PLA (5 mm x 5 mm x 1 
mm, ~5 g) were added in triplicate to experimental wells. In this initial test the XTC-3D 
oxirane resin was only washed once in PBS. The cells were incubated with the materials 
overnight and compared to unmodified control wells. The LDH activity within the media was 
quantified using the SPECTROstar Nano microplate reader (BMG LABTECH). The 
biocompatibility/cytotoxicity assay was then repeated using the fully coated, cured and 
washed bioreactor chamber, which included both the XTC-3D oxirane resin-coated walls and 
the Sylgard-184 coated well bases. The 3D printed culture chamber was sterilised with 70% 
HD USB camera 
Clamp stand 
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ethanol: initially all components were disassembled and washed in 70% ethanol before 
drying within a sterile cell culture hood for one hour. Once dry the 3D printed culture 
chamber was assembled and washed in 70% ethanol again and left to dry in a flow hood, 
washed again three times with PBS and left to dry. hMSCs were seeded onto cover slips at a 
density of 1.5 x105 cells/ml and placed in the bioreactor wells, then incubated overnight at 
37°C and assayed for LDH activity as described above.




3.5.1. Development of Bioreactor Chamber 
3.5.1.1. Anchor Post Design 
Initially the anchor frame was considered the anchor post and went through a number of 
iterations (Table 3.1) to develop a design that would meet the design criteria.  
Design Criteria - A rigid post that allows for a fibrin hydrogel to contract into a tendon like 
structure. Once contraction is complete the anchor post should attach to a tensile 
stimulation bioreactor to allow the stimulus to be applied to the fibrin hydrogel. The 3D 
printed posts should allow for consistent printing using the Ultimaker 2+ with high porosity 
within the attachment site (porosity >30%). 





Where Pt is the porosity, Vp is pore volume and Vt is the total volume. The volumes were 
calculated from only the attachment site, therefore excluding the solid section at the top of 
the anchor post. From the design criteria, posts mark 1 and 2’s porosity was below the 
minimum requirement (30%) and were excluded.  
The posts needed to be consistently printed. The consistency was measured by printing five 
of posts mark 3, 4 and 5 and judging the quality of the prints. Posts mark 3 and 4 did not print 
consistently with many of the holes throughout the structure being solid rather than open. 
Post mark 5 printed to a high consistency with low levels of post printing finishing required. 
Bubbles formed when generating fibrin hydrogels within Post mark 5, this resulted in the 
hydrogel easily breaking. To prevent bubbles from forming within the hydrogel, a chamfer 
was added to the roof of the attachment site (post mark 6), allowing any bubbles to easily 
escape. When loading began with post mark 6 system it was found that the fibrin hydrogel 
‘peeled’ away from the anchor post as only a small amount escaped the porous area. By 
removing half of the front face of the post, more of the hydrogel protruded generating a 
more stable structure and allowing stimulation to be applied without the hydrogel failing 
(mark 7). 
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Table 3.4. Design iterations of the 3D printed posts. Porosity measured using [Equation 12] 
and build quality measure by 3D printing five identical repeats. 
3.5.1.2. Initial Concept Designs for 3D Printed Posts and 
Loading Supports 
Anchor post mark 7 was taken forward to the loading phase. Initially two mark 7 posts where 
arranged within a six well plate and an alignment bridge was placed on top (Fig.3.4A). The 
alignment bridge ensured uniform positioning of the anchor posts and therefore a uniform 
length of the fibrin hydrogels. The fibrin hydrogels formed around the anchor posts and 
contracted to form tendon like structures (renders representation shown in Fig.3.4B). Once 
contracted the hydrogels were transferred to a bioreactor attachment and fixed in place via 
the anchor post (Fig.3.4C). The samples within the bioreactor attachments were then 
transferred into the EBERS TC-3 tensile culture chamber using sterile forceps. The 3D printed 
bioreactor attachment was fixed in place with 3D printed pins (Fig.3.4D). The culture 
chamber was then placed onto the EBERS TC-3 for tensile stimulation (Fig.3.4E). Once tensile 
stimulation was complete the process was reversed. 
Render 
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Figure 3.4. Schematic of the anchor posts from culture plate to bioreactor. (A) Anchor post 
layout in well plate before fibrin generation. (B) Render of fibrin hydrogel between anchor 
posts. (C) Fibrin hydrogels placed into bioreactor attachment via anchor posts. (D) Anchor 
posts within bioreactor culture chamber attached via bioreactor attachments. (E) Culture 
chamber mounted into EBERS TC-3 bioreactor 
The anchor post was further edited (Fig.3.5) to overcome the faults of the previous design; 
primarily the unintentional movement of the hydrogel when moving between the six well 
plate and culture chamber. This was achieved with the addition of handles on the top of the 
anchor post. The alignment bridge fitted around the handles ensuring uniform fibrin 
hydrogel formation. Once the contraction was complete the fibrin hydrogel was picked up 
with sterile forceps with the alignment bridge in place, preventing the fibrin hydrogel for 
moving from its fixed position. The anchor post were designed to have an attachment point 
built in rather than needing the bioreactor attachment system. With these updates the fibrin 
hydrogels formed around the anchor posts and contracted to form the tendon like structure 
as before. The sample was then fixed into the EBERS TC-3 culture chamber (Fig.3.5C) with 3D 
printed pins (Fig3.5A). Samples remained in the culture chamber during loading before being 
placed back into the six well plate. This design completely removed the mid step of the 
bioreactor attachment.  
However samples became infected within one week of entering the EBERS TC-3 culture 
chamber. The cause of infection was investigated to see if it was due to moving the samples 
between the culture chamber and six well plate before and after each tensile stimulation run 
(5% strain for 1 hour). The fibrin hydrogel was allowed to contract within the six well plate 
before moving into the culture chamber in triplicate where the samples remained for the 
loading regime (3 weeks). However, even with this mitigation the samples still became 
infected within one week. An alternative theory was that the flexible airtight membrane (the 
bellow) (Fig.3.5D) used to allow the tensile arm to move within the culture chamber whilst 
maintaining sterility was generating a liquid bridge for bacteria to travel. 
(A) (B) (C) (D) (E
) 
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Figure 3.5. Anchor post in EBERS TC3 chamber. (A) Render of the updated anchor posts, the 
top of the post features a handle and the top rear of the posts features a built in bioreactor 
attachment site. An alignment bridge held the two anchor posts in place and pins ran through 
the alignment bridge and into the built in bioreactor attachment sites. (B) Example of how 
the system would be moved with sterile forceps. (C) Three sets of anchor posts fixed in place 





3D printed pins 
(D) 
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3.5.1.3. Bioreactor Chamber Design mark 1 
As the EBERS TC-3 culture chamber was being over manipulated to facilitate the anchor posts 
it was no longer a viable option for the experimental needs. A 3D printed bioreactor chamber 
was designed to accommodate the anchor posts and mount onto pre-existing bioreactor 
systems. 
Design Criteria - The bioreactor chamber should have a minimum of three isolated culture 
wells and should not have a bellow that is submerged in cell culture media. The design should 
require minimal edits to allow it to mount onto a number of pre-existing bioreactors. The 
system should be able to be manufactured by 3D printing using bench top 3D printers (e.g. 
Ultimaker 2+) with minimal post manufacturing finishing required. 
The first design of the bioreactor culture chamber was designated mark 1 (Fig.3.6). The 
system was composed of ten main components: The main body, the transparent base, the 
transparent base housing, the 6-way tensile arm, the arm housing, bellow barrier, the EBERS 
TC-3 arm and the lid (not shown in Fig.3.6). The main body, transparent base housing, bellow 
barrier, 6-way tensile arm and the arm housing were all 3D printed using the Ultimaker 2+ 
with PLA filament. The transparent base and lid were manufactured using transparent 
polycarbonate sheet machined using a milling machine and pillar drill. This design used pre-
existing components from the EBERS TC-3 (EBERS TC-3 arm and runner) to ensure it would 
fit onto the EBERS TC-3.  The sub- components were acquired as off the shelf parts and 
included: the O-rings, bellows, grub screws, thumb nuts and screws. 
Once all the components were 3D printed and machined, screw threads were tapped to 
allow the screws to fix components together and grub screws to fix in place. However when 
fixing the components (main body, transparent base housing, bellow barrier, arm housing 
and EBERS TC-3 runner) with the screws it was found the resolution and consistency of the 
Ultimaker 2+ was not tight enough to ensure all components were printed exactly as the CAD 
designs specified. This prevented tight seals to form when mating two parts which is vital to 
create a sterile environment for cell culture. The mark 1 design was therefore not a viable 
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Figure 3.6. Initial design of 3D printed bioreactor chamber. The system included the runner 
from the EBERS TC-3 culture chamber and the tensile arm which connected to the 6-way 
tensile arm. The arm housing allowed for detachment from the chamber, allowing for 
multiple chambers to be used at once. The 6-way arm ran into six  culture wells each with a 
bellow to provide a flexible air tight membrane. The main body connected to the transparent 
base via screws and sealed with an O-ring. The O-ring slotted into an O-ring grove on the 
base of the main body. Six culture wells allowed for isolated culture of hydrogels. A sterile 
seal at the top of the main body was provided by fixing the lid over grub screws with thumb 
nuts over a second O-ring placed into the upper O-ring groove. 
 
EBERS TC-3 Runner 
Arm housing 
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3.5.1.4. Bioreactor Chamber Design mark 2 
The complexity of the bioreactor chamber mark 1 design resulted in the 3D printed 
components not correctly mating preventing a sterile seal from forming. Mark 2 (Fig.3.7) was 
designed to limit the number of components as much as possible. Here the design was made 
up of four main components as opposed to ten in the mark 1 design. The four components 
were: the chamber body, the 6-way tensile arm, the tensile runner and the lid (shown in 
Fig.3.7B). The design removed the bellow from the culture wells and into a separate sterile 
area of the main body, this prevented the culture media generating a liquid bridge with the 
bellow. 
3D printing was used to manufacture the chamber body, the 6-way tensile arm and the 
tensile runner. The lid was machined from polycarbonate sheet using a milling machine and 
pillar drill by Mr James Blackhurst in the William Henry Duncan building workshop (University 
of Liverpool). Sub components were acquired as off the shelf parts: the O-ring, the bellow, 
the grub screws and the screws.  
Fig.3.7B shows a separated view of the mark 2 design post manufacturing. The 3D printed 
components, the 6-way tensile arm and chamber body were initially manufactured using PLA 
filament. The chamber body required minimal finishing (thread tapping and removal of 
support structures produced during 3D printing) to allow the mating of other components. 
Once tapped nine grub screws fixed into place around the perimeter of the chamber body. 
The O-ring slotted into the O-ring grove on the top face of the chamber body. The lid had 
nine holes drilled using a pillar drill around the perimeter that were complementary to the 
grub screws holes on the chamber body,  allowing the lid to fit onto the chamber body. The 
lid was then fixed in place with nine thumb nuts, creating an airtight seal with the O-ring. 
Two holes were drilled and tapped on the lid above where the culture wells would be 
situated when the lid is fixed in position. The two holes allowed for two 0.2 μm nylon syringe 
filters to lock into Luer locks. This allowed for sterile air to circulate into the chamber body 
and culture wells. The bellow, acting as the flexible seal, fitted onto the 6-way tensile arm. 
The bellow and 6-way tensile arm then ran through the bellow hole into the chamber body. 
The tensile runner fitted onto the 6-way tensile arm and screwed into the rear of the 
chamber body creating a seal with the bellow. The tensile runner held the 6-way tensile arm 
in position whilst allowing for controlled linear movements into and out of the chamber 
body. 
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Figure 3.7. Bioreactor chamber mark 2. (A) The mark 2 design. Using a 3D printed tensile 
runner and 6-way tensile arm instead of the EBERS TC-3 parts, allowed for multiple systems 
to be printed and used at the same time. (B) Separated view of manufactured bioreactor 
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3.5.1.4.1. Updated Anchor Posts 
The anchor posts shown in Fig.3.4 were updated to not require the culture period in a six 
well plate. Instead the anchor post were installed within the chamber body and the fibrin 
hydrogel was formed and contracted directly within the bioreactor chamber. This was 
achieved by adding a barrier to the rear of one of the anchor posts in the pair (Fig.3.8A). The 
barrier was designed to maintain a consistent length of fibrin hydrogel across all culture wells 
by preventing the fibrin from running past it. The anchor post featuring the barrier was 
attached to the 6-way tensile arm whilst the anchor post without the barrier is placed onto 
the chamber body (Fig.3.8B). The base of the anchor posts were reduced to allow better 
contraction around the post rather than sticking to the base.  
Figure 3.8. Render of updated anchor posts. (A) Rear of one anchor post features a barrier 
to ensure the fibrin hydrogel dimensions are consistent across all culture wells. Base of 
anchor post was removed to allow better contraction of fibrin hydrogel around the post. (B) 
Anchor post with barrier was placed within culture well. Barrier prevents fibrin hydrogel from 
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3.5.1.5. Bioreactor Chamber Design Mark 2.1 
Due to only one attachment post on each arm of the 6-way tensile arm and chamber body 
the anchor posts rotated away from intended position. This was overcome by adding an extra 
attachment point to the 6-way tensile arm and chamber body. An extra attachment hole was 
added to the anchor posts attachment sites (Fig.3.9). These additions generated the 
bioreactor chamber design mark 2.1, the final design. 
The dimensions of the final bioreactor chamber are shown in (Fig.3.10). The main dimensions 
include: 
The culture well – 40 mm x 15 mm x 11.5 mm, holding up to 6.9 ml of culture media. 
The 6-way tensile arm run – 30 mm x 23 mm x 90 mm, when the 6-way tensile arm is installed 
it can move backwards and forwards by 8 mm. 
Figure 3.9. Render of updated bioreactor chamber and anchor posts. Extra attachment 
points have been added to the chamber body and an extra holes added to the attachment 
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Figure 3.10. Dimensions of bioreactor chamber body mark 2.1. (A) Outer dimensions of 
chamber body and internal length of chamber body. (B) O-ring groove dimension and grub 
screw tap hole diameter. (C) Culture well dimension and attachment pin dimension. (D) 6-
way tensile arm run area and bellow hole dimensions 
The mark 2.1 design for the bioreactor chamber was taken forward as the final design. As in 
the mark 2 design the bioreactor chamber was made up of four main components. Fig.3.11Ai 
shows the CAD drawings of the 3D printed main components: the chamber body, 6-way 
tensile arm and tensile runner. The fourth main component, the lid, is shown in Fig.3.11B, 
and is identical to the mark 2 design. The sub-components (Fig.3.7B) were all acquired as off 
the shelf parts: the bellow, grub screws, thread insert, thumb screw, O-ring, Luer lock and 
screws. A list of components is shown in Table 3.2. The PLA grub screw holes were able to be 
threaded but not consistently, thread inserts were therefore used to fix the grub screws in 
place. The O-ring slotted into the O-ring groove, the lid then slotted onto the grub screws via 
complementary holes (Fig.3.11Aii) and was fixed in place via thumb nuts forming an airtight 
seal with the O-ring. The lid featured two threaded holes over the culture wells that Luer 
locks fix into, allowing for the fixing of two 0.2 μm nylon syringe filters for sterile air 
exchange. The bellow fitted onto the 6-way tensile arm and both slotted through the bellow 
(A) (B) 
(C) (D) 
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hole and were held in place by the tensile runner which fixed onto the chamber body via 
screws, creating an airtight seal with the rear of the bellow. 
Following 3D printing the only steps required before the system was ready to use was to 
remove the 3D printing structural support, the insertion of the thread inserts, sealing the 
system with the XTC-3D waterproof resin and the addition of 1 ml of Sylgard 184 to each 
culture well.  
The bioreactor chamber was designed to mount onto a wide range of commercial and 
custom tensile stimulation bioreactors with minimal edits. Fig.3.11B shows the bioreactor 
culture chamber mounted onto the EBERS TC-3. The 6-way tensile arm attaches to the 
bioreactors linear actuator, which is operated via a well-established software. The chamber 
body mounts onto the bioreactor via alignment pins and thumb screws. The bioreactor 
chambers CAD model was adapted to mount onto the CellScale MCT6 (Fig.3.11C). This was 
only done as far as the CAD design, which was not subsequently 3D printed therefore the 
adapted chamber was never mounted onto a real CellScale MCT6. For the CAD model to 
theoretically mount onto the MCT6, changes needed to be made to the base of the chamber 
body, the length of the tensile runner and the attachment point of the 6-way tensile arm. A 
separate part was developed to fix the linear actuator to the 6-way tensile arm. These edits 
took around 3 hours to implement.  
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Figure 3.11. Final design of 3D printed culture chamber. (Ai) Seperated CAD drawing of the 
final 3D printed culture chamber, scale bar is 50mm. (Aii) Manufactured 3D printed culture 
chamber, the main body, tensile arm and tensile arm runner were manufactured by 3D 
printing using PLA filament. (B) 3D printed culture chamber mount onto the EBERS TC-3 
bioreactor. (Ci) CAD for 3D printed culture chamber adapted to the CellScale MCT6 
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Table 3.5. Full components list for the bioreactor chamber. 
Name Description Supplier Product Code 




RS Components 134-8190 




Grub screw M5 x 30 mm Accu.co.uk SSU-M5-30-A2 
Polycarbonate 
sheet 
1.25 m x 610 mm x 
6 mm 
RS components 681-665 




Simply Bearings simplybearings.co.uk 
XTC-3D Waterproof resin Smooth-on benam.co.uk/xtc-3d 
Thumb nut M5 RS components 664-4886 
Screw M3 RS components 280-981 
Sylgard 184 Low friction seal Farnell 101697 
Luer lock adapter Attaches air filter Cole Parmer OU-30800-00 
0.2 µm syringe 
filter 
Air filter Cole Parmer 16534----------K 
Thumb screw M3 Accu.co.uk SKT-M3-10-A1 
M3 Thread insert M3 Accu.co.uk HSTI-M3-A2 
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3.5.1.6. Final Anchor Frame Design 
The updated anchor posts featuring the barriers (Fig.3.8) did not function as designed. The 
fibrin hydrogel continued to run underneath the barrier generating non-uniform hydrogels. 
A final anchor post was designed to generate uniform fibrin hydrogels (Fig.3.12), this design 
was named the anchor frame. The solid PLA anchor frames were not coated in the XTC-3D 
resin or Sylgard-184. The design required the fibrin hydrogel to be formed within a six well 
plate. For the anchor frame system to initially fit within a 6-well plate before moving to the 
bioreactor chamber the design had to feature two main parts: the hydrogel attachment 
bracket (Fig.3.12i) and the 90° rotation arms (Fig.3.12ii). The hydrogel attachment bracket 
features breakable spars that maintain the uniformity of the structure during the fibrin 
hydrogel generation and contraction. Once the fibrin hydrogel had contracted (two week 
contraction phase) the 90° rotation arms are installed and the anchor frame system was 
moved into the appropriate culture well. The breakable spars were broken with sterile 
scissors, the fibrin then supported itself between the anchor frame allowing tensile loading 
to be applied directly to the fibrin hydrogel.  
Figure 3.12. Anchor frame. CAD drawing of the final anchor frame. (i) the hydrogel 
attachment bracket, (ii) the 90° rotation arms.  
The distance between the attachment posts on the hydrogel attachment bracket was 8 mm 
(12 mm from the wall behind the posts), the width of the main body was 7 mm and the depth 
of the main body was 4 mm (Fig.3.13). The volume of the fibrin hydrogels seeded within the 
hydrogel attachment bracket was 400 μl. Once printed the hydrogel attachment bracket 
fitted into a well of a 6-well plate and was held in position with sterile 4% agarose (Fig.3.14A).  
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The breakable spars were covered with spar covers (Fig.3.14A) to prevent the fibrin hydrogel 
from running out below the breakable spars. Once the fibrin hydrogel contraction phase was 
completed, the spar covers were removed and the 90° rotation arms were installed. The 
anchor frame was then moved from the 6-well plate to the culture well with sterile forceps 
(Fig.3.14B). Once in the bioreactor chamber the breakable spars were broken with sterile 
scissors, the fibrin hydrogel then supported itself between the anchor frame (Fig.3.14C). The 
anchor frame was held in a fixed position by the 6-way tensile arm which in turn was held in 
position by the linear actuator. This maintained the length of the fibrin hydrogel (8 mm) until 
tensile strain was applied, displacing the hydrogel. The 6-way tensile arm could displace a 
further 8 mm backwards, equating to 100% the initial length of the hydrogel. The media 
volume was carefully considered based on the volumes typically used in a 6-well cell culture 
plate. For this particular study 3.5 ml of culture media ensured the tissue engineered tendon 
was fully submerged throughout culture and loading. 
Figure 3.14. Flow of anchor frames from contraction to loading. (A) Anchor frame with spar 
covers installed, held in place with sterile 4% agarose. (B) Anchor frame moved to bioreactor 
chamber (C) Anchor frame within bioreactor chamber, breakable spars broken with sterile 
scissors. 
A B C 
4% Sterile Agarose 
Spar Cover 
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3.5.1.7. 3D Printed Culture Chamber Validation 
3.5.1.7.1. Well Displacement 
The bioreactor chamber was validated by measuring the displacement of the 6-way tensile 
arm in each well when mounted onto the EBERS TC-3 bioreactor (Fig.3.3). The displacement 
of the tensile arm was recorded as percentage displacement of the hydrogels initial length 
(8 mm) (Fig.3.15). At 4 mm (50% strain) the displacement across all wells was within 0.6% of 
the programmed value, with no significant differences between wells at strain rates 5% to 
50% across the wells (p>0.09) and a linear correlation between programmed and observed 
values. 
Figure 3.15. Linear displacement of the 6-way tensile arm by the software-controlled drive 
motor was shown to result in equal arm movement across each of the six wells of the printed 
chamber. n=3 technical repeats per well and n=6 experimental repeats across the chamber, 
significance measured using one-way ANOVA with Tukey’s post hoc test and multiple 
comparison. 
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3.5.1.7.2. Lactate Dehydrogenase Assay 
The biocompatibility and cytotoxicity of the bioreactor chamber was evaluated using the LDH 
assay (n=3), demonstrating that PLA has no cytotoxicity and was equivalent to tissue culture 
plastic controls (Fig.3.16A). The waterproof resin was found to induce significantly more LDH 
(2.5 fold increase, p<0.05), indicating toxicity (Fig.3.16A). The LDH assay was performed 
again, this time in the fully coated, cured and assembled bioreactor chamber. The culture 
wells were coated in XTC-3D oxirane resin and the base was coated in Sylgard-184. After the 
resins had completely cured the culture wells were thoroughly washed in six changes of PBS 
and the LDH assay was repeated within the bioreactor chamber, yielding equivalent LDH 
activity values to controls (6-well plate) (Fig.3.16B). This data indicates that repeat washing 
removes the toxic properties of the waterproof resin and renders it biocompatible. To 
further ensure biocompatibility a final layer of Sylgard was used to coat the inside of the 
chamber and provide a reduced friction surface for the moving parts of the arm and frame 
assembly. Maximum LDH production by the cells was induced by the addition of 10x Lysis 
Buffer. The maximum LDH was found to be 1.7 fold higher than the toxic Resin and 5.6 fold 
higher than the chamber (Fig.3.16). 
Figure 3.16. LDH assay for bioreactor chamber. (A) Cell viability as tested using the LDH assay 
within 6 well plate. (B) Cell viability tested using LDH assay with 3D printed culture chamber. 
Maximum represents induced LDH production.  n=3 repeats. Error bars represent standard 
















































In this investigation it was shown that 3D printing is a useful method for producing 
customisable bioreactors; in this case to overcome technological challenges in tendon tissue 
engineering. The objective was to produce an easily replicable system that could be broadly 
adapted by the tissue engineering community to help improve the consistency and 
availability of research tools. The bioreactor chamber that was developed observed 
appropriate displacement when driven by commercially available software in comparison to 
existing commercial systems, and is adaptable to multiple base-platforms, for example those 
manufactured by EBERS and CellScale, enabling electronics, motor assemblies and software 
to be used. The bioreactor chamber was designed using the EBERS TC-3 bioreactor platform 
as a base, keeping the linear motor assembly and proprietary software to drive the actuator 
arm. Design of the original prototypes through to the final product validation took 
approximately 7 months with multiple redesigns used to improve the specification, optimise 
print quality and speed.  
Several tests were performed to determine reliability and consistency across the bioreactor 
wells. Displacement of the 6-way tensile arm was measured and recorded as a percentage 
of the total hydrogel length (8 mm). The displacement was found to be uniform across each 
well and matched the programmed strain from 5% to 50% (± 0.6%). The correlation between 
applied and recorded displacement was determined to be within acceptable engineering 
design limits, and is comparable to other published studies such as a biaxial loading 
bioreactor designed by Yusoff et al. (2011) which had a correlation of ± 0.95%. 
The biocompatibility and cytotoxicity of the materials used to form the chamber was 
assessed using the LDH assay. The PLA base material was found to be non-toxic (no more 
LDH activity compared to tissue culture plastic controls), whilst the epoxy resin (oxirane) was 
initially discovered to be toxic. The toxicity was hypothesised to result from residual solvent 
and monomer leaching into the culture media, through repeat washing in PBS (6 washes) the 
resin-coated PLA showed no toxicity (LDH activity equal to tissue culture plastic controls). 
Other researchers have also shown that epoxy is compatible with cell culture (Pierce et al., 
2012). The base of the wells were coated with PDMS (Sylgard-184), a widely used material 
for cell culture applications which provided a hydrophobic barrier, ensuring low protein 
adhesion and smooth operation, and was found to be non-toxic. 
Polylactic acid (PLA) is a versatile polymer and the most common material available for FFF 
desktop 3D printing, followed by acrylonitrile butadiene styrene (ABS) and nylon. ABS is not 
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recommended for manufacturing the bioreactor chamber as it has no material advantages 
to PLA in this application and needs to be used in a controlled environment (e.g. a class I 
fume hood) due to the production of toxic fumes and particulates during high temperature 
extrusion (Steinle, 2016, Hall et al., 2018). Nylon is known to swell and distort when exposed 
to humidified environments and was therefore not used (Park et al., 2016).  
3.6.1. 150Conclusion 
Using sharable CAD and 3D printing, a tensile stimulation bioreactor chamber that enables 
equal tensile forces to be applied to six isolated, independent samples in one chamber over 
a large displacement range has been designed, manufactured and tested. The materials used 
in the design are readily available for desktop manufacturing, easy to work with and were 
shown to be durable and non-toxic once the appropriate curing, washing and processing 
techniques had been applied. The bioreactor was successfully sterilised with 70% ethanol 
and was used for 18 months without infection, highlighting its reusability. The design and 
optimisation of this bioreactor chamber provides a freely available and globally reproducible 
platform for ongoing comparative research in tendon biology and tissue engineering. The 
ease and speed of the 3D printing process allows for multiple bioreactor chambers to be 
manufactured for each experiment ensuring the control chamber is identical to the 
experimental chambers, which is often a compromise with high-cost commercially available 
bioreactor systems where the number and availability of culture chambers is often limited 
to a single unit. With minimal editing to the design the system can be manipulated to mount 
onto a range of commercially available and custom-made bioreactor, for example the EBERS 
TC-3 and CellScale MCT6. 
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Tensile Stimulation of hMSC Seeded Fibrin 
Hydrogels 




Tensile stimulation has long been used to drive the development of de novo tendons 
(Karamuk et al., 2004, Raif el and Seedhom, 2005). This approach derives from the role 
mechanotransduction plays during the development of musculoskeletal tissue from 
embryogenesis through to adulthood (Lee et al., 2017). Within the native environment the 
primary mechanical force applied to tendon is tensile stimulation (Wang, 2006). As muscle 
contracts the tendon is strained away from the bone acting as the transducer, transforming 
the generated force into skeletal movement (Glass et al., 2014). During development human 
tendon is thought to experience small amounts of cyclic strain coupled with constant strain 
resulting in an increase of up to 25% of the initial length (Kalson et al., 2011), whilst mature 
tendons are exposed to cyclic strain of up to 6% (Wang, 2006). The absence of tensile 
stimulation during in vivo embryonic growth of chicks has been shown to impair the 
development of the entire joint including tendons, highlighting the importance of 
mechanical stimulation for tissue generation (Mikic et al., 2000). 
During embryonic development the modulus and ultimate tensile strength of tendons 
increases (Marturano et al., 2013), a trend that continues post-natally until tendons are fully 
mature (Ansorge et al., 2009). Such properties are independent of increases in tendon length 
and diameter during tendon growth, which also improve extrinsic tensile biomechanical 
properties. Collagen type I, the most abundant protein in the tendons ECM,  forms string-like 
fibrils primarily aligned with the long axis of the tendon, which provide tendons with 
mechanical durability and strength (Buckley et al., 2013). As fibrils progress through 
embryonic development the diameters increase from around 30 nm to 80nm (Fleischmajer 
et al., 1988) but have a predominantly unimodal diameter distribution. Mature tendons 
display a bimodal or trimodal fibril diameter distribution with fibril diameters reaching 
approximately ten times that of embryonic tendon (Ezura et al., 2000, Goh et al., 2012, 
Ribitsch et al., 2020).  
Minor collagens occur in addition to type I collagen in healthy tendon, the minor collagens, 
comprise fibrillar types III, V, XI and FACIT collagens XII, and XIV (Riley et al., 1994). These less 
prominent collagens are often over looked in tissue engineering as a measure for the quality 
of the engineered tissues in favour of the more widely expressed ECM components. However 
the minor collagens play a key role in tendon homeostasis and without would render the 
tendon functionally impaired. Types V and XI form heterotypic (mixed) fibrils with type I 
collagen in tendon (Kadler et al., 2008). Type III reduces heterotypic fibril diameter and is 
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more abundant in elastic and distensible tissues (Asgari et al., 2017). During injury and aging 
the ratio of type III to type I increases, thereby altering tendon mechanical properties 
(Buckley et al., 2013). Types V and XI nucleate fibril assembly (Birk, 2001), with collagen type 
V influencing the diameter and number of fibrils assembled (Sun et al., 2015). Types XII and 
XIV are located at the surface of collagen fibrils with type XIV (Young et al., 2000) primarily 
present in developing tendon and replaced by collagen type XII during tendon maturation 
and ageing (Ansorge et al., 2009). 
Mechanical stimulation has been applied in tendon bioengineering using an array of different 
scaffolds, bioreactors and conditions as outlined in Table 4.1. Here fibrin has been selected 
as the scaffold of choice with the biomaterial having been shown to be superior to collagen 
hydrogels, with improved tenogenic gene expression, ECM alignment, packing density of 
fibrils and increased linear modulus when cultured with 2.4% strain for 14 days (Breidenbach 
et al., 2015). Fibrin acts as a blank slate material for collagen synthesis as the only collagen 
detected is that synthesised by the cells. Table 4.1 further show the variability between 
studies as the rate of cyclic strain applied to tissues varies from 1-15%. Here three distinct 
strain rates, 3%, 5% and 10%, have been selected based on previous work by Wang (2006) 
which states that a strain up to 6% are routinely applied to tendon, therefore representing 
physiological loads, whilst greater than 6% may lead to degeneration or rupture. 3% 
represents low physiological strain, 5% high physiological strain and 10% excessive 
(degenerative) physiological strain. 
In the present study cell-embedded hydrogels were generated using hMSCs in fibrin, which 
contracted around 3D printed attachment frames. To apply cyclic strain, the 3D printed 
bioreactor chamber was used as outlined in Chapter 3. The samples within their frames were 
incorporated into the bioreactor for 21 days, with one chamber for each condition (control, 
3%, 5% and 10%) and cyclic strain delivered at 0.5Hz for 5h per day. A comprehensive 
multimodal end point analysis was performed using histology, qPCR and Western blotting 
for collagen isoform expression, transmission electron microscopy to quantify collagen fibril 
diameter and analysis of collagen fibre alignment with a fluorescent collagen probe (CNA35). 
Tensile testing was then used to measure viscoelastic and failure properties of the cell-
engineered tendons in response to biomimetic cyclic strain.
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Table 4.1. Published work on cyclic tensile stimulation for tendon tissue engineering, showing the range in loading platforms and conditions. 
Study Strain (%) Duration (hr) Frequency (Hz) Overall Duration (day) Cell type Biomaterial 
Sample 
Number Bioreactor 
Garvin et al. (2003) 1 1 1 8 
Avian tendon internal 
fibroblasts 




Noth et al. (2005) 12 8 1 14 Human MSCs Collagen type I n=1 Custom 










Joshi and Webb 
(2008) 




Zhang and Wang 
(2010) 
4 or 8 12 0.5 3 













Morita et al. (2013) 
5, 10 or 
15 




Breidenbach et al. 
(2015) 
2.4 5 1 14 
Murine tendon progenitor 
cells 
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Youngstrom et al. 
(2016) 
3 1 0.33 10 
Tendon. Bone marrow and 




Carroll et al. (2017) 5 or 10 4 0.5 or 1 21 Porcine MSCs Fibrin n=6, shared 
culture well 
Custom 
Grier et al. (2017) 10 0.7 1 6 Human MSCs Collagen-GAG n=24, isolated 
culture well 
Custom 
Subramanian et al. 
(2017) 
2, 4 or 6 2 0.1 or 1 7 Human adipose derived 
MSCs 
Collagen type I n=4, isolated 
culture well 
Custom 














Engebretson et al. 
(2018) 
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Raimondi et al. 
(2018) 
10 12 0.5, 1 or 2 7 or 14 Porcine tenocytes Collagen type I n=4, shared 
culture well 
Custom 
Raveling et al. 
(2018) 
10 12 0.05 3 Murine MSCs Collagen tye I n=1 Custom 




Wunderli et al. 
(2018) 





Grier et al. (2019) 5 1 1 6 Human MSCs Collagen type I/GAG n=24, isolated 
culture wells 
Custom 
Hsiao et al. (2019) 4 or 8 8 0.5 1 Rat tendon derived cells Monolayer n=12, isolated 
culture wells 
Custom 
Atkinson et al. 
(2020) 
10 8 0.67 14 Equine tenocytes Collagen type I n=10, shared 
culture wells 
Custom 
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Banik and Brown 
(2020) 





Ciardulli et al. 
(2020) 




Deniz et al. (2020) 3 and 6 0.5 then 1 0.33 10 Human tenocytes Poly (glycerol-
sebacate) sheet 
n=1 EBERS TC-3 





Tohidnezhad et al. 
(2020) 
2.5 6 1 1 or 2 Rat tenocytes Rat tendon n=1 Custom 




Appropriate rates of intermittent, cyclic uniaxial tensile strain will drive the production of a 
complex collagen isoform repertoire (including types I, III, V, XI, XII and XIV), leading to 
improved structure and functional responses from tissue engineered tendon 
4.3. Aims 
1. Investigate the role of cyclic tensile strain on 3D culture hMSC differentiation and 
collagen production. 
2. Investigate the structural development of 3D cultured hMSCs in response to varying 
cyclic tensile strains. 
4.4. Experimental Setup 
4.4.1. Chamber Run design 
For this study four bioreactor chambers were 3D printed, one chamber for the control group 
and three for the tensile stimulated groups. To generate enough samples for the 
experimental analysis, six runs of complete tensile stimulation was required, this generated 
36 samples per group (138 samples in total): 
Assay      Number of samples 
§ Protein analysis (Western blotting)   [six samples] 
§ Gene expression analysis (qPCR)   [six samples] 
§ Fibril structural dimensions (TEM)  [three samples] 
§ Tissue microstructure (histology staining)  [three samples] 
§ Fibre Analysis (CNA35 Collagen-Probe)  [three samples] 
§ Mechanical testing    [three samples] 
The extra twelve samples not accounted for in the analysis techniques were generated as six 
replacements for any failed samples during each run and six samples to be sent to the 
University of Georgia, USA, for external analysis. 
As the bioreactor chamber was not mass produced but developed in-house, variations in the 
construction may have occurred during the manufacturing process. This variation was 
accounted for by rotating the stimulation groups chambers used during the experimental 
runs. The tensile stimulated bioreactor chambers were labelled 1, 2 or 3. On the first run 
chamber 1 was used for the 3% strain group, chamber 2 for the 5% strain group and chamber 
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3 for the 10% strain group. On run 2 chamber 1 was used for the 10% strain group, chamber 
2 for the 3% strain group and chamber 3 for the 5% strain group. For run 3 chamber 1 was 
used for the 5% strain group, chamber 2 for the 10% strain group and chamber 3 for the 3% 
strain group. This rotation was repeated for runs 4, 5 and 6. Samples taken for experimental 
repeats varied across each run: 
Run 1, 2 and 3 – two samples for protein analysis, two samples for gene analysis, two samples 
for the University of Georgia and one replacement sample per run. 
Run 4, 5 and 6 – one sample for second harmonic generation, one sample for histology, one 
sample for collagen probe, one sample for mechanical testing, one sample for TEM and one 
replacement sample per run.  
In order to efficiently generate the samples, each run was staggered over the five week 
experimental period (two week contraction phase, three week loading phase), this is shown 
in Fig.4.1. 
Figure 4.1. Tensile stimulation experimental run. Each run was staggered to optimise 
experimental run time (20 weeks), each run was made up of two parts, the two week 
contraction phase and three week loading phase. 
4.4.2. Tensile Stimulation 
The varying rates of tensile stimulation were sequentially applied to fixed groups of fibrin 
hydrogels after the samples had been moved into the bioreactor chamber. The four 
chambers (control and three stimulated) were all kept within the same non-humidified 
incubator at 37°C in 5% CO2 along with the EBERS TC3 bioreactor (Fig.4.2). When the culture 
chamber was mounted onto the EBERS TC-3, the 6-way tensile arm attached to the 
bioreactors linear actuator, this was how the tensile stimulation was applied to the fibrin 
hydrogels. When the linear actuator was displaced (controlled by the EBERS software) the 6-
way tensile arm was also displaced. Each chamber was pre-determined as to which 
stimulation group it would be in, either control (0%), 3%, 5% or 10% strain. Strain was applied 
as a percentage of the initial length of the fibrin hydrogel (distance between posts), initial 
length was 8 mm; therefore 3% strain was 0.24 mm, 5% strain was 0.4 mm and 10% strain 
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was 0.8 mm. Stimulation was applied for five hours a day (19 hours at static length), at 0.5 
Hz, five days a week (five days with stimulation, two days without) over three weeks. The 
stimulation was control by the EBERS software, the chamber was mounted onto the EBERS 
TC-3, and stimulation would begin. Once the five hours had elapsed the software would stop 
allowing the user to swap the chambers around. Stimulation was applied as a sinusoidal 
waveform as selected on the EBERS software.  
Figure 4.2. Bioreactor chambers and EBERS TC-3 in non-humidified incubator. 
 
3D printed culture 
chambers 
EBERS TC-3 




Qualitative histological analysis was used as an initial marker to determine the response of 
the tissue engineered tendons to the applied strain (Fig.4.3). H&E staining of the engineered 
tendon illustrates changes in tissue structure correlate with stain. Staining revealed that the 
static control group had little alignment within the structure. However, strained samples 
exhibited alignment to the direction of the strain. These results suggest that loading resulted 
in a more aligned structure compared to the static control.  
Alcian blue staining highlighted GAG production within the engineered tissue. The staining 
suggested that cyclic strain did not influence the production of GAGs with no difference 
observed across loading conditions. 
Alizarin red staining was used to investigate the calcium hydroxyapatite production within 
the engineered tissues. The control and 10% strain groups appeared to have produce 
significantly more calcium hydroxyapatite during culture than the 3% and 5% strain group. 
This suggests that physiologically appropriate rates of strain inhibit calcium hydroxyapatite 
production whilst the absence or excessive cyclic loading enables the production. 
Under polarised light the Picrosirius red staining shows fibrillar collagen illuminated red, 
green and yellow. There appeared to be little difference in collagen production between all 
cyclically strained and the control groups. This suggests that total fibrillar collagen 
production was not driven by the cyclic strain. 
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Figure 4.3. Histological analysis of tissue engineered tendons. Samples stained (from left to 
right) with H&E, Alcian blue, Alizarin red and Picrosirius Red (under polarized light). Both 
enhanced and original images are shown for Picrosirius Red staining highlighting how little 
collagen was initially detected before image enhancement. x10 objectives were used for 
each stain except Picrosirius red where x4 was used. n=2 experimental repeats. Scale bars 
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4.4.4. Alkaline Phosphatase Assay 
ALP content in the cell culture media was measured at day 0 (end of contraction phase), 7, 
14 and 21 (three week loading phase) (Fig.4.4). At day 0 no significant difference was seen 
across the three contraction plates. The control group peaked at day 7 being significantly 
higher than the three loaded groups (p<0.001). The 10% strained group peaked at day 14 
and was significantly higher than the other groups (p<0.001). Both the 3% and 5% strain 
groups appeared to have very low levels of calcium hydroxyapatite deposition (Fig.4.3) and 
lower alkaline phosphatase activity. 
Figure 4.4. Alkaline phosphatase expression of tissue engineered tendons during cyclic 
loading phase. Day 0 marks the end of the contraction phase and sees the lowest ALP 
expression with no difference between loading condition, as expected. At day 7 the control 
group has a significantly higher ALP expression than all other groups (p<0.05). At both day 
14 and 21 the 10% strain group has significantly higher ALP expression than all other groups 
(p<0.05). n=6. Significance was measured using two-way ANOVA with repeat measures and 
Tukey’s post hoc test (*indicates p<0.05, ** p<0.01, *** p<0.001).  
 



























Chapter 4  
164 
 
4.4.5. Tendon Gene Expression 
The tendon markers decorin, scleraxis and tenomodulin were assessed using qPCR (Fig.4.5) 
for all experimental strain conditions and monolayer hMSCs. An increase was seen for TNMD 
between the 2D cultured hMSCs (monolayer) and the 3D cultured hMSCs with significance 
seen for the 5% group compared to the monolayer. SCXA was increased with mechanical 
stimulation, but only one sample from the monolayer expressed detectable SCXA. Expression 
of decorin, a key proteoglycan present in tendon, was highest in the control group and 
significantly higher in the 3% strain group than with 5% or 10% strain. 
Figure 4.5. Gene expression analysis of tendon differentiation genes and a proteoglycan ECM 
gene. A) Screlaxis B) Tendomodulin and C) Decorin. Values shown normalised to YWHAZ. n=3 
experimental repeats from three separate experimental runs. Significance measured using 
one-way ANOVA with Tukey’s post hoc multiple comparisons test (*indicates p<0.05, ** 
indicates p<0.01, *** indicates  p<0.001). 
Quantification by qPCR of the tendon collagen gene composition (COL1A1, COL3A1, COL5A1, 
COL11A1, COL12A1 and COL14A1) was assessed after 21 days of cyclic tensile strain (or static 
for control) (Fig.4.6). COL2A1 expression was also assessed and acted as a marker for non-
tenogenic differentiation. COL2A1, COL3A1 and COL11A1 were found to be significantly 
higher with 5% cyclic strain than 3% cyclic strain or static conditions, with COL11A1 also 
higher than 10% cyclic strain. Conversely COL12A1 was significantly lower with 5% and 10% 
cyclic strain than the control group. A similar pattern was seen for COL1A1 and COL5A1 
though no significance was seen.   
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Figure 4.6. Gene expression analysis of collagen isoform composition in tissue engineered tendons. Relative expression is normalized to YWHAZ housekeeper. 
n=3 experimental repeats, each point designates one of three separate experimental runs. Significance was measured using a one-way ANOVA with Tukey’s 
post hoc test and multiple comparisons (* indicates p<0.05, ** indicates  p<0.01). 
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4.4.6. Complete Tendon Collagen Composition Expression 
The tendon collagen composition (types I, III, V, XI, XII, XIV) was investigated by western blot 
and the detected expression was quantified by densitometry (Fig.4.7). However collagen 
type V and type XIV were not detected in any samples. Collagen type II was used as a negative 
marker. Procollagen α1(I) and collagen α1(I) beta chain were both detected on the western 
blot membrane for collagen Iα1 and have been included in the analysis  of protein expression. 
No significance was detected for collagen types I, XI or XII. Collagen α1(II) was found to be 
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Figure 4.7. Western blot analysis of tendon collagen isoforms in tissue engineered tendons. Proteins were quantified using densitometry, with representative 
images of western blots show below each graph. Black bars indicate that a membrane has been cropped for the representative image. Values shown are 
normalised to total protein. Significance was measured using one-way ANOVA with Tukey’s post hoc test and multiple comparisons (* indicates p<0.05). 
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4.4.7. Transmission Electron Microscopy Analysis 
Fig.4.8A shows representative images for TEM analysis of the samples after five weeks in 
culture. The upper row of images shows the transverse cross-sections of the collagen fibrils 
running through the engineered tendon. The lower row of images shows the longitudinal 
orientation of collagen fibrils and highlight the anticipated surface banding pattern. Both sets 
of images were taken using a x110,000 objective lens, scale bars represent 100 nm. 
Fibrils in the 3% cyclic strain group developed the lowest diameter after the 21 day period 
with a median of 33.8 nm, this was found to be significantly lower than all other groups 
(p<0.001). The 10% strain group had the highest median diameter (41.2 nm), this was 
significantly higher than the control (36.3 nm) as well as the 3% strain group (p<0.001). The 
5% strain group (39.7 nm) was only significantly greater than the 3% strain group.  
The percentage frequency distribution of the fibril diameter (Fig.4.8Ci, ii and iii) was found 
for each sample using images of fibril cross sections across three experimental runs. The 
percentage frequency distribution of fibril diameter for each cyclically stimulated group was 
overlaid with the control groups diameter, highlighting the difference between static and 
cyclic conditions. The 3% strain group (Fig.4.8Ci) shows the same peak range as the control 
(30 nm to 36 nm). The 5% strain group (Fig.4.8Cii) has the same peak as the control group 
but the curve is wider than the 3% strain group or control groups curve (5% strain peaks at 
~11%, control and 3% strain peak at ~15%). The 10% strain groups (Fig.4.8Ciii) mode shifts 
away from the control groups to 38 nm to 43 nm.  Chi-squared tests between the control 
group and each of the strain groups showed significant differences for each strain rate, 
indicating that the application of any form of cyclic loading is resulting the a difference in the 
structure of the fibrin hydrogel. The 10% strain group showed the largest difference from the 
control group (p<0.0001). 
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Figure 4.8. TEM analysis of tissue engineered tendons. (A) TEM images of engineered 
tendons showing collagen fibrils. Upper images show transverse cross-sections, lower 
images show longitudinal sections, all after 21 days of intermittent cyclic tensile strain and 
at x11,000 objective. Analysis of individual fibres in transverse sections by imageJ (B) showed 
differences in fibre diameter with the extent of tensile strain. Data was generated from n=3 
experimental runs of each condition by analysing multiple images from each samples. Data 
from the same samples are indicated by identical coloured markers within each strain group. 
Fibril diameters are shown as frequency distributions for (Ci) 3% strain, (Cii) 5% strain and 
(Ciii) 10% strain, with the control group (orange) overlaid for comparison. Scale bars in (A) 
represent 200 nm. Statistical significance of the minimum diameters was determined using 
a linear mixed model whilst the distributions was measured with Chi-squared test (* 
indicates p<0.05, ** indicates p<0.01, *** indicates p<0.001). 
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4.4.8. CNA35 Collagen-Probe Analysis 
Representative images for DAPI, CNA35 collagen-probe staining and merged image are 
shown in Fig.4.9 for all stimulation groups. Images are shown at the anchor point (internal 
control) and the mid region (regions defined in section 2.2.8). Mid-region appeared to have 
greater alignment of collagen fibres compared to the anchor point region. 
Fibre orientation was measured after normalising orientation to 0°. The percentage 
frequency distribution of the orientation is shown for the control, 3% strain, 5% strain and 
10% strain groups, with the control mid region superimposed on the cyclically strained 
graphs (Fig.4.10). Representative images are shown from the alignment analysis, here colour 
has been assigned based on the orientation of the fibres (-90° to 90°): the more consistent 
the colour of the fibres, the more aligned the structure (colour key shown in section 2.2.8). 
It appears that the images from the mid region have more aligned fibres compared to the 
anchor point region. The control mid region versus the cyclically strained mid regions are 
shown above the x-axis whilst the anchor point region are shown below the x-axis. All groups 
had significantly increased alignment in the mid region compared to anchor point region 
except the control group (significance considered at 0°). All the strained groups had a more 
aligned mid region compared to the control mid region, however only the 10% strain group 
was significantly more aligned (above x-axis, significance considered at 0°), with 61.5% as 
compared to 40% alignment in the control group. Alignment in the 3% and 5% strain groups 
was intermediate between the control and 10% group at 45.7%, and 57.7% respectively. 
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Figure 4.9. Tissue engineered tendons stained with CNA35 collagen-probe and DAPI 
representative images. Upper images show the anchor point region of the hydrogel, the 
lower images show the mid region of the hydrogel. Images appear to agree with the 
hypothesis indicating that the mid region was more aligned in all conditions compared to the 
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Figure 4.10. CNA35 collagen fibre analysis. The ImageJ plug-in (OrientationJ) was used to 
visualise and quantify fibril orientation from the CNA35 collagen-probe images parallel to the 
strain axis (0° = parallel, shown as vertical in these images) in both regions. Graphs show the 
frequency distribution of fibres aligned with the strain axis, with the mid-region shown above 
the x-axis and the anchor point region shown below the x-axis. An overlay of the control 
group mid region (in orange) is shown in for comparison. Images are representative of n=3 
experimental repeats and scale bars represent 100 μm. Error bars represent standard 
deviation. Statistical significance cyclic strain vs static (above x-axis) and mid-point vs anchor 
point (below x-axis) was determined using one-way ANOVA with Tukey’s post hoc test with 
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4.4.9. Tensile Mechanical Testing 
To determine how strain-induced differences in collagen isoform composition and collagen 
fibril diameter relate to biomechanical function, the tensile and viscoelastic properties of the 
engineered tendons were measured. No significant differences in construct diameters were 
found across experimental groups (p>0.1),with the mean diameter being 2.43±0.32 mm. The 
stress against strain profile for each sample (Fig.4.11A) highlights the consistency of the 
trend for each stimulation, except for one control sample. The trend of the stress strain 
curves highlight the viscoelastic structure of the samples with the distinct “J” shape curve 
being apparent for each samples. In testing to failure the maximum stress, strain and Young’s 
modulus was found (Fig.4.11B-D). The 3% strain group had highest mean maximum stress 
(57.7 kPa) (Fig.4.11B). This is 2 fold higher than the maximum stress for the control and 10% 
strain group (p<0.025). The 5% strain group was 2.9 fold lower than the 3% group (20 kPa) 
(p<0.004). The maximum strain (Fig.4.11C) was not significantly different between 
experimental conditions. The static and 3% groups had the highest strain rates before 
rupture, whilst the 5% and 10% strain groups had the lowest. The Young’s modulus, 
calculated from the linear region of the stress strain curve was found to not be significantly 
different between experimental groups (Fig.4.11D). 
Chapter 4  
174 
 
Figure 4.11. Stress vs strain profiles for all tissue engineered tendon samples after 21 days 
of intermittent cyclic tensile strain (Ai-Aiv). The maximum stress (B), maximum strain (C) and 
Young’s modulus (D) were all calculated using the stress-strain profiles. The 3% strain group 
showed the highest maximum stress. The maximum strain and Young’s modulus displayed 
no significant changes across groups. Error bars represent standard deviation of the mean. 
n=3 experimental repeats. Statistical significance was determined using one-way ANOVA 
with Tukey’s post hoc test and multiple comparisons (*p<0.05, ** p<0.01). 
 
The fibrin hydrogels displayed further viscoelastic biomechanical properties, that were 
calculated from the preconditioning steps shown in (Fig.4.12B). Percentage energy loss was 
calculated from the hysteresis runs: the 10% strain group had the lowest energy loss (47%) 
whilst the 5% strain group had the highest (60%), however no significance was seen 
(Fig.4.12B).  
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Figure 4.12. Viscoelastic profiles of tissue engineered tendons. (A) The hysteresis response 
shows the recorded strain during sample loading and unloading. (B) The percentage energy 
loss depicts how much energy is lost between the loading and unloading phase. Error bars 
represent standard deviation of the mean. n=4 experimental repeats. Significance was 
measured using one-way ANOVA with Tukey’s post hoc test and multiple comparisons. 
In addition to hysteresis the relaxation of the samples was investigated to further understand 
the viscoelastic properties. Staggered stresses are shown on the y-axis of Fig.4.13A to 
separate the samples. The rate of stress relaxation was found between 0 and 60 s. The rate 
of relaxation increased with increasing strain rate with 10% having the highest mean value 
and was found to be significantly higher than the control group (p<0.05) (Fig.4.13B).  
Figure 4.13. The stress relaxation profiles (A) for the samples shows that all groups displayed 
this viscoelastic characteristic. The start stresses are staggered to separate experimental 
conditions. The rate of stress relaxation (B) was found to be highest in the 10% strain group 
(p<0.05 vs control). Error bars represent standard deviation of the mean. n=3 experimental 
repeats. Statistical significance was determined using one-way ANOVA with Tukey’s post hoc 
test and multiple comparisons (*p<0.05). 


















































































































































































































































































































































Following the design and fabrication of the bioreactor chamber, the system was used to 
apply cyclic tensile strain to MSC embedded fibrin hydrogels. Following a 14 days  contraction 
period the fibrin hydrogels were moved to the 3D printed chamber for 21 days of cyclic 
loading, or stasis for the control group. Gene and protein expression of tenogenic markers 
and collagens was altered by the extent of cyclic strain, as was collagenous tissue 
composition, fibril diameter, fibre alignment and machinal properties. 
H&E staining revealed that the tissue engineered tendons cultured with dynamic strain had 
a more visibly pronounced alignment and a greater abundance of cells and matrix at the 
surface than controls, supporting findings from previous studies (Noth et al., 2005, Benhardt 
and Cosgriff-Hernandez, 2009). Picrosirius red staining imaged under polarised light 
highlighted the areas rich in collagen due to the birefringent properties of collagen (Jett et 
al., 2020). The 5% and 10% strain group appeared to have the most aligned structures, with 
more widespread collagen supported by previous work showing increased collagen 
alignment with strain (Weidenhamer and Tranquillo, 2013). 
Alizarin red staining highlighted matrix mineralisation in both the static (control) and 10% 
strain groups. The osteogenic products seen in the matrix was reinforced by increased ALP 
activity in both groups suggesting that strain below or above physiologically acceptable levels 
has detrimental effects on the development of tissue engineered tendon. The population of 
cells used did not undergo cell sorting, it is therefore possible that the osteogenic products 
are resultant of a sub population of the hMSCs pre-disposed to the osteogenic lineage. The 
early (day 7) ALP peak in the control group suggests that tensile stimulation initially inhibits 
the osteogenic differentiation. By day 14 the levels of ALP in the control media is not 
significantly different to the 3% or 5% groups however the 10% group had become 
significantly higher than the other groups. As the 10% group is considered beyond the 
physiologically acceptable levels of strain, it appears that these excessive strains see the 
tendons begin to undergo calcification, which is often a marker of degeneration in the native 
tissue (Bethune et al., 2007, Seil et al., 2006).   
Tenogenic markers scleraxis and tenomodulin both saw changes between monolayer cells 
and 3D cultured cells. Scleraxis was only expressed by one monolayer sample whilst all 3D 
samples from each experimental group expressed the gene demonstrating that 3D culture 
alone results in greater expression of tendon markers. The highest loading group then saw 
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an significant increases in scleraxis compared to the control group suggesting that 5 and 10% 
cyclic strain results in a upregulation of tendon specific differentiation of MSCs. Tenomodulin 
was only found to be significant between the 5% strain group and the monolayer, this 
suggests that the 5% strain, physiologically appropriate strain, is upregulating both scleraxis 
and tenomodulin whilst the degenerative strain, 10%, is inhibiting tenomodulin.  
The complete collagen composition of tendon was investigated to assess the success of 
different rate of tensile stimulation for tissue engineered tendon, to the authors knowledge 
this has not been previously done before. The negative marker COL2A1 was found to be 
significantly higher in the 5% strain group compared to the control and 3% strain groups, 
disagreeing with the tendon specific gene expression. It should be noted that the expression 
of COL2A1 was the lowest of all collagen genes investigated as seen previously (Maeda et al., 
2010, Udeze et al., 2019). This demonstrates that despite the 5% strain group having a 
significantly higher expression it is not the dominant collagen being transcribed. Dynamic 
tensile stimulation increased collagen II inhibition as the detected protein collagen α1(II) was 
lower in all cyclically strained groups compared to the static control group (5% not 
significant). Alcian blue staining showed no obvious structural difference between 
conditions, aligning with the collagen II results and demonstrating that the 3D tendon culture 
inhibited chondrogenic differentiation which cyclic strain further supressed. 
Different studies have reported different collagen I and III responses to tensile stimulation. 
The rate of the stimulation and the 3D environment generate the largest variation across 
these studies. In collagen hydrogels increased expression of COL1A1 and COL3A1 has been 
reported with 2%, 4% and 6% strain at 0.1 Hz, and with 2% and 4% strain at 1 Hz, for 2 hours 
per day over 7 days (Subramanian et al., 2017). In crosslinked collagen scaffolds increased 
expression of COL3A1, but not COL1A1 has been reported (Qiu et al., 2016, Grier et al., 2017), 
whilst in decellularized tendon or synthetic scaffolds, increased expression of COL1A1 (Webb 
et al., 2006, Zhang and Wang, 2010, Xu et al., 2015) or both COL1A1 and COL3A1 (Xu et al., 
2014, Barber et al., 2013, Lee et al., 2018, Wu et al., 2017, Engebretson et al., 2018) with 
cyclic strain has been reported. However in some situations expression of these collagens is 
unchanged. It may be that high level synthesis of type I collagen occurs during formation of 
the embryonic tendons and that expression and protein content then stabilises. Alterations 
in fibril diameter and fibre alignment with strain may not require alterations in type I collagen 
content.  
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Increased expression of collagen XI has been suggested, along with collagen V, to indicate a 
more developed structure as these regulatory collagens decrease in abundance as they are 
no longer required to organise the collagen I fibrils (Wenstrup et al., 2011). In the present 
study the COL11A1 gene expression was highest in the cyclically stimulated groups (peaking 
for 5%) but the collagen α1(XI) protein detected was lowest in the stimulated groups, 
suggesting that cyclic stimulation drives the production of a more regulated ECM, therefore 
due to the high alignment the mRNA is not translated to protein. COL12A1 was the most 
highly expressed mRNA of all the collagens but with significantly lower expression in the 5% 
and 10% strained groups. Reductions in COL12A1 expression could indicate fibril remodelling 
although no significant alterations in protein levels were detected by western blotting. Type 
XIV collagen is highly expressed during embryonic tendon development (Young et al., 2000) 
and subsequently replaced with type XII (Ansorge et al., 2009). In the present study no type 
XIV was detected by western blot suggesting that the tissue engineered tendons had 
matured beyond the developmental stage or the type XIV antibody was less sensitive than 
that for type XII. 
The initial hypothesise was that 10% strain would act as a degenerative level of stimulation 
and result in impaired tendon formation based on reports (Wang, 2006) suggesting that >6% 
strain may result in damage to the structure of native tendon, but this was not strongly 
supported by the data. TEM analysis was used to investigate how the application of cyclic 
tensile stimulation manipulated collagen fibril maturation. Both longitudinal and transverse 
sections were used for imaging. The longitudinal sections show the length of the fibrils and 
clearly display the collagen banding pattern (Shoulders and Raines, 2009). The transverse 
sections were used to investigate the cross-sectional dimensions of the fibrils. In native 
tendon the collagen fibrils in the ECM have a varying cross sectional areas due to the 
presence of multiple fibril types. Starborg et al. (2013) show the diameter of rat tail collagen 
fibrils range from 0 nm to 240 nm. In the present study the fibril diameter peaked at 
approximately 80 nm suggesting that the collagen fibrils in the engineered samples are not 
as developed as that in native tendons. However the native rat tail tendon has approximately 
40% of all fibrils with a diameter of 0 to 80 nm. The fibril diameter was largest in the 10% 
group and lowest in the control and 3% groups. Similar results have been seen in previous 
studies where stimulation has resulted in an increase in the range of fibril areas (Breidenbach 
et al., 2015). Kalson et al. (2011) applied slow stretch which double the length of fibrin-based 
tendon-like constructs over 4 days and found an increase in fibril diameter from 34.4 to 38.4 
nm (a 12% increase). The present studies results would therefore suggest a more developed 
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tendon with the application of cyclic tensile loading. A comparable increase in collagen fibril 
diameters in cell engineered tendons to native tendons may require a combination of slow 
stretching, cyclic strain or optimised concentrations of suitable combinations of growth 
factor cocktails (Hagerty et al., 2012, West et al., 2015). 
Previous work by Lee et al. (2017) and Atkinson et al. (2020), both showed finite element 
analysis data for engineered tissue cyclically loaded between two posts (as with our study). 
The force displacement images across the sample showed that the highest and lowest value 
of force is located around the posts (high variation), whilst only the median force acts in the 
centre (low variation), it was therefore hypothesised that the highest alignment would be at 
the centre of the engineered tendons where the force is most consistent. Through staining 
with the CNA35 collagen-probe and image analysis this was observed for all groups. The 10% 
strain groups anchor point region was found to be the most aligned, however it is not 
currently known if this is due to purely mechanical processes, or if cell-directed fibril 
alignment or collagen isoform composition play a role in orientation.  
Several publications have routinely showed an increase in fibril cross sectional area and 
alignment results in an increase in the mechanical properties of tissue engineered tendon 
(Liao and Vesely, 2003, Battaglia et al., 2003, Lin et al., 2004). In the present study the 
increased maximum stress corresponded with a decrease in collagen fibril diameter (3% 
strain group), although ultimate stress has previously been shown to be unrelated to collagen 
fibril diameter, in ex-vivo stress-deprived tendons (Lavagnino et al., 2005). An increased rate 
stress relaxation was detected with increasing strain rates. Changes in the rate of stress 
relaxation may be in response to a decrease in GAGs, as fluid flow is disrupted into and out 
of the tissue, or a decrease in SLRPs (Elliott et al., 2003, Legerlotz et al., 2013, Ahmadzadeh 
et al., 2015, Robinson et al., 2017, Screen et al., 2011). GAGs were only investigated through 
a qualitative measurement, Alcian blue staining, highlighting no apparent differences 
between loading conditions, however the gene expression of the SLRP decorin was 
investigated with a quantitative assay. The 10% group showed the lowest gene expression 
of DCN aligning with increased rate of stress relaxation, decreased decorin has also been 
related to increased collagen fibril diameters (Zhang et al., 2006), of which the 10% group 
was found to have the largest. However no difference was detected for maximum stress or 
Young’s modulus across the strain groups whereas previous work has shown decorin null 
mice to be inhibited for these parameters (Zhang et al., 2006). No change in Young’s modulus 
between the static and cyclically strained groups aligns with a previous study which applied 
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2.4% cyclic strain to fibrin-based tendon-like constructs (Breidenbach et al., 2015). 
Conversely application of cyclic strain to collagen hydrogels at 2.4% strain or to poly-(ε-
caprolactone) scaffolds at 3% strain (Banik and Brown, 2020) was found to increase the final 
modulus (Juncosa-Melvin et al., 2007). The choice of material for 3D culture has a substantial 
effect on the final outcome of the tissue engineered structure, from fibril diameter and 
alignment to the mechanical capabilities, these parameters should all be considered when 
selecting an appropriate material. 
4.5.1. Conclusion 
The extent of cyclic strain influenced collagen isoform expression, fibril diameter and fibre 
alignment as well as the mechanical properties of the cell-engineered tendons-like 
biomaterials. 3% cyclic strain slightly decreased fibril diameter whilst increasing maximum 
stress two-fold. The 5% cyclically strained group showed increased expression of the 
tenogenic markers scleraxis and tenomodulin, as well as COL2A1, COL3A1 and COL11A1 
genes but significantly lower expression of the COL12A1 gene and reduced type III collagen 
protein content. COL12A1 expression was also decreased in 10% strain as was type II collagen 
protein content. The 10% strain group had increased expression of scleraxis, increased 
collagen fibre alignment in the mid-region and increased collagen fibril diameter, as well as 
a higher stress relaxation, indicative of an improved ability to alter its internal structure in 
response to external stress. Most parameters tested had a non-linear response to increasing 
cyclic strain during culture although fibre alignment, which increased with increasing cyclic 
strain, was a notable exception. These results suggest that different rates of cyclic loading 
will have varying effects on the engineered tissue. The structural response of the engineered 
tissue, collagen alignment and diameter, appeared to be more driven by the cyclic tensile 
loading than the production of specific collagens which showed less of a trend with loading. 
This suggests that structural properties of collagen can be driven by varying cyclic tensile 
loading alone, however the addition of specific supplements such as FGF or TGF-β may be 
required to see a more pronounced response within the collagen type composition. Further 
work is needed to confirm if the complete collagen composition can be used to determine 
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Compressive mechanical stimuli play important roles during bone and cartilage 
development, homeostasis and maintenance. These forces include hydrostatic pressure, 
which creates a mechanical-biological coupled relationship that translates macroscale forces 
to cells. Hydrostatic pressure is caused by confined compressive force acting on fluid-filled 
tissues. In bone, hydrostatic pressure has been repeatedly shown to stimulate differentiation 
and tissue building, with dynamic or cyclic pressures around 300 kPa associated with 
upregulation of osteogenic gene markers (e.g. Cox2, Runx2, Opn) and the mineralisation of 
the ECM (Liu et al., 2009b, Liu et al., 2010a, Sugimoto et al., 2017, Stavenschi et al., 2018). In 
cartilage, hydrostatic pressure has been shown to significantly upregulate chondrogenic 
gene expression (e.g. Sox9, aggrecan, collagen type II) (Angele et al., 2003, Wagner et al., 
2008, Ogawa et al., 2009) and chondrogenic matrix production from MSCs in some studies, 
whilst other researchers have found little chondrogenic effect (Finger et al., 2007, Zeiter et 
al., 2009). These previous studies indicate that hydrostatic pressure is a primary physiological 
stimulus driving bone adaptation to load, and a secondary (or contributary) stimulus in 
cartilage. 
MSCs have the potential to differentiate into chondrocytes and osteoblasts in response to 
appropriate chemical and mechanical stimulation. During chondrogenic differentiation MSCs 
differentiate first into chondroblasts which generate chondrogenic ECM (e.g. collagen II, 
collagen IX, and aggrecan), resulting in the chondroblasts separating from each other and 
terminally differentiating into chondrocytes with a distinctive spherical morphology and 
pericellular matrix, or chondron (Lefebvre and Smits, 2005). Under osteogenic stimuli, MSCs 
may differentiate into osteoblasts, resulting in the synthesis and secretion of bone ECM (e.g. 
collagen I, osteopontin) and in turn mineralisation of the structure which is mediated by 
alkaline phosphatase and embedded ECM proteins such as osteocalcin (Huang et al., 2007).  
Mature bone and cartilage can be subjected to both underloading (lack of exercise) and 
mechanical overloading (e.g. trauma) – which is theoretically transduced into broadly 
healthy and unhealthy levels of hydrostatic pressure (Elder and Athanasiou, 2009, Stavenschi 
et al., 2018). MSCs are therefore a good candidates for studying the role that physiological 
levels of exercise play in skeletal development by correlating macroscale forces associated 
with activity, to hydrostatic pressures generated in the tissue, and a characteristic response 
by musculoskeletal cells.  
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It has been calculated that due to stress shielding the actual pressure experienced by 
osteocytes in the canalicula-lacuna network of load-bearing bones is in the order of 300 kPa, 
significantly lower than that of pressure generated in the joint synovial fluid during exercise 
(~18 MPa) (Zhang et al., 1998). Therefore, is has been theorised that chondrocytes typically 
experience higher mechanical loads than osteoblasts, one aim of this study is to investigate 
if relatively low pressure inhibits or accelerates chondrogenic differentiation of adult MSCs. 
Chemical stimulation has also been widely used to induce differentiation in cultured MSCs. 
For chondrogenesis, TGF-β3, dexamethasone, Insulin-Transferrin-Selenium and L-ascorbic 
acid are added to the culture medium (Murdoch et al., 2007) whilst for osteogenesis; 
dexamethasone, β-glycerophosphate and L-ascorbic acid are used (Jaiswal et al., 1997). 
Though it is accepted that the MSCs will differentiate to the desired lineage, the resulting 
bone or cartilage does not display exactly the same ECM composition, structure or 
morphology as native tissue, which is thought to be due to the lack of physiological multi-
modal stimulation in cell culture (Wang and Chen, 2013). The application of mechanical 
stimulation to cells in culture has therefore become a major area of research in tissue 
engineering. Most published studies focus on the role of hydrostatic pressure as a stimulus 
in combination with a single type of differentiation media (e.g. osteogenic or chondrogenic), 
but rarely are these compared in a single experiment.  
The application of hydrostatic pressure in vitro is typically achieved through the use of 
bioreactors. There are a number of commercially available and custom designed hydrostatic 
pressure bioreactors, including the CartiGen HP which was developed by Professor Alicia El 
Haj and Dr James Henstock, engineered by TissueGrowth Technologies and originally 
marketed by Instron. The bioreactor was validated and used for several bone culture 
experiments, showing for example that expression of osteogenic genes (osteonectin and 
osteopontin) were significantly upregulated when chick femurs were cultured within the 
system, together with proportional increases in bone formation and density as the 
magnitude and frequency of pressure was increased (Henstock et al., 2013). Using the El Haj 
groups bioreactor as a basis an updated version was produced for the present study featuring 
the same culture chamber but with a new air compressor, valve manifold and software. 
The majority of published studies report the effects of hydrostatic pressure on key ECM 
genes/proteins, neglecting to investigate the less abundant ECM components which may 
nevertheless play an important role in regulating tissue neosynthesis and act as important 
biomarkers. Some of the most routinely overlooked ECM components are the minor 
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collagens. Eight collagens have been reported in adult cartilage ECM: I, II, V, VI, IX, X, XI, XII 
(Luo et al., 2017), whilst in bone there are eleven: I, II, III, V, VI, IX, X, XI, XII, XIV, and XXIV 
(Tzaphlidou, 2005). In this investigation some of the collagens that are expressed in both 
bone and cartilage have been investigated, therefore acting as conserved biomarkers to 
assay differential responses between chondrogenesis and osteogenesis in response to 
mechanical loading. Through these combinations of collagen isoform expression it is possible 
to determine the extent and ‘quality’ of the tissue which is formed, i.e. how closely the newly 
formed ECM corresponds to native tissue, and therefore assess functionality as 
bioengineered tissue for regenerative medicine.  
The effect of hydrostatic pressure on the differentiation of hMSCs and the subsequent 
collagen production has been investigated in the present study. Whilst it is well established 
that hydrostatic pressure aids in the differentiation of hMSCs cultured in osteogenic or 
chondrogenic media (Liu et al., 2009a, Saha et al., 2017) the isolated role is not. This study 
will look to apply a range of hydrostatic pressures from 0 kPa to 300 kPa, the upper limit of 
the bioreactor in use, to hMSCs cultured in either chondrogenic, osteogenic or supplement 
free (basic) media, establishing how significant of a role hydrostatic pressure plays in the 
differentiation of MSCs.  
5.2. Hypothesis 
Differentiation is not solely driven by chemical stimulation (culture media supplements) but 
can be achieved by varying one consistent form of mechanical stimulation applied to the cells 
to better reflect that of native tissue. The differentiation can then be established by 
investigating the collagens produced in response to the mechanical stimulation.  
5.3. Aims 
1. Investigate the role of relatively low levels of cyclic hydrostatic pressure in 
stimulation of chondrogenic differentiation of MSCs through characterising the 
collagens produced by the cells. 
2. Investigate the role of physiologically relevant levels of hydrostatic pressure in 
stimulation of osteogenic differentiation of MSCs through characterising the 
collagens produced by the cells. 
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5.4. Experimental setup 
5.4.1. Hydrostatic Pressure 
For the hydrostatic pressure study an in house developed bioreactor was utilised based on a 
previously published design outlined by Henstock et al. (2013). The system operates using a 
well plate placed within an airtight hydrostatic pressure chamber (HPC) (Fig.5.1). The 
chamber then connected to a valve manifold (Festo, UK) which was fed compressed air at 
400 kPa by an air compressor (BAMBI, UK) (Fig.5.1). The valve manifold was controlled by an 
in house developed software which regulated the magnitude, frequency and duration of 
pressure applied to the HPC. The compressed air could be supplied at a maximum of 300 kPa 
and was sterilised by passing through an air filter at the entrance of the HPC (Fig.5.1).  
Figure 5.1. Hydrostatic pressure bioreactor setup. 
Notes on usage: i) The temperature of the compressed air was not controlled, to account for 
this the none stimulated control group was left at room temperature for the same time 
period as the hydrostatically stimulated samples. ii) As the samples are stimulated with 




chamber entrance and 
airtight lid 
Air compressor 
Valve manifold Hydrostatic pressure 
chamber lid 
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groups), this was controlled by replacing the vapourised media with sterile PBS at the end of 
the stimulation period.  
Microtissues, the term used to denote the cell embedded fibrin hydrogels used throughout 
this study,  were generated as explained in section 2.2.3.2. Briefly 1.25x106 cell/ml of hMSCs 
were seeded in fibrin hydrogels within a 48 well plate and allowed to contract for one week 
in basic media. Following the contraction phase the samples randomly were transferred by 
passive suction into a 24 well plate and cultured in designated culture media (basic, 
chondrogenic or osteogenic) for three weeks whilst being subjected to 0 kPa, 100 kPa, 200 
kPa or 300 kPa hydrostatic pressure for one hour a day, five days a week at 1 Hz.  
Analysis. Analysis of the microtissues was by the following techniques, for which the relevant 
n-numbers of samples are indicated in [brackets] (randomisation and statistical strategy 
described below): 
 Assay      Number of samples 
§ Protein analysis (Western blotting)   [six samples] 
§ Gene expression analysis (qPCR)   [six samples] 
§ 3D morphometry and densitometry (μCT) [six samples] 
§ Tissue microstructure (histology staining)  [three samples] 
Experimental statistical design. All media types (basic, chondrogenic and osteogenic) were 
used across the plate to account for run variation. At the end of the contraction phase the 
microtissues were given a number (1-96) based on position in the 48 well plate (A1 on plate 
1=1, F8 on plate 2=96), a random number sequence was generated (Random.org) with the 
first number in the sequence moved to position A1 in the control 24 well plate and the final 
number in the sequence to D6 on the 300 kPa plate. For each hydrostatic pressure 
individually each well in the 24 well plate was then given a new number (1-24) based on well 
position (A1=1, D6=24), the number sequence was randomised (random.org) with the first 
eight numbers being cultured in basic media, the second in chondrogenic media and the last 
eight in osteogenic media. Three experimental runs were required to generate enough 
samples. At the end of each run the eight samples within each media group for each loading 
condition were designated a number 1-8 and the sequence was randomised (Random.org), 
the first and second samples in the sequence were used for protein analysis, the third and 
fourth for gene analysis, fifth and sixth for μCT, seventh for histology and eighth as a reserve.  
5.4.2. Hydrostatic Pressure Loading Regime 
After the one-week contraction period the samples were moved to a prepared 24 well plate 
and 500 μl of the appropriate media was added to each sample. When not being stimulated 
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the well plates were kept in the same humidified incubator at 37°C in 5% CO2. The HPC airline 
filter was sterilised using an autoclave whilst the HPC was sterilised with 70% ethanol and 
left to dry in a sterile cell culture hood. The air filter was then placed into the HPC and the 
air-tight lid was attached. Within the sterile cell culture hood the HPC lid was removed and 
the appropriate well plate was placed into the HPC. The well plate lid was then removed and 
the HPC lid was placed onto the HPC and secured. The HPC was then attached to the 
compressed air tank via the valve manifold and hydrostatic pressure was applied to the 
samples at either 100 kPa, 200 kPa or 300 kPa at 1 Hz for one hour a day, repeated for five 
days a week over three weeks. Stimulation was applied as a sinusoidal waveform as selected 
on the bioreactor control software. The control samples (not stimulated by pressure) were 
left in the sterile culture hood for one hour a day to replicate the temperature conditions of 
the loaded samples.  
 




5.5.1. Hydrogel weight and Appearance 
After the hydrostatic pressure regime (three weeks stimulation) the samples were removed 
from the well plate and imaged using a dissecting microscope (Fig.5.2). Distinct differences 
can be seen between size, colour and opacity of the samples.  
Figure 5.2. Representative images of microtissues cultured in basic, chondrogenic and 
osteogenic media following stimulation with intermittent, cyclic hydrostatic pressure for 21 
days. Scale bar = 10 mm. 
The wet weight of the samples was measured immediately after the completion of the 
experiment (Fig.5.3). Microtissues cultured in in basic medium showed a decrease in weight 
with increasing pressure, while microtissues in chondrogenic medium showed no change in 
weight over the range of pressures used in this study. Microtissues cultured in osteogenic 
media generated the heaviest samples with the 200 kPa group being the heaviest overall 
(36.4 mg) - this was significantly higher than both the 100 kPa (23.2 mg, p<0.001) and the 
300 kPa (25.9 mg, p<0.05) from the osteogenic group, whilst the control group was also 
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Figure 5.3. Weight of microtissues across basic, chondrogenic and osteogenic media groups. 
Error bars represent standard deviation. n=18 repeats. Statistical analysis using two-way 
























































































Qualitative histology was used to visually assess the response of the microtissues to the 
applied hydrostatic pressure. H&E staining (Fig.5.4) highlighted differences in tissue 
structure caused by the differentiation medias, but with minimal noticeable differences 
within each group in response to hydrostatic pressure. The basic and chondrogenic groups 
appear similar, however the osteogenic group appeared significantly different to the two 
others with far less intense staining across the whole structure suggesting less ECM 
production by the cells in this condition.    
Figure 5.4. H&E staining of microtissues cultured in basic, chondrogenic or osteogenic media 
following 21-days hydrostatic pressure stimulation at 100 kPa, 200 kPa or 300 kPa. 
Representative images were taken with 10x objective, n=3 repeats. Scale bars represent 500 
μm.  
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5.5.2.2. Alcian Blue 
The basic and osteogenic media groups both displayed small amounts of GAG using Alcian 
blue staining (Fig.5.5) The most staining appears to be in the chondrogenic media group, 
where there appears to be an intense streak of blue running through the centre of the control 
and 300 kPa samples of the chondrogenic group, this suggests that the media is having 
driving effect on chondrogenic differentiation which low levels of hydrostatic pressure may 
be inhibiting. However the 100 kPa and 200 kPa microtissues from the chondrogenic media 
group still appear to have greater statin than other media groups, cross comparison is 
impaired by varying light intensity between groups. Networks of increased GAG deposition 
could be due to increased regional cell density (not seen on H&E), or due to localised 
deformations, or creases in the hydrogel matrix.  
Figure 5.5. Alcian blue staining of microtissues cultured in basic, chondrogenic, or osteogenic 
media following 21-day period hydrostatic pressure stimulation at 100 kPa, 200 kPa or 300 
kPa. Representative images were taken with 10x objective, n=3 repeats. Scale bars represent 
500 μm.
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5.5.2.3. Alizarin Red 
Alizarin red stains calcium hydroxyapatite within the microtissue (Fig.4.6). Differences in 
overall staining intensity appear across the media groups, indicating various degrees of 
calcification occur in all samples, with noticeable changes in the pattern of mineralisation 
seen across hydrostatic pressure regimen.  
Calcification was minimal in basic media, whilst in chondrogenic media areas of 
mineralisation were detected in microtissues exposed to 300 kPa pressure. All stimulated 
osteogenic media samples showed a distinctive pattern of mineralisation, which was not 
seen in the osteogenic media control, basic or chondrogenic media groups, indicating 
interaction between media supplementation and mechanical loading. The nodular pattern 
of mineralisation was most prominent in the osteogenic 300 kPa group.  
Figure 5.6. Alizarin red staining of microtissues cultured in basic, chondrogenic, or osteogenic 
media following 14-day period hydrostatic pressure stimulation at 100 kPa, 200 kPa or 300 
kPa. Representative images were taken with 10x objective, n=3 repeats. Scale bar represents 
500 μm.  
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The amount of calcium hydroxyapatite in the osteogenic media group was quantified by 
staining six samples from each regimen with Alizarin red and quantifying the extracted 
staining using cetylpyridinium chloride solution. The absorbance of the chelate was then 
measured to give a quantitative reading (Fig.5.7). The 300 kPa group was most calcified 
(0.237 Abs) and was significantly higher than all other groups.  
Figure 5.7. Alizarin red assay for osteogenic microtissues. (A) Representative images of 
Alizarin red stained hydrogels from the osteogenic media group. (B) Absorbance readings for 
these-stained hydrogels. n=6 repeats. Error bars represent standard deviation of the mean. 
Statistical significance measured using one-way ANOVA with multiple comparisons and 
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5.5.2.4. Picrosirius Red 
Under polarised light collagen stained with Picrosirius red illuminates red, green and yellow 
due to the birefringent properties of collagen (Fig.5.8). The illuminated staining appeared to 
be the lowest in the osteogenic media group, with none detected in the control group. The 
chondrogenic group appeared to have the highest density of collagen in the core of the 
hydrogel for all conditions whilst the basic media group appeared to have staining across the 
hydrogel, especially in the centre and edges. To highlight the collagen in the different groups 
different levels of exposure was required therefore little comparisons can be made across 
groups, however the osteogenic group required the highest increase in exposure to highlight 
any collagen, suggesting this group produced the least. The original un-enhanced images are 
found in Appendix I.  
Figure 5.8. Picrosirius red staining of microtissues cultured in basic, chondrogenic, 
osteogenic media following 14-day period hydrostatic pressure stimulation at 100 kPa, 200 
kPa or 300 kPa. Representative images are shown for Picrosirius Red to show collagen 
deposition under polarised light, the osteogenic group required increased exposure to detect 
any collagen, basic and chondrogenic were captured with same parameters. Representative 
images were taken with 4x objective, n=3 repeats. Scale bar represents 500 μm. 
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5.5.3. Alkaline Phosphatase Assay 
ALP activity was measured in the culture medium at the end of each 7-day timepoint using 
the 4-methylumbelliferyl phosphate fluorescent substrate assay. No ALP activity was 
detected in samples cultured in chondrogenic media (fluorescence values were below the 
detection threshold / control even after extended incubation with the assay reagent).  
In basic media (Fig.5.9A), the application of any hydrostatic pressure regime appeared to 
decease ALP activity in the media compared to the unstimulated control, which was 
significant (p<0.01) at the 7- and 21-day time points. This same general response was also 
observed in the ALP activity of samples cultured in osteogenic media (Fig.5.9B). Similarly, ALP 
activity decreased over time in both the basic media and osteogenic media groups. 
Figure 5.9. Graphs of alkaline phosphatase media content over the hydrostatic pressure 
stimulation period for Basic (A) and osteogenic (B) media groups. Error bars represent 
standard deviation. n=6 repeats. Significance measured using two-way ANOVA with multiple 
comparisons and Tukey’s post hoc test and multiple comparisons (* indicates p<0.05, ** 
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5.5.4. Hydrostatic Pressure Collagen Gene Response 
Collagen gene expression was measured for a range of  collagen types found in bone and 
cartilage (Fig.5.10). COL2A1 was highest in the chondrogenic media group though no 
significance difference was seen across pressure regimen within the media groups. COL5A1 
was significantly lower in the control microtissues of the basic media group versus the 200 
kPa and 300 kPa microtissues. The basic 300 kPa microtissues were found to be significantly 
higher than the control microtissues for COL11A1. COL6A1 and COL9A1 were not detected 
in the basic media group. 
COL9A1 and COL24A1 were not detected in the chondrogenic media group. COL10A1 
showed a significant increase with hydrostatic pressure with both the 200 kPa and 300 kPa 
being higher than the control in the chondrogenic group. COL1A1, COL5A1, COL6A1 and 
COL11A1 all saw an increase with hydrostatic pressure peaking at different rates, none were 
significant. COL2A1 did not change across the pressure regime. 
For the osteogenic media COL2A1 peaked at 100 kPa and but was not significantly higher 
than other pressures. Similarly COL10A1 peaked at 100 kPa which was significantly higher 
than 200 kPa. COL6A1 and COL11A1 also peaked at mid pressure regimes (100 kPa) but only 
COL11A1 saw significance with control, 100 kPa and 200 kPa being significantly higher than 
300 kPa. COL5A1 was not detected in the control or 100 kPa regimes and only one sample 
expressed COL5A1 in the 200 kPa regime. COL24A1 was not detected.  
Two-way ANOVA showed significance between media type for COL5A1 (p<0.05) . A 
significant interaction between media groups and pressure regimes was detected for 
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Figure 5.10. Collagen gene expression for hydrostatic pressure regimen. Values are shown normalised to GAPDH. Error bars depict standard deviation of the 
mean. n≤6 experimental repeats. Significance measured using one way ANOVA with multiple comparisons and Tukey’s post hoc test for COL9A1 and COL24A1. 
Statistical significance measured using Two-way ANOVA with Tukey’s post hoc test and multiple comparisons were performed on remaining genes. For non-
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5.5.5. Collagen Composition in Response to Hydrostatic 
Pressure 
Densitometry was performed following western blotting to analyse the collagen synthesis by 
the microtissues in response to hydrostatic pressure (Fig.5.11). Collagen V, VI and IX were 
not detected for any samples across all media conditions.  
For basic media, mature alpha (tropocollagen), pro-form and beta (cross-linked) chain of 
collagen I all follow a similar trend of decreasing with increasing hydrostatic pressure. 
Collagen II and X follow a similar trend. Collagen XXIV sees an initial increase between the 
control group and 100 kPa and then a gradual decline up to 300 kPa, and all the pressure 
regimen are greater than the control group. Collagen XI was not detected. 
Procollagen I, collagen I beta chain and collagen II all show a similar trend of increasing with 
hydrostatic pressure for the chondrogenic media group. Collagen I shows very little change 
across all pressure regimes. Collagen X, XI and XXIV decrease slightly with increasing 
pressure. No chondrogenic collagen expression was found to be significant.  
Neither collagen II or XI was detected for any osteogenic media sample. Very little change is 
seen for collagen I, procollagen I or the collagen I beta chain across all pressure regimes with 
the 100 kPa group having the highest expression. Expression of collagen X did not change 
across pressure regimen. Collagen XXIV saw a decrease between the control and the 
hydrostatic pressure regimen, but was not found to be significant.  
Two-way ANOVA showed significance across media for collagen α1(XXIV) (p<0.001). The 
interaction between media and pressure was significant for collagen α1(I) beta chain and 
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Figure 5.11. Densitometry of collagen types for hydrostatic pressure regimen. Representative images of western blots shown below graphs. Values are shown 
normalised to total protein. Error bars depict standard deviation of the mean. n≤6 experimental repeats. Statistical significance measured using one way 
ANOVA with Tukey’s post hoc test and multiple comparisons for collagen α1(XI). Significance measured using Two-way ANOVA with Tukey’s post hoc test and 
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5.5.6. Micro-Computed Tomography 
Fig.5.12 depict representative μCT images of the hydrogels for the basic, chondrogenic and 
osteogenic media groups. The first column of the figure shows the total microtissue volume, 
the second column shows the mineralised deposits within the microtissue volume and the 
third column shows the mineralised deposits (red) superimposed on the total volume. It 
appears that the basic media group had the most consistent mineralised deposits across all 
hydrostatic pressure conditions. The chondrogenic group appears to have a higher number 
of mineralised deposits in the control and 300 kPa groups. The osteogenic media group has 
a similar amount of mineralised deposits in the control and 100 kPa groups however this 
appeared to dramatically drop with the 200 kPa and 300 kPa groups.  
The lowest percentage mineralised volume (Fig.5.13A) for all media types was the 200 kPa 
regime. The 300 kPa regime coupled with basic media had the highest overall percentage 
mineralised volume and was significantly higher than control (p<0.001) and 200 kPa 
(p<0.001). The control samples had the highest percentage volume for the chondrogenic 
media group, this was significantly higher than 100 kPa, 200 kPa and 300 kPa samples 
(p<0.001). Both 100 kPa and 300 kPa were found to be significantly higher than 200 kPa 
(p<0.01).  The osteogenic control and 100 kPa samples were both significantly higher than  
the 200 kPa and 300 kPa samples (p<0.001). Two-way ANOVA analysis showed that the 
interaction between pressure and media was significant (p<0.001). 
The density of the mineralised deposits (Fig.5.13B) was found to be highest overall in the 200 
kPa and 300 kPa microtissues from the osteogenic media groups, with both the 200 kPa and 
300 kPa samples being significantly higher than the osteogenic control (p<0.05) and 100 kPa 
samples (p<0.01). The 300 kPa basic media samples had the highest density whilst the 
control, 100 kPa and 200 kPa samples all have similar densities within the basic media group. 
The chondrogenic media group had the opposite trend to the basic media group with the 
control, 100 kPa and 200 kPa samples having similar and the highest densities in the media 
group. Two-way ANOVA analysis indicated a significant interaction between media and 
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Figure 5.12. Representative μCT images of microtissues from each media group and pressure regimen for total hydrogel volume, mineralised deposits and 
mineralised deposits superimposed onto total hydrogel volume. Scale bar = 10 mm. 
Osteogenic Media 
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Figure 5.13. μCT analysis of hydrostatic pressure microtissues. (A) Percentage of mineralised 
volume, comparison of all media groups. (B) Comparison of the density of mineralised 
deposits in microtissue across all media groups. Error bars depict standard deviation of the 
mean. n=6 repeats. Statistical significance measured using two-way ANOVA with Tukey’s 









































































































































































































Hydrostatic pressure was applied to MSCs seeded within fibrin hydrogels at 100 kPa, 200 kPa 
and 300 kPa based on previous studies which found pressures of approximately 300 kPa to 
be consistent with pressure sensed by osteocytes in the canalicula-lacuna network of load-
bearing bone (Zhang et al., 1998), this was also the upper limit of the bioreactor. The loading 
regimen was applied for three weeks at either 100 kPa, 200 kPa or 300 kPa, 1 Hz for 1 hour 
per day (five days on, two days off) following seven days of free swelling contraction in basic 
media. After the contraction period was completed the samples were either maintained in 
basic media or moved to osteogenic or chondrogenic differentiation media. 
The microtissue appeared to change more due to the culture medium than the pressure 
applied, with colour and size varying between differentiation groups. The basic and 
chondrogenic media groups showed yellowing in colour and appeared similar in size (the 
chondrogenic slightly larger) whilst the osteogenic media group remained whiter and much 
larger. The basic media group was found to be the lightest of all groups with no significant 
differences across pressure regimens. The chondrogenic media group again showed no 
differences between pressure regimes and was found to be lighter than the osteogenic 
media group. The 200 kPa samples cultured in osteogenic media were found to be the 
heaviest overall and significantly heavier than the osteogenic 100 kPa and 300 kPa. Changes 
in construct size and wight has previously been seen as a result of hydrostatic pressure, 
aligning with the findings shown within the present study (Angele et al., 2003, Henstock et 
al., 2013). Results suggest that the media type drives the weight and size of the samples more 
so than the hydrostatic pressure regimen, however within the osteogenic media group 
(heaviest) the hydrostatic pressure begins to have an effect on the weight of the samples. 
H&E staining intensity appeared consistent for the basic and chondrogenic media group but 
much lighter in the osteogenic media group (little effect across pressure regimen within 
media group), potentially due to a more sparse ECM owing to the significantly larger size of 
the hydrogel. A similar staining profile for Alcian blue, used to highlight GAG content within 
the ECM, was seen for the basic and osteogenic media groups suggested that hMSCs cultured 
in basic media were not differentiating towards the chondrogenic lineage. The chondrogenic 
media group appeared the have the most intense staining, particularly in the control and 300 
kPa samples, this suggested that the media type was having a greater effect on the ECM 
production than the hydrostatic pressure regimen.  
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Alizarin red staining appeared to be highest in the 300 kPa osteogenic samples, aligning with 
previous work by Stavenschi et al. (2018). Quantified Alizarin red staining showed that the 
300 kPa osteogenic samples were significantly more stained than all other regimens within 
the osteogenic media group. Staining in the chondrogenic and basic media groups appeared 
similar and lower than the osteogenic media group, which could suggest that the basic media 
alone is not enough to maintain differentiation as both Alcian Blue and Alizarin Red showed 
little expression of cartilage or bone markers within the ECM. Interestingly the 300 kPa 
chondrogenic samples appeared to show the highest level of Alizarin red staining. Previous 
work by Saha et al. (2017) also showed the highest amount of staining in the highest pressure 
group of cells cultured in chondrogenic media, suggesting that cells cultured under higher 
pressure may be undergoing hypertrophy. Hypertrophy would indicate bone formation 
beginning to occur within the microtissues as the MSCs have reached the end of the 
chondrogenic lineage and begin calcifying the cartilage (Mackie et al., 2008). However the 
alkaline phosphatase assay showed expression of ALP to be below the minimum detectable 
threshold for the chondrogenic samples, although this does not rule out that the cells may 
be undergoing hypertrophy in the higher pressure groups. The basic media group and 
osteogenic media group both expressed detectable levels of ALP, with highest expression at 
day 7 of hydrostatic pressure loading, aligning with previous work (Hess et al., 2010). The 
application of hydrostatic pressure sees the expression of ALP in the basic and osteogenic 
media groups to decrease after day 7, it therefore appears the highest level of osteogenic 
differentiation occurred during the first seven days of hydrostatic pressure.  
Little difference was seen across the hydrostatic pressure regimes within the same media 
group for picrosirius red staining. The basic media group appeared to have the most 
widespread collagen within the ECM whilst the osteogenic media group had the lowest, 
further supporting the suggestion that the size of the osteogenic hydrogels resulted in a 
more sparse ECM (as seen in the H&E images).  
Typically the minor collagen genes are not investigated when studies look to use mechanical 
stimulation to generate tissue engineered cartilage or bone. A range of major and minor 
collagens found within the ECM of both/either cartilage and bone has been investigated in 
the present study (I, II, V, VI, IX, X, XI, XXIV). Collagen I is the most abundant collagen in bone 
and seen as a marker of disease and ageing in cartilage. The expression of type I collagen at 
protein level was unexpectedly similar between the chondrogenic and the osteogenic media 
groups (osteogenic media group was expected to be higher), the basic media group had the 
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lowest expression of collagen α1(I) with no significance seen in any group. However the gene 
expression of COL1A1 was more regulated by the pressure applied. For the basic media group 
the gene expression of COL1A1 increased with pressure, though not significantly. The control 
and 300 kPa samples had the highest expression within both the chondrogenic and 
osteogenic media group. Previous work sees hydrostatic pressure decreasing COL1A1 gene 
expression in chondrogenic media samples (Ogawa et al., 2015) and an increase in COL1A1 
in osteogenic media samples (Huang and Ogawa, 2012) disagreeing with the results in the 
present study. As expected the trend in expression of pro-collagen α1(I) and collagen α1(I) 
beta chain was similar to that of collagen α1(I).  
As collagen II is the most abundant protein in cartilage it was expected to be highest in the 
chondrogenic media group and this was the case for the gene expression (COL2A1). There 
was no difference across the hydrostatic pressure regimens in any media group, therefore 
the main driver for COL2A1 expression appears to be media type. Despite the osteogenic 
media group having the second highest COL2A1 expression no protein was detected by 
western blot for this media group. The basic media group had very similar expression of 
collagen α1(II) to the chondrogenic media group with no difference between hydrostatic 
pressure regimens. Previous work has shown that a mixed medium containing both 
chondrogenic and osteogenic supplements sees significant increases in COL1A1 and COL2A1 
with 1000 kPa hydrostatic pressure (Wagner et al., 2008), this does not directly align with 
the present results and may suggest that a combination medium with higher levels of 
hydrostatic pressure is more appropriate than the relatively low levels applied with isolated 
medium types. It is also important to note that the Wagner et al. (2008) study used collagen 
I hydrogels not fibrin which may have significant effects on the COL1A1 and COL2A1 
expression.  
No protein expression was detected for collagen V, VI or IX in any media group. The gene 
expression for COL5A1 was highest in the basic media group with consistent increases with 
hydrostatic pressure, with 100 kPa and 300 kPa being significantly higher than the control. 
The lowest expression of COL5A1 was in the osteogenic media group, which was not 
anticipated as collagen V is typically found in tissues with high levels of collagen I (bone) (Birk 
et al., 1989). Collagen XI has a similar function to that of type V and is found in tissue with a 
high concentration of collagen II (Kadler et al., 2008). This is not observed at the gene level 
with the osteogenic media group having the highest expression (200 kPa osteogenic samples 
being the highest overall significantly). The basic media group had the lowest expression of 
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COL11A1. However at the protein level only the chondrogenic media group show any 
detectable expression, with no difference between hydrostatic pressure regimens. This is 
consistent across all protein expression for the different media groups (except collagen XXIV) 
suggesting that the media group is having a more pronounced effect on the collagen 
production that the hydrostatic pressure stimulation. COL6A1 and COL9A1 are typically 
found in chondrogenic ECM’s however here the highest expression of COL6A1 was in the 
osteogenic media group and the only detectable expression of COL9A1 in the osteogenic 
media group.  
COL10A1 had the highest expression in the chondrogenic media group with significance seen 
in the 200 kPa and 300 kPa microtissues vs the control, this aligns with previous work by 
Ogawa et al. (2009). As collagen X is a marker for endochondral ossification this supports the 
hypothesis that the cells are beginning to undergo hypertrophy as seen in the histological 
analysis. COL10A1 expression for the basic and osteogenic media groups is much lower than 
the chondrogenic media group and sees no difference between hydrostatic pressure 
regimens. A combination of hydrostatic pressure and shear forces has been suggested to 
inhibit the production of COL10A1 in cartilage tissue engineering (Nazempour et al., 2017). 
Therefore it may be important to combine multiple mechanical stimuli to engineer a more 
‘healthy’ engineered chondrogenic structure and prevent hypertrophy. 
COL24A1 is only detected in the basic media group despite being a marker for osteogenic 
differentiation (Wada et al., 2006, Matsuo et al., 2008). At the protein level the osteogenic 
media group has the highest expression, whilst the basic media group shows the lowest 
protein expression, further suggesting that the absence of chemical stimuli is limiting the 
differential potential of the hMSCs and preventing the cells for moving down a specific 
lineage, instead, based on collagen production, they appear to be moving between multiple 
lineages.  
μCT has been previously been proposed as a technique for investigating tissue engineered 
hydrogels (Dorsey et al., 2009), here Dorsey et al (2009) argue that whilst fluorescence 
imaging offer high resolution, μCT allows non-invasive imaging of more opaque structures 
and yields quantitative analysis. In the present study the representative images appear to 
show differences between samples within media groups exposed to different hydrostatic 
pressure regimens, for example there appears to be a low number of particles in the 300kPa 
osteogenic microtissues compared to the control microtissues whilst in the basic media 
group it appears to show the opposite. μCT analysis showed that the highly pressurised 
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osteogenic samples (200 kPa and 300 kPa) had by far the lowest percentage mineralised 
tissue of all groups. This was surprising when comparing to the alizarin red staining and assay. 
However when investigating the density of what had been produced it was clear that the 200 
kPa and 300 kPa samples from the osteogenic media group had produced the most dense 
mineral (significant), agreeing with previous work (Henstock et al., 2013). This suggest that 
the cells generated a more mature and developed mineralised component rather than a 
random production seen in other groups. Further it shows that for the production of 
appropriate mineral, the cells require the mechanical stimulation as well as the chemical 
stimulation as the control and 100kPa samples from the osteogenic media groups show very 
little difference in structure compared to samples in the basic and chondrogenic media 
groups. 
5.6.1. Conclusion  
The combination of the different analysis techniques appears to show that the chemical 
intervention is having the driving effect on the cell fate. The hydrostatic pressure regimen 
appeared to have a greater effect on the expression of the different collagen genes than the 
protein synthesis where the protein content was consistent across all hydrostatic pressure 
regimens with the only differences being generated between the different media types. This 
suggests that whilst the hydrostatic pressure is generating an intra-cellular response, the 
subsequent synthesis is being dictated by the media supplements. However the production 
of mineralised deposits within the osteogenic media group appears to be heavily influenced 
by the application of hydrostatic pressure. The synthesis of collagen α1(I) did not significantly 
change across the osteogenic media group with pressure whilst the mineral density did, 
suggesting that the mechanical stimulation influenced the mineralisation of the tissue, 
potentially a response to stiffen the structure. Hydrostatic pressure acting without a 
differentiation media did not appear to enable lineage commitment from the MSCs with the 
microtissues displaying both chondrogenic and osteogenic responses without significant 
commitment to either. The present work shows that these rates of hydrostatic pressure 
alone are not enough to drive differentiation, a variation in media supplements or a change 
to the rate or amount of hydrostatic pressure may be required to generate a greater level of 
differentiation by the MSCs. Collagen synthesis was not an ideal tool for determining the 
MSC differentiation with hydrostatic pressure but appeared more useable with the media 
types, this suggests that to generate a detectable response the hydrostatic pressure regime 
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During their time in space astronauts show a distinct loss of  bone mineral density of up to 
20% in the lumbar spine, pelvis and proximal femur (Grigoriev et al., 1998). It is apparent 
that the lack of gravity has a significant effect on the astronauts cells leading to bone loss 
and muscle wastage, with this response being traced back to the astronauts MSCs. 
Microgravity reduces the mechanical load acting on cells, including those cultured in vitro, 
and therefore presents an opportunity to investigate how cells respond to an absence of 
mechanical loading, rather than applied, directional forces.  
Research has shown that the reduction in loading caused by microgravity can supress the 
osteogenic differentiation of MSCs, with one study indicating that this occurs through 
inhibition of the mechanotransduction pathway, MAPK (Meyers et al., 2004). Phenotypic 
analysis of cells shows that microgravity induces a rounded cell morphology with a 
distinctively reorganised cytoskeleton compared to normal gravity in MCF-7 cells (breast 
cancer cell line) (Li et al., 2009). Blaber et al. (2015) demonstrated that microgravity inhibits 
murine embryonic stem cell differentiation and therefore that mechanical unloading results 
in the preservation of stemness, suggesting that microgravity may be a useful culture 
condition for sustained 3D culture of undifferentiated MSCs. 
A number of studies have shown greater expression of tissue specific genes from stem cells 
cultured under microgravity conditions compared to normal gravity culture. A consistent 
example across the literature is the increased neural potential for MSCs cultured in 
microgravity (Mitsuhara et al., 2013, Mattei et al., 2018, Otsuka et al., 2018), other have 
shown increased proliferation potential whilst maintaining the undifferentiated state of 
MSCs (Yuge et al., 2006, Yuge et al., 2011). The response of musculoskeletal tissue cells in 
microgravity varies with osteogenic cells typically showing impaired differentiation (Nabavi 
et al., 2011) and chondrogenic cells showing enhanced differentiation (Ulbrich et al., 2010). 
It is apparent that microgravity has a significant effect of the fate of cells and may be a useful 
tool in the long-term culture of MSCs for future therapies. 
As it is not possible to remove or entirely shield the gravitational force on Earth, multiple 
systems have been developed to apply microgravity to cell culture for ground-based 
experimentation. The three main options for investigators are: “free fall”, counteracting 
gravity or spatially distributing the gravity vector (Grimm et al., 2018).  
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Rotating ‘free fall’ Bioreactors. The rotating cell culture system (RCCS) (Fig.6.1A) was 
developed by NASA (Begley and Kleis, 2000) and enables cells to be cultured in free fall 
through the use of a slow-turning lateral vessel (STLV) (Schwarz et al., 1992). For the present 
study the free fall method has been utilised, this is achieved via a rotating vessel, specifically 
the RCCS 4H bioreactor (Synthecon, Houston, USA). 
Random positioning bioreactors. Random positioning machines work to make the average 
gravitational vector equal to zero (Hoson et al., 1997). In these bioreactors the vertical 
orientation at which cells grow is continuously changed so that the gravitational pull on the 
sample Is distributed equally, spatially and temporally, therefore preventing the biological 
system to adapt to a single gravitational vector (Grimm et al., 2018).  
Levitation strategies. The earths gravitational field can be counteracted using buoyancy or 
magnetic levitation. For this to be achieved for tissue engineering, the cells or biomaterial 
scaffold requires modification to enable magnetic forces to act, preventing this being an 
option for many studies. An example of this technique is the study by Hammer et al. (2009), 
in which MC3T3-E1s (an osteoblast cell line) were cultured on a specifically designed 
microcarrier and then held within a magnetic field to counteracted the gravitational force.  
Short term ‘true’ microgravity on Earth. Short term microgravity can also be achieved 
through parabolic flight and drop towers. Parabolic flight can be used to stimulate space 
flight by capturing the early effects of hyper/microgravity and is achieved through an 
aeroplane performing repeat parabolas (Grosse et al., 2012). An alternative technique for 
short term microgravity is the drop tower, where the experimental sample is placed within 
specially designed vessels, the vessel is then moved to the top of the drop tower and 
released, allowing it to fall a fixed distance, in the case of the ZARM drop tower this is 110 m 
and takes 4.74 seconds (ESA, 2003), enabling very short experimental observations. 
True microgravity. To provide long-term, true microgravity for extended and detailed 
biological research necessitates use of orbital platforms, such as microsatellites or facilities 
onboard the ISS. Several researchers have used the ISS for research, including a group at the 
University of Liverpool who aim to reach the ISS by the end of 2021 and are developing 
bioreactors for investigating links between muscle loss in astronauts and during ageing, with 
an emphasis on investigating the failure of adaptive responses to exercise in both situations 
(Jones et al., 2020). Several private companies now offer services to enable research groups 
to move their scientific investigations to the ISS, and national Space Agencies provide specific 
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funding for these activities. Consequently, research in true microgravity is a growing area 
with significant interest from a variety of stakeholders (Alwood et al., 2017, Afshinnekoo et 
al., 2020). 
Previous work looking at MSCs cultured in microgravity has shown that the duration of the 
microgravity culture can have a major effect on the differentiation properties of the MSC. 
Xue et al. (2017) found that after 3 days of free fall simulated microgravity, rat MSCs showed 
enhanced potential to differentiate into endothelial, neuronal and adipogenic cells, whilst 10 
days of culture promoted osteogenic differentiation. Studies have also focused on attempts 
to promote specific differentiation pathways in MSCs under microgravity culture. Mayer-
Wagner et al. (2014), found that both hypertrophy and chondrogenesis differentiation was 
impaired for hMSCs cultured in microgravity, with downregulated COL10A1 and COL2A1 as 
highlighted outcome measures. Therefore, whilst microgravity is not ideal for 
chondrogenesis it may be a useful tool in inhibiting hypertrophy at later stages of cartilage 
tissue engineering (Mayer-Wagner et al., 2014). 
The application of microgravity has been shown to partially regulate the differentiation of 
MSCs (Xue et al., 2017), work by Yuge et al. (2006) have gone on to shown that MSCs cultured 
in microgravity preserve their stemness through strong proliferative characteristics typical 
of stem cells and the ability to differentiate whilst their 1 g counterparts largely lost these 
abilities. The inhibition of differentiation may be due to microgravity preserving the 
undifferentiated state of the MSCs, and therefore enabling long term culture of the cells 
before differentiation is required. MSC culture in vitro generally leads to either spontaneous 
differentiation or eventual senescence (McCulloch et al., 1991, Digirolamo et al., 1999, Banfi 
et al., 2000, Baksh et al., 2004), and so strategies that may preserve undifferentiated or 
uncommitted MSC in vitro have multiple applications, particularly for the development of 
cell therapies (Huang et al., 2020).  
As reported in this chapter, the cells were cultured within a 3D fibrin hydrogel and 
maintained the culture in microgravity for 3 weeks using a rotating ‘free fall’ bioreactor, the 
RCCS 4H (Synthecon, Houston, USA) (Fig.6.1A). This bioreactor generates a 
microenvironment where high mass transfer is achieved with low shear stress. True 
microgravity would feature no downward gravitation force (Fig.6.1Bii) - this cannot be 
achived on earth, therefore the sample will experience gravitational force (Fig.6.1Bi) but this 
will mostly be offset by the centrifugal force and drag force generated by rotating the sample 
within the vessle (Ronaldson and Vunjak-Novakovic, 2016). Through an inner co-rotating 
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cylinder with a gas exchange membrane, the microgravity chamber can rotate at specified 
rates, whilst supplying the culture with appropriate gas exchange. The control group were 
replicate 3D cultures maintained in static culture within a 12 well plate. To account for the 
fluid shear and increased nutrient diffusion generated by the rotating liquid (Khodabukus et 
al., 2018), a third group was used, in which replicates cultured within a 12 well plate were 
placed onto a plate rocker to provide increased nutrient perfusion and shear flow under a 
constant gravity vector (Juhas and Bursac, 2014). Whilst the rocker plate may not generate 
the same level of increased nutrient diffusion as the bioreactor, this condition went some 
way to highlight the effects of nutrient diffusion provided by the bioreactor helping to 
separate the role of microgravity. As in previous chapters, differentiation of the MSCs was 
characterised via collagen production, specifically in this case by considering several 
collagens that are characteristic of a broad range of musculoskeletal tissues (tendon, bone 
and cartilage). 
Figure 6.1. Free fall microgravity bioreactor setup. (A)  Microgravity bioreactor RCCS 4H used 
to culture hMSCs under microgravity conditions. (B) Diagram of samples in simulated 
microgravity adapted from Ronaldson and Vunjak-Novakovic (2016). (C) Power supply 











The application of microgravity inhibits hMSC differentiation (preserves stemness) due to 
the lack of an over-riding mechanical stimulus. The collagen isoforms synthesised by the 
hMSCs during culture can be used to characterise the stemness of the cells.  
6.3. Aims 
1. Investigate the cell response to microgravity culture through the expression and 
synthesis collagen and microtissue structural changes.  
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6.4. Experimental Design 
6.4.1. Microgravity Culture 
The microtissues were generated as stated in section2.2.3.2, briefly 1.25x106 cells/ml were 
seeded within fibrin hydrogels within the well of a 48 well plate and cultured with basic 
media. The samples were scored from the edge of the well with a 10 μl pipette tip and 
allowed to free swell for one week.  After the one-week contraction period the microtissues 
were moved to the three different culture chambers: microgravity bioreactor, static plate or 
dynamic plate. To select which microtissues were moved into which condition, each was 
given a number and a random number sequence was generated (RANDOM.org). The first 24 
samples were placed under static condition, the second 24 under dynamic conditions and 
the final 27 in microgravity culture. The rotation speed of the microgravity bioreactor was 
defined as 35 rpm (Fig.6.1C) placing the samples in constant free fall and therefore under 
microgravity conditions (Maguire and Novik, 2010). The generated samples were used as: 
 Assay      Number of samples 
§ Protein analysis (Western blotting)   [six samples] 
§ Gene expression analysis (qPCR)   [six samples] 
§ 3D morphometry and densitometry (μCT) [six samples] 
§ Tissue microstructure (histology staining)  [three samples] 
The extra samples not accounted for in the analysis techniques provided replacements for 
any failed samples. Due to an infection on one plate from the dynamic group no samples 
were generated for histology and only five for μCT. 
The final microtissues in the microgravity chambers were removed and placed into a 24 well 
plate (i.e. one sample per well, three samples stored as reserves). For all culture conditions 
each microtissue was given a number from 1-24 based on the position in the plate (A1 = 1, 
H8 = 24) and a random number sequence was generated (Random.org). The first six numbers 
were used for protein analysis, the second six for gene analysis, the third six for μCT, the next 
three for histology and the remaining three as reserves 




6.5.1. Hydrogel Weight and Appearance 
Representative images of the microtissues for each condition are shown In Fig.6.2A. These 
images were taken at the end of the experimental regime and appear to show differences in 
the size of the samples between the conditions. Dynamic stimulation generated the smallest 
microtissues whilst the microgravity and static culture were both similar in size, which was 
confirmed by analysis of the wet weight of the microtissues (Fig.6.2B). The microgravity 
samples were found to have a heaviest mass, with the dynamic group the lowest. The static 
group was not significantly different to either.  
Figure 6.2. Size and weight of microgravity microtissues. (A) Representative images of the 
microtissues culture in normal gravity (static and dynamic) and microgravity conditions. (B) 
Weight of microtissues following one week contraction phase and three week microgravity 
or normal gravity phase. Error bars represent standard deviation. n=23 repeats. Statistical 
significance measured with one-way ANOVA with Tukey’s post hoc test and multiple 
comparisons (*** indicates p<0.001).  
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Due to a cell culture infection in the dynamic stimulation group not enough microtissues 
were produced for histological analysis, here only static and microgravity are compared. 
Representative images of H&E staining (Fig.6.3) appear to show similar structures for both 
the static and microgravity groups.  
Alcian blue staining (Fig.6.3) appeared to show increased GAG content in the core of the  of 
the static group compared to the very low levels of staining in the microgravity group. Alizarin 
red staining highlighted one calcified nodule in the ECM (indicated with black arrow) of the 
static group, no nodule staining was seen in the microgravity group, whilst nodules were not 
widespread they may suggested increased osteogenic differentiation. Collagen was stained 
with Picrosirius Red and imaged using polarised light. Both groups have some birefringent 
(organised) collagen, however more collagen appeared to be throughout the structure in the 
microgravity image, whilst the collagen distribution appears mostly on the microtissue’s 
edge in the static group. The picrosirius red images required a large amount of enhancement 
to highlight any illuminated collagen, the original un-enhanced images are included to 
highlight the difference. 
Figure 6.3. Histological sections of microtissues following 21-day microgravity and static 
culture. Representative images are shown for haematoxylin and eosin staining to show cell 
bodies and nuclei microscopy, Alcian blue staining highlighting GAGs within the ECM, Alizarin 
red staining for calcification and Picrosirius Red staining to show collagen deposition under 
polarised light. Picrosirius red staining is shown as both enhanced and original images. n=3 
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6.5.3. Alkaline Phosphatase Assay 
ALP content in the culture medium was measured at the end of each 7-day timepoint using 
4-methylumbelliferyl phosphate fluorescent substrate assay (Fig.6.4). The static and dynamic 
cultures followed the same pattern of activity over the three-week culture period with no 
significant difference seen between these two groups. In contrast, ALP activity in the 
microgravity group was significantly lower than both the static and dynamic cultures from 
day 7 onwards (p<0.001). ALP activity did increase in the microgravity group with time (day 
21 having a significantly higher concentration than day 7; p<0.001), but at a slower rate to 
both static and dynamic cultured microtissues.  
Figure 6.4. ALP activity in the media of static, dynamic and microgravity cultured 
microtissues. Absorbance measured at seven-day time points beginning at the end of the 
first week of culture and ending at the end of the experimental run. Error bars represent 
standard deviation. n=18 repeats for day 0 and n=9 for all later timepoints. Statistical 
significance measured using two-way ANOVA with Tukey’s post hoc test and multiple 
comparisons (*** indicates p<0.001).
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6.5.4. Microgravity Collagen Gene Response 
The expression of a repertoire of collagen genes found across different musculoskeletal 
tissues (cartilage, bone and tendon) was investigated to determine the level of 
differentiation and identify any lineage commitment of the hMSCs (Fig.6.5). Only COL6A1 
showed a significant differences with the static group being greater than the dynamic group. 
All other genes showed no significance at the experimental end-point between any of the 
groups, indicating a weak responses to the stimuli. 
The ratio of COL14A1 to COL12A1 was found to be significantly higher for the microgravity 
group versus the static group showing a 9 fold increase (Fig.6.6). 
The PCA showed evidence that the static culture grouped separately from the dynamic and 
microgravity culture (Fig.6.7A). The biplot (Fig.6.7B) highlights COL2A1, COL5A1, COL6A1, 
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Figure 6.5. Collagen gene expression for microgravity microtissues. Error bars represent standard deviation of the mean. n≤6 repeats. Statistical significance 
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Figure 6.6. Ratio of COL14A1 to COL12A1 to investigate the maturation of the microtissues 
in different culture conditions. Error bars represent standard deviation of the mean. n=4 
repeats. Statistical significance measured using one-way ANOVA with Tukey’s post hoc test 
and multiple comparisons (* indicates p<0.05). 
Figure 6.7. PCA of microgravity collagen gene expression. (A) PCA scores of all samples. Each 
point represents a sample with the colour designating the culture group (static-orange, 
dynamic-green and microgravity-grey). (B) Biplot of the PCA showing the variables that 
contribute to the most separation between the culture groups are COL2A1, COL5A1, COL6A1, 
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6.5.5. Collagen Composition in Response to Microgravity  
All collagen genes were measured at the protein level via western blot. The proteins 
synthesised due to the expression of COL2A1, COL5A1, COL6A1, COL10A1, COL11A1, 
COL12A1 and COL14A1, were not detected (Fig.6.8). This may be due to the concentration 
of these minor collagens being below the detectable threshold rather than being completely 
absent from the ECM. 
The expression of collagen α1(III) was significantly highest in the microgravity group 
compared to both the control groups (dynamic having the lowest) (Fig.6.8). Both forms of 
collagen I and collagen XXIV did not significantly change between culture conditions, with 
the microgravity group being lower than the static control in all cases (Fig.6.8). 
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Figure 6.8. Densitometry of collagen extracted from microgravity microtissues. 
Representative images of western blots show below graph. Values shown are normalised to 
total protein. n=3 repeats. Error bars represent standard deviation of the mean. Statistical 
significance measured using one-way ANOVA with Tukey’s post hoc test and multiple 
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6.5.6. Micro-Computed Tomography 
Representative μCT images of the three culture conditions is shown in Fig.6.9A. The total 
volume of the microtissue is shown in the left column, the mineralised deposits are shown 
in the middle column and the mineralised deposits superimposed onto the total volume in 
the right column. No noticeable difference was seen between any condition with each group 
appearing to shown a similar percentage of mineralised deposits. This is reflected in Fig.6.9B, 
the percentage mineralised volume. Fig.6.9C shows the difference in densities between the 
three culture groups. The static group was found to have a significantly higher density 
(0.082g/cm2) than the dynamic group (0.077g/cm2, p<0.05) but not the microgravity groups 
(0.078g/cm2).  
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Figure 6.9. μCT analysis of microgravity microtissues. (A) Representative images for μCT of 
static, dynamic and microgravity cultured hMSC seeded fibrin constructs highlighting total 
volume, mineralised particles and combination. (B) percentage mineralised volume and (C) 
mineral density for static, dynamic and microgravity cultured hMSC seeded fibrin constructs. 
n≤6 repeats. Error bars represent standard deviation of the mean. Statistical significance 
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Microgravity has the potential to be used as a tool to maintain and enhance the stem like 
properties of MSCs (Yuge et al., 2006, Lei et al., 2018). Collagen is typically used as a marker 
for cell differentiation, for example collagen type I is used as a tendon (Zhang et al., 2005) 
and bone marker (Cassella and Ali, 1992) whilst collagen type II is used for cartilage (Wardale 
and Duance, 1994). In the present study hMSCs were encapsulated in fibrin hydrogels and 
exposed to normal gravity (1 g) in either static or dynamic culture or microgravity (1x10-6 g) 
for three weeks. The dynamic culture was use to introduce a normal gravity condition with 
increased nutrient diffusion making it was possible to assess whether microgravity was the 
driving stimuli for differentiation relative to the effects of increased nutrient diffusion seen 
with the bioreactor used (Khodabukus et al., 2018).  
The size and weight of the microtissues was significantly increased for the samples cultured 
under microgravity compared to both normal gravity controls, suggesting that microgravity 
maintains a larger sized tissue engineered construct compared to normal gravity. This is 
supported by previous observations, here the study suggests that this increased size would 
be more suitable for a tissue engineered plug in a cell therapy application. (Sakai et al., 2009). 
Sakai et al. (2009) cultured hMSCs in chondrogenic differentiation media and went on to find 
that the microgravity samples increased the expression of chondrogenic markers (GAGs and 
collagen II), indicating that microgravity was upregulating chondrogenic differentiation. The 
microgravity group in the present study did not show a strong affinity towards the 
chondrogenic lineage, it appeared that only small areas of intense Alcian blue staining 
occurred within the ECM. There looked to be equally low Alizarin red staining and low 
absorbance was detected in the media for ALP indicating low levels of osteogenic 
differentiation. Bradamante et al. (2018) found that microgravity had little effect on 
osteogenic differentiation. Similarly to Sakai et al. (2009), Bradamante et al. (2018) used 
specific differentiation media for culture (osteogenic in this case), whilst in the present study 
the microtissues were cultured in basic medium, which was chosen to show how the cells 
responded to microgravity solely. If spontaneous differentiation were to occur due to the 
culture medium it was hypothesised that it would be towards the osteogenic lineage as the 
basic medium more closely aligns to osteogenic differentiation medium than chondrogenic.  
Only a small number of collagens are synthesised within the bone marrow niche; collagen 
type I, III, IV, V and VI along with a high percentage of proteoglycans, fibronectin and 
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laminins, among others (Gordon, 1988, Hamilton and Campbell, 1991). This goes some way 
to explain the low detection of collagen when only using basic media. Previous work looking 
at specific tissue types has seen a variation in the collagens synthesised. Cartilage tissue 
engineering typically sees beneficial responses with microgravity compared to normal gravity 
with an increased ratio of collagen II to collagen I (Ohyabu et al., 2009), and the 
downregulation of collagen X (Mayer-Wagner et al., 2014), a marker for hypertrophy that is 
often seen with cartilage tissue engineering (Jahangir et al., 2020). MSCs cultured in true 
microgravity (space) saw trans-differentiation from the osteogenic lineage towards the 
adipogenic lineage even with osteogenic medium (Zhang et al., 2018). It is apparent that the 
differential potential of MSCs in microgravity differs to MSCs in normal gravity, however the 
presence of differential medium appears to be required to show the true effects of 
microgravity. 
6.6.1. Microgravity Culture Differentiation 
The strongest expression of collagen genes within the microgravity culture group were for 
COL1A1, COL3A1, COL11A1, COL12A1, COL14A1 and COL24A1 (>0.001 relative to GAPDH), 
all collagen types that are found in tendon and bone ECM (Riley et al., 1994, Tzaphlidou, 
2005). COL2A1, COL5A1, COL6A1 and COL10A1 (<0.001 relative to GAPDH) all had the lowest 
expression and are types typically found in the cartilage ECM (Luo et al., 2017). The gene 
profile therefore points towards the microgravity group moving along the 
osteogenic/tenogenic lineage rather than the chondrogenic. Further no collagen II was 
detected by western blot whilst the bone/tendon markers collagen I and III were, as was the 
bone marker, collagen XXIV. The molecular data therefore points towards the promotion of 
an osteo/tenogenic differentiation of the MSCs when culture under microgravity. 
Functional outcomes were measured to clarify the differential lineage of the MSCs. ECM 
mineralisation was characterised by μCT, and analysis found that the microgravity group had 
the lowest mineralised volume and density. Despite the gene and protein profiles, the 
microgravity group was not distinctively maturing along a strongly osteogenic lineage, 
supporting similar observations from Alizarin Red staining of the microtissues and reduced 
ALP activity. MSCs cultured in growth medium without intervention will often differentiate 
towards the osteogenic lineages, however when cultured in microgravity the spontaneous 
differentiation appears to be inhibited, therefore maintaining the stemness of these cells. 
Wall et al. (2007) showed that irrespective of media type hMSCs will eventually differentiate 
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towards the osteogenic lineage, suggesting that these cells are pre-disposed towards the 
osteogenic lineage and require significant intervention to inhibit this differentiation.  
During early development of a native tissue’s ECM the cells will secrete collagen XIV as a 
major FACIT collagen, then as the ECM continues to develop and mature the synthesis of 
collagen XIV reduces and is replaced by collagen XII (Ansorge et al., 2009), highlighting 
collagen XII and XIV’s use as a measure of tissue maturity and development. Interestingly the 
ratio of COL14A1:COL12A1 gene expression was highest in the microgravity group indicating 
the delayed development of the tissue, demonstrating the inhibitory effect microgravity has 
on maturation and therefore spontaneous differentiation of the hMSCs. The work by Wall et 
al. (2007) found that later passages of hMSCs cultured within adipogenic media underwent 
spontaneous osteogenic differentiation, indicating that the more mature the cell the more 
likely it is to undergo the spontaneous differentiation. By delaying the maturation of the 
MSCs, the stemness of the cells will also be preserved. 
ALP activity in the media indicated greater osteogenic differentiation in the static group  
compared to the microgravity group. Despite the absence of osteogenic differentiation 
supplements the cells appear to be undergoing spontaneous osteogenic differentiation, 
however the application microgravity is acting as an inhibitor. 
6.6.2. Static Culture Differentiation 
The gene profile for the static culture was similar to that of the microgravity group. The 
osteogenic/tenogenic collagen types had a higher expression (>0.001 relative to GAPDH) 
than the chondrogenic collagens. Protein expression of collagen II was not detected in the 
static group, whilst collagen I, III and XXIV were, implying that the cells were not 
spontaneously differentiating towards the chondrogenic group but more likely towards the 
osteogenic or tenogenic lineages.  
The static group was found to have the lowest expression of the gene COL3A1 and the lowest 
expression of collagen a1(III) whilst microgravity had the highest expression for both the 
gene and protein (significantly). Fibrin is the biomaterial cells secreted at the site of a wound, 
initially the cells will then generate a unorganised matrix of collagen III before replacing it 
with organised collagen I and completing the healing process (maturation and development) 
(Clore et al., 1979). Is postulated that if the fibrin hydrogel is being matured by the cells as 
fibrin would be at a wound site it would suggest that a lower expression of collagen III and 
higher expression of collagen I would indicate a more mature structure, as seen with the 
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static versus the microgravity group. Inhibited wound healing with microgravity has 
previously been seen in rats, therefore suggesting the delayed maturation of the wound due 
to microgravity (Davidson et al., 1999).  
μCT analysis showed that the cells may have differentiated towards the osteogenic lineage 
in static culture as whilst the percentage of mineralised particles is similar to that of the 
microgravity culture, the density of the particles is highest in the static group, demonstrating 
a more advanced osteogenic ECM with dense hydroxyapatite regions. 
6.6.3. Dynamic Culture Differentiation 
The dynamic group expressed near identical ALP production within the media to the static 
group. The gene analysis showed a profile in between the static and microgravity groups with 
only COL2A1, COL6A1 and COL11A1 not lying between the other conditions. This would 
suggest that whilst gravity is having an effect which the microgravity bioreactor is somewhat 
removing there is an influence from the increased nutrient diffusion resulting in the dynamic 
group neither identically reflecting the static nor microgravity group. Again the 
osteogenic/tenogenic collagens have a higher expression than the chondrogenic genes, 
further indicating that within the basic media the cells are more likely to undergo 
spontaneous osteogenic/tenogenic differentiation. The PCA analysis of the collagen genes 
aligns the dynamic culture group more closely with the microgravity group, with COL2A1 
having the largest contribution to the position of the dynamic and microgravity groups whilst 
COL10A1 (among others) has one of the largest effect of the static group. COL10A1 is seen 
as a transition marker during the endochondral ossification of cartilage to bone (Shen, 2005), 
suggesting that the static samples are more aligned to an osteogenic differentiation that the 
dynamic and microgravity cultures.  
Protein analysis aligns the dynamic culture with the microgravity microtissues for collagen I 
and the static for collagen III and XXIV. Maturation of the dynamic microtissues appears to 
lie between the two cultures with the middle ratio of COL14A1to COL12A1 and the lowest 
expression of collagen a1(I) and a1(III). Increased nutrient diffusion appears to inhibit the 
maturation of the cells seen with static culture, the absence of gravity further exaggerates 
the inhibitory effect. Further the PCA biplot shows that COL12A1 strongly contributes to the 
separation of the static group from the dynamic and microgravity group, suggesting that 
increased nutrient diffusion is a major contributor to the delayed maturation of the MSCs 
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By observing both the microgravity and dynamic microtissues particle densities together 
(both similar and lower than static) it appears that the increased nutrient diffusion does work 
to inhibit spontaneous osteogenesis. Majd et al. (2009) showed that a form of dynamic 
culture maintained stem cell phenotypes and differential capacity, Frith et al. (2010) found 
that dynamic 3D culture in spinner flasks maintain the MSC phenotype compared to MSCs 
cultured in 2D monolayer, both these studies support the observation of inhibited 
spontaneous osteogenic differentiation with the increased nutrient diffusion (dynamic 
cultures). The results of the dynamic culture highlight a major issue with the RCCS 4H 
bioreactor, and other free-fall systems, in that a static control group in well plates will be 
affected by not only normal gravity but also reduced nutrient diffusion, therefore not acting 
as a true control. Future studies with this system should continue to utilise dynamic and 
static controls for true comparison.  
6.6.4. Conclusion 
Through comparison of the three culture types it appears that each are differentiating 
towards the osteogenic lineage as expected due to the spontaneous differentiation of hMSCs 
in long term culture. PCA analysis appeared to show the presence of increased nutrient 
diffusion separating both the  dynamic and microgravity groups form the static group with a 
more exaggerated separation seen in the microgravity group. This suggests that dynamic 
culture is having an initial effect on the MSCs which microgravity is amplifying. It was 
hypothesised that microgravity would help maintain the MSCs is a more naive state, 
inhibiting tissue specific collagen production and therefore ECM maturation. Microgravity 
had the greatest inhibitory effect as seen by the highest ratio of COL14A1 to COL12A1, whilst 
the static culture has the lowest, indicating the most mature ECM, the dynamic culture was 
found in between the two and significantly different to neither. COL12A1 was one of the 
main contributors In the separation of the static culture from the dynamic and microgravity, 
further indicating the maturation of the static ECM indicating the inhibitory effects of 
nutrient diffusion. The present study suggest microgravity may be an solution to prolonged 
growth of MSCs whilst maintaining the stemness of the cells, this would be a valuable 
solution to the bulk up of MSCs for autologous cell therapies. The present study suggests 
MSCs are in a less developed state after microgravity culture and the stemness is maintained, 
future work should look to investigate this by investigating the expansion and differential 
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The overall aim of this thesis was to apply mechanical stimulation to hMSCs encased within 
3D biomimetic constructs and monitor the collagen output from the cells. The collagen 
output was then used to investigate the differentiation of the MSCs and the ‘quality’ of the 
tissue engineering structure generated. Within healthy musculoskeletal tissues a specific 
composition of collagen isoforms are synthesised and form part of the ECM. Each of the 
collagens occur in different concentrations with the major fibril forming collagens typically 
accounting for the highest percentage of the dry protein weight. The minor collagen types, 
such as FACIT, MACIT and multiplexins are present along with proteoglycans and growth 
factors among other ECM components but at a smaller concentration. The composition, 
orientation and ratios of the different collagen types offer the tissue specific properties 
required to appropriately complete its routine task, such as force transduction between 
muscle and bone for tendons. Many tissue engineering studies do not investigate these 
minor collagens, generating an incomplete understanding of the tissue being generated. By 
investigating the complete collagen composition, a better understanding of how the cells are 
responding to the stimulus can be achieved enabling optimised tissue engineering. 
Three different forms of mechanical stimulation have been used throughout this study, cyclic 
tensile strain, hydrostatic pressure and microgravity, with all three being applied to hMSCs 
encased in fibrin hydrogels. Whilst the fibrin hydrogel was constant throughout the study 
the initial formation and culture environment differed based on the mechanical loading. 
Identical fibrin hydrogels (microtissues) were used for both microgravity and hydrostatic 
pressure, here the fibrin was generated within the well of a 48 well plate. For tensile 
stimulation a purpose built 3D printed frame was designed with posts at either end. The 
fibrin was generated within the frame and around the posts forcing the fibrin into a rod like 
structure similar to that of a tendon and allowing uniaxial cyclic strain to be applied. 
One of the main limitations seen in many studies when investigating the role of mechanical 
stimulation on cell differentiation and ECM production is the use of differentiation media, 
which, as seen with the hydrostatic pressure study, can have an overriding effect on the 
response of the cells subjected to the mechanical stimulation. Basic hMSCs proliferation 
media was used in all studies to show the sole effect of the mechanical stimulation on the 
cells collagen synthesis rather than the supplement driven production. However, it should 
be noted that the components of the basic media (DMEM, FBS, non-essential amino acids 
and ascorbic acid) more closely align with media used for osteogenic differentiation (missing 
dexamethasone and β-glycerophosphate), whilst culture media used for tenogenic and 
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chondrogenic differentiation typically remove FBS as a supplement and instead use a 
different combination of growth factors. It was therefore more likely that the hMSCs would 
spontaneously differentiate towards the osteogenic lineage due to the combination of media 
and the predisposition of bone marrow derived MSCs (Wall et al., 2007). Spontaneous 
differentiation appeared to be seen in all three studies when using the basic media and not 
subjecting the samples to any stimulation (the control groups), small amounts of osteogenic 
differentiation was present in the ECM through the formation of calcium hydroxyapatite 
nodules (Alizarin Red assay). This phenomenon has been previously reported by Zhang et al. 
(2016), here MSCs were seeded onto electrospun nanofibers and were cultured without 
osteogenic differentiation media, following 14 days of culture the cells showed increased 
expression of osteogenic markers Col1A1, OCN, ALP and Runx2.  
The spontaneous differentiation of the cells may have been further driven by the non-sorted 
population used. The cells went through MSC verification by flow cytometry and the tri-
lineage differentiation assay, demonstrating that this population could achieve adipogenic, 
chondrogenic and osteogenic differentiation. Flow cytometry showed that at the first 
passage the appropriate percentage of cells in the population (>95%) possessed the correct 
positive markers (CD73, CD90 and CD105) though the population exceeded the negative 
marker percentage by 0.83%. It is possible that a mixed cell population was used in this study 
and it contained cells that had already begun to differentiate down lineages, and may have 
then driven the spontaneous differentiation of other cells. 
The expression of different collagens varied across the different mechanical stimulations, 
and appeared to show some regulatory effects for the varying stimuli. Without cyclic strain 
the tensile control group had the highest expression of collagen α1(II) as has been seen by 
previous studies (Maeda et al., 2010, Udeze et al., 2019). As collagen II is typically seen as a 
negative marker in tendon tissue engineering it demonstrates the beneficial properties of 
appropriate mechanical stimulation. However within the hydrostatic pressure study it 
appears that the media supplements had an overriding effect on the collagen synthesis with 
no significant differences seen between the different loading regimens for either the 
osteogenic of chondrogenic media groups. The COL10A1 expression was highest in the 200 
kPa and 300 kPa samples from the chondrogenic media groups suggesting that hydrostatic 
pressure induces hypertrophy. Studies have shown that microgravity inhibits hypertrophy in 
cartilage tissue engineering (Mayer-Wagner et al., 2014), however whilst COL10A1 was 
found to have the lowest expression in the microgravity group it was not significantly lower 
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than the microgravity controls. A combination of hydrostatic pressure and microgravity may 
be beneficial for cartilage tissue engineering. 
Gene expression is commonly used to investigate collagen synthesis in response to 
experimental intervention. This is typically due to the difficulty found when extracting 
collagen from tissue engineered tissues, due in part to the enzymatic digestion required but 
also because of the low abundance of the minor collagen. This was observed in all three 
studies with some collagens detected at the gene level not detected by western blot. 
However what was clear from the collagens that were detected by both qPCR and western 
blot was the low alignment between the two. The protein expression is a far greater way to 
judge the present ECM in the tissue engineered structure, it is therefore imperative to 
investigate the collagens at the protein level as well as gene level were possible to get a true 
representation of the cells response.  
Changes between the loading and culture regimens was more apparent for the structural 
analysis than the molecular analysis, this indicated that whilst the collagen synthesis may not 
have been dramatically influenced by the stimulation applied, the way the collagens were 
embedding within the ECM was largely driven by these forces. In the tensile stimulation 
study the highest strain rate resulted in the largest diameter fibrils and the most aligned 
structure, whilst in the hydrostatic pressure study the highest pressures coupled with 
osteogenic medium resulted in the most dense mineral deposits indicating a more developed 
structure. The microgravity culture group had a lower mineralised density than the static 
group but this was also observed in the dynamic group suggesting here that the increased 
nutrient diffusion resulted in decreased osteogenic differentiation and therefore decreased 
mineralisation rather than the microgravity. 
Through analysis of the ratio of COL14A1 to COL12A1 it was established that the microgravity 
group had the least developed ECM due to the highest ratio. This was established through 
the roles collagen XII and XIV play during development. Collagen XIV, a FACIT collagen 
typically found in embryonic tissue is replaced by collagen XII as the tissue matures (Ansorge 
et al., 2009). These collagens were not investigated for hydrostatic pressure but in tensile 
stimulation an interesting trend occurred. At the gene level it appeared that the increase in 
cyclic stimulation resulted in a more immature construct with the 10% strain group having 
the highest expression of COL14A1 and lowest expression of COL12A1. This did not align with 
the more developed structural observations seen for the 10% strain group (diameter and 
alignment) but did support the mechanical properties seen.  
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7.1. Conclusion and Future Work 
Mechanical stimulation is consistently used to drivethe development of tissue engineered 
structures towards their native counterparts. From the present studies it is apparent that the 
type and variation of mechanical stimulation applied will have differing effects on the cells 
cultured within. For example microgravity appears to inhibit ECM development, as 
hypothesised in this study indicating longer preservation of the MSCs and delayed 
differentiation. Mapping the differentiation through the collagen profile is possible but does 
not appear to be as straight forward as initially anticipated.. If more studies investigate the 
complete composition of collagen a greater understating of how and why the collagens are 
synthesised in tissue engineered constructs will be developed. The profile of collagen is not 
a one dimensional measurement but appears to be dynamic and to vary with time and 
loading. Whilst the collagen profiles can be used to indicate the differentiation route taken 
by the cells it may be better used to indicate the developmental stage of the tissue.  
From the work presented it appears that the mechanical stimulation applied has a greater 
effect on the structural development of the collagen, with high levels of tensile strain 
resulting in thicker and more aligned collagen fibrils. The lack of mechanical loading, 
microgravity, appeared to reduce the ECM, resulting in a less developed tissue than that 
cultured under normal gravity. The presence of differential medias in the hydrostatic 
pressure study appeared to override the role of mechanical stimulation, resulting in 
consistent collagen production regardless of the pressure applied. However, the mineralised 
deposits that formed in the osteogenic group did appear to be driven by the hydrostatic 
pressure regimen. It therefore appears that differentiation medias will drive the production 
of specific collagens but without mechanical stimulation these collagens will not be 
incorporated into the ECM in an appropriate way.       
Future work with these studies should include more time point analysis. It is apparent that 
the collagen profile is continually changing but how this change progressed over time was 
not discovered. A larger protein and gene profile shown through proteomic analysis and RNA 
sequencing may indicate further collagens and other cellular and ECM components, 
therefore identifying ECM development missed during the present study. Combining these 
advanced analytical techniques with multiple time points may more clearly identify how the 

















8.1. Appendix A – Histology reagent recipes  
Solutions for stains were generated using the following recipes: 
Alcian blue solution: 
• 1 g Alcian Blue 8GX  
• 3% Acetic acid solution 
o 3 ml Glacial acetic acid 
o 97 ml distilled water 
• Mix well and adjust pH to 2.5 with acetic acid 
Alizarin red solution: 
• 2 g Alizarin Red S  
• 100 ml Distilled water 
• Mix well and adjust pH to 4.1-4.3 with 10% ammonium hydroxide. 
Mayer’s Haematoxylin: 
• 50 g Aluminium ammonium sulphate 
• 5 g Haematoxylin  
• 10 ml Ethanol 
• 1 g Sodium iodate 
• 20 ml Glacial acetic acid 
• 300 ml Glycerol 
• 700 ml Distilled water 
• Dissolve the aluminium ammonium sulphate in 250 ml of distilled water on 
a heated stirrer, add remaining distilled water and leave to cool. Dissolve the 
haematoxylin in the ethanol and add solution to dissolved aluminium 
ammonium sulphate. Add the remaining components. Mix well. 
Eosin: 
• 100 ml 1% Eosin Y 
o 1 g Eosin Y 
o 100 ml Distilled water 
• 10 ml 1% Aqueous phloxine 





o 100 ml Distilled water 
• 775 ml 95% Ethanol 
• 4 ml Glacial acetic acid 
0.3% Acid Alcohol: 
• 700 ml Ethanol 
• 300 ml Distilled water 
• 3 ml Hydrochloric acid  
Weigert’s Haematoxylin: 
• Stock solution A 
o 1 g Haematoxylin 
o 95% Ethanol 
• Stock solution B 
o 4 ml of 29% Ferric chloride 
§ 2.9 g Ferric chloride 
§ 10 ml Distilled water 
o 95 ml distilled water 
o 1 ml Hydrochloric acid 
• Mix equal parts stock solution A and B. 
Picrosirius red: 
• 0.5 g Direct Red 80 
• 500 ml of 1.3% Picric acid solution  
Acidified water: 
• 5 ml Glacial acetic acid 






8.2. Appendix B – Designed Primer Parameters  
Table 8.1. Table of primers used and their parameters. 
Gene Sequence CG% Melt Temp (°C) Nucleotides 
COL1A1 
(FWD) 
CGGCTCCTGCTCCTCTTAG 63 60.2 141-159 of 6728 
COL1A1 
(RVS) 
CACACGTCTCGGTCATGGTA 55 60.6 258-277 of 6728 
COL2A1 
(FWD) 
CCAGATTGAGAGCATCCGC 58 61.9 3585-3603 of 4257 
COL2A1 
(RVS) 
CCAGTAGTCTCCACTCTTCCAC 55 57.9 3669-3690 of 4257 
COL3A1 
(FWD) 
GGGTGAGAAAGGTGAAGGAG 55 58.7 2049-2068 of 3234 
COL3A1 
(RVS) 
CATTACTACCAGGAGGACCAG 52 56.3 2201-2221 of 3234 
COL10A1 
(FWD) 
GCAACTAAGGGCCTCAATGG 55 61.9 1537-1556 of 3306 
COL10A1 
(RVS) 
CTCAGGCATGACTGCTTGAC 55 59.6 1646-1665 of 3306 
COL11A1 
(FWD) 
AATGGAGCTGATGGACCACA 50 61.5 3858-3877 of 6158 
COL11A1 
(RVS) 
TCCTTTGGGACCGCCTAC 61 61 3972-3989 of 6158 
COL12A1 
(FWD) 
TTTAGTTAGCACAGCGGGCA 50 61.8 2538-2557 of 3135 
COL12A1 
(RVS) 
CGCTCGAAATACACAGCAGC 55 62 2605-2624 of 3135 
GAPDH 
(FWD) 
ATGGGGAAGGTGAAGGTCG 58 62.2 317-335 of 3855 
GAPDH 
(RVS) 
TAAAAGCAGCCCTGGTGACC 55 62.4 1999-2018 of 3855 
YWHAZ 
(FWD) 












8.3. Appendix C – Analysis of Primer Efficiencies and 
Melt Peaks  
Primer efficiency was tested on hMSCs before use in experiments. cDNA was serially diluted 
between 0.3125 and 5 ng. The Ct values were plotted against the log value for the sample 
concentration and the efficiency curve calculated. Fig.8.1B shows the representative 
efficiency curve for COL12A1 which generated a efficiency of 97.04%. Fig.8.1C shows the 






Figure 8.1. Example of primer efficiency calculation,(A) table shows extracted data for hMSC 
RNA and subsequent calculations, (B) graph shows scatter plot of the average Ct values vs 
the log concentration of the template to determine the linear equation. Efficiency for 
COL12A1 found to be 97.04%. (C) melt curve generated to show amplification of single PCR 
product. 
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8.4. Appendix D – Determination of House Keeper 
Genes  
House keeper genes were determined using the GeNorm algorithm (Vandesompele et al., 
2002) for each experiment (tensile, hydrostatic and microgravity), utilising optimisation 
samples from each condition. A range of stable hMSC genes were trialled including GAPDH, 
GUSB, HPRT1, TBP and YWHAZ. The GeNorm results for the tensile condition is shown in 
Fig.8.2 with GAPDH and YWHAZ found to be the most stable, YWHAZ was taken forward. 
Figure 8.2. Graphical representation of GeNorm calculation highlighting he most stable 































8.5. Appendix E – CNA35 reagent recipes  
100 ml Binding buffer – 50 mM NaH2Po4 
               300 mM NaCl 
               10 mM imidazole 
35 ml wash buffer –       50 mM NaH2PO4 
               300 mM NaCl 
               20 mM imidazole 
35 ml elution buffer –    50 mM NaH2PO4 
               300 mM NaCl 





8.6. Appendix F – CNA35 image acquisition  
 







8.7. Appendix G – μCT Analysis Macro for Hydrogel 
Mineralisation  
Table 8.2. Table of macro used to determine hydrogel mineralisation. 
Step 1: Filtering  
Mode Median (2D space) 
Kernel Round 
Radius 4 
Step 2: Thresholding (3D space)  
Mode Automatic (Otsu method) 
Background Dark 
Lower grey threshold 35 
Upper grey threshold  255 
Step 3: Morphological operations  
Type Erosion (2D space) 
Kernel Round 
Radius 8 
Apply to Image 
Step 3: Despeckle  
Type Sweep (2D space) 
Remove All except the largest object 
Apply to Image 
Step 4: Despeckle  
Type Sweep (3D space) 
Remove All except the largest object 





Step 5: Morphological operations  
Type Dilation (3D space) 
Kernel Round 
Radius 8 
Apply to Image 
Step 6: Despeckle  
Type Remove pores (2D space) 
Detected by By Image borders 
Apply to Image 
Step 7: Morphological operations  
Type Closing (3D space) 
Kernel Round 
Radius 3 
Apply to Image 
Step 8: Bitwise operations  
 <Regions of interest> = COPY<Image> 
Step 9: Reload image  
Step 10: Thresholding  
Mode Global 
Lower grey threshold 90 
Upper grey threshold 255 
Step 11: Bitwise operations  
 <Image>=<Image>AND<Region of 
Interest> 





File format bmp 
Step 13: Save bitmaps  
 <Images>=COPY<Clipboard> 
Step 14: 3D analysis  
 Abbreviations Unit 
Tissue volume TV μm3 
Bone volume BV μm3 
Percentage bone volume BV/TV % 
Tissue surface TS μm2 
Bone surface BS μm2 
Intersection surface i.S μm2 
Bone surface / volume ratio BS/BV 1/ μm 
Bone surface density BS/TV 1/ μm 
Trabecular pattern factor Tb.Pf 1/ μm 
Centroid (x) Crd.X μm 
Centroid (y) Crd.Y μm 
Centroid (z) Crd.Z μm 
Trabecular thickness Tb.Th μm 
Trabecular number Tb.N 1/ μm 
Trabecular separation Tb.Sp μm 
Number of objects Obj.N  
Number of closed pores Po.N(cl)  
Volume of closed pores Po.V(cl) μm3 
Surface of closed pores Po.S(cl) μm2 





Volume of open pore space Po.V(op) μm3 
Open porosity (percent) Po(op) % 
Total volume of pore space Po.V(tot) μm3 
Total porosity (percent) Po(tot) % 
Euler number Eu.N  
Connectivity Conn  





8.8. Appendix H – μCT Analysis Macro for Hydrogel 
Density  
Table 8.3. Table of macro used to determine hydrogel density. 
Step 1: Filtering  
Mode Median (2D space) 
Kernel Round 
Radius 4 
Step 2: thresholding (3D space)  
Mode Automatic (Otsu method) 
Background Dark 
Lower grey threshold 19 
Upper grey threshold  255 
Step 3: Morphological operations  
Type Erosion (2D space) 
Kernel Round 
Radius 8 
Apply to Image  
Step 4: Despeckle  
Type Sweep (2D space) 
Remove All except the largest object 
Apply to Image 
Step 5: Morphological operations  







Apply to Image 
Step 6: Despeckle  
Type Remove pores (2D space) 
Detected by By image borders 
Apply to Image 
Step 7: Morphological operations  
Type Closing (3D space) 
Kernel Round 
Radius 3 
Apply to Image 
Step 8: Bitwise operations  
 <Region of Interest>=COPY<Image> 
Step 9: Reload Image  
Step 10: Bitwise operations  
 <Clipboard>=COPY<Image> 
Step 12: Thresholding  
Mode Global 
Lower grey threshold 45 
Upper grey threshold 255 
Step 13: Bitwise operations  
 <region of interest>=COPY<Image> 
Step 14: Bitwise operations  
 <Image>=SWAP<Clipboard> 







Step 16: save bitmaps  
File format bmp 
Step 17: 3D analysis  
Mean density  
Standard deviation  
Standard error or mean  
95% confidence limit (minimum)  





8.9. Appendix I – Original Picrosirius red images for 
hydrostatic pressure study  
Figure 8.4. Original Picrosirius red images of microtissuescultured in basic, chondrogenic, 
osteogenic media following 14-day period hydrostatic pressure stimulation at 100 kPa, 200 
kPa or 300 kPa. Representative images were taken with 4x objective, n=3 repeats. Scale bar 































ACKERS, I. & MALGOR, R. 2018. Interrelationship of canonical and non-canonical Wnt signalling pathways in 
chronic metabolic diseases. Diab Vasc Dis Res, 15, 3-13. 
ADAMOWICZ, J., POKRYWCZYNSKA, M., VAN BREDA, S. V., KLOSKOWSKI, T. & DREWA, T. 2017. Concise Review: 
Tissue Engineering of Urinary Bladder; We Still Have a Long Way to Go? Stem Cells Transl Med, 6, 
2033-2043. 
AFOKE, N. Y., BYERS, P. D. & HUTTON, W. C. 1987. Contact pressures in the human hip joint. J Bone Joint Surg 
Br, 69, 536-41. 
AFSHINNEKOO, E., SCOTT, R. T., MACKAY, M. J., PARISET, E., CEKANAVICIUTE, E., BARKER, R., GILROY, S., 
HASSANE, D., SMITH, S. M., ZWART, S. R., NELMAN-GONZALEZ, M., CRUCIAN, B. E., PONOMAREV, S. 
A., ORLOV, O. I., SHIBA, D., MURATANI, M., YAMAMOTO, M., RICHARDS, S. E., VAISHAMPAYAN, P. A., 
MEYDAN, C., FOOX, J., MYRRHE, J., ISTASSE, E., SINGH, N., VENKATESWARAN, K., KEUNE, J. A., RAY, H. 
E., BASNER, M., MILLER, J., VITATERNA, M. H., TAYLOR, D. M., WALLACE, D., RUBINS, K., BAILEY, S. M., 
GRABHAM, P., COSTES, S. V., MASON, C. E. & BEHESHTI, A. 2020. Fundamental Biological Features of 
Spaceflight: Advancing the Field to Enable Deep-Space Exploration. Cell, 183, 1162-1184. 
AGARWAL, P., ZWOLANEK, D., KEENE, D. R., SCHULZ, J. N., BLUMBACH, K., HEINEGARD, D., ZAUCKE, F., 
PAULSSON, M., KRIEG, T., KOCH, M. & ECKES, B. 2012. Collagen XII and XIV, new partners of cartilage 
oligomeric matrix protein in the skin extracellular matrix suprastructure. J Biol Chem, 287, 22549-59. 
AHMADZADEH, H., FREEDMAN, B. R., CONNIZZO, B. K., SOSLOWSKY, L. J. & SHENOY, V. B. 2015. 
Micromechanical poroelastic finite element and shear-lag models of tendon predict large strain 
dependent Poisson's ratios and fluid expulsion under tensile loading. Acta Biomater, 22, 83-91. 
ALDRICH, S. 2020. 3D Bioprinting: Bioink Selection Guide [Online]. www.sigmaaldrich.com. Available: 
https://www.sigmaaldrich.com/technical-documents/articles/materials-science/3d-bioprinting-
bioinks.html#:~:text=While%20a%20wide%20variety%20of,based%20materials%20(Table%201). 
[Accessed 27/08/20 2020]. 
ALENGHAT, F. J. & INGBER, D. E. 2002. Mechanotransduction: all signals point to cytoskeleton, matrix, and 
integrins. Sci STKE, 2002, pe6. 
ALEXOPOULOS, L. G., YOUN, I., BONALDO, P. & GUILAK, F. 2009. Developmental and osteoarthritic changes in 
Col6a1-knockout mice: biomechanics of type VI collagen in the cartilage pericellular matrix. Arthritis 
Rheum, 60, 771-9. 
ALMEIDA, H. V., ESWARAMOORTHY, R., CUNNIFFE, G. M., BUCKLEY, C. T., O'BRIEN, F. J. & KELLY, D. J. 2016. 
Fibrin hydrogels functionalized with cartilage extracellular matrix and incorporating freshly isolated 
stromal cells as an injectable for cartilage regeneration. Acta Biomater, 36, 55-62. 
ALMELKAR, S., PATWARDHAN, A., DIVATE, S., AGRAWAL, N., BHONDE, R. & CHAUKAR, A. 2014. Fibrin matrix 
supports endothelial cell adhesion and migration in culture. OA Biology, 2, 5. 
ALTMAN, G. H., HORAN, R. L., MARTIN, I., FARHADI, J., STARK, P. R., VOLLOCH, V., RICHMOND, J. C., VUNJAK-
NOVAKOVIC, G. & KAPLAN, D. L. 2002. Cell differentiation by mechanical stress. FASEB J, 16, 270-2. 
ALWOOD, J. S., RONCA, A. E., MAINS, R. C., SHELHAMER, M. J., SMITH, J. D. & GOODWIN, T. J. 2017. From the 
bench to exploration medicine: NASA life sciences translational research for human exploration and 
habitation missions. NPJ Microgravity, 3, 5. 
AMENTA, P. S., SCIVOLETTI, N. A., NEWMAN, M. D., SCIANCALEPORE, J. P., LI, D. & MYERS, J. C. 2005. 
Proteoglycan-collagen XV in human tissues is seen linking banded collagen fibers subjacent to the 
basement membrane. J Histochem Cytochem, 53, 165-76. 
AN, Y. H. & MARTIN, K. L. 2003. Handbook of histology methods for bone and cartilage, Springer. 
ANGELE, P., YOO, J. U., SMITH, C., MANSOUR, J., JEPSEN, K. J., NERLICH, M. & JOHNSTONE, B. 2003. Cyclic 
hydrostatic pressure enhances the chondrogenic phenotype of human mesenchymal progenitor cells 
differentiated in vitro. J Orthop Res, 21, 451-7. 
ANSORGE, H. L., MENG, X., ZHANG, G., VEIT, G., SUN, M., KLEMENT, J. F., BEASON, D. P., SOSLOWSKY, L. J., 
KOCH, M. & BIRK, D. E. 2009. Type XIV Collagen Regulates Fibrillogenesis: PREMATURE COLLAGEN 
FIBRIL GROWTH AND TISSUE DYSFUNCTION IN NULL MICE. J Biol Chem, 284, 8427-38. 
ANTOINE, E. E., VLACHOS, P. P. & RYLANDER, M. N. 2014. Review of collagen I hydrogels for bioengineered 
tissue microenvironments: characterization of mechanics, structure, and transport. Tissue Eng Part B 
Rev, 20, 683-96. 
ANTTINEN, H., TUDERMAN, L., OIKARINEN, A. & KIVIRIKKO, K. I. 1977. Intracellular enzymes of collagen 
biosynthesis in human platelets. Blood, 50, 29-37. 
ARAI, F., MIYAMOTO, T., OHNEDA, O., INADA, T., SUDO, T., BRASEL, K., MIYATA, T., ANDERSON, D. M. & SUDA, 
T. 1999. Commitment and differentiation of osteoclast precursor cells by the sequential expression of 
c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med, 190, 1741-54. 
ARCHER, C. & RALPHS, J. 2010. Regenerative medicine and biomaterials for the repair of connective tissues, 
Elsevier. 
ARITA, N. A., PELAEZ, D. & CHEUNG, H. S. 2011. Activation of the extracellular signal-regulated kinases 1 and 2 
(ERK1/2) is needed for the TGFbeta-induced chondrogenic and osteogenic differentiation of 





ARMIENTO, A. R., ALINI, M. & STODDART, M. J. 2019. Articular fibrocartilage - Why does hyaline cartilage fail to 
repair? Adv Drug Deliv Rev, 146, 289-305. 
ARNOCZKY, S. P., TIAN, T., LAVAGNINO, M., GARDNER, K., SCHULER, P. & MORSE, P. 2002. Activation of stress-
activated protein kinases (SAPK) in tendon cells following cyclic strain: the effects of strain frequency, 
strain magnitude, and cytosolic calcium. J Orthop Res, 20, 947-52. 
ASADA, N., SATO, M. & KATAYAMA, Y. 2015. Communication of bone cells with hematopoiesis, immunity and 
energy metabolism. Bonekey Rep, 4, 748. 
ASLAN, H., KIMELMAN-BLEICH, N., PELLED, G. & GAZIT, D. 2008. Molecular targets for tendon neoformation. J 
Clin Invest, 118, 439-44. 
ASPBERG, A. 2016. Cartilage Proteoglycans. In: GRÄSSEL, S. & ASZÓDI, A. (eds.) Cartilage: Volume 1: Physiology 
and Development. Cham: Springer International Publishing. 
ATALA, A., BAUER, S. B., SOKER, S., YOO, J. J. & RETIK, A. B. 2006. Tissue-engineered autologous bladders for 
patients needing cystoplasty. Lancet, 367, 1241-6. 
ATKINSON, F., EVANS, R., GUEST, J. E., BAVIN, E. P., CACADOR, D., HOLLAND, C. & GUEST, D. J. 2020. Cyclical 
strain improves artificial equine tendon constructs in vitro. J Tissue Eng Regen Med. 
AUGST, A. D., KONG, H. J. & MOONEY, D. J. 2006. Alginate hydrogels as biomaterials. Macromol Biosci, 6, 623-
33. 
AWAD, H. A., BUTLER, D. L., BOIVIN, G. P., SMITH, F. N., MALAVIYA, P., HUIBREGTSE, B. & CAPLAN, A. I. 1999. 
Autologous mesenchymal stem cell-mediated repair of tendon. Tissue Eng, 5, 267-77. 
BACHINGER, H. P. 1987. The influence of peptidyl-prolyl cis-trans isomerase on the in vitro folding of type III 
collagen. J Biol Chem, 262, 17144-8. 
BACHINGER, H. P., BRUCKNER, P., TIMPL, R. & ENGEL, J. 1978. The role of cis-trans isomerization of peptide 
bonds in the coil leads to and comes from triple helix conversion of collagen. Eur J Biochem, 90, 605-
13. 
BACHINGER, H. P., BRUCKNER, P., TIMPL, R., PROCKOP, D. J. & ENGEL, J. 1980. Folding mechanism of the triple 
helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond 
isomerization. Eur J Biochem, 106, 619-32. 
BAGNANINCHI, P. O., YANG, Y., EL HAJ, A. J. & MAFFULLI, N. 2007. Tissue engineering for tendon repair. Br J 
Sports Med, 41, e10; discussion e10. 
BAILEY, A. J. 2001. Molecular mechanisms of ageing in connective tissues. Mech Ageing Dev, 122, 735-55. 
BAILEY, A. J., WOTTON, S. F., SIMS, T. J. & THOMPSON, P. W. 1993. Biochemical changes in the collagen of 
human osteoporotic bone matrix. Connect Tissue Res, 29, 119-32. 
BAKSH, D., SONG, L. & TUAN, R. S. 2004. Adult mesenchymal stem cells: characterization, differentiation, and 
application in cell and gene therapy. J Cell Mol Med, 8, 301-16. 
BALDOCK, C., SHERRATT, M. J., SHUTTLEWORTH, C. A. & KIELTY, C. M. 2003. The supramolecular organization of 
collagen VI microfibrils. J Mol Biol, 330, 297-307. 
BANFI, A., MURAGLIA, A., DOZIN, B., MASTROGIACOMO, M., CANCEDDA, R. & QUARTO, R. 2000. Proliferation 
kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: 
Implications for their use in cell therapy. Exp Hematol, 28, 707-15. 
BANIK, B. L. & BROWN, J. L. 2020. 3D-Printed Bioreactor Enhances Potential for Tendon Tissue Engineering. 
Regenerative Engineering and Translational Medicine, 1-10. 
BANYARD, J., BAO, L. & ZETTER, B. R. 2003. Type XXIII collagen, a new transmembrane collagen identified in 
metastatic tumor cells. J Biol Chem, 278, 20989-94. 
BARBER, J. G., HANDORF, A. M., ALLEE, T. J. & LI, W. J. 2013. Braided nanofibrous scaffold for tendon and 
ligament tissue engineering. Tissue Eng Part A, 19, 1265-74. 
BARD, F., CASANO, L., MALLABIABARRENA, A., WALLACE, E., SAITO, K., KITAYAMA, H., GUIZZUNTI, G., HU, Y., 
WENDLER, F., DASGUPTA, R., PERRIMON, N. & MALHOTRA, V. 2006. Functional genomics reveals 
genes involved in protein secretion and Golgi organization. Nature, 439, 604-7. 
BARD, F. & MALHOTRA, V. 2006. The formation of TGN-to-plasma-membrane transport carriers. Annu Rev Cell 
Dev Biol, 22, 439-55. 
BARNARD, K., LIGHT, N. D., SIMS, T. J. & BAILEY, A. J. 1987. Chemistry of the collagen cross-links. Origin and 
partial characterization of a putative mature cross-link of collagen. Biochem J, 244, 303-9. 
BARON, R., NEFF, L., LOUVARD, D. & COURTOY, P. J. 1985. Cell-mediated extracellular acidification and bone 
resorption: evidence for a low pH in resorbing lacunae and localization of a 100-kD lysosomal 
membrane protein at the osteoclast ruffled border. J Cell Biol, 101, 2210-22. 
BATES, D., MÄCHLER, M., BOLKER, B. & WALKER, S. 2015. Fitting Linear Mixed-Effects Models Using lme4. 2015, 
67, 48. 
BATTAGLIA, T. C., CLARK, R. T., CHHABRA, A., GASCHEN, V., HUNZIKER, E. B. & MIKIC, B. 2003. Ultrastructural 
determinants of murine achilles tendon strength during healing. Connect Tissue Res, 44, 218-24. 
BAUD, C. A. 1968. Submicroscopic structure and functional aspects of the osteocyte. Clin Orthop Relat Res, 56, 
227-36. 
BEGLEY, C. M. & KLEIS, S. J. 2000. The fluid dynamic and shear environment in the NASA/JSC rotating-wall 





BELLA, J. 2016. Collagen structure: new tricks from a very old dog. Biochem J, 473, 1001-25. 
BELLA, J. & HULMES, D. J. 2017. Fibrillar collagens. Fibrous proteins: structures and mechanisms. Springer. 
BEN-ARYE, T. & LEVENBERG, S. 2019. Tissue engineering for clean meat production. Frontiers in Sustainable 
Food Systems, 3, 46. 
BENAVIDES DAMM, T., WALTHER, I., WÜEST, S. L., SEKLER, J. & EGLI, M. 2014. Cell cultivation under different 
gravitational loads using a novel random positioning incubator. Biotechnology and bioengineering, 
111, 1180-1190. 
BENHARDT, H. A. & COSGRIFF-HERNANDEZ, E. M. 2009. The Role of Mechanical Loading in Ligament Tissue 
Engineering. Tissue Engineering Part B-Reviews, 15, 467-475. 
BENJAMIN, M. & RALPHS, J. 2004. Biology of fibrocartilage cells. International review of cytology, 233, 1-46. 
BENJAMIN, M. & RALPHS, J. R. 1998. Fibrocartilage in tendons and ligaments--an adaptation to compressive 
load. J Anat, 193 ( Pt 4), 481-94. 
BERNAL, P. N., DELROT, P., LOTERIE, D., LI, Y., MALDA, J., MOSER, C. & LEVATO, R. 2019. Volumetric Bioprinting 
of Complex Living-Tissue Constructs within Seconds. Adv Mater, 31, e1904209. 
BETHUNE, R., BULL, A. M., DICKINSON, R. J. & EMERY, R. J. 2007. Removal of calcific deposits of the rotator cuff 
tendon using an intra-articular ultrasound probe. Knee Surg Sports Traumatol Arthrosc, 15, 289-91. 
BEZNOUSSENKO, G. V., PARASHURAMAN, S., RIZZO, R., POLISHCHUK, R., MARTELLA, O., DI GIANDOMENICO, D., 
FUSELLA, A., SPAAR, A., SALLESE, M., CAPESTRANO, M. G., PAVELKA, M., VOS, M. R., RIKERS, Y. G., 
HELMS, V., MIRONOV, A. A. & LUINI, A. 2014. Transport of soluble proteins through the Golgi occurs 
by diffusion via continuities across cisternae. Elife, 3. 
BIAN, W., JUHAS, M., PFEILER, T. W. & BURSAC, N. 2012. Local tissue geometry determines contractile force 
generation of engineered muscle networks. Tissue Eng Part A, 18, 957-67. 
BIAN, W., LIAU, B., BADIE, N. & BURSAC, N. 2009. Mesoscopic hydrogel molding to control the 3D geometry of 
bioartificial muscle tissues. Nat Protoc, 4, 1522-34. 
BIDANSET, D. J., GUIDRY, C., ROSENBERG, L. C., CHOI, H. U., TIMPL, R. & HOOK, M. 1992. Binding of the 
proteoglycan decorin to collagen type VI. J Biol Chem, 267, 5250-6. 
BIEWENER, A. A. 1998. Muscle-tendon stresses and elastic energy storage during locomotion in the horse. 
Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 120, 73-87. 
BILEZIKIAN, J. P., RAISZ, L. G. & MARTIN, T. J. 2008. Principles of bone biology, Academic press. 
BIRK, D. E. 2001. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. 
Micron, 32, 223-37. 
BIRK, D. E. & BRUCKNER, P. 2005. Collagen suprastructures. Collagen. Springer. 
BIRK, D. E. & BRÜCKNER, P. 2011. Collagens, suprastructures, and collagen fibril assembly. The extracellular 
matrix: an overview. Springer. 
BIRK, D. E. & TRELSTAD, R. L. 1986. Extracellular compartments in tendon morphogenesis: collagen fibril, 
bundle, and macroaggregate formation. J Cell Biol, 103, 231-40. 
BIRK, D. E., ZYCBAND, E. I., WINKELMANN, D. A. & TRELSTAD, R. L. 1989. Collagen fibrillogenesis in situ: fibril 
segments are intermediates in matrix assembly. Proc Natl Acad Sci U S A, 86, 4549-53. 
BLABER, E. A., FINKELSTEIN, H., DVOROCHKIN, N., SATO, K. Y., YOUSUF, R., BURNS, B. P., GLOBUS, R. K. & 
ALMEIDA, E. A. 2015. Microgravity Reduces the Differentiation and Regenerative Potential of 
Embryonic Stem Cells. Stem Cells Dev, 24, 2605-21. 
BLAIR, H. C., TEITELBAUM, S. L., GHISELLI, R. & GLUCK, S. 1989. Osteoclastic bone resorption by a polarized 
vacuolar proton pump. Science, 245, 855-7. 
BLUMBACH, K., BASTIAANSEN-JENNISKENS, Y. M., DEGROOT, J., PAULSSON, M., VAN OSCH, G. J. & ZAUCKE, F. 
2009. Combined role of type IX collagen and cartilage oligomeric matrix protein in cartilage matrix 
assembly: cartilage oligomeric matrix protein counteracts type IX collagen-induced limitation of 
cartilage collagen fibril growth in mouse chondrocyte cultures. Arthritis Rheum, 60, 3676-85. 
BOETTCHER, K., KIENLE, S., NACHTSHEIM, J., BURGKART, R., HUGEL, T. & LIELEG, O. 2016. The structure and 
mechanical properties of articular cartilage are highly resilient towards transient dehydration. Acta 
Biomater, 29, 180-187. 
BOHANDY, J., KIM, B. & ADRIAN, F. 1986. Metal deposition from a supported metal film using an excimer laser. 
Journal of Applied Physics, 60, 1538-1539. 
BONEWALD, L. F. & JOHNSON, M. L. 2008. Osteocytes, mechanosensing and Wnt signaling. Bone, 42, 606-15. 
BONFANTI, L., MIRONOV, A. A., JR., MARTINEZ-MENARGUEZ, J. A., MARTELLA, O., FUSELLA, A., BALDASSARRE, 
M., BUCCIONE, R., GEUZE, H. J., MIRONOV, A. A. & LUINI, A. 1998. Procollagen traverses the Golgi 
stack without leaving the lumen of cisternae: evidence for cisternal maturation. Cell, 95, 993-1003. 
BOOS, N., NERLICH, A. G., WIEST, I., VON DER MARK, K. & AEBI, M. 1997. Immunolocalization of type X collagen 
in human lumbar intervertebral discs during ageing and degeneration. Histochem Cell Biol, 108, 471-
80. 
BOOT-HANDFORD, R. P., TUCKWELL, D. S., PLUMB, D. A., ROCK, C. F. & POULSOM, R. 2003. A novel and highly 
conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular 






BORSCHEL, G. H., HUANG, Y. C., CALVE, S., ARRUDA, E. M., LYNCH, J. B., DOW, D. E., KUZON, W. M., DENNIS, R. 
G. & BROWN, D. L. 2005. Tissue engineering of recellularized small-diameter vascular grafts. Tissue 
Eng, 11, 778-86. 
BOTH, S. K., VAN APELDOORN, A. A., JUKES, J. M., ENGLUND, M. C., HYLLNER, J., VAN BLITTERSWIJK, C. A. & DE 
BOER, J. 2011. Differential bone-forming capacity of osteogenic cells from either embryonic stem cells 
or bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med, 5, 180-90. 
BOURHIS, J. M., MARIANO, N., ZHAO, Y., HARLOS, K., EXPOSITO, J. Y., JONES, E. Y., MOALI, C., AGHAJARI, N. & 
HULMES, D. J. 2012. Structural basis of fibrillar collagen trimerization and related genetic disorders. 
Nat Struct Mol Biol, 19, 1031-6. 
BOYCE, B. F. & XING, L. 2008. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem 
Biophys, 473, 139-46. 
BRADAMANTE, S., RIVERO, D., BARENGHI, L., BALSAMO, M., MINARDI, S. P., VITALI, F. & CAVALIERI, D. 2018. 
SCD–stem cell differentiation toward osteoblast onboard the International Space Station. 
Microgravity Science and Technology, 30, 713-729. 
BRANDT, L., SCHUBERT, S., SCHEIBE, P., BREHM, W., FRANZEN, J., GROSS, C. & BURK, J. 2018. Tenogenic 
Properties of Mesenchymal Progenitor Cells Are Compromised in an Inflammatory Environment. Int J 
Mol Sci, 19. 
BREIDENBACH, A. P., DYMENT, N. A., LU, Y. H., RAO, M., SHEARN, J. T., ROWE, D. W., KADLER, K. E. & BUTLER, D. 
L. 2015. Fibrin Gels Exhibit Improved Biological, Structural, and Mechanical Properties Compared with 
Collagen Gels in Cell-Based Tendon Tissue-Engineered Constructs. Tissue Engineering Part A, 21, 438-
450. 
BRETSCHER, L. E., JENKINS, C. L., TAYLOR, K. M., DERIDER, M. L. & RAINES, R. T. 2001. Conformational stability of 
collagen relies on a stereoelectronic effect. J Am Chem Soc, 123, 777-8. 
BRITTBERG, M., LINDAHL, A., NILSSON, A., OHLSSON, C., ISAKSSON, O. & PETERSON, L. 1994. Treatment of deep 
cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med, 331, 889-95. 
BROWN, A. C. & BARKER, T. H. 2014. Fibrin-based biomaterials: modulation of macroscopic properties through 
rational design at the molecular level. Acta Biomater, 10, 1502-14. 
BROWN, J. C., MANN, K., WIEDEMANN, H. & TIMPL, R. 1993. Structure and binding properties of collagen type 
XIV isolated from human placenta. J Cell Biol, 120, 557-67. 
BROWNING, J. A., WALKER, R. E., HALL, A. C. & WILKINS, R. J. 1999. Modulation of Na+ x H+ exchange by 
hydrostatic pressure in isolated bovine articular chondrocytes. Acta Physiol Scand, 166, 39-45. 
BRUCKNER, P. & EIKENBERRY, E. F. 1984. Formation of the triple helix of type I procollagen in cellulo. 
Temperature-dependent kinetics support a model based on cis in equilibrium trans isomerization of 
peptide bonds. Eur J Biochem, 140, 391-5. 
BRUKER-MIKRO-CT, C. 2010. Bone mineral density (BMD) and tissue mineral density (TMD) calibration and 
measurement by micro-CT using Bruker-MicroCT. Bruker Method Note, 1-30. 
BUCKLEY, M. R., EVANS, E. B., MATUSZEWSKI, P. E., CHEN, Y. L., SATCHEL, L. N., ELLIOTT, D. M., SOSLOWSKY, L. J. 
& DODGE, G. R. 2013. Distributions of types I, II and III collagen by region in the human supraspinatus 
tendon. Connect Tissue Res, 54, 374-9. 
BURDICK, J. A. & PRESTWICH, G. D. 2011. Hyaluronic acid hydrogels for biomedical applications. Adv Mater, 23, 
H41-56. 
BURK, J., PLENGE, A., BREHM, W., HELLER, S., PFEIFFER, B. & KASPER, C. 2016. Induction of Tenogenic 
Differentiation Mediated by Extracellular Tendon Matrix and Short-Term Cyclic Stretching. Stem Cells 
Int, 2016, 7342379. 
BURKE, J. F., YANNAS, I. V., QUINBY, W. C., JR., BONDOC, C. C. & JUNG, W. K. 1981. Successful use of a 
physiologically acceptable artificial skin in the treatment of extensive burn injury. Ann Surg, 194, 413-
28. 
BURRIDGE, K., FATH, K., KELLY, T., NUCKOLLS, G. & TURNER, C. 1988. Focal adhesions: transmembrane junctions 
between the extracellular matrix and the cytoskeleton. Annu Rev Cell Biol, 4, 487-525. 
BYRNE, E. M., FARRELL, E., MCMAHON, L. A., HAUGH, M. G., O'BRIEN, F. J., CAMPBELL, V. A., PRENDERGAST, P. 
J. & O'CONNELL, B. C. 2008. Gene expression by marrow stromal cells in a porous collagen-
glycosaminoglycan scaffold is affected by pore size and mechanical stimulation. J Mater Sci Mater 
Med, 19, 3455-63. 
BYRNES, J. R., DUVAL, C., WANG, Y., HANSEN, C. E., AHN, B., MOOBERRY, M. J., CLARK, M. A., JOHNSEN, J. M., 
LORD, S. T., LAM, W. A., MEIJERS, J. C., NI, H., ARIENS, R. A. & WOLBERG, A. S. 2015. Factor XIIIa-
dependent retention of red blood cells in clots is mediated by fibrin alpha-chain crosslinking. Blood, 
126, 1940-8. 
CADIGAN, K. M. & PEIFER, M. 2009. Wnt signaling from development to disease: insights from model systems. 
Cold Spring Harb Perspect Biol, 1, a002881. 
CAHILL, K. S., MCCORMICK, P. C. & LEVI, A. D. 2015. A comprehensive assessment of the risk of bone 
morphogenetic protein use in spinal fusion surgery and postoperative cancer diagnosis. J Neurosurg 
Spine, 23, 86-93. 





CALIARI, S. R., RAMIREZ, M. A. & HARLEY, B. A. 2011. The development of collagen-GAG scaffold-membrane 
composites for tendon tissue engineering. Biomaterials, 32, 8990-8. 
CALORI, G. M., TAGLIABUE, L., GALA, L., D'IMPORZANO, M., PERETTI, G. & ALBISETTI, W. 2008. Application of 
rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective 
randomised clinical study on 120 patients. Injury, 39, 1391-402. 
CALVE, S., DENNIS, R. G., KOSNIK, P. E., 2ND, BAAR, K., GROSH, K. & ARRUDA, E. M. 2004. Engineering of 
functional tendon. Tissue Eng, 10, 755-61. 
CALVERT, J. W., MARRA, K. G., COOK, L., KUMTA, P. N., DIMILLA, P. A. & WEISS, L. E. 2000. Characterization of 
osteoblast-like behavior of cultured bone marrow stromal cells on various polymer surfaces. J Biomed 
Mater Res, 52, 279-84. 
CAMERON, G. J., ALBERTS, I. L., LAING, J. H. & WESS, T. J. 2002. Structure of type I and type III heterotypic 
collagen fibrils: an X-ray diffraction study. J Struct Biol, 137, 15-22. 
CAMPBELL, J. J., BADER, D. L. & LEE, D. A. 2008. Mechanical loading modulates intracellular calcium signaling in 
human mesenchymal stem cells. J Appl Biomater Biomech, 6, 9-15. 
CAMPBELL, M. A., WINTER, A. D., ILIC, M. Z. & HANDLEY, C. J. 1996. Catabolism and loss of proteoglycans from 
cultures of bovine collateral ligament. Arch Biochem Biophys, 328, 64-72. 
CANTY, E. G. & KADLER, K. E. 2005. Procollagen trafficking, processing and fibrillogenesis. J Cell Sci, 118, 1341-
53. 
CANTY, E. G., LU, Y., MEADOWS, R. S., SHAW, M. K., HOLMES, D. F. & KADLER, K. E. 2004. Coalignment of plasma 
membrane channels and protrusions (fibripositors) specifies the parallelism of tendon. J Cell Biol, 165, 
553-63. 
CAO, D. J., ZHAI, H. L., LIU, W., CUI, L., ZHONG, B. & CAO, Y. L. 2004. [Preliminary study on in vitro tendon 
engineering using tenocytes and polyglycolic acids]. Zhonghua Wai Ke Za Zhi, 42, 110-3. 
CAO, Y., LIU, Y., LIU, W., SHAN, Q., BUONOCORE, S. D. & CUI, L. 2002. Bridging tendon defects using autologous 
tenocyte engineered tendon in a hen model. Plast Reconstr Surg, 110, 1280-9. 
CARBONE, A., CARBALLO, C., MA, R., WANG, H., DENG, X., DAHIA, C. & RODEO, S. 2016. Indian hedgehog 
signaling and the role of graft tension in tendon-to-bone healing: Evaluation in a rat ACL 
reconstruction model. J Orthop Res, 34, 641-9. 
CARLEVARO, M. F., CERMELLI, S., CANCEDDA, R. & DESCALZI CANCEDDA, F. 2000. Vascular endothelial growth 
factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role 
during endochondral bone formation. J Cell Sci, 113 ( Pt 1), 59-69. 
CARROLL, S. F., BUCKLEY, C. T. & KELLY, D. J. 2017. Cyclic Tensile Strain Can Play a Role in Directing both 
Intramembranous and Endochondral Ossification of Mesenchymal Stem Cells. Frontiers in 
Bioengineering and Biotechnology, 5. 
CARTER, W. G. 1982. Transformation-dependent alterations is glycoproteins of extracellular matrix of human 
fibroblasts. Characterization of GP250 and the collagen-like GP140. J Biol Chem, 257, 13805-15. 
CASHION, A. T., CABALLERO, M., HALEVI, A., PAPPA, A., DENNIS, R. G. & VAN AALST, J. A. 2014. Programmable 
mechanobioreactor for exploration of the effects of periodic vibratory stimulus on mesenchymal stem 
cell differentiation. Biores Open Access, 3, 19-28. 
CASSCELLS, S. W. 1990. Articular cartilage and knee joint function: Basic science and arthroscopy. Arthroscopy, 
6, 167. 
CASSELLA, J. P. & ALI, S. Y. 1992. Abnormal collagen and mineral formation in osteogenesis imperfecta. Bone 
Miner, 17, 123-8. 
CELLINK. 2021. Box X [Online]. Available: https://www.cellink.com/bioprinting/bio-x-3d-bioprinter/ [Accessed 
2021]. 
CHAMBERS, T. J. 2000. Regulation of the differentiation and function of osteoclasts. J Pathol, 192, 4-13. 
CHAN, A. S. H., COUCOUVANIS, E., TOUSEY, S., ANDERSEN, M. D. & NI, J. H. T. 2007. Improved Expansion of MSC 
Without Loss of Differentiation Potential. Available: 
https://www.rndsystems.com/resources/posters/improved-expansion-msc-without-loss-
differentiation-potential. 
CHAN, B. P. & LEONG, K. W. 2008. Scaffolding in tissue engineering: general approaches and tissue-specific 
considerations. Eur Spine J, 17 Suppl 4, 467-79. 
CHAN, D., COLE, W. G., ROGERS, J. G. & BATEMAN, J. F. 1995. Type X collagen multimer assembly in vitro is 
prevented by a Gly618 to Val mutation in the alpha 1(X) NC1 domain resulting in Schmid metaphyseal 
chondrodysplasia. J Biol Chem, 270, 4558-62. 
CHANDRARAJAN, J. 1978. Separation of type III collagen from type I collagen and pepsin by differential 
denaturation and renaturation. Biochem Biophys Res Commun, 83, 180-6. 
CHANG, J., NAKAJIMA, H. & POOLE, C. A. 1997. Structural colocalisation of type VI collagen and fibronectin in 
agarose cultured chondrocytes and isolated chondrons extracted from adult canine tibial cartilage. J 
Anat, 190 ( Pt 4), 523-32. 
CHATTERJEE, D., CHAKRABORTY, M., LEIT, M., NEFF, L., JAMSA-KELLOKUMPU, S., FUCHS, R., BARTKIEWICZ, M., 
HERNANDO, N. & BARON, R. 1992. The osteoclast proton pump differs in its pharmacology and 





CHATZIZACHARIAS, N. A., KOURAKLIS, G. P. & THEOCHARIS, S. E. 2008. Disruption of FAK signaling: a side 
mechanism in cytotoxicity. Toxicology, 245, 1-10. 
CHELLAIAH, M., KIZER, N., SILVA, M., ALVAREZ, U., KWIATKOWSKI, D. & HRUSKA, K. A. 2000. Gelsolin deficiency 
blocks podosome assembly and produces increased bone mass and strength. J Cell Biol, 148, 665-78. 
CHEN, G., DENG, C. & LI, Y. P. 2012. TGF-beta and BMP signaling in osteoblast differentiation and bone 
formation. Int J Biol Sci, 8, 272-88. 
CHEN, H. C. & HU, Y. C. 2006. Bioreactors for tissue engineering. Biotechnol Lett, 28, 1415-23. 
CHEN, J. L., YIN, Z., SHEN, W. L., CHEN, X., HENG, B. C., ZOU, X. H. & OUYANG, H. W. 2010. Efficacy of hESC-MSCs 
in knitted silk-collagen scaffold for tendon tissue engineering and their roles. Biomaterials, 31, 9438-
51. 
CHEN, P., CESCON, M., ZUCCOLOTTO, G., NOBBIO, L., COLOMBELLI, C., FILAFERRO, M., VITALE, G., FELTRI, M. L. 
& BONALDO, P. 2015. Collagen VI regulates peripheral nerve regeneration by modulating macrophage 
recruitment and polarization. Acta Neuropathol, 129, 97-113. 
CHEN, Q., SHOU, P., ZHENG, C., JIANG, M., CAO, G., YANG, Q., CAO, J., XIE, N., VELLETRI, T., ZHANG, X., XU, C., 
ZHANG, L., YANG, H., HOU, J., WANG, Y. & SHI, Y. 2016. Fate decision of mesenchymal stem cells: 
adipocytes or osteoblasts? Cell Death Differ, 23, 1128-39. 
CHEN, W., LIU, J., MANUCHEHRABADI, N., WEIR, M. D., ZHU, Z. & XU, H. H. 2013. Umbilical cord and bone 
marrow mesenchymal stem cell seeding on macroporous calcium phosphate for bone regeneration in 
rat cranial defects. Biomaterials, 34, 9917-25. 
CHEN, X. D., DUSEVICH, V., FENG, J. Q., MANOLAGAS, S. C. & JILKA, R. L. 2007. Extracellular matrix made by 
bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and 
prevents their differentiation into osteoblasts. J Bone Miner Res, 22, 1943-56. 
CHEN, Y. J., HUANG, C. H., LEE, I. C., LEE, Y. T., CHEN, M. H. & YOUNG, T. H. 2008. Effects of cyclic mechanical 
stretching on the mRNA expression of tendon/ligament-related and osteoblast-specific genes in 
human mesenchymal stem cells. Connect Tissue Res, 49, 7-14. 
CHENG, M. T., YANG, H. W., CHEN, T. H. & LEE, O. K. 2009. Isolation and characterization of multipotent stem 
cells from human cruciate ligaments. Cell Prolif, 42, 448-60. 
CHIEN, S. 2007. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am J Physiol 
Heart Circ Physiol, 292, H1209-24. 
CHIQUET, M., BIRK, D. E., BONNEMANN, C. G. & KOCH, M. 2014. Collagen XII: Protecting bone and muscle 
integrity by organizing collagen fibrils. Int J Biochem Cell Biol, 53, 51-4. 
CHIU, C. L., HECHT, V., DUONG, H., WU, B. & TAWIL, B. 2012. Permeability of three-dimensional fibrin 
constructs corresponds to fibrinogen and thrombin concentrations. Biores Open Access, 1, 34-40. 
CHRISTIANO, A. M., GREENSPAN, D. S., LEE, S. & UITTO, J. 1994a. Cloning of human type VII collagen. Complete 
primary sequence of the alpha 1(VII) chain and identification of intragenic polymorphisms. J Biol 
Chem, 269, 20256-62. 
CHRISTIANO, A. M., HOFFMAN, G. G., CHUNG-HONET, L. C., LEE, S., CHENG, W., UITTO, J. & GREENSPAN, D. S. 
1994b. Structural organization of the human type VII collagen gene (COL7A1), composed of more 
exons than any previously characterized gene. Genomics, 21, 169-79. 
CHRISTIANO, A. M., ROSENBAUM, L. M., CHUNG-HONET, L. C., PARENTE, M. G., WOODLEY, D. T., PAN, T. C., 
ZHANG, R. Z., CHU, M. L., BURGESON, R. E. & UITTO, J. 1992. The large non-collagenous domain (NC-
1) of type VII collagen is amino-terminal and chimeric. Homology to cartilage matrix protein, the type 
III domains of fibronectin and the A domains of von Willebrand factor. Hum Mol Genet, 1, 475-81. 
CHRISTIANSEN, D. L., HUANG, E. K. & SILVER, F. H. 2000. Assembly of type I collagen: fusion of fibril subunits 
and the influence of fibril diameter on mechanical properties. Matrix Biol, 19, 409-20. 
CHU, M. L., MYERS, J. C., BERNARD, M. P., DING, J. F. & RAMIREZ, F. 1982. Cloning and characterization of five 
overlapping cDNAs specific for the human pro alpha 1(I) collagen chain. Nucleic Acids Res, 10, 5925-
34. 
CHUNG, C. & BURDICK, J. A. 2008. Engineering cartilage tissue. Adv Drug Deliv Rev, 60, 243-62. 
CHUNG, H. J. & UITTO, J. 2010. Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis 
bullosa. Dermatol Clin, 28, 93-105. 
CIARDULLI, M. C., MARINO, L., LOVECCHIO, J., GIORDANO, E., FORSYTH, N. R., SELLERI, C., MAFFULLI, N. & 
PORTA, G. D. 2020. Tendon and Cytokine Marker Expression by Human Bone Marrow Mesenchymal 
Stem Cells in a Hyaluronate/Poly-Lactic-Co-Glycolic Acid (PLGA)/Fibrin Three-Dimensional (3D) 
Scaffold. Cells, 9. 
CLARKE, B. 2008. Normal bone anatomy and physiology. Clin J Am Soc Nephrol, 3 Suppl 3, S131-9. 
CLORE, J. N., COHEN, I. K. & DIEGELMANN, R. F. 1979. Quantitation of collagen types I and III during wound 
healing in rat skin. Proc Soc Exp Biol Med, 161, 337-40. 
COCHIS, A., GRAD, S., STODDART, M. J., FARE, S., ALTOMARE, L., AZZIMONTI, B., ALINI, M. & RIMONDINI, L. 
2017. Bioreactor mechanically guided 3D mesenchymal stem cell chondrogenesis using a 
biocompatible novel thermo-reversible methylcellulose-based hydrogel. Sci Rep, 7, 45018. 
COLIGE, A., LI, S. W., SIERON, A. L., NUSGENS, B. V., PROCKOP, D. J. & LAPIERE, C. M. 1997. cDNA cloning and 





metalloproteinases with binding sites for cells and other matrix components. Proc Natl Acad Sci U S A, 
94, 2374-9. 
COLIGE, A., VANDENBERGHE, I., THIRY, M., LAMBERT, C. A., VAN BEEUMEN, J., LI, S. W., PROCKOP, D. J., 
LAPIERE, C. M. & NUSGENS, B. V. 2002. Cloning and characterization of ADAMTS-14, a novel ADAMTS 
displaying high homology with ADAMTS-2 and ADAMTS-3. J Biol Chem, 277, 5756-66. 
COLOMBO, F., SAMPOGNA, G., COCOZZA, G., GURAYA, S. Y. & FORGIONE, A. 2017. Regenerative medicine: 
Clinical applications and future perspectives. J Microsc Ultrastruct, 5, 1-8. 
COLOMBO, M., BRITTINGHAM, R. J., KLEMENT, J. F., MAJSTEREK, I., BIRK, D. E., UITTO, J. & FERTALA, A. 2003. 
Procollagen VII self-assembly depends on site-specific interactions and is promoted by cleavage of the 
NC2 domain with procollagen C-proteinase. Biochemistry, 42, 11434-42. 
CONNIZZO, B. K., FREEDMAN, B. R., FRIED, J. H., SUN, M., BIRK, D. E. & SOSLOWSKY, L. J. 2015. Regulatory role 
of collagen V in establishing mechanical properties of tendons and ligaments is tissue dependent. J 
Orthop Res, 33, 882-8. 
CORREIA, C., PEREIRA, A. L., DUARTE, A. R., FRIAS, A. M., PEDRO, A. J., OLIVEIRA, J. T., SOUSA, R. A. & REIS, R. L. 
2012. Dynamic culturing of cartilage tissue: the significance of hydrostatic pressure. Tissue Eng Part A, 
18, 1979-91. 
CORREIA, V., PANADERO, J. A., RIBEIRO, C., SENCADAS, V., ROCHA, J. G., GOMEZ RIBELLES, J. L. & LANCEROS-
MENDEZ, S. 2016. Design and validation of a biomechanical bioreactor for cartilage tissue culture. 
Biomech Model Mechanobiol, 15, 471-8. 
COULSON-THOMAS, Y. M., COULSON-THOMAS, V. J., NORTON, A. L., GESTEIRA, T. F., CAVALHEIRO, R. P., 
MENEGHETTI, M. C., MARTINS, J. R., DIXON, R. A. & NADER, H. B. 2015. The identification of 
proteoglycans and glycosaminoglycans in archaeological human bones and teeth. PLoS One, 10, 
e0131105. 
CRAM, D. J. 1988. The design of molecular hosts, guests, and their complexes. Science, 240, 760-7. 
CRAPO, P. M., GILBERT, T. W. & BADYLAK, S. F. 2011. An overview of tissue and whole organ decellularization 
processes. Biomaterials, 32, 3233-43. 
CUI, L., LIU, B., LIU, G., ZHANG, W., CEN, L., SUN, J., YIN, S., LIU, W. & CAO, Y. 2007. Repair of cranial bone 
defects with adipose derived stem cells and coral scaffold in a canine model. Biomaterials, 28, 5477-
86. 
CUKIERMAN, E., PANKOV, R., STEVENS, D. R. & YAMADA, K. M. 2001. Taking cell-matrix adhesions to the third 
dimension. Science, 294, 1708-12. 
DA SILVA MEIRELLES, L., CHAGASTELLES, P. C. & NARDI, N. B. 2006. Mesenchymal stem cells reside in virtually 
all post-natal organs and tissues. Journal of cell science, 119, 2204-2213. 
DANIELSON, K. G., BARIBAULT, H., HOLMES, D. F., GRAHAM, H., KADLER, K. E. & IOZZO, R. V. 1997. Targeted 
disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol, 136, 
729-43. 
DARLING, E. M. & ATHANASIOU, K. A. 2003. Articular cartilage bioreactors and bioprocesses. Tissue Eng, 9, 9-26. 
DAVIDSON, J. M., AQUINO, A. M., WOODWARD, S. C. & WILFINGER, W. W. 1999. Sustained microgravity 
reduces intrinsic wound healing and growth factor responses in the rat. FASEB J, 13, 325-9. 
DE BARI, C., DELL'ACCIO, F., TYLZANOWSKI, P. & LUYTEN, F. P. 2001. Multipotent mesenchymal stem cells from 
adult human synovial membrane. Arthritis Rheum, 44, 1928-42. 
DE MATTEIS, M. A. & LUINI, A. 2008. Exiting the Golgi complex. Nat Rev Mol Cell Biol, 9, 273-84. 
DELANY, A. M. & HANKENSON, K. D. 2009. Thrombospondin-2 and SPARC/osteonectin are critical regulators of 
bone remodeling. J Cell Commun Signal, 3, 227-38. 
DENG, Z. L., SHARFF, K. A., TANG, N., SONG, W. X., LUO, J., LUO, X., CHEN, J., BENNETT, E., REID, R., MANNING, 
D., XUE, A., MONTAG, A. G., LUU, H. H., HAYDON, R. C. & HE, T. C. 2008. Regulation of osteogenic 
differentiation during skeletal development. Front Biosci, 13, 2001-21. 
DENIZ, P., GULER, S., CELIK, E., HOSSEINIAN, P. & AYDIN, H. M. 2020. Use of cyclic strain bioreactor for the 
upregulation of key tenocyte gene expression on Poly(glycerol-sebacate) (PGS) sheets. Materials 
Science & Engineering C-Materials for Biological Applications, 106. 
DERIDER, M. L., WILKENS, S. J., WADDELL, M. J., BRETSCHER, L. E., WEINHOLD, F., RAINES, R. T. & MARKLEY, J. L. 
2002. Collagen stability: insights from NMR spectroscopic and hybrid density functional 
computational investigations of the effect of electronegative substituents on prolyl ring 
conformations. J Am Chem Soc, 124, 2497-505. 
DIAB, M., WU, J. J. & EYRE, D. R. 1996. Collagen type IX from human cartilage: a structural profile of 
intermolecular cross-linking sites. Biochem J, 314 ( Pt 1), 327-32. 
DIAZ, L. A., RATRIE, H., 3RD, SAUNDERS, W. S., FUTAMURA, S., SQUIQUERA, H. L., ANHALT, G. J. & GIUDICE, G. J. 
1990. Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by 
bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the 
hemidesmosome. J Clin Invest, 86, 1088-94. 
DIGIROLAMO, C. M., STOKES, D., COLTER, D., PHINNEY, D. G., CLASS, R. & PROCKOP, D. J. 1999. Propagation and 
senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies 





DILOGO, I. H., PRIMAPUTRA, M. R. A., PAWITAN, J. A. & LIEM, I. K. 2017. Modified Masquelet technique using 
allogeneic umbilical cord-derived mesenchymal stem cells for infected non-union femoral shaft 
fracture with a 12 cm bone defect: A case report. Int J Surg Case Rep, 34, 11-16. 
DOANE, K. J., HOWELL, S. J. & BIRK, D. E. 1998. Identification and functional characterization of two type VI 
collagen receptors, alpha 3 beta 1 integrin and NG2, during avian corneal stromal development. Invest 
Ophthalmol Vis Sci, 39, 263-75. 
DOMINICI, M., LE BLANC, K., MUELLER, I., SLAPER-CORTENBACH, I., MARINI, F., KRAUSE, D., DEANS, R., 
KEATING, A., PROCKOP, D. & HORWITZ, E. 2006. Minimal criteria for defining multipotent 
mesenchymal stromal cells. The International Society for Cellular Therapy position statement. 
Cytotherapy, 8, 315-7. 
DORSEY, S. M., LIN-GIBSON, S. & SIMON, C. G., JR. 2009. X-ray microcomputed tomography for the 
measurement of cell adhesionand proliferation in polymer scaffolds. Biomaterials, 30, 2967-74. 
DOYLE, A. D., CARVAJAL, N., JIN, A., MATSUMOTO, K. & YAMADA, K. M. 2015. Local 3D matrix 
microenvironment regulates cell migration through spatiotemporal dynamics of contractility-
dependent adhesions. Nat Commun, 6, 8720. 
DUOCASTELLA, M., COLINA, M., FERNÁNDEZ-PRADAS, J., SERRA, P. & MORENZA, J. 2007. Study of the laser-
induced forward transfer of liquids for laser bioprinting. Applied surface science, 253, 7855-7859. 
EHNIS, T., DIETERICH, W., BAUER, M., LAMPE, B. & SCHUPPAN, D. 1996. A chondroitin/dermatan sulfate form of 
CD44 is a receptor for collagen XIV (undulin). Exp Cell Res, 229, 388-97. 
EISENBERG, S. R. & GRODZINSKY, A. J. 1985. Swelling of articular cartilage and other connective tissues: 
electromechanochemical forces. J Orthop Res, 3, 148-59. 
EL SAYED, K., HAISCH, A., JOHN, T., MARZAHN, U., LOHAN, A., MULLER, R. D., KOHL, B., ERTEL, W., STOELZEL, K. 
& SCHULZE-TANZIL, G. 2010. Heterotopic autologous chondrocyte transplantation--a realistic 
approach to support articular cartilage repair? Tissue Eng Part B Rev, 16, 603-16. 
EL SAYED, K., MARZAHN, U., JOHN, T., HOYER, M., ZREIQAT, H., WITTHUHN, A., KOHL, B., HAISCH, A. & 
SCHULZE-TANZIL, G. 2013. PGA-associated heterotopic chondrocyte cocultures: implications of 
nasoseptal and auricular chondrocytes in articular cartilage repair. J Tissue Eng Regen Med, 7, 61-72. 
ELDER, B. D. & ATHANASIOU, K. A. 2009. Hydrostatic pressure in articular cartilage tissue engineering: from 
chondrocytes to tissue regeneration. Tissue Eng Part B Rev, 15, 43-53. 
ELLIOTT, D. M., ROBINSON, P. S., GIMBEL, J. A., SARVER, J. J., ABBOUD, J. A., IOZZO, R. V. & SOSLOWSKY, L. J. 
2003. Effect of altered matrix proteins on quasilinear viscoelastic properties in transgenic mouse tail 
tendons. Ann Biomed Eng, 31, 599-605. 
ENGEBRETSON, B., MUSSETT, Z., WILLIAMS, C., SIMMONS, A. & SIKAVITSAS, V. 2015. Tendon Tissue 
Engineering: Combined Tissue Engineering Approach for the Regeneration of Tendons. Tendon 
Regeneration. Elsevier. 
ENGEBRETSON, B., MUSSETT, Z. R. & SIKAVITSAS, V. I. 2018. The effects of varying frequency and duration of 
mechanical stimulation on a tissue-engineered tendon construct. Connective tissue research, 59, 167-
177. 
ENGEL, J. & PROCKOP, D. J. 1991. The zipper-like folding of collagen triple helices and the effects of mutations 
that disrupt the zipper. Annu Rev Biophys Biophys Chem, 20, 137-52. 
ENGLER, A. J., SEN, S., SWEENEY, H. L. & DISCHER, D. E. 2006. Matrix elasticity directs stem cell lineage 
specification. Cell, 126, 677-89. 
ERICKSON, G. R., GIMBLE, J. M., FRANKLIN, D. M., RICE, H. E., AWAD, H. & GUILAK, F. 2002. Chondrogenic 
potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun, 
290, 763-9. 
ESA. 2003. The ZARM drop tower in Bremen, Germany [Online]. The European Space Agency. Available: 
https://www.esa.int/Science_Exploration/Human_and_Robotic_Exploration/Research/Drop_towers 
[Accessed 2021]. 
ESCAMILLA, R. F. 2001. Knee biomechanics of the dynamic squat exercise. Med Sci Sports Exerc, 33, 127-41. 
EYRE, D. 2002. Collagen of articular cartilage. Arthritis Res, 4, 30-5. 
EYRE, D. R., WU, J. J., FERNANDES, R. J., PIETKA, T. A. & WEIS, M. A. 2002. Recent developments in cartilage 
research: matrix biology of the collagen II/IX/XI heterofibril network. Biochem Soc Trans, 30, 893-9. 
EYRICH, D., BRANDL, F., APPEL, B., WIESE, H., MAIER, G., WENZEL, M., STAUDENMAIER, R., GOEPFERICH, A. & 
BLUNK, T. 2007. Long-term stable fibrin gels for cartilage engineering. Biomaterials, 28, 55-65. 
EZURA, Y., CHAKRAVARTI, S., OLDBERG, A., CHERVONEVA, I. & BIRK, D. E. 2000. Differential expression of 
lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol, 
151, 779-88. 
FAN, D., CREEMERS, E. E. & KASSIRI, Z. 2014. Matrix as an interstitial transport system. Circ Res, 114, 889-902. 
FARNEBO, S., WOON, C. Y., SCHMITT, T., JOUBERT, L. M., KIM, M., PHAM, H. & CHANG, J. 2014. Design and 
characterization of an injectable tendon hydrogel: a novel scaffold for guided tissue regeneration in 





FERNANDES, R. J., HIROHATA, S., ENGLE, J. M., COLIGE, A., COHN, D. H., EYRE, D. R. & APTE, S. S. 2001. 
Procollagen II amino propeptide processing by ADAMTS-3. Insights on dermatosparaxis. J Biol Chem, 
276, 31502-9. 
FERNANDES, R. J., WEIS, M., SCOTT, M. A., SEEGMILLER, R. E. & EYRE, D. R. 2007. Collagen XI chain misassembly 
in cartilage of the chondrodysplasia (cho) mouse. Matrix Biol, 26, 597-603. 
FERRARI, S. L., TRAIANEDES, K., THORNE, M., LAFAGE-PROUST, M. H., GENEVER, P., CECCHINI, M. G., BEHAR, V., 
BISELLO, A., CHOREV, M., ROSENBLATT, M. & SUVA, L. J. 2000. A role for N-cadherin in the 
development of the differentiated osteoblastic phenotype. J Bone Miner Res, 15, 198-208. 
FIDLER, A. L., BOUDKO, S. P., ROKAS, A. & HUDSON, B. G. 2018. The triple helix of collagens - an ancient protein 
structure that enabled animal multicellularity and tissue evolution. J Cell Sci, 131. 
FINGER, A. R., SARGENT, C. Y., DULANEY, K. O., BERNACKI, S. H. & LOBOA, E. G. 2007. Differential effects on 
messenger ribonucleic acid expression by bone marrow-derived human mesenchymal stem cells 
seeded in agarose constructs due to ramped and steady applications of cyclic hydrostatic pressure. 
Tissue Eng, 13, 1151-8. 
FITZGERALD, J. & BATEMAN, J. F. 2001. A new FACIT of the collagen family: COL21A1. FEBS Lett, 505, 275-80. 
FITZGERALD, J., HOLDEN, P. & HANSEN, U. 2013. The expanded collagen VI family: new chains and new 
questions. Connect Tissue Res, 54, 345-50. 
FITZGERALD, J., RICH, C., ZHOU, F. H. & HANSEN, U. 2008. Three novel collagen VI chains, alpha4(VI), alpha5(VI), 
and alpha6(VI). J Biol Chem, 283, 20170-80. 
FLEISCHMAJER, R., PERLISH, J. S., TIMPL, R. & OLSEN, B. R. 1988. Procollagen intermediates during tendon 
fibrillogenesis. J Histochem Cytochem, 36, 1425-32. 
FLORENCIO-SILVA, R., SASSO, G. R., SASSO-CERRI, E., SIMOES, M. J. & CERRI, P. S. 2015. Biology of Bone Tissue: 
Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int, 2015, 421746. 
FONT, B., EICHENBERGER, D., ROSENBERG, L. M. & VAN DER REST, M. 1996. Characterization of the interactions 
of type XII collagen with two small proteoglycans from fetal bovine tendon, decorin and fibromodulin. 
Matrix Biol, 15, 341-8. 
FRANCHI, M., TRIRE, A., QUARANTA, M., ORSINI, E. & OTTANI, V. 2007. Collagen structure of tendon relates to 
function. ScientificWorldJournal, 7, 404-20. 
FRANCIS, S. L., DI BELLA, C., WALLACE, G. G. & CHOONG, P. F. M. 2018. Cartilage Tissue Engineering Using Stem 
Cells and Bioprinting Technology-Barriers to Clinical Translation. Front Surg, 5, 70. 
FRANK, E. H., JIN, M., LOENING, A. M., LEVENSTON, M. E. & GRODZINSKY, A. J. 2000. A versatile shear and 
compression apparatus for mechanical stimulation of tissue culture explants. J Biomech, 33, 1523-7. 
FRANZ-ODENDAAL, T. A., HALL, B. K. & WITTEN, P. E. 2006. Buried alive: how osteoblasts become osteocytes. 
Dev Dyn, 235, 176-90. 
FRASER, J. R., LAURENT, T. C. & LAURENT, U. B. 1997. Hyaluronan: its nature, distribution, functions and 
turnover. J Intern Med, 242, 27-33. 
FRIESS, W. 1998. Collagen--biomaterial for drug delivery. Eur J Pharm Biopharm, 45, 113-36. 
FRITH, J. E., THOMSON, B. & GENEVER, P. G. 2010. Dynamic three-dimensional culture methods enhance 
mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods, 16, 
735-49. 
GARA, S. K., GRUMATI, P., URCIUOLO, A., BONALDO, P., KOBBE, B., KOCH, M., PAULSSON, M. & WAGENER, R. 
2008. Three novel collagen VI chains with high homology to the alpha3 chain. J Biol Chem, 283, 10658-
70. 
GARCIA, A. G., LABRO, M. B., FARHAT, F., PEROT, J. B., DERMIGNY, Q., DUFRESNE, M., GROSSET, J. F., BEDOUI, F. 
& LEGALLAIS, C. 2018. Multi-scale approach to reconstruct a bioartificial system of system: the 
example of the bone-tendon-muscle continuum. 2018 13th Annual Conference on System of Systems 
Engineering (Sose), 408-410. 
GARVIN, J., QI, J., MALONEY, M. & BANES, A. J. 2003. Novel system for engineering bioartificial tendons and 
application of mechanical load. Tissue Eng, 9, 967-79. 
GELSE, K., POSCHL, E. & AIGNER, T. 2003. Collagens--structure, function, and biosynthesis. Adv Drug Deliv Rev, 
55, 1531-46. 
GERBER, H. P., VU, T. H., RYAN, A. M., KOWALSKI, J., WERB, Z. & FERRARA, N. 1999. VEGF couples hypertrophic 
cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med, 5, 
623-8. 
GHARRAVI, A. M., ORAZIZADEH, M., ANSARI-ASL, K., BANONI, S., IZADI, S. & HASHEMITABAR, M. 2012. Design 
and fabrication of anatomical bioreactor systems containing alginate scaffolds for cartilage tissue 
engineering. Avicenna J Med Biotechnol, 4, 65-74. 
GHARRAVI, A. M., ORAZIZADEH, M. & HASHEMITABAR, M. 2016. Fluid-induced low shear stress improves 
cartilage like tissue fabrication by encapsulating chondrocytes. Cell Tissue Bank, 17, 117-22. 
GIANCOTTI, F. G. & RUOSLAHTI, E. 1999. Integrin signaling. Science, 285, 1028-32. 
GIULIANI, N., LISIGNOLI, G., MAGNANI, M., RACANO, C., BOLZONI, M., DALLA PALMA, B., SPOLZINO, A., 
MANFERDINI, C., ABATI, C., TOSCANI, D., FACCHINI, A. & AVERSA, F. 2013. New insights into 





their potential clinical applications for bone regeneration in pediatric orthopaedics. Stem Cells Int, 
2013, 312501. 
GLASS, Z. A., SCHIELE, N. R. & KUO, C. K. 2014. Informing tendon tissue engineering with embryonic 
development. J Biomech, 47, 1964-8. 
GLICK, B. S. & NAKANO, A. 2009. Membrane traffic within the Golgi apparatus. Annu Rev Cell Dev Biol, 25, 113-
32. 
GLIMCHER, M. J. 1989. Mechanism of calcification: role of collagen fibrils and collagen-phosphoprotein 
complexes in vitro and in vivo. Anat Rec, 224, 139-53. 
GOH, K. L., HOLMES, D. F., LU, Y., PURSLOW, P. P., KADLER, K. E., BECHET, D. & WESS, T. J. 2012. Bimodal 
collagen fibril diameter distributions direct age-related variations in tendon resilience and resistance 
to rupture. J Appl Physiol (1985), 113, 878-88. 
GOLDRING, S. R. 2015. The osteocyte: key player in regulating bone turnover. RMD Open, 1, e000049. 
GOLDSTEIN, A. S., JUAREZ, T. M., HELMKE, C. D., GUSTIN, M. C. & MIKOS, A. G. 2001. Effect of convection on 
osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials, 22, 
1279-88. 
GOMES, M. E., REIS, R. L. & RODRIGUES, M. T. 2015. Tendon regeneration: understanding tissue physiology and 
development to engineer functional substitutes, Academic Press. 
GOMES, M. E., SIKAVITSAS, V. I., BEHRAVESH, E., REIS, R. L. & MIKOS, A. G. 2003. Effect of flow perfusion on the 
osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional 
scaffolds. J Biomed Mater Res A, 67, 87-95. 
GONCALVES, T. J. M., BOUTILLON, F., LEFEBVRE, S., GOFFIN, V., IWATSUBO, T., WAKABAYASHI, T., OURY, F. & 
ARMAND, A. S. 2019. Collagen XXV promotes myoblast fusion during myogenic differentiation and 
muscle formation. Sci Rep, 9, 5878. 
GONCALVES-NETO, J., WITZEL, S. S., TEODORO, W. R., CARVALHO-JUNIOR, A. E., FERNANDES, T. D. & 
YOSHINARI, H. H. 2002. Changes in collagen matrix composition in human posterior tibial tendon 
dysfunction. Joint Bone Spine, 69, 189-94. 
GONZALEZ DE TORRE, I., WEBER, M., QUINTANILLA, L., ALONSO, M., JOCKENHOEVEL, S., RODRIGUEZ CABELLO, 
J. C. & MELA, P. 2016. Hybrid elastin-like recombinamer-fibrin gels: physical characterization and in 
vitro evaluation for cardiovascular tissue engineering applications. Biomater Sci, 4, 1361-70. 
GOOCH, K. J., BLUNK, T., COURTER, D. L., SIEMINSKI, A. L., VUNJAK-NOVAKOVIC, G. & FREED, L. E. 2002. Bone 
morphogenetic proteins-2, -12, and -13 modulate in vitro development of engineered cartilage. Tissue 
Eng, 8, 591-601. 
GORDON, M. K., FOLEY, J. W., LISENMAYER, T. F. & FITCH, J. M. 1996. Temporal expression of types XII and XIV 
collagen mRNA and protein during avian corneal development. Dev Dyn, 206, 49-58. 
GORDON, M. K. & HAHN, R. A. 2010. Collagens. Cell Tissue Res, 339, 247-57. 
GORDON, M. Y. 1988. Extracellular matrix of the marrow microenvironment. Br J Haematol, 70, 1-4. 
GRÄSSEL, S. & ASZÓDI, A. 2016. Collagens in Hyaline Cartilage. Cartilage. Springer, Cham. 
GRAYSON, W. L., BHUMIRATANA, S., CANNIZZARO, C. & VUNJAK-NOVAKOVIC, G. 2011. Bioreactor cultivation of 
functional bone grafts. Methods Mol Biol, 698, 231-41. 
GREEN, W. T., JR. 1977. Articular cartilage repair. Behavior of rabbit chondrocytes during tissue culture and 
subsequent allografting. Clin Orthop Relat Res, 237-50. 
GREGORY, K. E., KEENE, D. R., TUFA, S. F., LUNSTRUM, G. P. & MORRIS, N. P. 2001. Developmental distribution 
of collagen type XII in cartilage: association with articular cartilage and the growth plate. J Bone Miner 
Res, 16, 2005-16. 
GRIER, W. G., MOY, A. S. & HARLEY, B. A. 2017. Cyclic tensile strain enhances human mesenchymal stem cell 
Smad 2/3 activation and tenogenic differentiation in anisotropic collagen-glycosaminoglycan 
scaffolds. Eur Cell Mater, 33, 227-239. 
GRIER, W. K., SUN HAN CHANG, R. A., RAMSEY, M. D. & HARLEY, B. A. C. 2019. The influence of cyclic tensile 
strain on multi-compartment collagen-GAG scaffolds for tendon-bone junction repair. Connect Tissue 
Res, 60, 530-543. 
GRIGORIEV, A. I., OGANOV, V. S., BAKULIN, A. V., POLIAKOV, V. V., VORONIN, L. I., MORGUN, V. V., SHNAIDER, 
V. S., MURASHKO, L. V., NOVIKOV, V. E., LEBLANK, A. & SHAKLEFORD, L. 1998. [Clinical and 
physiological evaluation of bone changes among astronauts after long-term space flights]. Aviakosm 
Ekolog Med, 32, 21-5. 
GRIMM, D., EGLI, M., KRUGER, M., RIWALDT, S., CORYDON, T. J., KOPP, S., WEHLAND, M., WISE, P., INFANGER, 
M., MANN, V. & SUNDARESAN, A. 2018. Tissue Engineering Under Microgravity Conditions-Use of 
Stem Cells and Specialized Cells. Stem Cells Dev, 27, 787-804. 
GROSSE, J., WEHLAND, M., PIETSCH, J., MA, X., ULBRICH, C., SCHULZ, H., SAAR, K., HUBNER, N., HAUSLAGE, J., 
HEMMERSBACH, R., BRAUN, M., VAN LOON, J., VAGT, N., INFANGER, M., EILLES, C., EGLI, M., 
RICHTER, P., BALTZ, T., EINSPANIER, R., SHARBATI, S. & GRIMM, D. 2012. Short-term weightlessness 
produced by parabolic flight maneuvers altered gene expression patterns in human endothelial cells. 





GUILAK, F., ALEXOPOULOS, L. G., UPTON, M. L., YOUN, I., CHOI, J. B., CAO, L., SETTON, L. A. & HAIDER, M. A. 
2006. The pericellular matrix as a transducer of biomechanical and biochemical signals in articular 
cartilage. Ann N Y Acad Sci, 1068, 498-512. 
GUO, Y., SIRKIS, D. W. & SCHEKMAN, R. 2014. Protein sorting at the trans-Golgi network. Annu Rev Cell Dev Biol, 
30, 169-206. 
GURKAN, U. A. & AKKUS, O. 2008. The mechanical environment of bone marrow: a review. Ann Biomed Eng, 36, 
1978-91. 
HAGERTY, P., LEE, A., CALVE, S., LEE, C. A., VIDAL, M. & BAAR, K. 2012. The effect of growth factors on both 
collagen synthesis and tensile strength of engineered human ligaments. Biomaterials, 33, 6355-61. 
HAGG, P., REHN, M., HUHTALA, P., VAISANEN, T., TAMMINEN, M. & PIHLAJANIEMI, T. 1998a. Type XIII collagen 
is identified as a plasma membrane protein. J Biol Chem, 273, 15590-7. 
HAGG, P. M., HAGG, P. O., PELTONEN, S., AUTIO-HARMAINEN, H. & PIHLAJANIEMI, T. 1997. Location of type XV 
collagen in human tissues and its accumulation in the interstitial matrix of the fibrotic kidney. Am J 
Pathol, 150, 2075-86. 
HAGG, R., BRUCKNER, P. & HEDBOM, E. 1998b. Cartilage fibrils of mammals are biochemically heterogeneous: 
differential distribution of decorin and collagen IX. J Cell Biol, 142, 285-94. 
HAGLUND, L., TILLGREN, V., ONNERFJORD, P. & HEINEGARD, D. 2013. The C-terminal peptide of 
chondroadherin modulates cellular activity by selectively binding to heparan sulfate chains. J Biol 
Chem, 288, 995-1008. 
HAGMANN, S., MORADI, B., FRANK, S., DREHER, T., KAMMERER, P. W., RICHTER, W. & GOTTERBARM, T. 2013. 
FGF-2 addition during expansion of human bone marrow-derived stromal cells alters MSC surface 
marker distribution and chondrogenic differentiation potential. Cell Prolif, 46, 396-407. 
HAKIM, F. T., CRANLEY, R., BROWN, K. S., EANES, E. D., HARNE, L. & OPPENHEIM, J. J. 1984. Hereditary joint 
disorder in progressive ankylosis (ank/ank) mice. I. Association of calcium hydroxyapatite deposition 
with inflammatory arthropathy. Arthritis Rheum, 27, 1411-20. 
HALL, A. C. 1999. Differential effects of hydrostatic pressure on cation transport pathways of isolated articular 
chondrocytes. J Cell Physiol, 178, 197-204. 
HALL, A. C., HORWITZ, E. R. & WILKINS, R. J. 1996. The cellular physiology of articular cartilage. Exp Physiol, 81, 
535-45. 
HALL, S. 1997. Axonal regeneration through acellular muscle grafts. J Anat, 190 ( Pt 1), 57-71. 
HALL, S., PENEGELLY, I., STAFF, J., PLANT, N. & EVANS, G. 2018. Measuring and Controlling Emissions from 
Polymer Filament Desktop 3D Printers. In: EXECUTIVE, H. A. S. (ed.). Research Reports. 
HAMILTON, R. & CAMPBELL, F. R. 1991. Immunochemical localization of extracellular materials in bone marrow 
of rats. Anat Rec, 231, 218-24. 
HAMMER, B. E., KIDDER, L. S., WILLIAMS, P. C. & XU, W. W. 2009. Magnetic Levitation of MC3T3 Osteoblast 
Cells as a Ground-Based Simulation of Microgravity. Microgravity Sci Technol, 21, 311-318. 
HAN, D. S., CHANG, H. K., KIM, K. R. & WOO, S. M. 2014. Consideration of bone regeneration effect of stem 
cells: comparison of bone regeneration between bone marrow stem cells and adipose-derived stem 
cells. J Craniofac Surg, 25, 196-201. 
HAN, Y., YOU, X., XING, W., ZHANG, Z. & ZOU, W. 2018. Paracrine and endocrine actions of bone-the functions 
of secretory proteins from osteoblasts, osteocytes, and osteoclasts. Bone Res, 6, 16. 
HANGODY, L., RATHONYI, G. K., DUSKA, Z., VASARHELYI, G., FULES, P. & MODIS, L. 2004. Autologous 
osteochondral mosaicplasty. Surgical technique. J Bone Joint Surg Am, 86-A Suppl 1, 65-72. 
HANKENSON, K. D., BAIN, S. D., KYRIAKIDES, T. R., SMITH, E. A., GOLDSTEIN, S. A. & BORNSTEIN, P. 2000. 
Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking 
thrombospondin 2. J Bone Miner Res, 15, 851-62. 
HANSEN, N., GUDMANN, N. & KARSDAL, M. 2019. Type VIII collagen. Biochemistry of Collagens, Laminins and 
Elastin. Elsevier. 
HANSMA, P. K., TURNER, P. J. & RUOFF, R. S. 2006. Optimized adhesives for strong, lightweight, damage-
resistant, nanocomposite materials: new insights from natural materials. Nanotechnology, 18. 
HANSON, A. D., MARVEL, S. W., BERNACKI, S. H., BANES, A. J., VAN AALST, J. & LOBOA, E. G. 2009. Osteogenic 
effects of rest inserted and continuous cyclic tensile strain on hASC lines with disparate 
osteodifferentiation capabilities. Ann Biomed Eng, 37, 955-65. 
HARDINGHAM, T. 2010. Cell- and tissue-based approaches for cartilage repair. Altern Lab Anim, 38 Suppl 1, 35-
9. 
HARDINGHAM, T. E. 1979. The role of link-protein in the structure of cartilage proteoglycan aggregates. 
Biochem J, 177, 237-47. 
HARTIGAN, N., GARRIGUE-ANTAR, L. & KADLER, K. E. 2003. Bone morphogenetic protein-1 (BMP-1). 
Identification of the minimal domain structure for procollagen C-proteinase activity. J Biol Chem, 278, 
18045-9. 
HASHIMOTO, T., WAKABAYASHI, T., WATANABE, A., KOWA, H., HOSODA, R., NAKAMURA, A., KANAZAWA, I., 





component derived from a transmembrane precursor, CLAC-P/collagen type XXV. EMBO J, 21, 1524-
34. 
HATTORI, T., MULLER, C., GEBHARD, S., BAUER, E., PAUSCH, F., SCHLUND, B., BOSL, M. R., HESS, A., SURMANN-
SCHMITT, C., VON DER MARK, H., DE CROMBRUGGHE, B. & VON DER MARK, K. 2010. SOX9 is a major 
negative regulator of cartilage vascularization, bone marrow formation and endochondral 
ossification. Development, 137, 901-11. 
HEARD, M. E., BESIO, R., WEIS, M., RAI, J., HUDSON, D. M., DIMORI, M., ZIMMERMAN, S. M., KAMYKOWSKI, J. 
A., HOGUE, W. R., SWAIN, F. L., BURDINE, M. S., MACKINTOSH, S. G., TACKETT, A. J., SUVA, L. J., EYRE, 
D. R. & MORELLO, R. 2016. Sc65-Null Mice Provide Evidence for a Novel Endoplasmic Reticulum 
Complex Regulating Collagen Lysyl Hydroxylation. PLoS Genet, 12, e1006002. 
HEATH, D. E. 2019. A review of decellularized extracellular matrix biomaterials for regenerative engineering 
applications. Regenerative Engineering and Translational Medicine, 5, 155-166. 
HEDBOM, E. & HEINEGARD, D. 1989. Interaction of a 59-kDa connective tissue matrix protein with collagen I 
and collagen II. J Biol Chem, 264, 6898-905. 
HEHER, P., MALEINER, B., PRULLER, J., TEUSCHL, A. H., KOLLMITZER, J., MONFORTE, X., WOLBANK, S., REDL, H., 
RUNZLER, D. & FUCHS, C. 2015. A novel bioreactor for the generation of highly aligned 3D skeletal 
muscle-like constructs through orientation of fibrin via application of static strain. Acta Biomater, 24, 
251-65. 
HEHLGANS, S., HAASE, M. & CORDES, N. 2007. Signalling via integrins: implications for cell survival and 
anticancer strategies. Biochim Biophys Acta, 1775, 163-80. 
HENRY, S. P., TAKANOSU, M., BOYD, T. C., MAYNE, P. M., EBERSPAECHER, H., ZHOU, W., DE CROMBRUGGHE, B., 
HOOK, M. & MAYNE, R. 2001. Expression pattern and gene characterization of asporin. a newly 
discovered member of the leucine-rich repeat protein family. J Biol Chem, 276, 12212-21. 
HENSTOCK, J. R., ROTHERHAM, M., RASHIDI, H., SHAKESHEFF, K. M. & EL HAJ, A. J. 2014. Remotely Activated 
Mechanotransduction via Magnetic Nanoparticles Promotes Mineralization Synergistically With Bone 
Morphogenetic Protein 2: Applications for Injectable Cell Therapy. Stem Cells Transl Med, 3, 1363-74. 
HENSTOCK, J. R., ROTHERHAM, M., ROSE, J. B. & EL HAJ, A. J. 2013. Cyclic hydrostatic pressure stimulates 
enhanced bone development in the foetal chick femur in vitro. Bone, 53, 468-77. 
HESS, R., DOUGLAS, T., MYERS, K. A., RENTSCH, B., RENTSCH, C., WORCH, H., SHRIVE, N. G., HART, D. A. & 
SCHARNWEBER, D. 2010. Hydrostatic pressure stimulation of human mesenchymal stem cells seeded 
on collagen-based artificial extracellular matrices. J Biomech Eng, 132, 021001. 
HESSLE, L., JOHNSON, K. A., ANDERSON, H. C., NARISAWA, S., SALI, A., GODING, J. W., TERKELTAUB, R. & 
MILLAN, J. L. 2002. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 
are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A, 99, 9445-9. 
HILL, T. P., TAKETO, M. M., BIRCHMEIER, W. & HARTMANN, C. 2006. Multiple roles of mesenchymal beta-
catenin during murine limb patterning. Development, 133, 1219-29. 
HODGE, A. J. & SCHMITT, F. O. 1960. The Charge Profile of the Tropocollagen Macromolecule and the Packing 
Arrangement in Native-Type Collagen Fibrils. Proc Natl Acad Sci U S A, 46, 186-97. 
HOFFMAN, G. G., BRANAM, A. M., HUANG, G., PELEGRI, F., COLE, W. G., WENSTRUP, R. M. & GREENSPAN, D. S. 
2010. Characterization of the six zebrafish clade B fibrillar procollagen genes, with evidence for 
evolutionarily conserved alternative splicing within the pro-alpha1(V) C-propeptide. Matrix Biol, 29, 
261-75. 
HOLMGREN, S. K., BRETSCHER, L. E., TAYLOR, K. M. & RAINES, R. T. 1999. A hyperstable collagen mimic. Chem 
Biol, 6, 63-70. 
HOLTORF, H. L., DATTA, N., JANSEN, J. A. & MIKOS, A. G. 2005a. Scaffold mesh size affects the osteoblastic 
differentiation of seeded marrow stromal cells cultured in a flow perfusion bioreactor. J Biomed 
Mater Res A, 74, 171-80. 
HOLTORF, H. L., JANSEN, J. A. & MIKOS, A. G. 2005b. Flow perfusion culture induces the osteoblastic 
differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed 
Mater Res A, 72, 326-34. 
HOLTROP, M. E. & KING, G. J. 1977. The ultrastructure of the osteoclast and its functional implications. Clin 
Orthop Relat Res, 177-96. 
HONG, J. H., HWANG, E. S., MCMANUS, M. T., AMSTERDAM, A., TIAN, Y., KALMUKOVA, R., MUELLER, E., 
BENJAMIN, T., SPIEGELMAN, B. M., SHARP, P. A., HOPKINS, N. & YAFFE, M. B. 2005. TAZ, a 
transcriptional modulator of mesenchymal stem cell differentiation. Science, 309, 1074-8. 
HOPKINS, D. R., KELES, S. & GREENSPAN, D. S. 2007. The bone morphogenetic protein 1/Tolloid-like 
metalloproteinases. Matrix Biol, 26, 508-23. 
HOPKINSON, S. B., FINDLAY, K., DEHART, G. W. & JONES, J. C. 1998. Interaction of BP180 (type XVII collagen) 
and alpha6 integrin is necessary for stabilization of hemidesmosome structure. J Invest Dermatol, 111, 
1015-22. 
HOSON, T., KAMISAKA, S., MASUDA, Y., YAMASHITA, M. & BUCHEN, B. 1997. Evaluation of the three-





HOSPODIUK, M., DEY, M., SOSNOSKI, D. & OZBOLAT, I. T. 2017. The bioink: A comprehensive review on 
bioprintable materials. Biotechnol Adv, 35, 217-239. 
HOWELL, S. J. & DOANE, K. J. 1998. Type VI collagen increases cell survival and prevents anti-beta 1 integrin-
mediated apoptosis. Exp Cell Res, 241, 230-41. 
HSIAO, M. Y., LIN, P. C., LIAO, W. H., CHEN, W. S., HSU, C. H., HE, C. K., WU, Y. W., GEFEN, A., IAFISCO, M., LIU, L. 
& LIN, F. H. 2019. The Effect of the Repression of Oxidative Stress on Tenocyte Differentiation: A 
Preliminary Study of a Rat Cell Model Using a Novel Differential Tensile Strain Bioreactor. Int J Mol Sci, 
20. 
HUANG, C. & OGAWA, R. 2012. Effect of hydrostatic pressure on bone regeneration using human mesenchymal 
stem cells. Tissue Eng Part A, 18, 2106-13. 
HUANG, P., RUSSELL, A. L., LEFAVOR, R., DURAND, N. C., JAMES, E., HARVEY, L., ZHANG, C., COUNTRYMAN, S., 
STODIECK, L. & ZUBAIR, A. C. 2020. Feasibility, potency, and safety of growing human mesenchymal 
stem cells in space for clinical application. NPJ Microgravity, 6, 16. 
HUANG, W., YANG, S., SHAO, J. & LI, Y. P. 2007. Signaling and transcriptional regulation in osteoblast 
commitment and differentiation. Front Biosci, 12, 3068-92. 
HULMES, D. 2008. Collagen diversity, synthesis and assembly. Collagen. Springer. 
HULMES, D. J., KADLER, K. E., MOULD, A. P., HOJIMA, Y., HOLMES, D. F., CUMMINGS, C., CHAPMAN, J. A. & 
PROCKOP, D. J. 1989. Pleomorphism in type I collagen fibrils produced by persistence of the 
procollagen N-propeptide. J Mol Biol, 210, 337-45. 
INADA, M., WANG, Y., BYRNE, M. H., RAHMAN, M. U., MIYAURA, C., LOPEZ-OTIN, C. & KRANE, S. M. 2004. 
Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in 
endochondral ossification. Proc Natl Acad Sci U S A, 101, 17192-7. 
INGRAM, J. H., KOROSSIS, S., HOWLING, G., FISHER, J. & INGHAM, E. 2007. The use of ultrasonication to aid 
recellularization of acellular natural tissue scaffolds for use in anterior cruciate ligament 
reconstruction. Tissue Eng, 13, 1561-72. 
INOUYE, K., SAKAKIBARA, S. & PROCKOP, D. J. 1976. Effects of the stereo-configuration of the hydroxyl group in 
4-hydroxyproline on the triple-helical structures formed by homogenous peptides resembling 
collagen. Biochim Biophys Acta, 420, 133-41. 
INSOGNA, K. L., SAHNI, M., GREY, A. B., TANAKA, S., HORNE, W. C., NEFF, L., MITNICK, M., LEVY, J. B. & BARON, 
R. 1997. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine 
phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest, 100, 2476-85. 
IOZZO, R. V. & SCHAEFER, L. 2015. Proteoglycan form and function: A comprehensive nomenclature of 
proteoglycans. Matrix Biol, 42, 11-55. 
ISHIKAWA, Y. & BACHINGER, H. P. 2013. A molecular ensemble in the rER for procollagen maturation. Biochim 
Biophys Acta, 1833, 2479-91. 
ITO, S. & NAGATA, K. 2017. Biology of Hsp47 (Serpin H1), a collagen-specific molecular chaperone. Semin Cell 
Dev Biol, 62, 142-151. 
IZU, Y., EZURA, Y., KOCH, M., BIRK, D. E. & NODA, M. 2016. Collagens VI and XII form complexes mediating 
osteoblast interactions during osteogenesis. Cell Tissue Res, 364, 623-635. 
IZU, Y., EZURA, Y., MIZOGUCHI, F., KAWAMATA, A., NAKAMOTO, T., NAKASHIMA, K., HAYATA, T., HEMMI, H., 
BONALDO, P. & NODA, M. 2012. Type VI collagen deficiency induces osteopenia with distortion of 
osteoblastic cell morphology. Tissue Cell, 44, 1-6. 
JAGODZINSKI, M., DRESCHER, M., ZEICHEN, J., HANKEMEIER, S., KRETTEK, C., BOSCH, U. & VAN GRIENSVEN, M. 
2004. Effects of cyclic longitudinal mechanical strain and dexamethasone on osteogenic 
differentiation of human bone marrow stromal cells. Eur Cell Mater, 7, 35-41; discussion 41. 
JAHANGIR, S., EGLIN, D., POTTER, N., KHOZAEI RAVARI, M., STODDART, M. J., SAMADIKUCHAKSARAEI, A., ALINI, 
M., BAGHABAN ESLAMINEJAD, M. & SAFA, M. 2020. Inhibition of hypertrophy and improving 
chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin 
sulfate-platelet lysate hydrogel. Stem Cell Res Ther, 11, 436. 
JAISWAL, N., HAYNESWORTH, S. E., CAPLAN, A. I. & BRUDER, S. P. 1997. Osteogenic differentiation of purified, 
culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem, 64, 295-312. 
JANG, J. Y., LEE, S. W., PARK, S. H., SHIN, J. W., MUN, C., KIM, S. H., KIM, D. H. & SHIN, J. W. 2011. Combined 
effects of surface morphology and mechanical straining magnitudes on the differentiation of 
mesenchymal stem cells without using biochemical reagents. J Biomed Biotechnol, 2011, 860652. 
JANG, Y., KOH, Y. G., CHOI, Y. J., KIM, S. H., YOON, D. S., LEE, M. & LEE, J. W. 2015. Characterization of adipose 
tissue-derived stromal vascular fraction for clinical application to cartilage regeneration. In Vitro Cell 
Dev Biol Anim, 51, 142-50. 
JANVIER, A. J., CANTY-LAIRD, E. G. & HENSTOCK, J. R. 2020. A universal multi-platform 3D printed bioreactor 
chamber for tendon tissue engineering. Journal of Tissue Engineering, 11, 1-15. 
JELINSKY, S. A., ARCHAMBAULT, J., LI, L. & SEEHERMAN, H. 2010. Tendon-selective genes identified from rat and 
human musculoskeletal tissues. J Orthop Res, 28, 289-97. 
JETT, S. V., HUDSON, L. T., BAUMWART, R., BOHNSTEDT, B. N., MIR, A., BURKHART, H. M., HOLZAPFEL, G. A., 





biaxial mechanical testing system for quantification of load-dependent collagen architecture in soft 
collagenous tissues. Acta Biomater, 102, 149-168. 
JIANG, Y., JAHAGIRDAR, B. N., REINHARDT, R. L., SCHWARTZ, R. E., KEENE, C. D., ORTIZ-GONZALEZ, X. R., REYES, 
M., LENVIK, T., LUND, T., BLACKSTAD, M., DU, J., ALDRICH, S., LISBERG, A., LOW, W. C., LARGAESPADA, 
D. A. & VERFAILLIE, C. M. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. 
Nature, 418, 41-9. 
JILKA, R. L., WEINSTEIN, R. S., BELLIDO, T., PARFITT, A. M. & MANOLAGAS, S. C. 1998. Osteoblast programmed 
cell death (apoptosis): modulation by growth factors and cytokines. J Bone Miner Res, 13, 793-802. 
JIN, M., EMKEY, G. R., SIPARSKY, P., TRIPPEL, S. B. & GRODZINSKY, A. J. 2003. Combined effects of dynamic 
tissue shear deformation and insulin-like growth factor I on chondrocyte biosynthesis in cartilage 
explants. Arch Biochem Biophys, 414, 223-31. 
JIN, M., FRANK, E. H., QUINN, T. M., HUNZIKER, E. B. & GRODZINSKY, A. J. 2001. Tissue shear deformation 
stimulates proteoglycan and protein biosynthesis in bovine cartilage explants. Arch Biochem Biophys, 
395, 41-8. 
JOHNSON, K. A., HESSLE, L., VAINGANKAR, S., WENNBERG, C., MAURO, S., NARISAWA, S., GODING, J. W., SANO, 
K., MILLAN, J. L. & TERKELTAUB, R. 2000. Osteoblast tissue-nonspecific alkaline phosphatase 
antagonizes and regulates PC-1. Am J Physiol Regul Integr Comp Physiol, 279, R1365-77. 
JOHNSTONE, B., HERING, T. M., CAPLAN, A. I., GOLDBERG, V. M. & YOO, J. U. 1998. In vitro chondrogenesis of 
bone marrow-derived mesenchymal progenitor cells. Exp Cell Res, 238, 265-72. 
JOHNSTONE, I. L. 2000. Cuticle collagen genes. Expression in Caenorhabditis elegans. Trends Genet, 16, 21-7. 
JONES, S. W., JANVIER, A. J., SHIGDAR, S. M., HENSTOCK, J. R., MCARDLE, C., HOETTGES, K., MCARDLE, A. & 
JACKSON, M. J. 2020. Development of Functional, Contractile 3-D Human Muscle Constructs for 
Studies of the Effects of Microgravity on Muscle Mass and Function. The FASEB Journal, 34, 1-1. 
JOSHI, S. D. & WEBB, K. 2008. Variation of cyclic strain parameters regulates development of elastic modulus in 
fibroblast/substrate constructs. J Orthop Res, 26, 1105-13. 
JUHAS, M. & BURSAC, N. 2014. Roles of adherent myogenic cells and dynamic culture in engineered muscle 
function and maintenance of satellite cells. Biomaterials, 35, 9438-46. 
JULIN, J., JAMSEN, E., PUOLAKKA, T., KONTTINEN, Y. T. & MOILANEN, T. 2010. Younger age increases the risk of 
early prosthesis failure following primary total knee replacement for osteoarthritis. A follow-up study 
of 32,019 total knee replacements in the Finnish Arthroplasty Register. Acta Orthop, 81, 413-9. 
JUNCOSA-MELVIN, N., MATLIN, K. S., HOLDCRAFT, R. W., NIRMALANANDHAN, V. S. & BUTLER, D. L. 2007. 
Mechanical stimulation increases collagen type I and collagen type III gene expression of stem cell-
collagen sponge constructs for patellar tendon repair. Tissue Eng, 13, 1219-26. 
JUNCOSA-MELVIN, N., SHEARN, J. T., BOIVIN, G. P., GOOCH, C., GALLOWAY, M. T., WEST, J. R., 
NIRMALANANDHAN, V. S., BRADICA, G. & BUTLER, D. L. 2006. Effects of mechanical stimulation on the 
biomechanics and histology of stem cell-collagen sponge constructs for rabbit patellar tendon repair. 
Tissue Eng, 12, 2291-300. 
KADLER, K. E., BALDOCK, C., BELLA, J. & BOOT-HANDFORD, R. P. 2007. Collagens at a glance. J Cell Sci, 120, 
1955-8. 
KADLER, K. E., HILL, A. & CANTY-LAIRD, E. G. 2008. Collagen fibrillogenesis: fibronectin, integrins, and minor 
collagens as organizers and nucleators. Curr Opin Cell Biol, 20, 495-501. 
KADLER, K. E., HOJIMA, Y. & PROCKOP, D. J. 1987. Assembly of collagen fibrils de novo by cleavage of the type I 
pC-collagen with procollagen C-proteinase. Assay of critical concentration demonstrates that collagen 
self-assembly is a classical example of an entropy-driven process. J Biol Chem, 262, 15696-701. 
KADLER, K. E., HOJIMA, Y. & PROCKOP, D. J. 1990. Collagen fibrils in vitro grow from pointed tips in the C- to N-
terminal direction. Biochem J, 268, 339-43. 
KADLER, K. E., HOLMES, D. F., TROTTER, J. A. & CHAPMAN, J. A. 1996. Collagen fibril formation. Biochem J, 316 ( 
Pt 1), 1-11. 
KAIPATUR, N. R., MURSHED, M. & MCKEE, M. D. 2008. Matrix Gla protein inhibition of tooth mineralization. J 
Dent Res, 87, 839-44. 
KALAMAJSKI, S., ASPBERG, A., LINDBLOM, K., HEINEGARD, D. & OLDBERG, A. 2009. Asporin competes with 
decorin for collagen binding, binds calcium and promotes osteoblast collagen mineralization. Biochem 
J, 423, 53-9. 
KALSON, N. S., HOLMES, D. F., HERCHENHAN, A., LU, Y., STARBORG, T. & KADLER, K. E. 2011. Slow stretching 
that mimics embryonic growth rate stimulates structural and mechanical development of tendon-like 
tissue in vitro. Dev Dyn, 240, 2520-8. 
KANAFI, M. M., RAMESH, A., GUPTA, P. K. & BHONDE, R. R. 2014. Dental pulp stem cells immobilized in alginate 
microspheres for applications in bone tissue engineering. Int Endod J, 47, 687-97. 
KANAUJIYA, J., BASTOW, E., LUXMI, R., HAO, Z., ZATTAS, D., HOCHSTRASSER, M., REICHENBERGER, E. J. & CHEN, 
I. P. 2018. Rapid degradation of progressive ankylosis protein (ANKH) in craniometaphyseal dysplasia. 
Sci Rep, 8, 15710. 





KAPOOR, R., BORNSTEIN, P. & SAGE, E. H. 1986. Type VIII collagen from bovine Descemet's membrane: 
structural characterization of a triple-helical domain. Biochemistry, 25, 3930-7. 
KAPOOR, R., SAKAI, L. Y., FUNK, S., ROUX, E., BORNSTEIN, P. & SAGE, E. H. 1988. Type VIII collagen has a 
restricted distribution in specialized extracellular matrices. J Cell Biol, 107, 721-30. 
KAPS, C., BRAMLAGE, C., SMOLIAN, H., HAISCH, A., UNGETHUM, U., BURMESTER, G. R., SITTINGER, M., GROSS, 
G. & HAUPL, T. 2002. Bone morphogenetic proteins promote cartilage differentiation and protect 
engineered artificial cartilage from fibroblast invasion and destruction. Arthritis Rheum, 46, 149-62. 
KARAGLANI, M., TOUMPOULIS, I., GOUTAS, N., POUMPOURIDOU, N., VLACHODIMITROPOULOS, D., VASILAROS, 
S., RIZOS, I. & KROUPIS, C. 2015. Development of novel real-time PCR methodology for quantification 
of COL11A1 mRNA variants and evaluation in breast cancer tissue specimens. BMC Cancer, 15, 694. 
KARAMUK, E., MAYER, J. & RAEBER, G. 2004. Tissue engineered composite of a woven fabric scaffold with 
tendon cells, response on mechanical simulation in vitro. Composites science and technology, 64, 885-
891. 
KARSDAL, M. 2019. Biochemistry of collagens, laminins and elastin: structure, function and biomarkers, 
Academic Press. 
KARSDAL, M. A., NIELSEN, S. H., LEEMING, D. J., LANGHOLM, L. L., NIELSEN, M. J., MANON-JENSEN, T., SIEBUHR, 
A., GUDMANN, N. S., RONNOW, S., SAND, J. M., DANIELS, S. J., MORTENSEN, J. H. & SCHUPPAN, D. 
2017. The good and the bad collagens of fibrosis - Their role in signaling and organ function. Adv Drug 
Deliv Rev, 121, 43-56. 
KARYSTINOU, A., ROELOFS, A. J., NEVE, A., CANTATORE, F. P., WACKERHAGE, H. & DE BARI, C. 2015. Yes-
associated protein (YAP) is a negative regulator of chondrogenesis in mesenchymal stem cells. 
Arthritis Res Ther, 17, 147. 
KASSNER, A., HANSEN, U., MIOSGE, N., REINHARDT, D. P., AIGNER, T., BRUCKNER-TUDERMAN, L., BRUCKNER, P. 
& GRASSEL, S. 2003. Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded 
microfibrils. Matrix Biol, 22, 131-43. 
KATTAMIS, N. T., PURNICK, P. E., WEISS, R. & ARNOLD, C. B. 2007. Thick film laser induced forward transfer for 
deposition of thermally and mechanically sensitive materials. Applied Physics Letters, 91, 171120. 
KAUX, J. F., FORTHOMME, B., GOFF, C. L., CRIELAARD, J. M. & CROISIER, J. L. 2011. Current opinions on 
tendinopathy. J Sports Sci Med, 10, 238-53. 
KAWANISHI, M., OURA, A., FURUKAWA, K., FUKUBAYASHI, T., NAKAMURA, K., TATEISHI, T. & USHIDA, T. 2007. 
Redifferentiation of dedifferentiated bovine articular chondrocytes enhanced by cyclic hydrostatic 
pressure under a gas-controlled system. Tissue Eng, 13, 957-64. 
KEANE, T. J., DEWARD, A., LONDONO, R., SALDIN, L. T., CASTLETON, A. A., CAREY, L., NIEPONICE, A., LAGASSE, E. 
& BADYLAK, S. F. 2015. Tissue-Specific Effects of Esophageal Extracellular Matrix. Tissue Eng Part A, 
21, 2293-300. 
KEARNEY, E. M., PRENDERGAST, P. J. & CAMPBELL, V. A. 2008. Mechanisms of strain-mediated mesenchymal 
stem cell apoptosis. J Biomech Eng, 130, 061004. 
KEENE, D. R., ENGVALL, E. & GLANVILLE, R. W. 1988. Ultrastructure of type VI collagen in human skin and 
cartilage suggests an anchoring function for this filamentous network. J Cell Biol, 107, 1995-2006. 
KEENE, D. R., LUNSTRUM, G. P., MORRIS, N. P., STODDARD, D. W. & BURGESON, R. E. 1991. Two type XII-like 
collagens localize to the surface of banded collagen fibrils. J Cell Biol, 113, 971-8. 
KEENE, D. R., SAKAI, L. Y., LUNSTRUM, G. P., MORRIS, N. P. & BURGESON, R. E. 1987. Type VII collagen forms an 
extended network of anchoring fibrils. J Cell Biol, 104, 611-21. 
KELLY, B. E., BHATTACHARYA, I., HEIDARI, H., SHUSTEFF, M., SPADACCINI, C. M. & TAYLOR, H. K. 2019. 
Volumetric additive manufacturing via tomographic reconstruction. Science, 363, 1075-1079. 
KERSTEEN, E. A. & RAINES, R. T. 2001. Contribution of tertiary amides to the conformational stability of collagen 
triple helices. Biopolymers, 59, 24-8. 
KESSLER, E., TAKAHARA, K., BINIAMINOV, L., BRUSEL, M. & GREENSPAN, D. S. 1996. Bone morphogenetic 
protein-1: the type I procollagen C-proteinase. Science, 271, 360-2. 
KHARAZ, Y. A., TEW, S. R., PEFFERS, M., CANTY-LAIRD, E. G. & COMERFORD, E. 2016. Proteomic differences 
between native and tissue-engineered tendon and ligament. Proteomics, 16, 1547-56. 
KHODABUKUS, A., PRABHU, N., WANG, J. & BURSAC, N. 2018. In Vitro Tissue-Engineered Skeletal Muscle 
Models for Studying Muscle Physiology and Disease. Adv Healthc Mater, 7, e1701498. 
KHOSHNOODI, J., PEDCHENKO, V. & HUDSON, B. G. 2008. Mammalian collagen IV. Microsc Res Tech, 71, 357-
70. 
KHUNMANEE, S., JEONG, Y. & PARK, H. 2017. Crosslinking method of hyaluronic-based hydrogel for biomedical 
applications. J Tissue Eng, 8, 2041731417726464. 
KHURANA, J. S. 2009. Bone pathology, Springer Science & Business Media. 
KIELTY, C. M., WHITTAKER, S. P., GRANT, M. E. & SHUTTLEWORTH, C. A. 1992. Type VI collagen microfibrils: 
evidence for a structural association with hyaluronan. J Cell Biol, 118, 979-90. 






KIM, S. J., SHIN, Y. W., YANG, K. H., KIM, S. B., YOO, M. J., HAN, S. K., IM, S. A., WON, Y. D., SUNG, Y. B., JEON, T. 
S., CHANG, C. H., JANG, J. D., LEE, S. B., KIM, H. C. & LEE, S. Y. 2009. A multi-center, randomized, 
clinical study to compare the effect and safety of autologous cultured osteoblast(Ossron) injection to 
treat fractures. BMC Musculoskelet Disord, 10, 20. 
KIM, Y. & KUMAR, S. 2014. CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and 
invasive motility. Mol Cancer Res, 12, 1416-29. 
KINDBLOM, J. M., NILSSON, O., HURME, T., OHLSSON, C. & SAVENDAHL, L. 2002. Expression and localization of 
Indian hedgehog (Ihh) and parathyroid hormone related protein (PTHrP) in the human growth plate 
during pubertal development. J Endocrinol, 174, R1-6. 
KIRTON, J. P., CROFTS, N. J., GEORGE, S. J., BRENNAN, K. & CANFIELD, A. E. 2007. Wnt/beta-catenin signaling 
stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to 
vascular disease? Circ Res, 101, 581-9. 
KISHIMOTO, Y., OHKAWARA, B., SAKAI, T., ITO, M., MASUDA, A., ISHIGURO, N., SHUKUNAMI, C., DOCHEVA, D. & 
OHNO, K. 2017. Wnt/beta-catenin signaling suppresses expressions of Scx, Mkx, and Tnmd in tendon-
derived cells. PLoS One, 12, e0182051. 
KJAER, M. 2004. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. 
Physiol Rev, 84, 649-98. 
KNIGHT, R. L., WILCOX, H. E., KOROSSIS, S. A., FISHER, J. & INGHAM, E. 2008. The use of acellular matrices for 
the tissue engineering of cardiac valves. Proc Inst Mech Eng H, 222, 129-43. 
KNOTT, L. & BAILEY, A. J. 1998. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, 
and clinical relevance. Bone, 22, 181-7. 
KNUPP, C., PINALI, C., MUNRO, P. M., GRUBER, H. E., SHERRATT, M. J., BALDOCK, C. & SQUIRE, J. M. 2006. 
Structural correlation between collagen VI microfibrils and collagen VI banded aggregates. J Struct 
Biol, 154, 312-26. 
KNUPP, C. & SQUIRE, J. M. 2003. Molecular packing in network-forming collagens. ScientificWorldJournal, 3, 
558-77. 
KOCH, M., FOLEY, J. E., HAHN, R., ZHOU, P., BURGESON, R. E., GERECKE, D. R. & GORDON, M. K. 2001. alpha 
1(Xx) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted 
triple helices. J Biol Chem, 276, 23120-6. 
KOCH, M., LAUB, F., ZHOU, P., HAHN, R. A., TANAKA, S., BURGESON, R. E., GERECKE, D. R., RAMIREZ, F. & 
GORDON, M. K. 2003. Collagen XXIV, a vertebrate fibrillar collagen with structural features of 
invertebrate collagens: selective expression in developing cornea and bone. J Biol Chem, 278, 43236-
44. 
KOCH, M., SCHULZE, J., HANSEN, U., ASHWODT, T., KEENE, D. R., BRUNKEN, W. J., BURGESON, R. E., BRUCKNER, 
P. & BRUCKNER-TUDERMAN, L. 2004. A novel marker of tissue junctions, collagen XXII. J Biol Chem, 
279, 22514-21. 
KOCH, M., VEIT, G., STRICKER, S., BHATT, P., KUTSCH, S., ZHOU, P., REINDERS, E., HAHN, R. A., SONG, R., 
BURGESON, R. E., GERECKE, D. R., MUNDLOS, S. & GORDON, M. K. 2006. Expression of type XXIII 
collagen mRNA and protein. J Biol Chem, 281, 21546-57. 
KOHN, A. D. & MOON, R. T. 2005. Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium, 
38, 439-46. 
KOMORI, T. 2006. Regulation of osteoblast differentiation by transcription factors. J Cell Biochem, 99, 1233-9. 
KOMORI, T. 2010. Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue 
Res, 339, 189-95. 
KONG, X. B., TANG, Q. Y., CHEN, X. Y., TU, Y., SUN, S. Z. & SUN, Z. L. 2017. Polyethylene glycol as a promising 
synthetic material for repair of spinal cord injury. Neural Regen Res, 12, 1003-1008. 
KORHONEN, R. K. & JURVELIN, J. S. 2010. Compressive and tensile properties of articular cartilage in axial 
loading are modulated differently by osmotic environment. Med Eng Phys, 32, 155-60. 
KOSTENUIK, P. & MIRZA, F. M. 2017. Fracture healing physiology and the quest for therapies for delayed healing 
and nonunion. J Orthop Res, 35, 213-223. 
KRAHN, K. N., BOUTEN, C. V., VAN TUIJL, S., VAN ZANDVOORT, M. A. & MERKX, M. 2006. Fluorescently labeled 
collagen binding proteins allow specific visualization of collagen in tissues and live cell culture. Anal 
Biochem, 350, 177-85. 
KUO, H. J., MASLEN, C. L., KEENE, D. R. & GLANVILLE, R. W. 1997. Type VI collagen anchors endothelial 
basement membranes by interacting with type IV collagen. J Biol Chem, 272, 26522-9. 
KUPCSIK, L., ALINI, M. & STODDART, M. J. 2009. Epsilon-aminocaproic acid is a useful fibrin degradation 
inhibitor for cartilage tissue engineering. Tissue Eng Part A, 15, 2309-13. 
KURODA, R., USAS, A., KUBO, S., CORSI, K., PENG, H., ROSE, T., CUMMINS, J., FU, F. H. & HUARD, J. 2006. 
Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum, 
54, 433-42. 
KWAN, A. P., CUMMINGS, C. E., CHAPMAN, J. A. & GRANT, M. E. 1991. Macromolecular organization of chicken 





KWAN, K. M., PANG, M. K., ZHOU, S., COWAN, S. K., KONG, R. Y., PFORDTE, T., OLSEN, B. R., SILLENCE, D. O., 
TAM, P. P. & CHEAH, K. S. 1997. Abnormal compartmentalization of cartilage matrix components in 
mice lacking collagen X: implications for function. J Cell Biol, 136, 459-71. 
LACEY, D. L., TIMMS, E., TAN, H. L., KELLEY, M. J., DUNSTAN, C. R., BURGESS, T., ELLIOTT, R., COLOMBERO, A., 
ELLIOTT, G., SCULLY, S., HSU, H., SULLIVAN, J., HAWKINS, N., DAVY, E., CAPPARELLI, C., ELI, A., QIAN, Y. 
X., KAUFMAN, S., SAROSI, I., SHALHOUB, V., SENALDI, G., GUO, J., DELANEY, J. & BOYLE, W. J. 1998. 
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell, 93, 
165-76. 
LAHM, A., MROSEK, E., SPANK, H., ERGGELET, C., KASCH, R., ESSER, J. & MERK, H. 2010. Changes in content and 
synthesis of collagen types and proteoglycans in osteoarthritis of the knee joint and comparison of 
quantitative analysis with Photoshop-based image analysis. Arch Orthop Trauma Surg, 130, 557-64. 
LAMANDE, S. R., MORGELIN, M., ADAMS, N. E., SELAN, C. & ALLEN, J. M. 2006. The C5 domain of the collagen VI 
alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular 
matrix of cultured cells. J Biol Chem, 281, 16607-14. 
LANDIS, W. J. & JACQUET, R. 2013. Association of calcium and phosphate ions with collagen in the 
mineralization of vertebrate tissues. Calcif Tissue Int, 93, 329-37. 
LANZA, R., LANGER, R., VACANTI, J. P. & ATALA, A. 2020. Principles of tissue engineering, Academic press. 
LATVANLEHTO, A., FOX, M. A., SORMUNEN, R., TU, H., OIKARAINEN, T., KOSKI, A., NAUMENKO, N., 
SHAKIRZYANOVA, A., KALLIO, M., ILVES, M., GINIATULLIN, R., SANES, J. R. & PIHLAJANIEMI, T. 2010. 
Muscle-derived collagen XIII regulates maturation of the skeletal neuromuscular junction. J Neurosci, 
30, 12230-41. 
LATVANLEHTO, A., SNELLMAN, A., TU, H. & PIHLAJANIEMI, T. 2003. Type XIII collagen and some other 
transmembrane collagens contain two separate coiled-coil motifs, which may function as 
independent oligomerization domains. J Biol Chem, 278, 37590-9. 
LAVAGNINO, M., ARNOCZKY, S. P., FRANK, K. & TIAN, T. 2005. Collagen fibril diameter distribution does not 
reflect changes in the mechanical properties of in vitro stress-deprived tendons. J Biomech, 38, 69-75. 
LAVIEU, G., ZHENG, H. & ROTHMAN, J. E. 2013. Stapled Golgi cisternae remain in place as cargo passes through 
the stack. Elife, 2, e00558. 
LAWRIE, A. S., MCDONALD, S. J., PURDY, G., MACKIE, I. J. & MACHIN, S. J. 1998. Prothrombin time derived 
fibrinogen determination on Sysmex CA-6000. J Clin Pathol, 51, 462-6. 
LAZARINI, M., BORDEAUX-REGO, P., GIARDINI-ROSA, R., DUARTE, A. S. S., BARATTI, M. O., ZORZI, A. R., DE 
MIRANDA, J. B., LENZ CESAR, C., LUZO, A. & OLALLA SAAD, S. T. 2017. Natural Type II Collagen 
Hydrogel, Fibrin Sealant, and Adipose-Derived Stem Cells as a Promising Combination for Articular 
Cartilage Repair. Cartilage, 8, 439-443. 
LEBLEU, V. S., MACDONALD, B. & KALLURI, R. 2007. Structure and function of basement membranes. Exp Biol 
Med (Maywood), 232, 1121-9. 
LEE, J. H. & KIM, H. W. 2018. Emerging properties of hydrogels in tissue engineering. J Tissue Eng, 9, 
2041731418768285. 
LEE, J. K., HUWE, L. W., PASCHOS, N., ARYAEI, A., GEGG, C. A., HU, J. C. & ATHANASIOU, K. A. 2017. Tension 
stimulation drives tissue formation in scaffold-free systems. Nat Mater, 16, 864-873. 
LEE, K. I., LEE, J. S., KANG, K. T., SHIM, Y. B., KIM, Y. S., JANG, J. W., MOON, S. H. & D'LIMA, D. D. 2018. In Vitro 
and In Vivo Performance of Tissue-Engineered Tendons for Anterior Cruciate Ligament 
Reconstruction. Am J Sports Med, 46, 1641-1649. 
LEE, Y. J., RICE, R. H. & LEE, Y. M. 2006. Proteome analysis of human hair shaft: from protein identification to 
posttranslational modification. Mol Cell Proteomics, 5, 789-800. 
LEFEBVRE, V. & SMITS, P. 2005. Transcriptional control of chondrocyte fate and differentiation. Birth Defects 
Res C Embryo Today, 75, 200-12. 
LEGERLOTZ, K., RILEY, G. P. & SCREEN, H. R. 2013. GAG depletion increases the stress-relaxation response of 
tendon fascicles, but does not influence recovery. Acta Biomater, 9, 6860-6. 
LEI, X., CAO, Y., ZHANG, Y., QIAN, J., ZHAO, Q., LIU, F., ZHANG, T., ZHOU, J., GU, Y., XIA, G. & DUAN, E. 2018. 
Effect of microgravity on proliferation and differentiation of embryonic stem cells in an automated 
culturing system during the TZ-1 space mission. Cell Prolif, 51, e12466. 
LEMMA, S., AVNET, S., SALERNO, M., CHANO, T. & BALDINI, N. 2016. Identification and Validation of 
Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells. PLoS One, 11, e0149481. 
LENDECKEL, S., JODICKE, A., CHRISTOPHIS, P., HEIDINGER, K., WOLFF, J., FRASER, J. K., HEDRICK, M. H., 
BERTHOLD, L. & HOWALDT, H. P. 2004. Autologous stem cells (adipose) and fibrin glue used to treat 
widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg, 32, 370-3. 
LENTH, R. 2020. emmeans: Estimated Marginal Means, aka Least-Squares Means. . 1.5-2.1 ed. 
LI, A., WEI, Y., HUNG, C. & VUNJAK-NOVAKOVIC, G. 2018. Chondrogenic properties of collagen type XI, a 
component of cartilage extracellular matrix. Biomaterials, 173, 47-57. 
LI, G., FU, N., YANG, X., LI, M., BA, K., WEI, X., FU, Y., YAO, Y., CAI, X. & LIN, Y. 2013. Mechanical compressive 





LI, J., BAO, Q., CHEN, S., LIU, H., FENG, J., QIN, H., LI, A., LIU, D., SHEN, Y., ZHAO, Y. & ZONG, Z. 2017a. Different 
bone remodeling levels of trabecular and cortical bone in response to changes in Wnt/beta-catenin 
signaling in mice. J Orthop Res, 35, 812-819. 
LI, J., ZHANG, S., CHEN, J., DU, T., WANG, Y. & WANG, Z. 2009. Modeled microgravity causes changes in the 
cytoskeleton and focal adhesions, and decreases in migration in malignant human MCF-7 cells. 
Protoplasma, 238, 23-33. 
LI, K., ZHANG, C., QIU, L., GAO, L. & ZHANG, X. 2017b. Advances in Application of Mechanical Stimuli in 
Bioreactors for Cartilage Tissue Engineering. Tissue Eng Part B Rev, 23, 399-411. 
LI, S. W., SIERON, A. L., FERTALA, A., HOJIMA, Y., ARNOLD, W. V. & PROCKOP, D. J. 1996. The C-proteinase that 
processes procollagens to fibrillar collagens is identical to the protein previously identified as bone 
morphogenic protein-1. Proc Natl Acad Sci U S A, 93, 5127-30. 
LIAO, J. & VESELY, I. 2003. A structural basis for the size-related mechanical properties of mitral valve chordae 
tendineae. J Biomech, 36, 1125-33. 
LIN, G. L. & HANKENSON, K. D. 2011. Integration of BMP, Wnt, and notch signaling pathways in osteoblast 
differentiation. J Cell Biochem, 112, 3491-501. 
LIN, T. W., CARDENAS, L. & SOSLOWSKY, L. J. 2004. Biomechanics of tendon injury and repair. J Biomech, 37, 
865-77. 
LIN, X., PATIL, S., GAO, Y. G. & QIAN, A. 2020. The Bone Extracellular Matrix in Bone Formation and 
Regeneration. Front Pharmacol, 11, 757. 
LINDROOS, B., MAENPAA, K., YLIKOMI, T., OJA, H., SUURONEN, R. & MIETTINEN, S. 2008. Characterisation of 
human dental stem cells and buccal mucosa fibroblasts. Biochem Biophys Res Commun, 368, 329-35. 
LISIGNOLI, G., CODELUPPI, K., TODOERTI, K., MANFERDINI, C., PIACENTINI, A., ZINI, N., GRASSI, F., CATTINI, L., 
PIVA, R., RIZZOLI, V., FACCHINI, A., GIULIANI, N. & NERI, A. 2009. Gene array profile identifies collagen 
type XV as a novel human osteoblast-secreted matrix protein. J Cell Physiol, 220, 401-9. 
LIU, C., ZHAO, Y., CHEUNG, W. Y., GANDHI, R., WANG, L. & YOU, L. 2010a. Effects of cyclic hydraulic pressure on 
osteocytes. Bone, 46, 1449-56. 
LIU, C. F., BREIDENBACH, A., ASCHBACHER-SMITH, L., BUTLER, D. & WYLIE, C. 2013. A role for hedgehog 
signaling in the differentiation of the insertion site of the patellar tendon in the mouse. PLoS One, 8, 
e65411. 
LIU, J., ZHAO, Z., LI, J., ZOU, L., SHULER, C., ZOU, Y., HUANG, X., LI, M. & WANG, J. 2009a. Hydrostatic pressures 
promote initial osteodifferentiation with ERK1/2 not p38 MAPK signaling involved. J Cell Biochem, 
107, 224-32. 
LIU, J., ZOU, L., WANG, J., SCHULER, C., ZHAO, Z., LI, X., ZHANG, J. & LIU, Y. 2009b. Hydrostatic pressure 
promotes Wnt10b and Wnt4 expression dependent and independent on ERK signaling in early-
osteoinduced MSCs. Biochem Biophys Res Commun, 379, 505-9. 
LIU, L., WU, W., TUO, X., GENG, W., ZHAO, J., WEI, J., YAN, X., YANG, W., LI, L. & CHEN, F. 2010b. Novel strategy 
to engineer trachea cartilage graft with marrow mesenchymal stem cell macroaggregate and 
hydrolyzable scaffold. Artif Organs, 34, 426-33. 
LIU, Q., HATTA, T., QI, J., LIU, H., THORESON, A. R., AMADIO, P. C., MORAN, S. L., STEINMANN, S. P., GINGERY, A. 
& ZHAO, C. 2018. Novel engineered tendon-fibrocartilage-bone composite with cyclic tension for 
rotator cuff repair. J Tissue Eng Regen Med, 12, 1690-1701. 
LIU, Z. J., ZHUGE, Y. & VELAZQUEZ, O. C. 2009c. Trafficking and differentiation of mesenchymal stem cells. J Cell 
Biochem, 106, 984-91. 
LOHAN, A., MARZAHN, U., EL SAYED, K., HAISCH, A., MULLER, R. D., KOHL, B., STOLZEL, K., ERTEL, W., JOHN, T. & 
SCHULZE-TANZIL, G. 2014. Osteochondral articular defect repair using auricle-derived autologous 
chondrocytes in a rabbit model. Ann Anat, 196, 317-26. 
LONG, F. 2011. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol, 13, 
27-38. 
LORENZ, J., SEEBACH, E., HACKMAYER, G., GRETH, C., BAUER, R. J., KLEINSCHMIDT, K., BETTENWORTH, D., 
BOHM, M., GRIFKA, J. & GRASSEL, S. 2014. Melanocortin 1 receptor-signaling deficiency results in an 
articular cartilage phenotype and accelerates pathogenesis of surgically induced murine 
osteoarthritis. PLoS One, 9, e105858. 
LORTHONGPANICH, C., THUMANU, K., TANGKIETTRAKUL, K., JIAMVORAPHONG, N., LAOWTAMMATHRON, C., 
DAMKHAM, N., Y, U. P. & ISSARAGRISIL, S. 2019. YAP as a key regulator of adipo-osteogenic 
differentiation in human MSCs. Stem Cell Res Ther, 10, 402. 
LOTERIE, D., DELROT, P. & MOSER, C. 2018. Volumetric 3D printing of elastomers by tomographic back-
projection. Preprint at https://doi. org/10.13140/RG, 2. 
LU, D. & KASSAB, G. S. 2011. Role of shear stress and stretch in vascular mechanobiology. J R Soc Interface, 8, 
1379-85. 
LU, Y., MAPILI, G., SUHALI, G., CHEN, S. & ROY, K. 2006. A digital micro-mirror device-based system for the 






LUO, Y., SINKEVICIUTE, D., HE, Y., KARSDAL, M., HENROTIN, Y., MOBASHERI, A., ONNERFJORD, P. & BAY-JENSEN, 
A. 2017. The minor collagens in articular cartilage. Protein Cell, 8, 560-572. 
LUYTEN, F. P., YU, Y. M., YANAGISHITA, M., VUKICEVIC, S., HAMMONDS, R. G. & REDDI, A. H. 1992. Natural 
bovine osteogenin and recombinant human bone morphogenetic protein-2B are equipotent in the 
maintenance of proteoglycans in bovine articular cartilage explant cultures. J Biol Chem, 267, 3691-5. 
MACKIE, E. J., AHMED, Y. A., TATARCZUCH, L., CHEN, K. S. & MIRAMS, M. 2008. Endochondral ossification: how 
cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol, 40, 46-62. 
MAEDA, E., FLEISCHMANN, C., MEIN, C. A., SHELTON, J. C., BADER, D. L. & LEE, D. A. 2010. Functional analysis of 
tenocytes gene expression in tendon fascicles subjected to cyclic tensile strain. Connect Tissue Res, 
51, 434-44. 
MAEHATA, Y., TAKAMIZAWA, S., OZAWA, S., IZUKURI, K., KATO, Y., SATO, S., LEE, M. C., KIMURA, A. & HATA, R. 
2007. Type III collagen is essential for growth acceleration of human osteoblastic cells by ascorbic acid 
2-phosphate, a long-acting vitamin C derivative. Matrix Biol, 26, 371-81. 
MAGID, A. & LAW, D. J. 1985. Myofibrils bear most of the resting tension in frog skeletal muscle. Science, 230, 
1280-2. 
MAGNUSSON, S. P., HANSEN, P. & KJAER, M. 2003. Tendon properties in relation to muscular activity and 
physical training. Scand J Med Sci Sports, 13, 211-23. 
MAGUIRE, T. J. & NOVIK, E. 2010. Methods in Bioengineering: Alternative Technologies to Animal Testing, 
Artech House. 
MAJD, H., WIPFF, P. J., BUSCEMI, L., BUENO, M., VONWIL, D., QUINN, T. M. & HINZ, B. 2009. A novel method of 
dynamic culture surface expansion improves mesenchymal stem cell proliferation and phenotype. 
Stem Cells, 27, 200-9. 
MAJESKA, R. J. & WUTHIER, R. E. 1975. Studies on matrix vesicles isolated from chick epiphyseal cartilage. 
Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochim Biophys 
Acta, 391, 51-60. 
MAK, K. K., CHEN, M. H., DAY, T. F., CHUANG, P. T. & YANG, Y. 2006. Wnt/beta-catenin signaling interacts 
differentially with Ihh signaling in controlling endochondral bone and synovial joint formation. 
Development, 133, 3695-707. 
MAK, K. M. & MEI, R. 2017. Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology 
and Value as Fibrosis Biomarkers of Liver Disease. Anat Rec (Hoboken), 300, 1371-1390. 
MAK, K. M., PNG, C. Y. & LEE, D. J. 2016. Type V Collagen in Health, Disease, and Fibrosis. Anat Rec (Hoboken), 
299, 613-29. 
MAKRIS, E. A., GOMOLL, A. H., MALIZOS, K. N., HU, J. C. & ATHANASIOU, K. A. 2015. Repair and tissue 
engineering techniques for articular cartilage. Nat Rev Rheumatol, 11, 21-34. 
MALHOTRA, V. & ERLMANN, P. 2015. The pathway of collagen secretion. Annu Rev Cell Dev Biol, 31, 109-24. 
MALHOTRA, V., ERLMANN, P. & NOGUEIRA, C. 2015. Procollagen export from the endoplasmic reticulum. 
Biochem Soc Trans, 43, 104-7. 
MANDRYCKY, C., WANG, Z., KIM, K. & KIM, D. H. 2016. 3D bioprinting for engineering complex tissues. 
Biotechnol Adv, 34, 422-434. 
MANOLAGAS, S. C. 2000. Birth and death of bone cells: basic regulatory mechanisms and implications for the 
pathogenesis and treatment of osteoporosis. Endocr Rev, 21, 115-37. 
MARCACCI, M., KON, E., MOUKHACHEV, V., LAVROUKOV, A., KUTEPOV, S., QUARTO, R., MASTROGIACOMO, M. 
& CANCEDDA, R. 2007. Stem cells associated with macroporous bioceramics for long bone repair: 6- 
to 7-year outcome of a pilot clinical study. Tissue Eng, 13, 947-55. 
MARCELINO, J., CARPTEN, J. D., SUWAIRI, W. M., GUTIERREZ, O. M., SCHWARTZ, S., ROBBINS, C., SOOD, R., 
MAKALOWSKA, I., BAXEVANIS, A., JOHNSTONE, B., LAXER, R. M., ZEMEL, L., KIM, C. A., HERD, J. K., 
IHLE, J., WILLIAMS, C., JOHNSON, M., RAMAN, V., ALONSO, L. G., BRUNONI, D., GERSTEIN, A., 
PAPADOPOULOS, N., BAHABRI, S. A., TRENT, J. M. & WARMAN, M. L. 1999. CACP, encoding a secreted 
proteoglycan, is mutated in camptodactyly-arthropathy-coxa vara-pericarditis syndrome. Nat Genet, 
23, 319-22. 
MARESCHI, K., FERRERO, I., RUSTICHELLI, D., ASCHERO, S., GAMMAITONI, L., AGLIETTA, M., MADON, E. & 
FAGIOLI, F. 2006. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone 
marrow. J Cell Biochem, 97, 744-54. 
MARINOVICH, R., SOENJAYA, Y., WALLACE, G. Q., ZUSKOV, A., DUNKMAN, A., FOSTER, B. L., AO, M., BARTMAN, 
K., LAM, V., RIZKALLA, A., BEIER, F., SOMERMAN, M. J., HOLDSWORTH, D. W., SOSLOWSKY, L. J., 
LAGUGNE-LABARTHET, F. & GOLDBERG, H. A. 2016. The role of bone sialoprotein in the tendon-bone 
insertion. Matrix Biol, 52-54, 325-338. 
MARTEL-PELLETIER, J., BOILEAU, C., PELLETIER, J. P. & ROUGHLEY, P. J. 2008. Cartilage in normal and 
osteoarthritis conditions. Best Pract Res Clin Rheumatol, 22, 351-84. 
MARTIN, I., WENDT, D. & HEBERER, M. 2004. The role of bioreactors in tissue engineering. Trends Biotechnol, 
22, 80-6. 
MARTINSEN, A., SKJAK-BRAEK, G. & SMIDSROD, O. 1989. Alginate as immobilization material: I. Correlation 





MARTURANO, J. E., ARENA, J. D., SCHILLER, Z. A., GEORGAKOUDI, I. & KUO, C. K. 2013. Characterization of 
mechanical and biochemical properties of developing embryonic tendon. Proc Natl Acad Sci U S A, 
110, 6370-5. 
MATSUO, N., TANAKA, S., YOSHIOKA, H., KOCH, M., GORDON, M. K. & RAMIREZ, F. 2008. Collagen XXIV 
(Col24a1) gene expression is a specific marker of osteoblast differentiation and bone formation. 
Connect Tissue Res, 49, 68-75. 
MATTEI, C., ALSHAWAF, A., D'ABACO, G., NAYAGAM, B. & DOTTORI, M. 2018. Generation of Neural Organoids 
from Human Embryonic Stem Cells Using the Rotary Cell Culture System: Effects of Microgravity on 
Neural Progenitor Cell Fate. Stem Cells Dev, 27, 848-857. 
MAYER-WAGNER, S., HAMMERSCHMID, F., REDEKER, J. I., SCHMITT, B., HOLZAPFEL, B. M., JANSSON, V., BETZ, 
O. B. & MULLER, P. E. 2014. Simulated microgravity affects chondrogenesis and hypertrophy of 
human mesenchymal stem cells. Int Orthop, 38, 2615-21. 
MCBEATH, R., PIRONE, D. M., NELSON, C. M., BHADRIRAJU, K. & CHEN, C. S. 2004. Cell shape, cytoskeletal 
tension, and RhoA regulate stem cell lineage commitment. Dev Cell, 6, 483-95. 
MCCARTHY, H. E., BARA, J. J., BRAKSPEAR, K., SINGHRAO, S. K. & ARCHER, C. W. 2012. The comparison of equine 
articular cartilage progenitor cells and bone marrow-derived stromal cells as potential cell sources for 
cartilage repair in the horse. Vet J, 192, 345-51. 
MCCAUGHEY, J., STEVENSON, N. L., CROSS, S. & STEPHENS, D. J. 2019. ER-to-Golgi trafficking of procollagen in 
the absence of large carriers. J Cell Biol, 218, 929-948. 
MCCULLOCH, C. A., STRUGURESCU, M., HUGHES, F., MELCHER, A. H. & AUBIN, J. E. 1991. Osteogenic progenitor 
cells in rat bone marrow stromal populations exhibit self-renewal in culture. Blood, 77, 1906-11. 
MCMAHON, L. A., CAMPBELL, V. A. & PRENDERGAST, P. J. 2008. Involvement of stretch-activated ion channels 
in strain-regulated glycosaminoglycan synthesis in mesenchymal stem cell-seeded 3D scaffolds. J 
Biomech, 41, 2055-9. 
MCNEILLY, C. M., BANES, A. J., BENJAMIN, M. & RALPHS, J. R. 1996. Tendon cells in vivo form a three 
dimensional network of cell processes linked by gap junctions. J Anat, 189 ( Pt 3), 593-600. 
MEGENS, R. T., OUDE EGBRINK, M. G., CLEUTJENS, J. P., KUIJPERS, M. J., SCHIFFERS, P. H., MERKX, M., SLAAF, D. 
W. & VAN ZANDVOORT, M. A. 2007. Imaging collagen in intact viable healthy and atherosclerotic 
arteries using fluorescently labeled CNA35 and two-photon laser scanning microscopy. Mol Imaging, 
6, 247-60. 
MEINERT, C., SCHROBBACK, K., HUTMACHER, D. W. & KLEIN, T. J. 2017. A novel bioreactor system for biaxial 
mechanical loading enhances the properties of tissue-engineered human cartilage. Sci Rep, 7, 16997. 
MENDLER, M., EICH-BENDER, S. G., VAUGHAN, L., WINTERHALTER, K. H. & BRUCKNER, P. 1989. Cartilage 
contains mixed fibrils of collagen types II, IX, and XI. J Cell Biol, 108, 191-7. 
MESIMAKI, K., LINDROOS, B., TORNWALL, J., MAUNO, J., LINDQVIST, C., KONTIO, R., MIETTINEN, S. & 
SUURONEN, R. 2009. Novel maxillary reconstruction with ectopic bone formation by GMP adipose 
stem cells. Int J Oral Maxillofac Surg, 38, 201-9. 
MEYER, K. 1958. Chemical structure of hyaluronic acid. Fed Proc, 17, 1075-7. 
MEYERS, V. E., ZAYZAFOON, M., GONDA, S. R., GATHINGS, W. E. & MCDONALD, J. M. 2004. Modeled 
microgravity disrupts collagen I/integrin signaling during osteoblastic differentiation of human 
mesenchymal stem cells. J Cell Biochem, 93, 697-707. 
MIENALTOWSKI, M. J. & BIRK, D. E. 2014. Structure, physiology, and biochemistry of collagens. Adv Exp Med 
Biol, 802, 5-29. 
MIKIC, B., JOHNSON, T. L., CHHABRA, A. B., SCHALET, B. J., WONG, M. & HUNZIKER, E. B. 2000. Differential 
effects of embryonic immobilization on the development of fibrocartilaginous skeletal elements. J 
Rehabil Res Dev, 37, 127-33. 
MILLER, E. A. & SCHEKMAN, R. 2013. COPII - a flexible vesicle formation system. Curr Opin Cell Biol, 25, 420-7. 
MILLER, E. J. & MATUKAS, V. J. 1969. Chick cartilage collagen: a new type of alpha 1 chain not present in bone 
or skin of the species. Proc Natl Acad Sci U S A, 64, 1264-8. 
MILLER, K., CHINZEI, K., ORSSENGO, G. & BEDNARZ, P. 2000. Mechanical properties of brain tissue in-vivo: 
experiment and computer simulation. J Biomech, 33, 1369-76. 
MINER, J. H. 2011. Basement membranes. The extracellular matrix: An overview. Springer. 
MIRONOV, V., BOLAND, T., TRUSK, T., FORGACS, G. & MARKWALD, R. R. 2003. Organ printing: computer-aided 
jet-based 3D tissue engineering. Trends Biotechnol, 21, 157-61. 
MISAWA, K., KANAZAWA, T., IMAI, A., ENDO, S., MOCHIZUKI, D., FUKUSHIMA, H., MISAWA, Y. & MINETA, H. 
2014. Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer 
patients. Mol Clin Oncol, 2, 285-291. 
MISOF, K., RAPP, G. & FRATZL, P. 1997. A new molecular model for collagen elasticity based on synchrotron X-
ray scattering evidence. Biophys J, 72, 1376-81. 
MITSUHARA, T., TAKEDA, M., YAMAGUCHI, S., MANABE, T., MATSUMOTO, M., KAWAHARA, Y., YUGE, L. & 
KURISU, K. 2013. Simulated microgravity facilitates cell migration and neuroprotection after bone 





MIZOKAMI, A., KAWAKUBO-YASUKOCHI, T. & HIRATA, M. 2017. Osteocalcin and its endocrine functions. 
Biochem Pharmacol, 132, 1-8. 
MODDER, U. I. & KHOSLA, S. 2008. Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, 
and relationship to the bone remodeling compartment. J Cell Biochem, 103, 393-400. 
MONTAGNE, K., ONUMA, Y., ITO, Y., AIKI, Y., FURUKAWA, K. S. & USHIDA, T. 2017. High hydrostatic pressure 
induces pro-osteoarthritic changes in cartilage precursor cells: A transcriptome analysis. PLoS One, 12, 
e0183226. 
MOOREHEAD, C., PRUDNIKOVA, K. & MARCOLONGO, M. 2019. The regulatory effects of proteoglycans on 
collagen fibrillogenesis and morphology investigated using biomimetic proteoglycans. J Struct Biol, 
206, 204-215. 
MORITA, Y., WATANABE, S., JU, Y. & XU, B. 2013. Determination of optimal cyclic uniaxial stretches for stem 
cell-to-tenocyte differentiation under a wide range of mechanical stretch conditions by evaluating 
gene expression and protein synthesis levels. Acta Bioeng Biomech, 15, 71-9. 
MOSS, D. W., EATON, R. H., SMITH, J. K. & WHITBY, L. G. 1967. Association of inorganic-pyrophosphatase 
activity with human alkaline-phosphatase preparations. Biochem J, 102, 53-7. 
MOW, V. C., HOLMES, M. H. & LAI, W. M. 1984. Fluid transport and mechanical properties of articular cartilage: 
a review. J Biomech, 17, 377-94. 
MOW, V. C. & WANG, C. C. 1999. Some bioengineering considerations for tissue engineering of articular 
cartilage. Clin Orthop Relat Res, S204-23. 
MUELLER, M. B. & TUAN, R. S. 2008. Functional characterization of hypertrophy in chondrogenesis of human 
mesenchymal stem cells. Arthritis Rheum, 58, 1377-88. 
MUNDLOS, S., CHAN, D., MCGILL, J. & BATEMAN, J. F. 1996. An alpha 1(II) Gly913 to Cys substitution prevents 
the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage 
from a patient with hypochondrogenesis. Am J Med Genet, 63, 129-36. 
MUNDLOS, S. & OLSEN, B. R. 1997. Heritable diseases of the skeleton. Part II: Molecular insights into skeletal 
development-matrix components and their homeostasis. FASEB J, 11, 227-33. 
MURDOCH, A. D., GRADY, L. M., ABLETT, M. P., KATOPODI, T., MEADOWS, R. S. & HARDINGHAM, T. E. 2007. 
Chondrogenic differentiation of human bone marrow stem cells in transwell cultures: generation of 
scaffold-free cartilage. Stem Cells, 25, 2786-96. 
MURSHED, M., HARMEY, D., MILLAN, J. L., MCKEE, M. D. & KARSENTY, G. 2005. Unique coexpression in 
osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to 
bone. Genes Dev, 19, 1093-104. 
MURSHID, A. & PRESLEY, J. F. 2004. ER-to-Golgi transport and cytoskeletal interactions in animal cells. Cell Mol 
Life Sci, 61, 133-45. 
MYERS, J. C., CHU, M. L., FARO, S. H., CLARK, W. J., PROCKOP, D. J. & RAMIREZ, F. 1981. Cloning a cDNA for the 
pro-alpha 2 chain of human type I collagen. Proc Natl Acad Sci U S A, 78, 3516-20. 
MYERS, J. C., DION, A. S., ABRAHAM, V. & AMENTA, P. S. 1996. Type XV collagen exhibits a widespread 
distribution in human tissues but a distinct localization in basement membrane zones. Cell Tissue Res, 
286, 493-505. 
MYERS, J. C., KIVIRIKKO, S., GORDON, M. K., DION, A. S. & PIHLAJANIEMI, T. 1992. Identification of a previously 
unknown human collagen chain, alpha 1(XV), characterized by extensive interruptions in the triple-
helical region. Proc Natl Acad Sci U S A, 89, 10144-8. 
MYERS, J. C., LI, D., AMENTA, P. S., CLARK, C. C., NAGASWAMI, C. & WEISEL, J. W. 2003. Type XIX collagen 
purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous 
subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding 
amino termini. J Biol Chem, 278, 32047-57. 
NABAVI, N., KHANDANI, A., CAMIRAND, A. & HARRISON, R. E. 2011. Effects of microgravity on osteoclast bone 
resorption and osteoblast cytoskeletal organization and adhesion. Bone, 49, 965-74. 
NARANDA, J., SUSEC, M., MAVER, U., GRADISNIK, L., GORENJAK, M., VUKASOVIC, A., IVKOVIC, A., RUPNIK, M. S., 
VOGRIN, M. & KRAJNC, P. 2016. Polyester type polyHIPE scaffolds with an interconnected porous 
structure for cartilage regeneration. Sci Rep, 6, 28695. 
NAZEMPOUR, A., QUISENBERRY, C. R., ABU-LAIL, N. I. & VAN WIE, B. J. 2017. Combined effects of oscillating 
hydrostatic pressure, perfusion and encapsulation in a novel bioreactor for enhancing extracellular 
matrix synthesis by bovine chondrocytes. Cell Tissue Res, 370, 179-193. 
NEBELUNG, S., GAVENIS, K., RATH, B., TINGART, M., LADENBURGER, A., STOFFEL, M., ZHOU, B. & MUELLER-
RATH, R. 2011. Continuous cyclic compressive loading modulates biological and mechanical properties 
of collagen hydrogels seeded with human chondrocytes. Biorheology, 48, 247-61. 
NG, K. W., MAUCK, R. L., WANG, C. C., KELLY, T. A., HO, M. M., CHEN, F. H., ATESHIAN, G. A. & HUNG, C. T. 2009. 
Duty Cycle of Deformational Loading Influences the Growth of Engineered Articular Cartilage. Cell Mol 
Bioeng, 2, 386-394. 
NGO, T. D., KASHANI, A., IMBALZANO, G., NGUYEN, K. T. & HUI, D. 2018. Additive manufacturing (3D printing): A 






NIELSEN, E. H. & BYTZER, P. 1979. High resolution scanning electron microscopy of elastic cartilage. J Anat, 129, 
823-31. 
NISHIYAMA, T., MCDONOUGH, A. M., BRUNS, R. R. & BURGESON, R. E. 1994. Type XII and XIV collagens mediate 
interactions between banded collagen fibers in vitro and may modulate extracellular matrix 
deformability. J Biol Chem, 269, 28193-9. 
NIYIBIZI, C. & EYRE, D. R. 1994. Structural characteristics of cross-linking sites in type V collagen of bone. Chain 
specificities and heterotypic links to type I collagen. Eur J Biochem, 224, 943-50. 
NOGUEIRA, C., ERLMANN, P., VILLENEUVE, J., SANTOS, A. J., MARTINEZ-ALONSO, E., MARTINEZ-MENARGUEZ, J. 
A. & MALHOTRA, V. 2014. SLY1 and Syntaxin 18 specify a distinct pathway for procollagen VII export 
from the endoplasmic reticulum. Elife, 3, e02784. 
NOHE, A., HASSEL, S., EHRLICH, M., NEUBAUER, F., SEBALD, W., HENIS, Y. I. & KNAUS, P. 2002. The mode of 
bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling 
pathways. J Biol Chem, 277, 5330-8. 
NOTH, U., SCHUPP, K., HEYMER, A., KALL, S., JAKOB, F., SCHUTZE, N., BAUMANN, B., BARTHEL, T., EULERT, J. & 
HENDRICH, C. 2005. Anterior cruciate ligament constructs fabricated from human mesenchymal stem 
cells in a collagen type I hydrogel. Cytotherapy, 7, 447-455. 
NOURISSAT, G., BERENBAUM, F. & DUPREZ, D. 2015. Tendon injury: from biology to tendon repair. Nat Rev 
Rheumatol, 11, 223-33. 
O'CONNOR, W. J., BOTTI, T., KHAN, S. N. & LANE, J. M. 2000. The use of growth factors in cartilage repair. 
Orthop Clin North Am, 31, 399-410. 
OGAWA, R., MIZUNO, S., MURPHY, G. F. & ORGILL, D. P. 2009. The effect of hydrostatic pressure on three-
dimensional chondroinduction of human adipose-derived stem cells. Tissue Eng Part A, 15, 2937-45. 
OGAWA, R., ORGILL, D. P., MURPHY, G. F. & MIZUNO, S. 2015. Hydrostatic pressure-driven three-dimensional 
cartilage induction using human adipose-derived stem cells and collagen gels. Tissue Eng Part A, 21, 
257-66. 
OH, J. H., KIM, H. J., KIM, T. I. & WOO, K. M. 2014. Comparative evaluation of the biological properties of fibrin 
for bone regeneration. BMB Rep, 47, 110-4. 
OHYABU, Y., ADEGAWA, T., YOSHIOKA, T., IKOMA, T., SHINOZAKI, K., UEMURA, T. & TANAKA, J. 2009. A collagen 
sponge incorporating a hydroxyapatite/chondroitinsulfate composite as a scaffold for cartilage tissue 
engineering. J Biomater Sci Polym Ed, 20, 1861-74. 
OLDERSHAW, R. A. & HARDINGHAM, T. E. 2010. Notch signaling during chondrogenesis of human bone marrow 
stem cells. Bone, 46, 286-93. 
OLSEN, B. R. 1997. Collagen IX. Int J Biochem Cell Biol, 29, 555-8. 
OMARI, S., MAKAREEVA, E., GORRELL, L., JARNIK, M., LIPPINCOTT-SCHWARTZ, J. & LEIKIN, S. 2020. Mechanisms 
of procollagen and HSP47 sorting during ER-to-Golgi trafficking. Matrix Biol. 
ONNERFJORD, P., KHABUT, A., REINHOLT, F. P., SVENSSON, O. & HEINEGARD, D. 2012. Quantitative proteomic 
analysis of eight cartilaginous tissues reveals characteristic differences as well as similarities between 
subgroups. J Biol Chem, 287, 18913-24. 
OPTN. 2020. Organ Procurement and Transplantation network (OPTN) Data Reports [Online]. Available: 
https://optn.transplant.hrsa.gov/data/ [Accessed 2020]. 
OSATHANON, T., LINNES, M. L., RAJACHAR, R. M., RATNER, B. D., SOMERMAN, M. J. & GIACHELLI, C. M. 2008. 
Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. Biomaterials, 29, 4091-9. 
OTSUKA, T., IMURA, T., NAKAGAWA, K., SHRESTHA, L., TAKAHASHI, S., KAWAHARA, Y., SUEDA, T., KURISU, K. & 
YUGE, L. 2018. Simulated Microgravity Culture Enhances the Neuroprotective Effects of Human 
Cranial Bone-Derived Mesenchymal Stem Cells in Traumatic Brain Injury. Stem Cells Dev, 27, 1287-
1297. 
OTT, S. M. 2018. Cortical or Trabecular Bone: What's the Difference? Am J Nephrol, 47, 373-375. 
OXLUND, H., BARCKMAN, M., ORTOFT, G. & ANDREASSEN, T. T. 1995. Reduced concentrations of collagen 
cross-links are associated with reduced strength of bone. Bone, 17, 365S-371S. 
OZBOLAT, I. T., PENG, W. & OZBOLAT, V. 2016. Application areas of 3D bioprinting. Drug Discov Today, 21, 
1257-71. 
PACE, J. M., CORRADO, M., MISSERO, C. & BYERS, P. H. 2003. Identification, characterization and expression 
analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol, 22, 3-14. 
PAIVA, K. B. S. & GRANJEIRO, J. M. 2017. Matrix Metalloproteinases in Bone Resorption, Remodeling, and 
Repair. Prog Mol Biol Transl Sci, 148, 203-303. 
PAKDEL, M. & VON BLUME, J. 2018. Exploring new routes for secretory protein export from the trans-Golgi 
network. Mol Biol Cell, 29, 235-240. 
PARFITT, A. M. 2002. Misconceptions (2): turnover is always higher in cancellous than in cortical bone. Bone, 30, 
807-9. 
PARK, H. W., KIM, Y. C., YU, B., MOROISHI, T., MO, J. S., PLOUFFE, S. W., MENG, Z., LIN, K. C., YU, F. X., 
ALEXANDER, C. M., WANG, C. Y. & GUAN, K. L. 2015. Alternative Wnt Signaling Activates YAP/TAZ. 





PARK, J. Y., HA, S., PARK, E., KWON, D. & KIM, N. 2016. Hygroscopic Swelling Behavior of 3d Printed Parts Due to 
Changes in Environmental Conditions. Proceedings of the Asme International Design Engineering 
Technical Conferences and Computers and Information in Engineering Conference, 2016, Vol 1a. 
PARKIN, J. D., SAN ANTONIO, J. D., PERSIKOV, A. V., DAGHER, H., DALGLEISH, R., JENSEN, S. T., JEUNEMAITRE, X. 
& SAVIGE, J. 2017. The collalphagen III fibril has a "flexi-rod" structure of flexible sequences 
interspersed with rigid bioactive domains including two with hemostatic roles. PLoS One, 12, 
e0175582. 
PARKINSON, J., SAMIRIC, T., ILIC, M. Z., COOK, J. & HANDLEY, C. J. 2011. Involvement of proteoglycans in 
tendinopathy. J Musculoskelet Neuronal Interact, 11, 86-93. 
PARSONS, J. R. & BLACK, J. 1979. Mechanical behavior of articular cartilage: quantitative changes with 
alteration of ionic environment. J Biomech, 12, 765-73. 
PARSONS, P., GILBERT, S. J., VAUGHAN-THOMAS, A., SORRELL, D. A., NOTMAN, R., BISHOP, M., HAYES, A. J., 
MASON, D. J. & DUANCE, V. C. 2011. Type IX collagen interacts with fibronectin providing an 
important molecular bridge in articular cartilage. J Biol Chem, 286, 34986-97. 
PATEL, D., SHARMA, S., SCREEN, H. R. C. & BRYANT, S. J. 2018. Effects of cell adhesion motif, fiber stiffness, and 
cyclic strain on tenocyte gene expression in a tendon mimetic fiber composite hydrogel. Biochem 
Biophys Res Commun, 499, 642-647. 
PAXTON, J. Z., WUDEBWE, U. N., WANG, A., WOODS, D. & GROVER, L. M. 2012. Monitoring sinew contraction 
during formation of tissue-engineered fibrin-based ligament constructs. Tissue Eng Part A, 18, 1596-
607. 
PECINA, M., JELIC, M., MARTINOVIC, S., HASPL, M. & VUKICEVIC, S. 2002. Articular cartilage repair: the role of 
bone morphogenetic proteins. Int Orthop, 26, 131-6. 
PELHAM, R. J., JR. & WANG, Y. 1997. Cell locomotion and focal adhesions are regulated by substrate flexibility. 
Proc Natl Acad Sci U S A, 94, 13661-5. 
PELTONEN, S., HENTULA, M., HAGG, P., YLA-OUTINEN, H., TUUKKANEN, J., LAKKAKORPI, J., REHN, M., 
PIHLAJANIEMI, T. & PELTONEN, J. 1999. A novel component of epidermal cell-matrix and cell-cell 
contacts: transmembrane protein type XIII collagen. J Invest Dermatol, 113, 635-42. 
PEPPER, M. E., SESHADRI, V., BURG, T. C., BURG, K. J. & GROFF, R. E. 2012. Characterizing the effects of cell 
settling on bioprinter output. Biofabrication, 4, 011001. 
PEREZ, J. R., KOUROUPIS, D., LI, D. J., BEST, T. M., KAPLAN, L. & CORREA, D. 2018. Tissue Engineering and Cell-
Based Therapies for Fractures and Bone Defects. Front Bioeng Biotechnol, 6, 105. 
PETERSON, B., ZHANG, J., IGLESIAS, R., KABO, M., HEDRICK, M., BENHAIM, P. & LIEBERMAN, J. R. 2005. Healing 
of critically sized femoral defects, using genetically modified mesenchymal stem cells from human 
adipose tissue. Tissue Eng, 11, 120-9. 
PFAFFL, M. W., TICHOPAD, A., PRGOMET, C. & NEUVIANS, T. P. 2004. Determination of stable housekeeping 
genes, differentially regulated target genes and sample integrity: BestKeeper--Excel-based tool using 
pair-wise correlations. Biotechnol Lett, 26, 509-15. 
PIERCE, B. F., PITTERMANN, E., MA, N., GEBAUER, T., NEFFE, A. T., HOLSCHER, M., JUNG, F. & LENDLEIN, A. 
2012. Viability of human mesenchymal stem cells seeded on crosslinked entropy-elastic gelatin-based 
hydrogels. Macromol Biosci, 12, 312-21. 
PIHLAJAMAA, T., LANKINEN, H., YLOSTALO, J., VALMU, L., JAALINOJA, J., ZAUCKE, F., SPITZNAGEL, L., GOSLING, 
S., PUUSTINEN, A., MORGELIN, M., PERANEN, J., MAURER, P., ALA-KOKKO, L. & KILPELAINEN, I. 2004. 
Characterization of recombinant amino-terminal NC4 domain of human collagen IX: interaction with 
glycosaminoglycans and cartilage oligomeric matrix protein. J Biol Chem, 279, 24265-73. 
PITTENGER, M. F., MACKAY, A. M., BECK, S. C., JAISWAL, R. K., DOUGLAS, R., MOSCA, J. D., MOORMAN, M. A., 
SIMONETTI, D. W., CRAIG, S. & MARSHAK, D. R. 1999. Multilineage potential of adult human 
mesenchymal stem cells. Science, 284, 143-7. 
POLISHCHUK, E. V., DI PENTIMA, A., LUINI, A. & POLISHCHUK, R. S. 2003. Mechanism of constitutive export from 
the golgi: bulk flow via the formation, protrusion, and en bloc cleavage of large trans-golgi network 
tubular domains. Mol Biol Cell, 14, 4470-85. 
POLLARD, T. D., EARNSHAW, W. C., LIPPINCOTT-SCHWARTZ, J. & JOHNSON, G. T. 2017. Connective Tissues. Cell 
Biology. 3 ed.: Elsevier. 
PORTER, B. D., LIN, A. S., PEISTER, A., HUTMACHER, D. & GULDBERG, R. E. 2007. Noninvasive image analysis of 
3D construct mineralization in a perfusion bioreactor. Biomaterials, 28, 2525-33. 
PORTNER, R., NAGEL-HEYER, S., GOEPFERT, C., ADAMIETZ, P. & MEENEN, N. M. 2005. Bioreactor design for 
tissue engineering. J Biosci Bioeng, 100, 235-45. 
POWELL, D. W., PINCHUK, I. V., SAADA, J. I., CHEN, X. & MIFFLIN, R. C. 2011. Mesenchymal cells of the intestinal 
lamina propria. Annu Rev Physiol, 73, 213-37. 
QI, M. C., HU, J., ZOU, S. J., CHEN, H. Q., ZHOU, H. X. & HAN, L. C. 2008. Mechanical strain induces osteogenic 
differentiation: Cbfa1 and Ets-1 expression in stretched rat mesenchymal stem cells. Int J Oral 





QIAN, J., ITO, S., SATOH, J., GENG, H., TANAKA, K., HATTORI, S., KOJIMA, K., TAKITA, T. & YASUKAWA, K. 2017. 
The cleavage site preference of the porcine pepsin on the N-terminal alpha1 chain of bovine type I 
collagen: a focal analysis with mass spectrometry. Biosci Biotechnol Biochem, 81, 514-522. 
QIU, Y., LEI, J., KOOB, T. J. & TEMENOFF, J. S. 2016. Cyclic tension promotes fibroblastic differentiation of human 
MSCs cultured on collagen-fibre scaffolds. J Tissue Eng Regen Med, 10, 989-999. 
RADA, J. A., CORNUET, P. K. & HASSELL, J. R. 1993. Regulation of corneal collagen fibrillogenesis in vitro by 
corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res, 56, 635-48. 
RADA, T., REIS, R. L. & GOMES, M. E. 2009. Adipose tissue-derived stem cells and their application in bone and 
cartilage tissue engineering. Tissue Eng Part B Rev, 15, 113-25. 
RAIF EL, M. & SEEDHOM, B. B. 2005. Effect of cyclic tensile strain on proliferation of synovial cells seeded onto 
synthetic ligament scaffolds--an in vitro simulation. Bone, 36, 433-43. 
RAIMONDI, M. T., LAGANA, M., CONCI, C., CRESTANI, M., DI GIANCAMILLO, A., GERVASO, F., DEPONTI, D., 
BOSCHETTI, F., NAVA, M. M., SCANDONE, C., DOMENEGHINI, C., SANNINO, A. & PERETTI, G. M. 2018. 
Development and biological validation of a cyclic stretch culture system for the ex vivo engineering of 
tendons. Int J Artif Organs, 41, 400-412. 
RALSTON, S. H. 2017. Bone structure and metabolism. Medicine, 45, 560-564. 
RAMCHANDRAN, R., DHANABAL, M., VOLK, R., WATERMAN, M. J., SEGAL, M., LU, H., KNEBELMANN, B. & 
SUKHATME, V. P. 1999. Antiangiogenic activity of restin, NC10 domain of human collagen XV: 
comparison to endostatin. Biochem Biophys Res Commun, 255, 735-9. 
RAMESH, N., MORATTI, S. C. & DIAS, G. J. 2018. Hydroxyapatite-polymer biocomposites for bone regeneration: 
A review of current trends. J Biomed Mater Res B Appl Biomater, 106, 2046-2057. 
RAMSHAW, J. A., SHAH, N. K. & BRODSKY, B. 1998. Gly-X-Y tripeptide frequencies in collagen: a context for 
host-guest triple-helical peptides. J Struct Biol, 122, 86-91. 
RASI, K., HURSKAINEN, M., KALLIO, M., STAVEN, S., SORMUNEN, R., HEAPE, A. M., AVILA, R. L., KIRSCHNER, D., 
MUONA, A., TOLONEN, U., TANILA, H., HUHTALA, P., SOININEN, R. & PIHLAJANIEMI, T. 2010. Lack of 
collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, 
leads to basement membrane abnormalities and sensorimotor dysfunction. J Neurosci, 30, 14490-
501. 
RATH, B., NAM, J., KNOBLOCH, T. J., LANNUTTI, J. J. & AGARWAL, S. 2008. Compressive forces induce osteogenic 
gene expression in calvarial osteoblasts. J Biomech, 41, 1095-103. 
RAVELING, A. R., THEODOSSIOU, S. K. & SCHIELE, N. R. 2018. A 3D printed mechanical bioreactor for 
investigating mechanobiology and soft tissue mechanics. Methodsx, 5, 924-932. 
RCORETEAM. 2020. R: A language and environment for statistical computing [Online]. Vienna: Foundation for 
Statistical Computing. Available: https://www.R-project.org/ [Accessed 2020]. 
REDMAN, S. N., OLDFIELD, S. F. & ARCHER, C. W. 2005. Current strategies for articular cartilage repair. Eur Cell 
Mater, 9, 23-32; discussion 23-32. 
REES, S. G., DAVIES, J. R., TUDOR, D., FLANNERY, C. R., HUGHES, C. E., DENT, C. M. & CATERSON, B. 2002. 
Immunolocalisation and expression of proteoglycan 4 (cartilage superficial zone proteoglycan) in 
tendon. Matrix Biol, 21, 593-602. 
REES, S. G., FLANNERY, C. R., LITTLE, C. B., HUGHES, C. E., CATERSON, B. & DENT, C. M. 2000. Catabolism of 
aggrecan, decorin and biglycan in tendon. Biochem J, 350 Pt 1, 181-8. 
REES, S. G., WAGGETT, A. D., KERR, B. C., PROBERT, J., GEALY, E. C., DENT, C. M., CATERSON, B. & HUGHES, C. E. 
2009. Immunolocalisation and expression of keratocan in tendon. Osteoarthritis Cartilage, 17, 276-9. 
REHN, M., HINTIKKA, E. & PIHLAJANIEMI, T. 1994. Primary structure of the alpha 1 chain of mouse type XVIII 
collagen, partial structure of the corresponding gene, and comparison of the alpha 1(XVIII) chain with 
its homologue, the alpha 1(XV) collagen chain. J Biol Chem, 269, 13929-35. 
REHN, M. & PIHLAJANIEMI, T. 1994. Alpha 1(XVIII), a collagen chain with frequent interruptions in the 
collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl 
Acad Sci U S A, 91, 4234-8. 
REING, J. E., BROWN, B. N., DALY, K. A., FREUND, J. M., GILBERT, T. W., HSIONG, S. X., HUBER, A., KULLAS, K. E., 
TOTTEY, S., WOLF, M. T. & BADYLAK, S. F. 2010. The effects of processing methods upon mechanical 
and biologic properties of porcine dermal extracellular matrix scaffolds. Biomaterials, 31, 8626-33. 
REINWALD, Y., LEONARD, K. H., HENSTOCK, J. R., WHITELEY, J. P., OSBORNE, J. M., WATERS, S. L., LEVESQUE, P. 
& EL HAJ, A. J. 2015. Evaluation of the growth environment of a hydrostatic force bioreactor for 
preconditioning of tissue-engineered constructs. Tissue Eng Part C Methods, 21, 1-14. 
RESPONTE, D. J., LEE, J. K., HU, J. C. & ATHANASIOU, K. A. 2012. Biomechanics-driven chondrogenesis: from 
embryo to adult. FASEB J, 26, 3614-24. 
RHEE, D. K., MARCELINO, J., BAKER, M., GONG, Y., SMITS, P., LEFEBVRE, V., JAY, G. D., STEWART, M., WANG, H., 
WARMAN, M. L. & CARPTEN, J. D. 2005. The secreted glycoprotein lubricin protects cartilage surfaces 
and inhibits synovial cell overgrowth. J Clin Invest, 115, 622-31. 
RIBITSCH, I., GUELTEKIN, S., KEITH, M. F., MINICHMAIR, K., PEHAM, C., JENNER, F. & EGERBACHER, M. 2020. 
Age-related changes of tendon fibril micro-morphology and gene expression. J Anat, 236, 688-700. 





RICE, R. H. 2011. Proteomic analysis of hair shaft and nail plate. J Cosmet Sci, 62, 229-36. 
RILEY, G. P., HARRALL, R. L., CONSTANT, C. R., CHARD, M. D., CAWSTON, T. E. & HAZLEMAN, B. L. 1994. Tendon 
degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator 
cuff tendons in rotator cuff tendinitis. Ann Rheum Dis, 53, 359-66. 
ROBERT, L., MOCZAR, M. & ROBERT, M. 1974. Biogenesis, maturation and aging of elastic tissue. Experientia, 
30, 211-2. 
ROBERTSSON, O., STEFANSDOTTIR, A., LIDGREN, L. & RANSTAM, J. 2007. Increased long-term mortality in 
patients less than 55 years old who have undergone knee replacement for osteoarthritis: results from 
the Swedish Knee Arthroplasty Register. J Bone Joint Surg Br, 89, 599-603. 
ROBINSON, K. A., SUN, M., BARNUM, C. E., WEISS, S. N., HUEGEL, J., SHETYE, S. S., LIN, L., SAEZ, D., ADAMS, S. 
M., IOZZO, R. V., SOSLOWSKY, L. J. & BIRK, D. E. 2017. Decorin and biglycan are necessary for 
maintaining collagen fibril structure, fiber realignment, and mechanical properties of mature tendons. 
Matrix Biol, 64, 81-93. 
ROBUBI, A., BERGER, C., SCHMID, M., HUBER, K. R., ENGEL, A. & KRUGLUGER, W. 2014. Gene expression profiles 
induced by growth factors in in vitro cultured osteoblasts. Bone Joint Res, 3, 236-40. 
RODAN, G. A. & MARTIN, T. J. 1981. Role of osteoblasts in hormonal control of bone resorption--a hypothesis. 
Calcif Tissue Int, 33, 349-51. 
RONALDSON, K. & VUNJAK-NOVAKOVIC, G. 2016. Microgravity and Microgravity Analogue Studies of Cartilage 
and Cardiac Tissue Engineering. Effect of Spaceflight and Spaceflight Analogue Culture on Human and 
Microbial Cells. Springer. 
RONZIERE, M. C., PERRIER, E., MALLEIN-GERIN, F. & FREYRIA, A. M. 2010. Chondrogenic potential of bone 
marrow- and adipose tissue-derived adult human mesenchymal stem cells. Biomed Mater Eng, 20, 
145-58. 
ROSSET, E. M. & BRADSHAW, A. D. 2016. SPARC/osteonectin in mineralized tissue. Matrix Biol, 52-54, 78-87. 
RUBIN, J., MURPHY, T. C., FAN, X., GOLDSCHMIDT, M. & TAYLOR, W. R. 2002. Activation of extracellular signal-
regulated kinase is involved in mechanical strain inhibition of RANKL expression in bone stromal cells. 
J Bone Miner Res, 17, 1452-60. 
RUHLAND, C., SCHONHERR, E., ROBENEK, H., HANSEN, U., IOZZO, R. V., BRUCKNER, P. & SEIDLER, D. G. 2007. 
The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the 
early stages of fibrillogenesis. FEBS J, 274, 4246-55. 
RUI, Y. F., LUI, P. P., NI, M., CHAN, L. S., LEE, Y. W. & CHAN, K. M. 2011. Mechanical loading increased BMP-2 
expression which promoted osteogenic differentiation of tendon-derived stem cells. J Orthop Res, 29, 
390-6. 
SAADA, J. I., PINCHUK, I. V., BARRERA, C. A., ADEGBOYEGA, P. A., SUAREZ, G., MIFFLIN, R. C., DI MARI, J. F., 
REYES, V. E. & POWELL, D. W. 2006. Subepithelial myofibroblasts are novel nonprofessional APCs in 
the human colonic mucosa. J Immunol, 177, 5968-79. 
SAARELA, J., REHN, M., OIKARINEN, A., AUTIO-HARMAINEN, H. & PIHLAJANIEMI, T. 1998. The short and long 
forms of type XVIII collagen show clear tissue specificities in their expression and location in basement 
membrane zones in humans. Am J Pathol, 153, 611-26. 
SABATELLI, P., GARA, S. K., GRUMATI, P., URCIUOLO, A., GUALANDI, F., CURCI, R., SQUARZONI, S., ZAMPARELLI, 
A., MARTONI, E., MERLINI, L., PAULSSON, M., BONALDO, P. & WAGENER, R. 2011. Expression of the 
collagen VI alpha5 and alpha6 chains in normal human skin and in skin of patients with collagen VI-
related myopathies. J Invest Dermatol, 131, 99-107. 
SAHA, A., ROLFE, R., CARROLL, S., KELLY, D. J. & MURPHY, P. 2017. Chondrogenesis of embryonic limb bud cells 
in micromass culture progresses rapidly to hypertrophy and is modulated by hydrostatic pressure. Cell 
Tissue Res, 368, 47-59. 
SAITO, K., CHEN, M., BARD, F., CHEN, S., ZHOU, H., WOODLEY, D., POLISCHUK, R., SCHEKMAN, R. & MALHOTRA, 
V. 2009. TANGO1 facilitates cargo loading at endoplasmic reticulum exit sites. Cell, 136, 891-902. 
SAITO, K., YAMASHIRO, K., ICHIKAWA, Y., ERLMANN, P., KONTANI, K., MALHOTRA, V. & KATADA, T. 2011. 
cTAGE5 mediates collagen secretion through interaction with TANGO1 at endoplasmic reticulum exit 
sites. Mol Biol Cell, 22, 2301-8. 
SAKAGUCHI, Y., SEKIYA, I., YAGISHITA, K. & MUNETA, T. 2005. Comparison of human stem cells derived from 
various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum, 52, 2521-9. 
SAKAI, L. Y., KEENE, D. R., MORRIS, N. P. & BURGESON, R. E. 1986. Type VII collagen is a major structural 
component of anchoring fibrils. J Cell Biol, 103, 1577-86. 
SAKAI, S., MISHIMA, H., ISHII, T., AKAOGI, H., YOSHIOKA, T., OHYABU, Y., CHANG, F., OCHIAI, N. & UEMURA, T. 
2009. Rotating three-dimensional dynamic culture of adult human bone marrow-derived cells for 
tissue engineering of hyaline cartilage. J Orthop Res, 27, 517-21. 
SAKAI, T., LARSEN, M. & YAMADA, K. M. 2003. Fibronectin requirement in branching morphogenesis. Nature, 
423, 876-81. 
SAKAO, K., TAKAHASHI, K. A., ARAI, Y., INOUE, A., TONOMURA, H., SAITO, M., YAMAMOTO, T., KANAMURA, N., 
IMANISHI, J., MAZDA, O. & KUBO, T. 2008. Induction of chondrogenic phenotype in synovium-derived 





SALDIN, L. T., CRAMER, M. C., VELANKAR, S. S., WHITE, L. J. & BADYLAK, S. F. 2017. Extracellular matrix 
hydrogels from decellularized tissues: Structure and function. Acta Biomater, 49, 1-15. 
SALO, J., LEHENKARI, P., MULARI, M., METSIKKO, K. & VAANANEN, H. K. 1997. Removal of osteoclast bone 
resorption products by transcytosis. Science, 276, 270-3. 
SAMIRIC, T., ILIC, M. Z. & HANDLEY, C. J. 2004a. Characterisation of proteoglycans and their catabolic products 
in tendon and explant cultures of tendon. Matrix Biol, 23, 127-40. 
SAMIRIC, T., ILIC, M. Z. & HANDLEY, C. J. 2004b. Large aggregating and small leucine-rich proteoglycans are 
degraded by different pathways and at different rates in tendon. Eur J Biochem, 271, 3612-20. 
SANTOS, A. J., RAOTE, I., SCARPA, M., BROUWERS, N. & MALHOTRA, V. 2015. TANGO1 recruits ERGIC 
membranes to the endoplasmic reticulum for procollagen export. Elife, 4. 
SARASA-RENEDO, A. & CHIQUET, M. 2005. Mechanical signals regulating extracellular matrix gene expression in 
fibroblasts. Scand J Med Sci Sports, 15, 223-30. 
SASAI, Y., EIRAKU, M. & SUGA, H. 2012. In vitro organogenesis in three dimensions: self-organising stem cells. 
Development, 139, 4111-4121. 
SASAKI, T., FUKAI, N., MANN, K., GOHRING, W., OLSEN, B. R. & TIMPL, R. 1998. Structure, function and tissue 
forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor 
endostatin. EMBO J, 17, 4249-56. 
SASAKI, T., LARSSON, H., KREUGER, J., SALMIVIRTA, M., CLAESSON-WELSH, L., LINDAHL, U., HOHENESTER, E. & 
TIMPL, R. 1999. Structural basis and potential role of heparin/heparan sulfate binding to the 
angiogenesis inhibitor endostatin. EMBO J, 18, 6240-8. 
SASAKI, T., LARSSON, H., TISI, D., CLAESSON-WELSH, L., HOHENESTER, E. & TIMPL, R. 2000. Endostatins derived 
from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-
angiogenic activity. J Mol Biol, 301, 1179-90. 
SATO, K., YOMOGIDA, K., WADA, T., YORIHUZI, T., NISHIMUNE, Y., HOSOKAWA, N. & NAGATA, K. 2002. Type 
XXVI collagen, a new member of the collagen family, is specifically expressed in the testis and ovary. J 
Biol Chem, 277, 37678-84. 
SATOH, M., HIRAYOSHI, K., YOKOTA, S., HOSOKAWA, N. & NAGATA, K. 1996. Intracellular interaction of 
collagen-specific stress protein HSP47 with newly synthesized procollagen. J Cell Biol, 133, 469-83. 
SCHAEFER, L., BABELOVA, A., KISS, E., HAUSSER, H. J., BALIOVA, M., KRZYZANKOVA, M., MARSCHE, G., YOUNG, 
M. F., MIHALIK, D., GOTTE, M., MALLE, E., SCHAEFER, R. M. & GRONE, H. J. 2005. The matrix 
component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in 
macrophages. J Clin Invest, 115, 2223-33. 
SCHEGG, B., HULSMEIER, A. J., RUTSCHMANN, C., MAAG, C. & HENNET, T. 2009. Core glycosylation of collagen is 
initiated by two beta(1-O)galactosyltransferases. Mol Cell Biol, 29, 943-52. 
SCHINDELIN, J., ARGANDA-CARRERAS, I., FRISE, E., KAYNIG, V., LONGAIR, M., PIETZSCH, T., PREIBISCH, S., 
RUEDEN, C., SAALFELD, S., SCHMID, B., TINEVEZ, J. Y., WHITE, D. J., HARTENSTEIN, V., ELICEIRI, K., 
TOMANCAK, P. & CARDONA, A. 2012. Fiji: an open-source platform for biological-image analysis. Nat 
Methods, 9, 676-82. 
SCHLESINGER, P. H., BLAIR, H. C., TEITELBAUM, S. L. & EDWARDS, J. C. 1997. Characterization of the osteoclast 
ruffled border chloride channel and its role in bone resorption. J Biol Chem, 272, 18636-43. 
SCHNEIDER, G. B., ZAHARIAS, R. & STANFORD, C. 2001. Osteoblast integrin adhesion and signaling regulate 
mineralization. J Dent Res, 80, 1540-4. 
SCHWARTZ, M. A. 2010. Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect 
Biol, 2, a005066. 
SCHWARTZ, M. A. & DESIMONE, D. W. 2008. Cell adhesion receptors in mechanotransduction. Curr Opin Cell 
Biol, 20, 551-6. 
SCHWARZ, R. P., GOODWIN, T. J. & WOLF, D. A. 1992. Cell culture for three-dimensional modeling in rotating-
wall vessels: an application of simulated microgravity. J Tissue Cult Methods, 14, 51-7. 
SCOTT, I. C., BLITZ, I. L., PAPPANO, W. N., IMAMURA, Y., CLARK, T. G., STEIGLITZ, B. M., THOMAS, C. L., MAAS, S. 
A., TAKAHARA, K., CHO, K. W. & GREENSPAN, D. S. 1999. Mammalian BMP-1/Tolloid-related 
metalloproteinases, including novel family member mammalian Tolloid-like 2, have differential 
enzymatic activities and distributions of expression relevant to patterning and skeletogenesis. Dev 
Biol, 213, 283-300. 
SCREEN, H., SETO, J., KRAUSS, S., BOESECKE, P. & GUPTA, H. 2011. Extrafibrillar diffusion and intrafibrillar 
swelling at the nanoscale are associated with stress relaxation in the soft collagenous matrix tissue of 
tendons. Soft Matter, 7, 11243-11251. 
SCREEN, H. R. 2009. Hierarchical approaches to understanding tendon mechanics. Journal of Biomechanical 
Science and Engineering, 4, 481-499. 
SCREEN, H. R., BERK, D. E., KADLER, K. E., RAMIREZ, F. & YOUNG, M. F. 2015. Tendon functional extracellular 
matrix. J Orthop Res, 33, 793-9. 
SCREEN, H. R., LEE, D. A., BADER, D. L. & SHELTON, J. C. 2004. An investigation into the effects of the 






SEET, L. F., TOH, L. Z., CHU, S. W. L., FINGER, S. N., CHUA, J. L. L. & WONG, T. T. 2017. Upregulation of distinct 
collagen transcripts in post-surgery scar tissue: a study of conjunctival fibrosis. Dis Model Mech, 10, 
751-760. 
SEGEV, F., HEON, E., COLE, W. G., WENSTRUP, R. J., YOUNG, F., SLOMOVIC, A. R., ROOTMAN, D. S., WHITAKER-
MENEZES, D., CHERVONEVA, I. & BIRK, D. E. 2006. Structural abnormalities of the cornea and lid 
resulting from collagen V mutations. Invest Ophthalmol Vis Sci, 47, 565-73. 
SEIF-NARAGHI, S. B., SINGELYN, J. M., SALVATORE, M. A., OSBORN, K. G., WANG, J. J., SAMPAT, U., KWAN, O. L., 
STRACHAN, G. M., WONG, J. & SCHUP-MAGOFFIN, P. J. 2013. Safety and efficacy of an injectable 
extracellular matrix hydrogel for treating myocardial infarction. Science translational medicine, 5, 
173ra25-173ra25. 
SEIL, R., LITZENBURGER, H., KOHN, D. & RUPP, S. 2006. Arthroscopic treatment of chronically painful calcifying 
tendinitis of the supraspinatus tendon. Arthroscopy, 22, 521-7. 
SEN, B., XIE, Z., CASE, N., MA, M., RUBIN, C. & RUBIN, J. 2008. Mechanical strain inhibits adipogenesis in 
mesenchymal stem cells by stimulating a durable beta-catenin signal. Endocrinology, 149, 6065-75. 
SENSINI, A., CRISTOFOLINI, L., ZUCCHELLI, A., FOCARETE, M. L., GUALANDI, C., A, D. E. M., KAO, A. P., ROLDO, 
M., BLUNN, G. & TOZZI, G. 2019. Hierarchical electrospun tendon-ligament bioinspired scaffolds 
induce changes in fibroblasts morphology under static and dynamic conditions. J Microsc. 
SHAPIRO, I. M., ADAMS, C. S., FREEMAN, T. & SRINIVAS, V. 2005. Fate of the hypertrophic chondrocyte: 
microenvironmental perspectives on apoptosis and survival in the epiphyseal growth plate. Birth 
Defects Res C Embryo Today, 75, 330-9. 
SHARIFI, N. & GHARRAVI, A. M. 2019. Shear bioreactors stimulating chondrocyte regeneration, a systematic 
review. Inflamm Regen, 39, 16. 
SHARMA, P. & MAFFULLI, N. 2006. Biology of tendon injury: healing, modeling and remodeling. J Musculoskelet 
Neuronal Interact, 6, 181-90. 
SHAW, L. M. & OLSEN, B. R. 1991. FACIT collagens: diverse molecular bridges in extracellular matrices. Trends 
Biochem Sci, 16, 191-4. 
SHEN, G. 2005. The role of type X collagen in facilitating and regulating endochondral ossification of articular 
cartilage. Orthod Craniofac Res, 8, 11-7. 
SHEPHERD, J. H. & SCREEN, H. R. 2013. Fatigue loading of tendon. Int J Exp Pathol, 94, 260-70. 
SHERWIN, A. F., CARTER, D. H., POOLE, C. A., HOYLAND, J. A. & AYAD, S. 1999. The distribution of type VI 
collagen in the developing tissues of the bovine femoral head. Histochem J, 31, 623-32. 
SHI, G. X., ZHENG, X. F., ZHU, C., LI, B., WANG, Y. R., JIANG, S. D. & JIANG, L. S. 2017. Evidence of the Role of R-
Spondin 1 and Its Receptor Lgr4 in the Transmission of Mechanical Stimuli to Biological Signals for 
Bone Formation. Int J Mol Sci, 18. 
SHIMIZU, T., TANAKA, T., ISO, T., MATSUI, H., OOYAMA, Y., KAWAI-KOWASE, K., ARAI, M. & KURABAYASHI, M. 
2011. Notch signaling pathway enhances bone morphogenetic protein 2 (BMP2) responsiveness of 
Msx2 gene to induce osteogenic differentiation and mineralization of vascular smooth muscle cells. J 
Biol Chem, 286, 19138-48. 
SHIMOKOMAKI, M., WRIGHT, D. W., IRWIN, M. H., VAN DER REST, M. & MAYNE, R. 1990. The structure and 
macromolecular organization of type IX collagen in cartilage. Ann N Y Acad Sci, 580, 1-7. 
SHORT, A. R., CZEISLER, C., STOCKER, B., COLE, S., OTERO, J. J. & WINTER, J. O. 2017. Imaging Cell-Matrix 
Interactions in 3D Collagen Hydrogel Culture Systems. Macromol Biosci, 17. 
SHOULDERS, M. D., GUZEI, I. A. & RAINES, R. T. 2008. 4-chloroprolines: synthesis, conformational analysis, and 
effect on the collagen triple helix. Biopolymers, 89, 443-54. 
SHOULDERS, M. D. & RAINES, R. T. 2009. Collagen structure and stability. Annu Rev Biochem, 78, 929-58. 
SIKAVITSAS, V. I., BANCROFT, G. N., LEMOINE, J. J., LIEBSCHNER, M. A., DAUNER, M. & MIKOS, A. G. 2005. Flow 
perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable 
nonwoven fiber mesh scaffolds. Ann Biomed Eng, 33, 63-70. 
SIMMONS, C. A., MATLIS, S., THORNTON, A. J., CHEN, S., WANG, C. Y. & MOONEY, D. J. 2003. Cyclic strain 
enhances matrix mineralization by adult human mesenchymal stem cells via the extracellular signal-
regulated kinase (ERK1/2) signaling pathway. J Biomech, 36, 1087-96. 
SINGH, A., GILL, G., KAUR, H., AMHMED, M. & JAKHU, H. 2018. Role of osteopontin in bone remodeling and 
orthodontic tooth movement: a review. Prog Orthod, 19, 18. 
SMITH, R. K., BIRCH, H., PATTERSON-KANE, J., FIRTH, E. C., WILLIAMS, L., CHERDCHUTHAM, W., VAN WEEREN, 
W. R. & GOODSHIP, A. E. 1999. Should equine athletes commence training during skeletal 
development?: changes in tendon matrix associated with development, ageing, function and exercise. 
Equine Vet J Suppl, 201-9. 
SMITH, R. L., RUSK, S. F., ELLISON, B. E., WESSELLS, P., TSUCHIYA, K., CARTER, D. R., CALER, W. E., SANDELL, L. J. 
& SCHURMAN, D. J. 1996. In vitro stimulation of articular chondrocyte mRNA and extracellular matrix 
synthesis by hydrostatic pressure. J Orthop Res, 14, 53-60. 
SOHN, H. S. & OH, J. K. 2019. Review of bone graft and bone substitutes with an emphasis on fracture surgeries. 





SOLCHAGA, L. A., PENICK, K., GOLDBERG, V. M., CAPLAN, A. I. & WELTER, J. F. 2010. Fibroblast growth factor-2 
enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-
derived mesenchymal stem cells. Tissue Eng Part A, 16, 1009-19. 
SOLCHAGA, L. A., PENICK, K., PORTER, J. D., GOLDBERG, V. M., CAPLAN, A. I. & WELTER, J. F. 2005. FGF-2 
enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived 
mesenchymal stem cells. J Cell Physiol, 203, 398-409. 
SOMMERFELDT, D. W. & RUBIN, C. T. 2001. Biology of bone and how it orchestrates the form and function of 
the skeleton. Eur Spine J, 10 Suppl 2, S86-95. 
SOMOZA, R. A., WELTER, J. F., CORREA, D. & CAPLAN, A. I. 2014. Chondrogenic differentiation of mesenchymal 
stem cells: challenges and unfulfilled expectations. Tissue Eng Part B Rev, 20, 596-608. 
SOPHIA FOX, A. J., BEDI, A. & RODEO, S. A. 2009. The basic science of articular cartilage: structure, composition, 
and function. Sports Health, 1, 461-8. 
SOUCACOS, P. N., DAILIANA, Z., BERIS, A. E. & JOHNSON, E. O. 2006. Vascularised bone grafts for the 
management of non-union. Injury, 37 Suppl 1, S41-50. 
SOYSA, N. S. & ALLES, N. 2016. Osteoclast function and bone-resorbing activity: An overview. Biochem Biophys 
Res Commun, 476, 115-20. 
SPINELLA-JAEGLE, S., RAWADI, G., KAWAI, S., GALLEA, S., FAUCHEU, C., MOLLAT, P., COURTOIS, B., BERGAUD, 
B., RAMEZ, V., BLANCHET, A. M., ADELMANT, G., BARON, R. & ROMAN-ROMAN, S. 2001. Sonic 
hedgehog increases the commitment of pluripotent mesenchymal cells into the osteoblastic lineage 
and abolishes adipocytic differentiation. J Cell Sci, 114, 2085-94. 
STARBORG, T., KALSON, N. S., LU, Y., MIRONOV, A., COOTES, T. F., HOLMES, D. F. & KADLER, K. E. 2013. Using 
transmission electron microscopy and 3View to determine collagen fibril size and three-dimensional 
organization. Nat Protoc, 8, 1433-48. 
STAVENSCHI, E., CORRIGAN, M. A., JOHNSON, G. P., RIFFAULT, M. & HOEY, D. A. 2018. Physiological cyclic 
hydrostatic pressure induces osteogenic lineage commitment of human bone marrow stem cells: a 
systematic study. Stem Cell Res Ther, 9, 276. 
STEADMAN, J. R., RODKEY, W. G., BRIGGS, K. K. & RODRIGO, J. J. 1999. [The microfracture technic in the 
management of complete cartilage defects in the knee joint]. Orthopade, 28, 26-32. 
STEINLE, P. 2016. Characterization of emissions from a desktop 3D printer and indoor air measurements in 
office settings. J Occup Environ Hyg, 13, 121-32. 
STENBECK, G. & HORTON, M. A. 2004. Endocytic trafficking in actively resorbing osteoclasts. J Cell Sci, 117, 827-
36. 
STEPHAN, S., SHERRATT, M. J., HODSON, N., SHUTTLEWORTH, C. A. & KIELTY, C. M. 2004. Expression and 
supramolecular assembly of recombinant alpha1(viii) and alpha2(viii) collagen homotrimers. J Biol 
Chem, 279, 21469-77. 
STEWARD, A. J. & KELLY, D. J. 2015. Mechanical regulation of mesenchymal stem cell differentiation. J Anat, 
227, 717-31. 
STEWARD, A. J., KELLY, D. J. & WAGNER, D. R. 2014. The role of calcium signalling in the chondrogenic response 
of mesenchymal stem cells to hydrostatic pressure. Eur Cell Mater, 28, 358-71. 
STOCKWELL, R. A. 1971. The interrelationship of cell density and cartilage thickness in mammalian articular 
cartilage. J Anat, 109, 411-21. 
STRICKER, S., FUNDELE, R., VORTKAMP, A. & MUNDLOS, S. 2002. Role of Runx genes in chondrocyte 
differentiation. Dev Biol, 245, 95-108. 
STRIOGA, M., VISWANATHAN, S., DARINSKAS, A., SLABY, O. & MICHALEK, J. 2012. Same or not the same? 
Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal 
cells. Stem Cells Dev, 21, 2724-52. 
SUBRAMANIAN, G., STASUK, A., ELSAADANY, M. & YILDIRIM-AYAN, E. 2017. Effect of Uniaxial Tensile Cyclic 
Loading Regimes on Matrix Organization and Tenogenic Differentiation of Adipose-Derived Stem Cells 
Encapsulated within 3D Collagen Scaffolds. Stem Cells Int, 2017, 6072406. 
SUDA, T., TAKAHASHI, N., UDAGAWA, N., JIMI, E., GILLESPIE, M. T. & MARTIN, T. J. 1999. Modulation of 
osteoclast differentiation and function by the new members of the tumor necrosis factor receptor 
and ligand families. Endocr Rev, 20, 345-57. 
SUGIMOTO, A., MIYAZAKI, A., KAWARABAYASHI, K., SHONO, M., AKAZAWA, Y., HASEGAWA, T., UEDA-
YAMAGUCHI, K., KITAMURA, T., YOSHIZAKI, K., FUKUMOTO, S. & IWAMOTO, T. 2017. Piezo type 
mechanosensitive ion channel component 1 functions as a regulator of the cell fate determination of 
mesenchymal stem cells. Sci Rep, 7, 17696. 
SUMANASINGHE, R. D., BERNACKI, S. H. & LOBOA, E. G. 2006. Osteogenic differentiation of human 
mesenchymal stem cells in collagen matrices: effect of uniaxial cyclic tensile strain on bone 
morphogenetic protein (BMP-2) mRNA expression. Tissue Eng, 12, 3459-65. 
SUN, M., CONNIZZO, B. K., ADAMS, S. M., FREEDMAN, B. R., WENSTRUP, R. J., SOSLOWSKY, L. J. & BIRK, D. E. 
2015. Targeted deletion of collagen V in tendons and ligaments results in a classic Ehlers-Danlos 





SUN, S., GENOVESE, F. & KARSDAL, M. 2019. Type VI collagen. Biochemistry of Collagens, Laminins and elastin. 
Elsevier. 
SUND, M., VAISANEN, T., KAUKINEN, S., ILVES, M., TU, H., AUTIO-HARMAINEN, H., RAUVALA, H. & 
PIHLAJANIEMI, T. 2001. Distinct expression of type XIII collagen in neuronal structures and other 
tissues during mouse development. Matrix Biol, 20, 215-31. 
SUTMULLER, M., BRUIJN, J. A. & DE HEER, E. 1997. Collagen types VIII and X, two non-fibrillar, short-chain 
collagens. Structure homologies, functions and involvement in pathology. Histol Histopathol, 12, 557-
66. 
SVEC, D., TICHOPAD, A., NOVOSADOVA, V., PFAFFL, M. W. & KUBISTA, M. 2015. How good is a PCR efficiency 
estimate: Recommendations for precise and robust qPCR efficiency assessments. Biomol Detect 
Quantif, 3, 9-16. 
TALÒ, G., D'ARRIGO, D., LORENZI, S., MORETTI, M. & LOVATI, A. B. 2020. Independent, Controllable Stretch-
Perfusion Bioreactor Chambers to Functionalize Cell-Seeded Decellularized Tendons. Annals of 
Biomedical Engineering, 48, 1112-1126. 
TANAKA, T., WAKABAYASHI, T., OIZUMI, H., NISHIO, S., SATO, T., HARADA, A., FUJII, D., MATSUO, Y., 
HASHIMOTO, T. & IWATSUBO, T. 2014. CLAC-P/collagen type XXV is required for the intramuscular 
innervation of motoneurons during neuromuscular development. J Neurosci, 34, 1370-9. 
TEITELBAUM, S. L. 2000. Bone resorption by osteoclasts. Science, 289, 1504-8. 
TEITELBAUM, S. L. & ROSS, F. P. 2003. Genetic regulation of osteoclast development and function. Nat Rev 
Genet, 4, 638-49. 
TEN DIJKE, P. & ARTHUR, H. M. 2007. Extracellular control of TGFbeta signalling in vascular development and 
disease. Nat Rev Mol Cell Biol, 8, 857-69. 
TETI, A., BLAIR, H. C., TEITELBAUM, S. L., KAHN, A. J., KOZIOL, C., KONSEK, J., ZAMBONIN-ZALLONE, A. & 
SCHLESINGER, P. H. 1989. Cytoplasmic pH regulation and chloride/bicarbonate exchange in avian 
osteoclasts. J Clin Invest, 83, 227-33. 
THEOBALD, P., BENJAMIN, M., NOKES, L. & PUGH, N. 2005. Review of the vascularisation of the human Achilles 
tendon. Injury, 36, 1267-72. 
THORPE, C. T., BIRCH, H. L., CLEGG, P. D. & SCREEN, H. R. 2013. The role of the non-collagenous matrix in 
tendon function. Int J Exp Pathol, 94, 248-59. 
THORPE, C. T., CLEGG, P. D. & BIRCH, H. L. 2010. A review of tendon injury: why is the equine superficial digital 
flexor tendon most at risk? Equine Vet J, 42, 174-80. 
THORPE, C. T., GODINHO, M. S. C., RILEY, G. P., BIRCH, H. L., CLEGG, P. D. & SCREEN, H. R. C. 2015. The 
interfascicular matrix enables fascicle sliding and recovery in tendon, and behaves more elastically in 
energy storing tendons. J Mech Behav Biomed Mater, 52, 85-94. 
THORPE, C. T., RILEY, G. P., BIRCH, H. L., CLEGG, P. D. & SCREEN, H. R. 2014. Effect of fatigue loading on 
structure and functional behaviour of fascicles from energy-storing tendons. Acta Biomater, 10, 3217-
24. 
TILLGREN, V., ONNERFJORD, P., HAGLUND, L. & HEINEGARD, D. 2009. The tyrosine sulfate-rich domains of the 
LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-
binding proteins, including bioactive factors. J Biol Chem, 284, 28543-53. 
TIMPL, R. & BROWN, J. C. 1996. Supramolecular assembly of basement membranes. Bioessays, 18, 123-32. 
TIMPL, R., WIEDEMANN, H., VAN DELDEN, V., FURTHMAYR, H. & KUHN, K. 1981. A network model for the 
organization of type IV collagen molecules in basement membranes. Eur J Biochem, 120, 203-11. 
TOHIDNEZHAD, M., ZANDER, J., SLOWIK, A., KUBO, Y., DURSUN, G., WILLENBERG, W., ZENDEDEL, A., KWEIDER, 
N., STOFFEL, M. & PUFE, T. 2020. Impact of Uniaxial Stretching on Both Gliding and Traction Areas of 
Tendon Explants in a Novel Bioreactor. Int J Mol Sci, 21. 
TOMOAIA, G. & PASCA, R. D. 2015. On the Collagen Mineralization. A Review. Clujul Med, 88, 15-22. 
TSE, J. R. & ENGLER, A. J. 2010. Preparation of hydrogel substrates with tunable mechanical properties. Curr 
Protoc Cell Biol, Chapter 10, Unit 10 16. 
TULI, R., TULI, S., NANDI, S., HUANG, X., MANNER, P. A., HOZACK, W. J., DANIELSON, K. G., HALL, D. J. & TUAN, 
R. S. 2003. Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal 
progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-
talk. J Biol Chem, 278, 41227-36. 
TWORKOSKI, E., GLUCKSBERG, M. R. & JOHNSON, M. 2018. The effect of the rate of hydrostatic pressure 
depressurization on cells in culture. PLoS One, 13, e0189890. 
TZAPHLIDOU, M. 2005. The role of collagen in bone structure: an image processing approach. Micron, 36, 593-
601. 
TZAPHLIDOU, M. 2008. Bone architecture: collagen structure and calcium/phosphorus maps. J Biol Phys, 34, 39-
49. 
UDEZE, C. P., JONES, E. R., RILEY, G. P., MORRISSEY, D. & SCREEN, H. R. C. 2019. An in vitro investigation into the 





ULBRICH, C., WESTPHAL, K., PIETSCH, J., WINKLER, H. D., LEDER, A., BAUER, J., KOSSMEHL, P., GROSSE, J., 
SCHOENBERGER, J., INFANGER, M., EGLI, M. & GRIMM, D. 2010. Characterization of human 
chondrocytes exposed to simulated microgravity. Cell Physiol Biochem, 25, 551-60. 
UNSOLD, C., PAPPANO, W. N., IMAMURA, Y., STEIGLITZ, B. M. & GREENSPAN, D. S. 2002. Biosynthetic 
processing of the pro-alpha 1(V)2pro-alpha 2(V) collagen heterotrimer by bone morphogenetic 
protein-1 and furin-like proprotein convertases. J Biol Chem, 277, 5596-602. 
VAANANEN, H. K. & HORTON, M. 1995. The osteoclast clear zone is a specialized cell-extracellular matrix 
adhesion structure. J Cell Sci, 108 ( Pt 8), 2729-32. 
VAANANEN, H. K., ZHAO, H., MULARI, M. & HALLEEN, J. M. 2000. The cell biology of osteoclast function. J Cell 
Sci, 113 ( Pt 3), 377-81. 
VACANTI, J. P. 1988. Beyond transplantation. Third annual Samuel Jason Mixter lecture. Arch Surg, 123, 545-9. 
VALCOURT, U., GOUTTENOIRE, J., MOUSTAKAS, A., HERBAGE, D. & MALLEIN-GERIN, F. 2002. Functions of 
transforming growth factor-beta family type I receptors and Smad proteins in the hypertrophic 
maturation and osteoblastic differentiation of chondrocytes. J Biol Chem, 277, 33545-58. 
VAN HUIZEN, N. A., IJZERMANS, J. N. M., BURGERS, P. C. & LUIDER, T. M. 2019. Collagen analysis with mass 
spectrometry. Mass Spectrom Rev. 
VAN OSCH, G. J., MANDL, E. W., JAHR, H., KOEVOET, W., NOLST-TRENITE, G. & VERHAAR, J. A. 2004. 
Considerations on the use of ear chondrocytes as donor chondrocytes for cartilage tissue engineering. 
Biorheology, 41, 411-21. 
VANDESOMPELE, J., DE PRETER, K., PATTYN, F., POPPE, B., VAN ROY, N., DE PAEPE, A. & SPELEMAN, F. 2002. 
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple 
internal control genes. Genome Biol, 3, RESEARCH0034. 
VAUGHAN, L., MENDLER, M., HUBER, S., BRUCKNER, P., WINTERHALTER, K. H., IRWIN, M. I. & MAYNE, R. 1988. 
D-periodic distribution of collagen type IX along cartilage fibrils. J Cell Biol, 106, 991-7. 
VAUGHAN-THOMAS, A., YOUNG, R. D., PHILLIPS, A. C. & DUANCE, V. C. 2001. Characterization of type XI 
collagen-glycosaminoglycan interactions. J Biol Chem, 276, 5303-9. 
VEIT, G., KOBBE, B., KEENE, D. R., PAULSSON, M., KOCH, M. & WAGENER, R. 2006. Collagen XXVIII, a novel von 
Willebrand factor A domain-containing protein with many imperfections in the collagenous domain. J 
Biol Chem, 281, 3494-504. 
VIDAL BDE, C. & MELLO, M. L. 2016. FT-IR Microspectroscopy of Rat Ear Cartilage. PLoS One, 11, e0151989. 
VINARDELL, T., ROLFE, R. A., BUCKLEY, C. T., MEYER, E. G., AHEARNE, M., MURPHY, P. & KELLY, D. J. 2012. 
Hydrostatic pressure acts to stabilise a chondrogenic phenotype in porcine joint tissue derived stem 
cells. Eur Cell Mater, 23, 121-32; discussion 133-4. 
VOGEL, K. G., PAULSSON, M. & HEINEGARD, D. 1984. Specific inhibition of type I and type II collagen 
fibrillogenesis by the small proteoglycan of tendon. Biochem J, 223, 587-97. 
VOGEL, K. G., SANDY, J. D., POGANY, G. & ROBBINS, J. R. 1994. Aggrecan in bovine tendon. Matrix Biol, 14, 171-
9. 
VOGEL, V. & SHEETZ, M. P. 2009. Cell fate regulation by coupling mechanical cycles to biochemical signaling 
pathways. Curr Opin Cell Biol, 21, 38-46. 
VOLETI, P. B., BUCKLEY, M. R. & SOSLOWSKY, L. J. 2012. Tendon healing: repair and regeneration. Annu Rev 
Biomed Eng, 14, 47-71. 
VON DER MARK, K. 2006. Structure, biosynthesis and gene regulation of collagens in cartilage and bone. 
Dynamics of Bone and Cartilage Metabolism. Principles and Clinical Applications. Academic 
Press/Elsevier Burlington, MA. 
VON EISENHART, R., ADAM, C., STEINLECHNER, M., MULLER-GERBL, M. & ECKSTEIN, F. 1999. Quantitative 
determination of joint incongruity and pressure distribution during simulated gait and cartilage 
thickness in the human hip joint. J Orthop Res, 17, 532-9. 
WADA, H., OKUYAMA, M., SATOH, N. & ZHANG, S. 2006. Molecular evolution of fibrillar collagen in chordates, 
with implications for the evolution of vertebrate skeletons and chordate phylogeny. Evol Dev, 8, 370-
7. 
WAGNER, D. R., LINDSEY, D. P., LI, K. W., TUMMALA, P., CHANDRAN, S. E., SMITH, R. L., LONGAKER, M. T., 
CARTER, D. R. & BEAUPRE, G. S. 2008. Hydrostatic pressure enhances chondrogenic differentiation of 
human bone marrow stromal cells in osteochondrogenic medium. Ann Biomed Eng, 36, 813-20. 
WALCHLI, C., KOCH, M., CHIQUET, M., ODERMATT, B. F. & TRUEB, B. 1994. Tissue-specific expression of the 
fibril-associated collagens XII and XIV. J Cell Sci, 107 ( Pt 2), 669-81. 
WALDMAN, S. D., SPITERI, C. G., GRYNPAS, M. D., PILLIAR, R. M. & KANDEL, R. A. 2003. Long-term intermittent 
shear deformation improves the quality of cartilaginous tissue formed in vitro. J Orthop Res, 21, 590-
6. 
WALL, M. E., BERNACKI, S. H. & LOBOA, E. G. 2007. Effects of serial passaging on the adipogenic and osteogenic 
differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng, 13, 1291-8. 
WALTERS, B. D. & STEGEMANN, J. P. 2014. Strategies for directing the structure and function of three-





WANG, J. H., JIA, F., YANG, G., YANG, S., CAMPBELL, B. H., STONE, D. & WOO, S. L. 2003a. Cyclic mechanical 
stretching of human tendon fibroblasts increases the production of prostaglandin E2 and levels of 
cyclooxygenase expression: a novel in vitro model study. Connect Tissue Res, 44, 128-33. 
WANG, J. H. C. 2006. Mechanobiology of tendon. Journal of Biomechanics, 39, 1563-1582. 
WANG, M. & PENG, Z. 2015. Wear in human knees. Biosurface and Biotribology, 1, 98-112. 
WANG, N., TYTELL, J. D. & INGBER, D. E. 2009. Mechanotransduction at a distance: mechanically coupling the 
extracellular matrix with the nucleus. Nat Rev Mol Cell Biol, 10, 75-82. 
WANG, Q., HUANG, C., XUE, M. & ZHANG, X. 2011. Expression of endogenous BMP-2 in periosteal progenitor 
cells is essential for bone healing. Bone, 48, 524-32. 
WANG, W., LI, B., YANG, J., XIN, L., LI, Y., YIN, H., QI, Y., JIANG, Y., OUYANG, H. & GAO, C. 2010. The restoration 
of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. 
Biomaterials, 31, 8964-73. 
WANG, X., HARRIS, R. E., BAYSTON, L. J. & ASHE, H. L. 2008. Type IV collagens regulate BMP signalling in 
Drosophila. Nature, 455, 72-7. 
WANG, X., MANNER, P. A., HORNER, A., SHUM, L., TUAN, R. S. & NUCKOLLS, G. H. 2004. Regulation of MMP-13 
expression by RUNX2 and FGF2 in osteoarthritic cartilage. Osteoarthritis Cartilage, 12, 963-73. 
WANG, Y., UEMURA, T., DONG, J., KOJIMA, H., TANAKA, J. & TATEISHI, T. 2003b. Application of perfusion 
culture system improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblastic cells in 
porous ceramic materials. Tissue Eng, 9, 1205-14. 
WANG, Y. K. & CHEN, C. S. 2013. Cell adhesion and mechanical stimulation in the regulation of mesenchymal 
stem cell differentiation. J Cell Mol Med, 17, 823-32. 
WARD, D. F., JR., SALASZNYK, R. M., KLEES, R. F., BACKIEL, J., AGIUS, P., BENNETT, K., BOSKEY, A. & PLOPPER, G. 
E. 2007. Mechanical strain enhances extracellular matrix-induced gene focusing and promotes 
osteogenic differentiation of human mesenchymal stem cells through an extracellular-related kinase-
dependent pathway. Stem Cells Dev, 16, 467-80. 
WARDALE, R. J. & DUANCE, V. C. 1994. Characterisation of articular and growth plate cartilage collagens in 
porcine osteochondrosis. J Cell Sci, 107 ( Pt 1), 47-59. 
WASSEN, M. H., LAMMENS, J., TEKOPPELE, J. M., SAKKERS, R. J., LIU, Z., VERBOUT, A. J. & BANK, R. A. 2000. 
Collagen structure regulates fibril mineralization in osteogenesis as revealed by cross-link patterns in 
calcifying callus. J Bone Miner Res, 15, 1776-85. 
WATKINS, J. 2009. Pocket Podiatry: Functional Anatomy, Elsevier Health Sciences. 
WATT, S. L., LUNSTRUM, G. P., MCDONOUGH, A. M., KEENE, D. R., BURGESON, R. E. & MORRIS, N. P. 1992. 
Characterization of collagen types XII and XIV from fetal bovine cartilage. J Biol Chem, 267, 20093-9. 
WEBB, K., HITCHCOCK, R. W., SMEAL, R. M., LI, W., GRAY, S. D. & TRESCO, P. A. 2006. Cyclic strain increases 
fibroblast proliferation, matrix accumulation, and elastic modulus of fibroblast-seeded polyurethane 
constructs. J Biomech, 39, 1136-44. 
WEIDENHAMER, N. K. & TRANQUILLO, R. T. 2013. Influence of Cyclic Mechanical Stretch and Tissue Constraints 
on Cellular and Collagen Alignment in Fibroblast-Derived Cell Sheets. Tissue Engineering Part C-
Methods, 19, 386-395. 
WEISEL, J. W. & LITVINOV, R. I. 2013. Mechanisms of fibrin polymerization and clinical implications. Blood, 121, 
1712-9. 
WEN, L., CHEN, J., DUAN, L. & LI, S. 2018. Vitamin Kdependent proteins involved in bone and cardiovascular 
health (Review). Mol Med Rep, 18, 3-15. 
WENSTRUP, R. J., SMITH, S. M., FLORER, J. B., ZHANG, G., BEASON, D. P., SEEGMILLER, R. E., SOSLOWSKY, L. J. & 
BIRK, D. E. 2011. Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate 
interactions with collagens V and XI in developing tendon. J Biol Chem, 286, 20455-65. 
WEST, D. W., LEE-BARTHEL, A., MCINTYRE, T., SHAMIM, B., LEE, C. A. & BAAR, K. 2015. The exercise-induced 
biochemical milieu enhances collagen content and tensile strength of engineered ligaments. J Physiol, 
593, 4665-75. 
WHEDON, D. G. & HEANEY, R. P. 2019. Bone [Online]. Encyclopaedia Britannica: Encyclopaedia Britannica, inc. 
Available: https://www.britannica.com/science/bone-anatomy [Accessed July 14 2020]. 
WHITE, L. J., TAYLOR, A. J., FAULK, D. M., KEANE, T. J., SALDIN, L. T., REING, J. E., SWINEHART, I. T., TURNER, N. 
J., RATNER, B. D. & BADYLAK, S. F. 2017. The impact of detergents on the tissue decellularization 
process: A ToF-SIMS study. Acta Biomater, 50, 207-219. 
WIBERG, C., HEDBOM, E., KHAIRULLINA, A., LAMANDE, S. R., OLDBERG, A., TIMPL, R., MORGELIN, M. & 
HEINEGARD, D. 2001. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple 
helix. J Biol Chem, 276, 18947-52. 
WIBERG, C., HEINEGARD, D., WENGLEN, C., TIMPL, R. & MORGELIN, M. 2002. Biglycan organizes collagen VI into 
hexagonal-like networks resembling tissue structures. J Biol Chem, 277, 49120-6. 
WIBERG, C., KLATT, A. R., WAGENER, R., PAULSSON, M., BATEMAN, J. F., HEINEGARD, D. & MORGELIN, M. 2003. 
Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II 





WILKERSON, R. 2016. Patellar Tendon Tear [Online]. OrthoInfo.org. Available: 
https://orthoinfo.aaos.org/en/diseases--conditions/patellar-tendon-tear/ [Accessed 2021]. 
WILLIAMS, J. N., KAMBRATH, A. V., PATEL, R. B., KANG, K. S., MEVEL, E., LI, Y., CHENG, Y. H., PUCYLOWSKI, A. J., 
HASSERT, M. A., VOOR, M. J., KACENA, M. A., THOMPSON, W. R., WARDEN, S. J., BURR, D. B., ALLEN, 
M. R., ROBLING, A. G. & SANKAR, U. 2018. Inhibition of CaMKK2 Enhances Fracture Healing by 
Stimulating Indian Hedgehog Signaling and Accelerating Endochondral Ossification. J Bone Miner Res, 
33, 930-944. 
WILSON, D. G., PHAMLUONG, K., LI, L., SUN, M., CAO, T. C., LIU, P. S., MODRUSAN, Z., SANDOVAL, W. N., 
RANGELL, L., CARANO, R. A., PETERSON, A. S. & SOLLOWAY, M. J. 2011. Global defects in collagen 
secretion in a Mia3/TANGO1 knockout mouse. J Cell Biol, 193, 935-51. 
WONG, A. J., POLLARD, T. D. & HERMAN, I. M. 1983. Actin filament stress fibers in vascular endothelial cells in 
vivo. Science, 219, 867-9. 
WOODRUFF, M. A. & HUTMACHER, D. W. 2010. The return of a forgotten polymer—Polycaprolactone in the 
21st century. Progress in polymer science, 35, 1217-1256. 
WU, J. J., WEIS, M. A., KIM, L. S., CARTER, B. G. & EYRE, D. R. 2009. Differences in chain usage and cross-linking 
specificities of cartilage type V/XI collagen isoforms with age and tissue. J Biol Chem, 284, 5539-45. 
WU, S., WANG, Y., STREUBEL, P. N. & DUAN, B. 2017. Living nanofiber yarn-based woven biotextiles for tendon 
tissue engineering using cell tri-culture and mechanical stimulation. Acta Biomater, 62, 102-115. 
WUNDERLI, S. L., WIDMER, J., AMREIN, N., FOOLEN, J., SILVAN, U., LEUPIN, O. & SNEDEKER, J. G. 2018. Minimal 
mechanical load and tissue culture conditions preserve native cell phenotype and morphology in 
tendon-a novel ex vivo mouse explant model. J Orthop Res, 36, 1383-1390. 
WUTHIER, R. 1988. Mechanism of matrix vesicles-mediated mineralization of cartilage. ISI Atlas Sci Biochem, 1, 
231-241. 
XIONG, J., ONAL, M., JILKA, R. L., WEINSTEIN, R. S., MANOLAGAS, S. C. & O'BRIEN, C. A. 2011. Matrix-embedded 
cells control osteoclast formation. Nat Med, 17, 1235-41. 
XU, Y., DONG, S., ZHOU, Q., MO, X., SONG, L., HOU, T., WU, J., LI, S., LI, Y., LI, P., GAN, Y. & XU, J. 2014. The 
effect of mechanical stimulation on the maturation of TDSCs-poly(L-lactide-co-e-
caprolactone)/collagen scaffold constructs for tendon tissue engineering. Biomaterials, 35, 2760-72. 
XU, Y., WANG, Q., LI, Y., GAN, Y., LI, P., LI, S., ZHOU, Y. & ZHOU, Q. 2015. Cyclic Tensile Strain Induces Tenogenic 
Differentiation of Tendon-Derived Stem Cells in Bioreactor Culture. Biomed Res Int, 2015, 790804. 
XU, Y., WU, J., WANG, H., LI, H., DI, N., SONG, L., LI, S., LI, D., XIANG, Y., LIU, W., MO, X. & ZHOU, Q. 2013. 
Fabrication of electrospun poly(L-lactide-co-epsilon-caprolactone)/collagen nanoyarn network as a 
novel, three-dimensional, macroporous, aligned scaffold for tendon tissue engineering. Tissue Eng 
Part C Methods, 19, 925-36. 
XUE, L., LI, Y. & CHEN, J. 2017. Duration of simulated microgravity affects the differentiation of mesenchymal 
stem cells. Mol Med Rep, 15, 3011-3018. 
YAMAGUCHI, Y., MANN, D. M. & RUOSLAHTI, E. 1990. Negative regulation of transforming growth factor-beta 
by the proteoglycan decorin. Nature, 346, 281-4. 
YEATTS, A. B. & FISHER, J. P. 2011. Bone tissue engineering bioreactors: dynamic culture and the influence of 
shear stress. Bone, 48, 171-81. 
YEUNG, C. Y., ZEEF, L. A., LALLYETT, C., LU, Y., CANTY-LAIRD, E. G. & KADLER, K. E. 2015. Chick tendon fibroblast 
transcriptome and shape depend on whether the cell has made its own collagen matrix. Sci Rep, 5, 
13555. 
YLONEN, R., KYRONLAHTI, T., SUND, M., ILVES, M., LEHENKARI, P., TUUKKANEN, J. & PIHLAJANIEMI, T. 2005. 
Type XIII collagen strongly affects bone formation in transgenic mice. J Bone Miner Res, 20, 1381-93. 
YOUNG, B. B., GORDON, M. K. & BIRK, D. E. 2000. Expression of type XIV collagen in developing chicken 
tendons: association with assembly and growth of collagen fibrils. Dev Dyn, 217, 430-9. 
YOUNG, B. B., ZHANG, G., KOCH, M. & BIRK, D. E. 2002. The roles of types XII and XIV collagen in fibrillogenesis 
and matrix assembly in the developing cornea. J Cell Biochem, 87, 208-20. 
YOUNG, R. G., BUTLER, D. L., WEBER, W., CAPLAN, A. I., GORDON, S. L. & FINK, D. J. 1998. Use of mesenchymal 
stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res, 16, 406-13. 
YOUNGSTROM, D. W., LADOW, J. E. & BARRETT, J. G. 2016. Tenogenesis of bone marrow-, adipose-, and 
tendon-derived stem cells in a dynamic bioreactor. Connective Tissue Research, 57, 454-465. 
YOUNGSTROM, D. W., RAJPAR, I., KAPLAN, D. L. & BARRETT, J. G. 2015. A bioreactor system for in vitro tendon 
differentiation and tendon tissue engineering. J Orthop Res, 33, 911-8. 
YUAN, X., CAO, J., HE, X., SERRA, R., QU, J., CAO, X. & YANG, S. 2016. Ciliary IFT80 balances canonical versus 
non-canonical hedgehog signalling for osteoblast differentiation. Nat Commun, 7, 11024. 
YUGE, L., KAJIUME, T., TAHARA, H., KAWAHARA, Y., UMEDA, C., YOSHIMOTO, R., WU, S. L., YAMAOKA, K., 
ASASHIMA, M., KATAOKA, K. & IDE, T. 2006. Microgravity potentiates stem cell proliferation while 
sustaining the capability of differentiation. Stem Cells Dev, 15, 921-9. 
YUGE, L., SASAKI, A., KAWAHARA, Y., WU, S. L., MATSUMOTO, M., MANABE, T., KAJIUME, T., TAKEDA, M., 





the undifferentiated state and enhances the neural repair potential of bone marrow stromal cells. 
Stem Cells Dev, 20, 893-900. 
YUSOFF, N., ABU OSMAN, N. A. & PINGGUAN-MURPHY, B. 2011. Design and validation of a bi-axial loading 
bioreactor for mechanical stimulation of engineered cartilage. Med Eng Phys, 33, 782-8. 
ZEITER, S., LEZUO, P. & ITO, K. 2009. Effect of TGF beta1, BMP-2 and hydraulic pressure on chondrogenic 
differentiation of bovine bone marrow mesenchymal stromal cells. Biorheology, 46, 45-55. 
ZELENCHUK, L. V., HEDGE, A. M. & ROWE, P. S. 2015. Age dependent regulation of bone-mass and renal 
function by the MEPE ASARM-motif. Bone, 79, 131-42. 
ZELZER, E., GLOTZER, D. J., HARTMANN, C., THOMAS, D., FUKAI, N., SOKER, S. & OLSEN, B. R. 2001. Tissue 
specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev, 
106, 97-106. 
ZHANG, D., WEINBAUM, S. & COWIN, S. C. 1998. Estimates of the peak pressures in bone pore water. J Biomech 
Eng, 120, 697-703. 
ZHANG, G., EZURA, Y., CHERVONEVA, I., ROBINSON, P. S., BEASON, D. P., CARINE, E. T., SOSLOWSKY, L. J., IOZZO, 
R. V. & BIRK, D. E. 2006. Decorin regulates assembly of collagen fibrils and acquisition of 
biomechanical properties during tendon development. J Cell Biochem, 98, 1436-49. 
ZHANG, G., YOUNG, B. B. & BIRK, D. E. 2003. Differential expression of type XII collagen in developing chicken 
metatarsal tendons. J Anat, 202, 411-20. 
ZHANG, G., YOUNG, B. B., EZURA, Y., FAVATA, M., SOSLOWSKY, L. J., CHAKRAVARTI, S. & BIRK, D. E. 2005. 
Development of tendon structure and function: regulation of collagen fibrillogenesis. J Musculoskelet 
Neuronal Interact, 5, 5-21. 
ZHANG, J., HU, Q., WANG, S., TAO, J. & GOU, M. 2020. Digital Light Processing Based Three-dimensional Printing 
for Medical Applications. Int J Bioprint, 6, 242. 
ZHANG, J. & WANG, J. H. C. 2010. Mechanobiological response of tendon stem cells: implications of tendon 
homeostasis and pathogenesis of tendinopathy. Journal of orthopaedic research, 28, 639-643. 
ZHANG, L., TRAN, N., CHEN, H. Q., KAHN, C. J., MARCHAL, S., GROUBATCH, F. & WANG, X. 2008. Time-related 
changes in expression of collagen types I and III and of tenascin-C in rat bone mesenchymal stem cells 
under co-culture with ligament fibroblasts or uniaxial stretching. Cell Tissue Res, 332, 101-9. 
ZHANG, N., XIAO, Q.-R., MAN, X.-Y., LIU, H.-X., LÜ, L.-X. & HUANG, N.-P. 2016. Spontaneous osteogenic 
differentiation of mesenchymal stem cells on electrospun nanofibrous scaffolds. RSC advances, 6, 
22144-22152. 
ZHAO, B., TUMANENG, K. & GUAN, K. L. 2011a. The Hippo pathway in organ size control, tissue regeneration 
and stem cell self-renewal. Nat Cell Biol, 13, 877-83. 
ZHAO, Q., EBERSPAECHER, H., LEFEBVRE, V. & DE CROMBRUGGHE, B. 1997. Parallel expression of Sox9 and 
Col2a1 in cells undergoing chondrogenesis. Dev Dyn, 209, 377-86. 
ZHAO, T., WEINHOLD, P. S., LEE, N. Y. & DAHNERS, L. E. 2011b. Some observations on the subfibrillar structure 
of collagen fibrils as noted during treatment with NKISK and cathepsin G with mechanical agitation. J 
Electron Microsc (Tokyo), 60, 177-82. 
ZHENG, M. H., CHEN, J., KIRILAK, Y., WILLERS, C., XU, J. & WOOD, D. 2005. Porcine small intestine submucosa 
(SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human 
implantation. J Biomed Mater Res B Appl Biomater, 73, 61-7. 
ZHONG, W., TIAN, K., ZHENG, X., LI, L., ZHANG, W., WANG, S. & QIN, J. 2013. Mesenchymal stem cell and 
chondrocyte fates in a multishear microdevice are regulated by Yes-associated protein. Stem Cells 
Dev, 22, 2083-93. 
ZHU, J. & CLARK, R. A. F. 2014. Fibronectin at select sites binds multiple growth factors and enhances their 
activity: expansion of the collaborative ECM-GF paradigm. J Invest Dermatol, 134, 895-901. 
ZHU, J., ZHANG, X., WANG, C., PENG, X. & ZHANG, X. 2008. Different magnitudes of tensile strain induce human 
osteoblasts differentiation associated with the activation of ERK1/2 phosphorylation. Int J Mol Sci, 9, 
2322-32. 
ZUK, P. A., ZHU, M., ASHJIAN, P., DE UGARTE, D. A., HUANG, J. I., MIZUNO, H., ALFONSO, Z. C., FRASER, J. K., 
BENHAIM, P. & HEDRICK, M. H. 2002. Human adipose tissue is a source of multipotent stem cells. Mol 
Biol Cell, 13, 4279-95. 
ZUR NIEDEN, N. I., KEMPKA, G., RANCOURT, D. E. & AHR, H. J. 2005. Induction of chondro-, osteo- and 
adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on 
differentiating lineages. BMC Dev Biol, 5, 1. 
References 
  
287 
 
 
